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RÉSUMÉ 
Cette thèse par articles s'intéresse à la problématique de la distribution des aliments 
santé et aux intentions de comportement des consommateurs à leur égard. 
Depuis au moins deux décennies, 1' industrie des aliments santé au Canada est 
dynamique et en pleine évolution (Hobbs, 2002; Malla et al. , 2013). Elle connaît une 
croissance continue en terme des produits offerts sur Je marché, du nombre des 
entreprises actives, des revenus générés et des dépenses engagées en R-D (Cinnamon, 
2007; Khamphoune, 2013; Malla et al. , 2013; Palinic, 2005; Tebbens, 2002). 
Toutefois, à l 'instar d'autres secteurs, cette croissance s' accompagne par des défi s 
relatifs aux consommateurs, à l 'entreprise, au marché et à la réglementation (Malla et 
al., 2013). En effet, l' environnement est très volatile et incertain (Boehlje, Roucan-
Kane et Broring, 2011; Hobbs, 2002; Siedlok, Smart et Gupta, 2010) et les chaînes de 
valeur sont complexes et dynamiques (Broring, 2008; Hobbs, 2002; Sakaran, 2005; 
Sakaran et Mouly, 2007) et ce, en raison de la nature des fonctions à réaliser, de 
l'implication de diverses parties prenantes et de leurs interrelations (Hobbs, 2002; 
Sankaran 2005; Sakaran et Mouly, 2007). 
Par ailleurs, la littérature existante en management du marketing met beaucoup 
l'accent sur la compréhension du passé plutôt que de prendre en compte la 
complexité, l ' incertitude et la dynamique du présent et du futur (Gummesson, 
Kuusela et Narvanen, 2014). Le marketing stratégique se limite à l' analyse des 
données relatives au couple produit/marché et inclut peu d' informations contextuelles 
qui dépassent cette frontière (Logman, 2011). Par conséquent, la prise de décision 
stratégique en marketing est dépourvue d'une vision systémique et holistique soit 
d ' une compréhension de la dynamique du marché (Gummesson, Kuusela et 
Narvanen, 2014). 
Pour combler cet écart dans la littérature, cette thèse propose dans un premier temps 
de mener une étude prospective et exploratoire (article 1) en appliquant une méthode 
de recherche mixte intégrée: la cartographie des concepts en groupe (Kane et 
Trochim, 2007). Ainsi, l 'article 1 s' intéresse à l'amélioration de la distribution des 
aliments santé. L'étude a été menée auprès de diverses parties prenantes de l'industrie 
des aliments santé au Québec (fabricants d' ingrédients, fabricants et transformateurs, 
experts et chercheurs en développement de la technologie, en sciences de la 
consommation, en distribution et en marketing alimentaire, et représentants du 
gouvernement). La cartographie des concepts en groupe a permis d'identifier un 
cadre conceptuel émergent que les participants partagent sur les interventions 
spécifiques à entreprendre visant l'amélioration de la distribution des aliments santé. 
Ces interventions ont été regroupées en six (6) groupements, à savoir: (1) 
--- - - ----------------------------------------
XlV 
Information et communication avec les consommateurs , (2) Communication avec les 
professionnels de la santé et possibilités règlementaires, (3) Gestion de l'innovation 
contextualisée avec le marché, ( 4) Réseau tage et support institutionnel, (5) Gestion de 
la relation avec les détaillants, et (6) Stratégies marketing. 
En se basant sur ce cadre conceptuel émergent, l'objectif de l'article 2 est de 
comprendre les interactions entre les interventions spécifiques à entreprendre par les 
parties prenantes de l'industrie des aliments santé pour améliorer la distribution de 
ces produits. L'article 2 utilise une approche qualitative associée à la dynamique des 
systèmes (DS) en élaborant un diagramme d' influence (DI) qui met l'accent sur les 
forces dynamiques entre les six (6) groupements obtenus dans l'article 1 de cette 
thèse. Les données ont été recueillies à partir d' entrevues individuelles non 
structurées avec des experts en aliments santé et également à partir d'un groupe de 
discussion de 18 participants (fabricants d'ingrédients, fabricants/transformateurs, 
experts et chercheurs en développement de la technologie, en sciences de la 
consommation, en distribution et en marketing alimentaire, et représentants du 
gouvernement). 
Finalement, l'article 3 examine les effets de la traçabilité, des allégations santé et de 
la vérification des allégations santé sur les intentions de comportement des 
consommateurs (intention d'acheter, intention de recommander et intention de servir 
aux autres) à l'égard des aliments enrichis d'acides gras oméga-3. Le design 
expérimental consiste en une analyse de variance mixte de type inter et intra-sujets 
dans lequel la traçabilité et les allégations santé sont deux facteurs inter sujets, d' une 
part, et la vérification des allégations santé et les catégories de produits enrichis 
d'acides gras oméga-3 sont deux facteurs intra-sujets, d'autre part. Un questionnaire a 
été administré à un échantillon de 463 répondants à Montréal et à Ottawa. Les 
résultats montrent que la traçabilité et la vérification des allégations santé ont des 
effets significatifs sur les intentions des consommateurs d'acheter, de recommander et 
de servir aux autres des aliments d'acides gras-oméga-3. De plus , des effets 
d'interaction significatifs double et triple ont été trouvés pour l'intention de 
recommander et ce, entre les allégations santé et la vérification des allégations santé, 
d'une part, et entre la traçabilité, les allégations santé et la vérification des allégations 
santé, d'autre part. 
MOTS-CLÉS : Cartographie des concepts en groupe, aliments santé, distribution, 
planification stratégique, dynamique des systèmes (DS), diagramme de système 
inductif (inductive system diagram), analyse qualitative, diagramme d'influence (DI), 
traçabilité, allégations santé, vérification des allégations santé, intention d'acheter, 
intention de recommander, intention de servir, acides gras oméga-3 , analyse de 
variance mixte de type inter et intra-sujets. 
ABSTRACT 
This thesis is structured around three essays on health enhancing food distribution 
and consumers' behavioral intentions toward these food products. 
For two decades, the Canadian health enhancing food industry has been dynamic and 
evolving (Hobbs, 2002; Malla et al., 2013). It has been growing steadily in tenns of 
products offered in the market, number of active firms, revenues generated and 
incurred R&D expenses (Cinnamon, 2007; Khamphoune, 2013; Malla et al. , 2013; 
Palinic, 2005; Tebbens , 2002). However, like other sectors, this growth is 
accompanied by challenges related to consumers, firm, market and regulation (Malla 
et al., 2013). Indeed, the environment is very volatile and uncertain (Boehlje, Roucan-
Kane and Broring, 2011; Hobbs , 2002; Siedlok, Sm art and Gupta, 201 0) and value 
chains are complex and dynamic (Broring, 2008; Hobbs, 2002; Sakaran, 2005; 
Sakaran and Mouly, 2007) because of the nature of functions to be performed, the 
involvement of various stakeholders and their interrelationships (Hobbs, 2002; 
Sankaran 2005; Sakaran and Mouly, 2007). 
Furthermore, the existing literature in marketing management has heavily focused on 
understanding the past rather than taking into account complexity, uncertainty and 
dynamics of the present and the future (Gummesson, Kuusela and Narvanen, 2014). 
Strategie marketing is often limited to analyze information related to product/market 
couple and includes little contextual information that go beyond this boundary 
(Logman, 2011). Consequently, strategie deci sion making in marketing is without a 
systemic and holistic view and therefore without a dynamic understanding of the 
market (Gummesson, Kuusela and Narvanen, 2014). 
To address this gap, this thesis proposes, firstly, to conduct a prospective and 
exploratory study (Article 1) by using an integrated mixed-method namely: Concept 
mapping (Kane and Trochim, 2007). Article 1 focuses on improving health enhancing 
food distribution. The study was carried with the participation of health enhancing 
food industry stakeholders (ingredient -makers, food manufacturers/processors, 
experts and researchers in food technology development, in consumer sciences, in 
food distribution and in marketing, and government representatives) . Group concept 
mapping allowed identifying a conceptual framework that participants' share about 
initiatives to be undertaken for improving health enhancing food distribution. These 
initiatives were grouped by participants into six clusters, namely: Information and 
communication with consumers, (2) Communication with health professionals and 
regulatory options, (3) Market-oriented innovation management, (4) Networking and 
institutional support, (5) Retailers ' relationship management, and (6) Marketing 
strategies. 
XVI 
Based on the emergent conceptual framework of Article 1, Article 2 ai ms to 
understand the interactions between initiatives to be undertaken by individual 
stakeholders of health enhancing foods industry to improve their products' 
distribution. To do so, article 2 uses a qualitative approach of system dynamics (SD). 
The influence diagram (ID) emphasizes on the dynamic forces between the six 
clusters obtained in Article 1. Data were collected from both unstructured individual 
interviews with experts in health enhancing foods and from a group discussion with 
18 participants (ingredient-makers, food manufacturers/processors, experts and 
researchers in food technology development, in consumer sciences, in food 
distribution and marketing, and government representatives) . 
Finally, Article 3 investigates the effects of traceability, health claims and verification 
of health daims on consumers' behavioral intentions (intention to purchase, intention, 
to recommend and intention to serve) toward omega-3 fatty acids enriched foods. A 
mixed between-within-subjects analysis of variance was used with traceability and 
health daims as between-subjects factors and verification of health daims and food 
product categories enriched with omega-3 fatty acids as within-subjects factors . A 
questionnaire was administered to 463 subjects in Montreal and Ottawa. The results 
show that traceability and verification of health daims have significant effects on 
consumers' intention to purchase, to recommend and to serve to others foods enriched 
with omega-3 fatty acids. Moreover, significant two-way and three-way interactions 
were obtained for intention to recommend and that, between health claims, 
verification of health daims, at one hand, and between traceability, health daims and 
verification of health daims, on the other hand. 
KEY WORDS : Concept mapping, health enhancing foods , distribution, strategie 
planning, System dynamics (SD), inductive system diagram, qualitative analysis , 
influence diagram (ID), traceability, health daims, verification of health daims, 
intention to purchase, intention to recommend, intention to serve, omega-3 fatty 
acids, a mixed between-within subjects analysis of variance. 
INTRODUCTION 
a) Problématique générale de la thèse 
L' industrie des aliments santé 1au Canada a beaucoup évolué durant la dernière 
décennie (AAC2, 2014; Malla et al. , 2013). Le nombre des entreprises qui fabriquent 
des aliments fonctionnels3 et des produits de santé naturels (PSN)4 a plus que doublé 
entre les années 2002 et 2011. Ce nombre est passé de 294 à 750 entreprises dans 
cette même période (Khamphoune, 2013; Tebbens, 2002). La croissance du secteur 
des aliments santé au Canada est attribuable à un ensemble de facteurs tels que: 
l 'augmentation des coûts des soins de santé, le vieillissement de la population , la 
conscience des consommateurs du lien entre 1' alimentation, la santé et la maladie, les 
progrès scientifiques et technologiques et les changements dans la réglementation des 
aliments santé (Cinnamon, 2007; Hobbs, 2002). 
Selon Malla et al. (2013), cette croissance s'accompagne pour les entreprises de ce 
secteur par des enjeux qui se rapportent aux consommateurs, à l' entreprise, au marché 
1Un aliment santé est un «Produit alimentaire possédant une composition particulière (native ou 
induite) ou élaboré à partir d'une technologie particulière ayant pour but d 'améliorer la teneur en 
nutriments et/ou composés bioactifs de cet aliment comparativement à un produit conventionnel et 
procurant ainsi des bénéfices pour la santé démontrés scientifiquement.» (Cortuff et al., 20 1 1, p. l ). On 
retrouve dans cette catégorie les aliments fonctionnel s et les produits de santé naturels (PSN) (Cortuff 
et al. , 2011 ; Mali a et al. , 20 13). 
2 Agriculture et Agroalimentaire Canada 
3Un aliment fonctionnel est un aliment qui ressemble en apparence aux aliments conventionnels et il 
fait partie d ' une alimentation dite « normale». En plus des fonctions nutritionnelles de base, un 
aliment fonctionnel, procure des bienfaits physiologiques démontrés et (ou) réduit le ri sque de maladie 
chronique (AAC, 20 14). 
4Un produit de santé naturel (PSN) est un produit de source nature lle, vendu sous forme posologique, 
et conçu pour préserver ou promouvoir la santé, restaurer ou corriger la fo nction de santé humaine; ou 
diagnostiquer, traiter et prévenir la maladie (AAC, 20 14 ). 
2 
et à la réglementation. En effet, l'industrie des aliments santé au Canada présente 
quelques caractéristiques qui engendrent de nombreux défis pour les entreprises qui la 
composent (Hobbs, 2002; Hodgins, 2011). Premièrement, cette industrie se 
caractérise par des chaînes de valeurs complexes (Hobbs , 2002) dans lesquelles un 
réseau complexe d'acteurs s'impliquent (Basu, Thomas et Acharya, 2007) et 
collaborent ensemble (Brèiring et Cloutier, 2008; Hobbs, 2002) pour mener diverses 
fonctions liées à la recherche et développement, au transfert de la technologie , à la 
production et à la transformation, à 1' approbation du produit et à 1' élaboration des 
stratégies marketing (Herath et al. , 2008; Hobbs, 2002). Deuxièmement, les chaînes 
de valeurs dans l'industrie canadienne des aliments santé sont dynamiques et en 
perpétuelle évolution (Hobbs, 2002; Malla et al. , 2013) . En fait, ces chaînes de valeur 
sont de plus en plus orientées vers la demande et contrôlées par des détaillants 
consolidés ayant un pouvoir de plus en plus important (Hodgins, 2011; OSEC, 2011). 
Finalement, l'industrie des aliments santé au Canada opère dans un marché de 
consommateurs incertain et un environnement (scientifique-technologique, 
réglementaire, social et concurrentiel) très changeant (Hobbs , 2002; Malla et al. , 
2013; MAPAQ, 2007, 2009; Moorsel, Cranfield et Sparling, 2007) . 
Ces caractéristiques génèrent de la confusion chez les consommateurs , les décideurs 
politiques, les professionnels de la santé et les gestionnaires de marketing (Malla et 
al., 2013). Les entreprises de cette industrie font face à plusieurs problématiques qui 
concernent, par exemple, les ressources financières pour Je développement et la 
commercialisation des nouveaux produits, les problèmes liés aux droits de propriété 
intellectuelle, l'incertitude et la lenteur du processus d'approbation réglementaüe, Je 
maintien de la confiance du consommateur face à la prolifération des produits et des 
allégations santé, etc.(Malla et al., 2013). De plus , dans le cadre de la présente thèse 
des entretiens individuels non structurés, menés auprès d'experts qui viennent en aide 
3 
aux entreprises des aliments santé au Québec (Canada), révèlent que les gestionnaires 
de marketing dans ces entreprises doivent non seulement prendre des décisions dans 
des environnements (technologique et scientifique, réglementaire, économique, et 
soèial) incertains, tenir compte des besoins et des intérêts des consommateurs et des 
distributeurs , de même que des pratiques des concurrents, tout en œuvrant dans une 
industrie dynamique et complexe, mais doivent aussi veiller à ce que les décisions 
prises au niveau de l'aspect consommateur soient cohérentes à la fois avec la 
réglementation et les avancements scientifiques dans le domaine des aliments santé. 
Par ailleurs, au mveau de la littérature disponible en management du marketing, 
Ardley (2011) et McCole (2004) affirment que cette dernière n 'a pas réellement 
apporté aux gestionnaires un éclairage dans leurs prises de déci sions. En effet, le 
courant de pensée dominant en marketing met peu l'accent sur la gestion des relations 
complexes dans des réseaux où plusieurs parties prenantes interagissent et créent de 
la valeur (Gummesson, Kuusela et Narvanen , 2014). De plus, Logman (2007, 2008, 
2011) considère que le marketing stratégique est limité à l 'analyse de données liées 
au couple produit/marché et n'inclut pas d'informations contextuelles comme les 
processus marketing et les circuits de distribution qui dépassent cette frontière. Par 
conséquent, la prise de décision en marketing se fait sans une vision systémique et 
balistique qui tient compte de la complexité, de 1' incertitude et de la dynamique du 
marché (Gummesson, Kuusela et Narvanen, 2014) . Selon ces auteurs, un nouveau 
paradigme en théorie du marketing a récemment émergé. li met l'accent sur les 
parties prenantes, la complexité et la génération de la théorie et ainsi fournit une 
vision systémique et balistique sans pour autant négliger les détails (Gummesson, 
Kuusela et Narvanen, 2014). 
Au niveau méthodologique, Gummesson, Kuusela et Narvanen (2014) ajoutent que 
les méthodes utilisées en recherche marketing se basent sur des relations causales 
---~--
-- -----~---- ------ - ---------------------------------------, 
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unidirectionnelles entre quelques variables statiques, simples, déconnectées et 
historiques comme par exemple, la satisfaction du consommateur, la valeur de la 
marque, la publicité et son impact et l'efficience du canal de distribution (Hans sens 
Rust et Srivastava, 2009; Sheth et Sisodia, 2005; Srinivasan et Hanssens, 2009; 
Verhoef et Leeflang, 2009; Workman, Homburg et Gruner, 1998). En définitive, 
Trochim et Cabrera (2005) affirment que tandis que les fondements scientifique et 
philosophique de la complexité sont bien établis, il y a étonnamment très peu de 
méthod~s qui peuvent être utilisées par les gestionnaires pour appréhender la 
complexité de leurs systèmes organisationnels. 
En se basant sur ces limites théoriques et méthodologiques d' une part, et sur les 
besoins managériaux exprimés par les experts en aliments santé, interviewés dans le 
cadre de la présente recherche, d'autre part, cette thèse par articles s' intéresse à la 
problématique de la distribution et aux intentions de comportement des 
consommateurs à l'égard des aliments santé. 
Ainsi, dans le premier article intitulé «Development of a Conceptual Frmnework for 
lmproving Health Enhancing Food Distribution» ayant pour objet de recherche la 
distribution des aliments santé, l'objectif consiste à développer un cadre conceptuel 
partagé par diverses parties prenantes5 de l'industrie des aliments santé permettant 
d'identifier et de prioriser des interventions visant l 'amélioration de la distribution de 
ces produits. Pour cela, cet article présente une étude qui utilise la méthode de la 
cartographie des concepts en groupe (Concept mapping) (Kane et Trochim, 2007) qui 
permet de prendre en considération la complexité des marchés et de faire participer 
plusieurs parties prenantes (Trochim et Cabrera, 2005). Ainsi, cet article s' inspire du 
5 Fabricants d'ingrédients, fabricants et transformateurs, experts et chercheurs en développement de la 
technologie, en sciences de la consommation, en distribution et en marketing alimentaire, et 
représentants du gouvernement. 
~---------------------------------------- -- -
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nouveau paradigme en marketing qui met 1' accent sur la complexité, 1 'incertitude et 
les parties prenantes (Gummesson, Kuusela et Narvanen, 2014). 
Dans le deuxième article intitulé «lmproving the Distribution of Health Enhancing 
Foods: A Qualitative System Dynamics Approach», l'objet de recherche porte aussi , 
comme 1' article 1, sur la distribution des aliments santé. De même, comme le premier 
article, cet article se base sur le nouveau paradigme en marketing tel qu ' énoncé par 
Gummesson, Kuusela et Narvanen (2014) . En effet, l 'objectif de l'article 2 consiste à 
fournir une meilleure compréhension de la dynamique entre les interventions visant 
l'amélioration de la distribution des aliments santé identifiées dans le premier article. 
Pour cela, l'article 2 utilise l' approche qualitative de la dynamique des systèmes (DS) 
qui permet de comprendre la structure sous jacente aux systèmes complexes 
(Gharajedaghi, 2006; Homer, 1996; Luna-Reyes and Anderson 2003; Senge, 1990; 
Sterman, 2000, 2001 ). Ainsi, comme l'illustre la figure 0, les résultats de 1' article 1 
ont guidé la conduite de l'étude dans l'article 2. 
Finalement, le troisième article, intitulé «Effects of Traceability, Health Claùns and 
Verification of Health Claims on Consumers ' Behavioral Intentions Toward Foods 
Enriched with Omega-3 Fatty Acids» a pour objet de recherche les intentions de 
comportement des consommateurs face aux aliments santé. Selon Malla et al. (2013), 
la demande est un aspect très important à étudier étant donné que le succès de 
l'industrie des aliments santé en dépend largement. Contrairement aux deux premiers 
articles, l'article 3 porte s~ulement sur un ensemble d' interventions qui visent 
l'amélioration de la distribution des aliments santé, déjà identifiées dans l'article!. 
Cet ensemble d'interventions porte, par exemple, sur 1' allégation santé, l'étiquette du 
produit, les logos de certification ou d'homologation, etc. Ainsi, une partie des 
résultats de l'article 1 ont servi pour mener l'étude dans l'article 3 (Figure 0). Plus 
précisément, l'article 3 s'intéresse à étudier les effets de certains indices 
6 
d'information (information eues) comme la traçabilité, les allégations santé et la 
vérification des allégations santé sur les intentions de comportement des 
consommateurs. Comparativement aux deux premiers articles, cet article utilise plutôt 
une démarche déductive qui consiste à élaborer un design expérimental de type 
'between-within' pour tester les effets principaux et les effets d'interaction sur les 
variables dépendantes de cette étude (intentions de comportement : intentions 
d'acheter, intentions de recommander et intentions de servir aux autres). De plus, par 
rapport aux articles 1 et 2, 1' article 3 ne porte pas sur les aliments santé en général 
mais sur une catégorie spécifique d'aliments santé à savoir ceux enrichis d'acides gras 
ornéga-3. Le choix des aides gras oméga-3 , comme ingrédient fonctionnel , ajoutés 
aux produits alimentaires se justifie par plusieurs raisons. Premièrement, les acides 
gras oméga-3 jouissent d'une grande popularité commerciale (McManus, Merga et 
Newton, 2011). Ils sont ajoutés comme ingrédient fonctionnel dans plusieurs produits 
tels que le lait, les œufs, le pain, etc. (Garg et al., 2006). Deuxièmement, plusieurs 
études ont démontré les bénéfices santé des acides gras oméga-3 et ce, pour le 
développement de l'enfant, l'hypertension, les maladies cardiovasculaires, le cancer, 
la démence, 1' Alzheimer et la dépression (Riediger et al., 2009; Ruxton et Derbyshire, 
2009). Troisièmement, les allégations santé fonctionnelle (relatives à la santé du 
cœur), de réduction de risque et celles de prévention de maladies (relatives aux 
maladies coronariennes et le cancer) ne sont pas encore acceptées au Canada sur les 
étiquettes des aliments enrichis d'acides gras oméga-3 CACIA, 2014; Zou, 2011). 
Étant donné que la réglementation canadienne est en pleine évolution (Malla et al. , 
2013), il est possible qu'il pourra y avoir prochainement une nouvelle réglementation 
dans ce sens (Zou, 2011). Les résultats de cet article peuvent donc être utiles pour 
informer les responsables de la réglementation des allégations santé des aliments 
santé de la réaction des consommateurs à différents types d'allégation santé 
(fonctionnelle, réduction de risque de maladie et prévention de maladie) et les effets 
de leur vérification par différentes parties (agence gouvernementale et tierce 
organisation à but non lucratif). 
Article 1 
Développement cl 'un cadre conceptuel 
pmu l'amélioration de la clistribntion 
des aliments santé 
Article 2 
Amélimation cle la disttibution des 
aliments sante une approche 
qualitative de la dy1l3mique des 
systèmes 
Figure 0 Liens entre les articles de la thèse 
b) Sommaire des articles de la thèse 
Effets de la traçabilité. des allégations 
santé et de la vérification des 
allégations sm de sm les intentions de 
COJll]lOI1ement des COnSOIJUllatenrs a 
l'égard des aliments emichis en acides 
gras oméga-3 
7 
Le tableau 0 présente brièvement 1 'objectif, le type et 1' approche de recherche, 1' outil 
de collecte de données, les participants ainsi que la méthode d'analyse de données de 
chacun des trois articles de la thèse. Ces articles sont détaillés respectivement dans les 
chapitres II, III et IV de la présente thèse. 
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c) Plan de la thèse 
Comme mentionné précédemment, cette thèse est présentée en trois essais se 
rapportant à l'étude de la distribution des aliments santé et aux intentions de 
comportement des consommateurs à l'égard d' une catégorie spécifique d'aliments 
santé à savoir les aliments enrichis d'acides gras oméga-3. Bien que l'introduction, le 
chapitre I (contexte de la recherche: le secteur des aliments santé) et la conclusion de 
la thèse soient écrites en français, les trois articles et leurs préfaces (chapitres II, III et 
IV) ont été rédigés en anglais. 
Suite à l'introduction, le premier chapitre présente le contexte de la recherche à savoir 
le secteur des aliments santé au Canada en abordant la réglementation des aliments 
santé, la définition des aliments santé, les caractéristiques de la demande et de l'offre 
des aliments santé. Le but de ce chapitre consiste à mieux situer la problématique 
générale de la thèse dans son contexte de recherche. Le premier article de la thèse fait 
l'objet du chapitre II. Le deuxième article de la thèse est présenté dans le chapitre III. 
Quant au troisième article, il fait partie du chapitre IV. Finalement, la conclusion de 
la thèse discute les conclusions spécifiques des articles, leurs limites , les voies de 
recherches futures et les contributions de la recherche. 
d) Contributions de la thèse 
Les contributions de cette thèse se situent aux niveaux théorique, méthodologique 
managérial et également au niveau des politiques publiques dans le domaine des 
aliments santé. 
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Au niveau théorique cette thèse permet d'enrichir la littérature en marketing qui selon 
Gummesson, Kuusela et Narvanen (2014) tient peu compte de la complexité, de 
l ' incertitude et de la dynamique du marché et par conséquent, est dépourvue de vision 
systémique et holistique. En effet, l 'apport théorique de cette thèse se résume en trois 
contributions majeures: 
- Développer un cadre conceptuel partagé sur les interventions à entreprendre 
pour améliorer la distribution des aliments santé en faisant participer diverses 
parties prenantes de l'industrie de ces produits. 
- Élaborer un diagramme d ' influence permettant de comprendre l' interaction 
des interventions à entreprendre pour améliorer la di stribution des aliments 
santé en mettant en évidence l ' interdépendance et la complexité dynamique. 
- Investiguer les effets principaux et les effets d' interaction de certaines 
interventions visant l'amélioration de la distribution des aliments santé comme 
l'allégation santé, la traçabilité et la vérification des allégations santé sur les 
intentions de comportement des consommateurs à l'égard des aliments santé. 
Au niveau méthodologique, l 'apport de cette thèse réside dans l ' utili sation dans les 
articles 1 et 2 de méthodes de recherche qui permettent de saisir la complexité comme 
la cartographie des concepts en groupe (Trochim and Cabrera, 2005) et la dynamique 
des systèmes (Behara, 1995; Gharajedaghi , 2006; Homer, 1996; Luna-Reyes et 
Anderson 2003; Senge, 1990; Sterman, 2000, 2001). 
Au niveau managérial , les résultats de cette thèse fournissent un nombre important 
d'implications susceptibles d'aider les gestionnaires à: 
- Comprendre la complexité des enjeux liés à la distribution de leurs produits, 
- Identifier des interventions susceptibles d'améliorer la distribution de leurs 
produits tout en impliquant diverses parties prenantes, 
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- Comprendre les effets de certaines interventions visant 1' amélioration de la 
distribution des aliments santé sur les intentions de comportement des 
consommateurs. 
Finalement, pour les implications au niveau des politiques publiques, les résultats de 
cette thèse pourraient être utiles pour les responsables de la réglementation des 
aliments santé au Canada en les aidant à mieux comprendre les réactions des 
consommateurs face à des indices d'information qu'on pourrai t retrouver sur les 
étiquettes des produits santé tels que la traçabilité, les allégations santé et la 
vérification des allégations santé et à entreprendre des changements adéquats dans le 
système de réglementation des aliments santé au Canada. 
1.1 Introduction 
CHAPITRE 1 
CONTEXTE DE LA RECHERCHE: 
LE SECTEUR DES ALIMENTS SANTÉ 
Le but de ce chapitre est de présenter un survol du secteur des aliments santé au 
Canada. Tout d'abord, la réglementation du secteur des aliments santé au Canada est 
présentée à la section 1.2. Ensuite, la section 1.3 présente les définitions des termes 
aliments santé, aliment fonctionnels et produits de santé naturels (PSN). Puis , la 
section 1.4 dresse un portrait de l'industrie des aliments santé au Canada. La section 
1.5, quant à elle, décrit les caractéristiques de la demande pour ces produits . 
Finalement, ce chapitre conclut avec les principaux enjeux dans l'industrie des 
aliments santé au Canada. 
1.2 La réglementation des aliments santé au Canada 
Au Canada, les aliments fonctionnels et les produits de santé naturels sont 
rigoureusement réglementés par Santé Canada et l'Agence Canadienne d ' Inspection 
des Aliments (ACIA) (Khamphoune, 2013). Les aliments fonctionnels, définis 
comme des aliments ressemblant aux aliments conventionnels et procurant des 
bienfaits physiologiques démontrés et (ou) réduisant le risque de maladie chronique 
(AAC, 2014), sont régis par le Règlement sur les Aliments et Drogues (RAD). Les 
produits de santé naturels (PSN), étant des produits de source naturelle, vendus sous 
forme posologique et conçus pour préserver ou promouvoir la santé, restaurer ou 
corriger la fonction de santé humaine; ou diagnostiquer, traiter et prévenir la maladie 
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(AAC, 2014), sont assujettis au Règlement sur les Produits de Santé Naturels 
(RPSN). Par conséquent, les PSN sont plus strictement réglementés que les aliments 
fonctionnels (Malla, Hobbs et Sogah, 2013). 
Le rôle de Santé Canada consiste à élaborer des politiques, des règlements et des 
normes liés aux aspects de la santé, de la salubrité et de la nutrition des aliments régis 
par la loi et ses règlements. De plus, Santé Canada élabore également des documents 
de référence pour aider l'industrie à se conformer aux exigences réglementaires en 
matière d'allégation santé sur les étiquettes des produits alimentaires (AAC6, 20 12). 
Quant à l' ACIA, son rôle est de veiller à l ' application de la loi et des exigences 
connexes établies par Santé Canada en ce qui concerne la salubrité et la qualité 
nutritionnelle des aliments. L'ACIA tient à jour le Guide d'étiquetage et de publicité 
sur les aliments, un outil destiné à aider l'industrie, les consommateurs et les 
inspecteurs de l'ACIA à interpréter les politiques et les règlements sur les aliments 
(AAC, 2012) . 
En matière d 'étiquetage des aliments fonctionnels et des PSN, Santé Canada et 
l' ACIA répertorient les allégations santé7 en quatre grandes catégories: (a) les 
allégations santé générales , (b) les allégations fonctionnelles , ( c) les allégations de 
réduction du risque de maladies , et finalement (d) les allégations de prévention de 
maladie ou thérapeutiques (ACIA, 2014)8. 
6 Agriculture et agroalimentaire Canada. 
7 Une allégation santé « est un énoncé ou toute autre représentation figurant sur l'étiquette ou dans la 
publicité d'un produit, qui indique de façon explicite ou implicite le lien qui existe entre la 
consommation d'un aliment ou d'un ingrédient dans un aliment et la santé d'une personne » Disponible 
à: http ://www.inspection.gc.ca/francais/fssallabeti /gui de/ch8f.shtml#a8 4 
8 Les définitions de ces quatre types d ' allégation santé sont disponibles en li gne à: 
http://www. inspec ti on.gc.ca/aliments/etiq uetage/l -etiquetage-des-aliments-pour-l- industr ie/all egations-
san te/fTal 1392834838383/1392834887794 ?chap= 14 
----- ---- ------------------------------
14 
Les allégations santé générales « sont des énoncés généraux qui font la promotion de 
la santé par une saine alùnentation ou qui présentent des lignes directrices 
alimentaires» (ACIA, 2014). Ces allégations ne doivent pas faire référence à un effet 
sur la santé, à une maladie ou à un problème de santé particulier. À titre d'exemple 
d'allégation santé générales acceptables au Canada, on peut citer : « Dans le cadre 
d'un régùne alimentaire sain, cet alùnent peut aider à atteindre et à maintenir un 
poids santé parce qu'il fournit des portions contrôlées. » ou bien « Le guide 
alùnentaire canadien recommande de consommer au moins un légume vert foncé et 
un légume orangé chaque jour». 
Les allégations fonctionnelles sont généralement « des énoncés portant sur certains 
effets bénéfiques de la consommation d'un aliment ou d'un constituant alimentaire 
(c.-à-d., un nutriment ou une composante nutritionnelle) sur les fonctions nonnales 
ou les activités biologiques de l'organisme » (ACIA, 2014). Ainsi, les allégations 
fonctionnelles sont relatives au rôle que joue l'aliment ou le constituant alimentaire 
lorsqu'il est consommé en quantités correspondant à des habitudes alimentaires 
normales. Comme exemple d'une allégation fonctionnelle relative à un aliment, on 
peut citer «La consommation de thé vert aide à prévenir l'oxydation des lipides 
sanguins ». Pour l'allégation fonctionnelle relative à un nutriment ou une composante 
nutritionnelle, on cite par exemple : « La Vitanûne D joue un rôle dans la formation 
et le maintien de bons os et de saines dents» (ACIA, 2014). 
Les allégations fonctionnelles relatives à la consommation d'un aliment qu1 sont 
permises au Canada sont les suivantes (ACIA, 2014): 
- Son de blé grossier et la régularité/les fonctions intestinales 
- Thé vert et la capacité antioxydante dans le sang 
Psyllium et la régularité/les fonctions intestinales: 
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Quant aux allégations fonctionnelles, relatives à un nutriment, acceptables légalement 
au Canada, elles sont au nombre de vingt-trois (23)9(ACIA, 2014). À titre d'exemple, 
citons, la protéine et la formation de muscles forts , l'acide gras oméga-3 et le 
développement normal du cerveau, des nerfs et des yeux chez les enfants, la vitamine 
D et le maintien de bons os et de dents saines, etc. (ACIA, 2014). 
Par ailleurs, il est important de mentionner que les allégations fonctionnelles (quelles 
soient relatives à un aliment ou à un nutriment) ne doivent pas faire référence 
directement ou indirectement au traitement, l'atténuation ou à la prévention d'une 
maladie ou de ses symptômes, ni à la restauration des fonctions anormales de 
l ' organisme (ACIA, 2014). 
Les allégations de réduction de risque de maladie, quant à elles, « sont généralement 
des énoncés qui établissent un lien entre un aliment ou un constituant d'un alùnent et . 
la réduction du risque d 'être atteint d'une maladie (comme l'ostéoporose, le cancer, 
l'hypertension) liée au régime alimentaire, dans le contexte d'un régime alimentaire 
global» (ACIA, 2014). Neuf allégations de réduction du risque de maladies à l' égard 
des aliments sont autorisées au Canada pour les aliments fonctionnels et les PSN 
(Malla, Hobbs and Sogah, 2013). Ces allégations de réduction du risque de maladies 
sont les suivantes: 
1. Sodium, potassium et l'hypertension; 
2. Vitamine D, calcium et ostéoporose; 
3. Gras saturés, gras trans et les maladies du cœur; 
4. Fruits, légumes et cancer; 
5. Glucides fermentables et les caries dentaires; 
9 Ces allégations sont disponibles en ligne à: http://www.inspection.gc.ca/aliments/etiquetage/1-
etiq uetage-des-al i ments-pour - l-i nd us trie/al legations-
sante/fra/ l 392834838383/ l 392834887794 ?chap=8#s l 6c8 
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6. Stérols végétaux et diminution du taux de cholestérol sanguin; 
7. Produits d'avoine et diminution du taux de cholestérol sanguin; 
8. Orge et diminution du taux de cholestérol sanguin; 
9. Gras non saturés et diminution du taux de cholestérol sanguin . 
Les allégations de prévention de maladie, quant à elles, «sont des énoncées relatifs 
au traitement, à l'atténuation d'une maladie ou d'une condition liée à la santé, ou 
ayant trait au rétablissement, à la correction ou à la nwdification de fonctions 
corporelles chez l 'hwnain ». Présentement, aucune allégation thérapeutique n'a été 
autorisée sur les aliments au Canada (ACIA, 2014). 
li est à noter que les exigences réglementaires varient entre ces différents types 
d'allégation santé (Malla, Hobbs et Sogah, 2013) . Ainsi les allégations santé 
générales et les allégations fonctionnelles sont moins exigeantes en matière de 
réglementation et d'évidence scientifiques que les allégations de réduction de risque 
de maladie et les allégations de prévention de maladie. En effet, pour les fabricants 
d'aliments fonctionnels et de PSN, étant donné que les deux derniers types 
d'allégations santé établissent des liens entre un aliment ou un constituant alimentaire 
(allégation de réduction de maladie) et un aliment ou un constituant alimentaire et le 
traitement ou l'atténuation d'une maladie (allégation de prévention de maladie), elles 
requièrent une forte évidence scientifique incluant des essais cliniques et donc exigent 
un processus d'approbation réglementaire plus long (Malla, Hobbs et Sogah, 2013). 
L'environnement réglementaire des aliments santé au Canada a connu plusieurs 
changements au cours des dernières années (Blandon, Cranfield et Henson, 2007; 
Malla, Hobbs and Sogah, 2013). Le plus récent régime réglementaire a été mis en 
place en janvier 2004 pour les PSN portant le nom du RSPN (Santé Canada, 2012). 
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De plus, de nouvelles allégations fonctionnelles et de réduction de nsque des 
maladies ont été permises par Santé Canada en 2010 relativement aux produits 
d'avoine et aux stérols végétaux et la diminution du cholestérol sanguin (Mali a, 
Hobbs and Sogah, 2013). 
Par ailleurs, en comparaison à d'autres pays comme le Japon, les États-Unis et 
l'Union Européenne, le système de réglementation canadien pour les aliments santé 
est considéré restrictif (Malla, Hobbs and Sogah, 2013). À titre d'exemple , seulement 
neuf (9) allégations santé de type réduction du risque de maladie sont permises au 
Canada alors qu'aux États-Unis on en compte dix-sept (17). De plus, la majorité des 
allégations fonctionnelles au Canada sont permises aux États-Unis comme des 
allégations de réduction de risque de maladie. Ces dernières requièrent un processus 
d'approbation plus long et une évidence scientifique plus forte basée sur des essais 
cliniques (Malla, Hobbs et Sogah, 2013) . De surcroît, alors que les États-Unis 
permettent les allégations qui se basent sur des évidences crédibles mais non 
conclusives, comme par exemple les acides gras oméga-3 (les acides mnéga-3 
pourraient réduire le risque des nwladies du cœur. L 'évidence scientifïque est 
prometteuse mais non concluante) (FDA 10, 2009), au Canada, ces allégations ne sont 
pas encore permises légalement. 
1.3 Définitions 
1.3.1 Définition d'un aliment santé 
Un aliment santé est un «Produit alùnentaire possédant une composition particulière 
(native ou induite) ou élaboré à partir d 'une technologie particulière ayant pour but 
10 Federal Drug Administration. 
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d'améliorer la teneur en nutriments et/ou composés bioactifs de cet alùnent 
comparativement à un produit conventionnel et procurant ainsi des bénéfices pour la 
santé délnontrés scientifiquement. » (Cortuff et al., 2011 , p.1). De plus, au delà de sa 
valeur nutritive de base, un aliment santé apporte des bienfaits sur la santé pouvant 
ainsi justifier l'utilisation d' une allégation nutritionnelle, fonctionnelle ou de 
réduction de risque (Cortuff et al., 2011). Dans la catégorie des aliments santé on 
retrouve les aliments fonctionnels (AF), les nutraceutiques 11 et les produits de santé 
naturels (PSN) (Cortuff et al., 2011; Malla et al. , 2013). 
1.3.2 Définition d' un aliment fonctionnel 
Un aliment fonctionnel (AF) est un aliment qui ressemble en apparence aux aliments 
conventionnels et il fait partie d'une alimentation dite « normale ». Toutefois , en plus 
des fonctions nutritionnelles de base, un aliment fonctionnel , procure des bienfaits 
physiologiques démontrés et( ou) réduit le risque de maladie chronique (AAC, 2014). 
L'étendue de la catégorie des aliments fonctionnels est vaste. Comme le montre le 
tableau 1.1, les aliments fonctionnels incluent: (1) les aliments de base qui 
contiennent un niveau naturellement élevé d' un composant bioactif12, (2) les aliments 
transformés avec un composant ajouté, (3) les aliments transformés avec un 
composant éliminé et (4) les aliments améliorés par augmentation de la concentration 
d'un composant naturellement présent. Ceci se fait par une sélection traditionnelle, 
11 Il est à noter que depuis l'entrée en vigueur de la réglementation sur les produits de santé naturel s en 
2004, le terme nutraceutique a été remplacé par PSN (Cinnamon, 2007). 
12 Un composant bioactif, est un composé chimique naturel contenu dans un végétal , un animal ou une 
source marine ou qui est dérivé de ceux-ci et qui produit des avantages en matière de santé/bi en-être 
(ex. , acides gras oméga-3 dans le lin ou des huiles de poisson et bêta-glucanes dérivés de l'avoine et de 
l'orge). 
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une alimentation spéciale des animaux ou par le biais du génie génétique (AAC, 
2012) (Tableau 1.1). 
Tableau 1.1 Les catégories d 'aliments fonctionnels 
Catégories 
Aliments de base 
Aliments transformés avec un 
composant ajouté 
Aliments transformés avec un 
composant éliminé (aliments 
allégés) 
Aliments améliorés 
Exemples 
-Carottes (contient un niveau naturellement 
élevé de bêta-carotène, un antioxydant) 
- Aliments transformés : céréales de son 
d'avoine (contient un niveau naturellement 
élevé de bêta-glucane, une fibre soluble) 
-Jus de fruits enrichi de calcium 
-Lait enrichi en oméga-3 
- Yaourt contenant des probiotiques 
- Les craquelins et biscuits sans gras trans 
-Œufs contenant des acides gras oméga-3 
du lin 
- Fraises plus riches en antioxydants 
-Tomates à teneur élevée en lycopène (un 
caroténoïde antioxydant) 
- Son d'avoine à teneur élevée en bêta-
lucane 
Source: Adapté de AAC (2012) et Cortuff et al. (2011) 
1.3 .3 Définition d' un produit de santé naturel (PSN) 
Un produit de santé naturel (PSN) est un produit de source naturelle, vendu sous 
forme posologique, et conçu pour préserver ou promouvoir la santé, restaurer ou 
coniger la fonction de santé humaine; ou diagnostiquer, traiter et prévenir la maladie 
(AAC, 2014). En vertu du règlement sur les produits de santé naturel s, qui est entré 
en vigueur le 1er janvier 2004, Santé Canada classe dans les produits de santé naturels 
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(PSN) 13 : les vitamines et minéraux, les plantes médicinales, les remèdes 
homéopathiques, les remèdes traditionnels (ex.: médecine traditionnelle chinoise), les 
probiotiques et d'autres produits tels que les acides aminés et les acides gras 
essentiels. 
1.4 Industrie des aliments santé au Canada 
Le but de cette sous-section est de dresser un portrait de l'industrie des aliments santé 
au Canada. Premièrement, la structure de l' industrie des aliments santé au Canada est 
décrite. Ensuite, une vue d'ensemble des entreprises appartenant à cette industrie est 
présentée en y analysant les revenus , les exportations, l'effectif des employés, les 
dépenses consenties en R-D, les gammes des produits offerts ainsi que les canaux de 
distribution utilisés. Pour ce faire, les enquêtes sur les aliments santé menées par 
Statistique Canada en 2002, 2005 , 2007 et 2011 ont été consultées. L' enquête de 
2011 , étant la plus récente étude réalisée par Statistique Canada. Elle a été publiée en 
septembre 2013 (Kamphoune, 2013). 
En 2011, 750 entreprises se livraient à des activités liées aux aliments santé 
(Kkamphoune, 2013). Ce nombre a grandement évolué durant la dernière décennie. 
Selon Statistique Canada, il y avait 294 entreprises d' aliments santé en 2002 
(Tebbbens, 2002). En 2005 , il y avait 389 entreprises (Palinic, 2005). Pour ce qui est 
de 2007, le nombre d'entreprise d' aliments santé est passé à 689 entreprises 
(Cinnamon, 2007) (Tableau 1.2). 
13 Voir le site Internet de Santé Canada (2013): http://hc-sc.gc.ca/dhp-mps/prodnaturlindex-fra.php 
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Tableau 1.2 Évolution du secteur des aliments santé au Canada entre 2002 et 2011 
2002 2005 2007 2011 
Nombre d'entreprises 294 394 689 750 
Revenus (en milliers de $) 2 886 538 3 691 831 11 264 670 
Revenus à l'exportation en 545 013 731 631 1 690 206 
milliers de$) 
Employés 12 872 13 975 16 259 
Dépenses en R-D (en 74 554 147 955 238 094 
milliers de $) 
Gammes de produits 9715 22 062 32 266 
Source: Adapté de Statistique Canada (Khamphoune, 2013) 
Selon l'enquête de 2011 , les 750 entreprises d'aliments santé appartenaient à quatre 
sous-secteurs à savoir:(l ) les aliments fonctionnels 14 (AF);(2) les produits de santé 
naturels15 (PSN); (3) les aliments fonctionnels et les produits de santé naturels (AF et 
les PSN) et ( 4) les services seulement (Figure 1.1 ). Ainsi, parmi les 750 entreprises, 
plus de la moitié (n = 422, 56%) produisait ou développait des PSN. Près de 16% 
(n=117) exerçaient ces mêmes activités dans le domaine des aliments fonctionnels 
alors que 19% (n=144) étaient actives dans les deux sous-secteurs (AF et PSN à la 
fois). Par ailleurs, 66 entreprises (9%) offraient exclusivement des services dans l' un 
ou l' autre sous-secteur, comme le contrôle de la qualité, la recherche et le 
développement (R-D) ou la réglementation (Khamphoune, 2013). 
14Un aliment fonctionnel est un aliment qui ressemble en apparence aux aliments conventi onnels et i 1 
fait partie d' une alimentati on dite « normale )) . En plus des fonctions nutritionnelles de base, un 
aliment fonctionnel, procure des bienfaits phys iologiques démontrés et (ou) réduit le ri sque de maladie 
chronique (AAC , 201 4) . 
15Un produit de santé naturel (PSN) est un produit de source naturell e, vendu sous forme posologique, 
et conçu pour préserver ou promouvoir la santé , restaurer ou coiTiger la fo ncti on de santé humaine; ou 
diagnostiquer , traiter et prévenir la maladie (AAC, 20 14 ). 
144 
19% 
li sous-secteur 1- Aliments fonctionnels 
11111 sous-secteur 2- Produits de santé na turels 
til sous-secteur 3 - Actifs dans les deux domaine 
111!1 sous-sector 4 - Services seulement 
Figure 1.1 Nombre des entreprises par sous-secteurs. Source: Statistique Canada, 
Khamphoune (2013) 
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Cette répartition des entreprises d ' aliments santé a changé comparativement aux 
années 2002, 2005 et 2007 (Tableau 1.3). Tandis que la répartition des entreprises 
entre les sous secteurs des aliments fonctionnels , des PSN, des aliments fonctionnels 
et des PSN et des services est demeurée presque la même 16 entre 2002, 2005 et 2007, 
en 2011 elle a significativement changé. En effet, en 2011 , il y a moins d'entreprises 
actives dans les sous-secteurs aliments fonctionnels et aliments fonctionnel s et PSN 
mais plus d'entreprises actives dans le sous secteur des PSN et celui des services 
(Tableau 1.3). 
16 Excepté qu 'en 2011 il y a près de 7% de firmes actives dans le sous secteur des services (Cinnamon, 
2007). 
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Tableau 1.3 Répartition des firmes d'aliments santé au Canada entre 2002 et 2011 
Firmes AF Firmes PSN Firmes Firmes de 
actives dans service 
les deux sous 
secteurs AF et 
PSN 
2002 28% 46% 26% N.A 
2005 30.3% 44.7% 25% N.A 
2007 25.3% 42.1 o/o 25.7 % 6.9% 
2011 16% . 56% 19% 9% 
Source: Tebbens (2002), Palinic (2005); Cinnamon (2007) et Khamphoune (2013). 
Les revenus des entreprises d'aliments santé au Canada totalisaient en 2011 près de 
11,3 milliards de dollars (Tableau 1.2). Ces revenus ont connu un taux de croissance 
près de 75 % depuis 2005 (Malla et al. , 2013). En effet, en 2005 les revenus 
totalisaient seulement 2,9 milliards de dollars (Tableau 1.2) (Palinic, 2005). En 2011 , 
les entreprises actives dans le sous-secteur des aliments fonctionnels ont généré le 
plus de revenus ( 40%) soit près de 4,4 milliards de dollars . Celles œuvrant à la fois 
dans le domaine des aliments fonctionnels et des PSN ont généré près et de 3,3 
milliards de dollars (29% des revenus totaux) . Les entreprises spécialisées dans les 
PSN, ont également réalisé les mêmes revenus la même année. Les entreprises de 
services, quant à elles, ont r.éalisé près de 216 millions de dollars (2 o/o des revenus 
totaux) (Tableau 1.4 ). 
Les revenus provenant des exportations des aliments santé ont plus que triplé entre 
2005 et 2011. lis sont passés de 545 millions de dollars en 2005 à près de 732 
millions en 2007 et près de 1,7 milliards de dollars en 2011(Cinnamon, 2007; 
Khamphoune, 2013; Palinic, 2005) (Tableau 1.2). En 2011, ce sont les entreprises de 
PSN qui ont exporté le plus de produits (735 421 millions de dollars) , soit près du 
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double des exportations des entreprises d' aliments fonctionnels (Khamphoune, 20 13) 
(Tableau 1.4). Les destinations d'exportation varient selon les sous-secteurs. Pour les 
entreprises d'aliments fonctionnels, les États-Unis constituaient le principal marché, 
alors que pour les entreprises de PSN les exportations sont plus diversifiées 
(l'Europe, la Chine, le Japon et autres pays) (Khamphoune, 2013) . 
Tableau 1.4 Aperçu du secteur des aliments santé au Canada en 2011 
Firmes 
Firmes Firmes actives Firmes 
AF PSN dans les de services Total deux sous seulement 
sectem·s 
Nombre 4713 6185 4718 643 16 259 
d' 1 / 17 em oyes 
milliers de $ 
Revenus 18 4 453 928 3 281 776 3313073 215 893 11 264 670 
E . 19 xportatwns 269 062 735 421 685 723 1 690 206 
Dépenses en 18 345 98 130 107 563 14 056 238 094 
R-D2o 
Gammes de 3444 19 818 9004 32 266 
2roduits vendus 
Source : Adapté de Statistique Canada (Kamphoune, 2013) 
Concernant le nombre d'employés, les entreprises du secteur des aliments santé au 
Canada avaient en 201 1 un effectif de 16 259 personnes ayant des fonctions liées aux 
aliments santé. Ce nombre représente 44% du nombre total des employés de ces 
17 Ayant des fonctio ns li ées aux AF et aux PSN. 
18Tirés d'activités liées aux aliments santé. 
19 Provenant d 'aliments santé seulement. 
2° Consacrées à des activités liées aux aliments santé. 
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entreprises (37 253 employés) (Kamphoune, 2013). Par ailleurs, comme l'illustrait le 
Tableau 1.2, l'effectif des employés a nettement augmenté entre 2005, 2007 et 2011. 
En 2011, les entreprises de PSN ont le plus d'employés (6185). Les entreprises 
actives dans les deux domaines aliments fonctionnels seulement et aliments 
fonctionnels et PSN viennent en deuxième rang avec 4718 employés suivies des 
entreprises spécialisées en aliments fonctionnels (4713 employés) et des entreprises 
de services seulement (643 employés) (Tableau 1.4). 
Les dépenses en R-D sont importantes et servent à assurer le succès des entreprises 
du secteur des aliments santé (Malla et al. , 2013). Au Canada, ces dépenses ont plus 
que triplé entre 2005 et 2011. Alors qu'elles totalisaient 74 millions en 2005 , elles se 
chiffraient à près de 148 millions et à près de 238 millions respectivement en 2007 et 
2011(Tableau 1.2). En 2011, les entreprises actives dans les deux domaines ont 
dépensé le plus en R-D (environ 108millions de dollars) suivies des entreprises 
spécialisées en PSN (98 millions de dollars). Les entreprises d' aliments fonctionnels 
et celles de services ont dépensé en R-D près de 18 et 14 millions de dollars , 
respectivement (Khamphoune, 2013) (Tableau 1.4). 
Par ailleurs, les entreprises des aliments santé forment des alliances avec d'autres 
firmes principalement pour mener des fonctions liées à la R-D, la production, le 
marketing et l'accès aux canaux de distribution (Malla et al., 2013). En effet étant 
donné la complexité et le caractère évolutif des chaînes de valeur des entreprises 
canadiennes de ce secteur (Hobbs, 2002), ces dernières se voient dans J'obligation de 
se former en réseau complexe avec divers acteurs de 1 'industrie alimentaire et 
pharmaceutique, les centres et laboratoires de recherche, les universités (aussi bien au 
Canada qu 'à 1' extérieur), les détaillants, les professionnels de la santé, les 
compagnies d ' assurances, etc. (Basu, Thomas et Acharya, 2007; Khamphoune, 2013). 
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Pour ce qui est des gammes de produits, les résultats des enquêtes de Statistique 
Canada menées en 2005, 2007 et 2011 ont révélé que les gammes de produits offertes 
sur le marché par les entreprises du secteur des aliments santé a connu une croissance 
importante (Cinnamon, 2007; Khamphoune, 2013; Palinic, 2005) (Tableau 1.2). En 
2005, les entreprises d'aliments santé offraient 9715 gammes de produits. En 2007 , 
ce nombre a continué d'augmenter en passant à 22 062 gammes de produits . En 2011, 
le total des gammes de produits offertes s'élevait à 32 266. Dans cette même année, 
les entreprises de PSN ont offert le plus de produits avec 19 818 gammes, ce qui 
représente 61 % du nombre de gammes de toutes les entreprises du secteur. Les 
entreprises actives dans les deux domaines (aliments fonctionnel s et PSN) ont offert 
9004 gammes de produits (soit 28% du total des gammes de produits de toutes les 
entreprises) alors que les entreprises d'aliments fonctionnels seulement ont offerts 
3444 gammes de produits sur le marché, soit 11 % du total de gammes de produits 
offertes par l'ensemble des entreprises dans le secteur (Khamphoune, 2013) (Tableau 
1.4 ). Ces gammes de produits touchent principalement la santé et le bien être en 
général et la réduction du risque de maladies cardiovasculaires, de cancer, de diabète 
et d'arthrite (Kbamphoune 2013). 
Finalement, les canaux de distribution utilisés par les entreprises du secteur des 
aliments santé ont changé entre 2002 et 2011. En 2002 et 2005, les grossistes 
constituaient le canal de distribution le plus souvent utilisé par les entreprises du 
secteur (Tebbens, 2002; Palinic, 2005). En 2007 et 2011 , la vente directe aux 
détaillants (magasin d'aliments naturels , épicerie, pharmacie) constitue le canal de 
distribution le plus utilisé par les entreprises des aliments santé (Cinnamon, 2007; 
Khamphoune 2013). Pour l'enquête de 2011, les résultats montraient que 46,8% des 
ventes des entreprises du secteur des aliments santé provenaient des détaillants, 
suivies de la marque maison (24,5 %) et des autres fabricants (10,5%) (Tableau 1.5). 
Ainsi, pour les entreprises d'aliments fonctionnels (AF) et celles fabriquant à la fois 
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des aliments fonctionnels et des PSN, les ventes ont été le plus réalisées par 
l'intermédiaire des grandes chaînes. Ceux-ci représentaient respectivement 55,3% et 
34% de leurs ventes (Tableau 1.5). Pour les entreprises de PSN, les ventes ont été 
réalisées en ayant recours à divers détaillants comme les magasins d'aliments 
naturels, les épiceries et les pharmacies avec une proportion des ventes plus élevée 
pour les magasins d'aliments naturels (14,6%) (Tableau 1.5). Étant donné qu'au 
Canada le marché d'épicerie de détail est concentré et verticalement intégré en amont 
(fonction de gros) (Malla et al., 2013; OSEC21, 2011), il est peu surprenant que les 
détaillants constituent pour les aliments santé le canal de distribution le plus 
important (Malla et al., 2013). 
210SEC (2011). The Canadian Food Retail Sector. Opportunities for Swi ss companies. Available 
on li ne at: http:// www.s-ge.com/en/fi lefield-private/fi les/2344/field blog publ ic fil es/] 272 
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Tableau 1.5 Proportion des ventes d' aliments santé selon les modes de distribution et 
le sous-secteur 
Entreprises Entreprises Entreprises Entreprises Total 
AF PSN actives dans de services 
les deux sous seulement 
secteurs 
en pourcentage% 
Tous revenus 100 100 100 100 100 
V ente directe 0,1 13 1,1 0 3,3 
Détaillants 55,8 31,3 46,7 0 46,8 
-Magasin 
d ' aliments 0,4 14,6 6,1 0 5,5 
naturels 
-Autre magasin 55 ,3 6,7 34 0 36,8 
au détail 22 
-Pharmacie 0,1 10 6,6 0 4,5 
Grossiste 2,6 11 15,1 34,2 9 
Margue maison 18 6,5 29,1 24,5 
Autres 28,9 7,6 29,5 36 7E 10,5 
' fabricants 
Autre 12,6 19 1,1 0 10 
Source : Adapté de Statistique Canada, Khamphoune (2013) 
1.5 La demande pour les aliments santé au Canada 
Plusieurs études canadiennes ont conclu que les consommateurs ont une attitude 
positive à l 'égard des aliments santé et qu ' ils sont prêts à payer une prime sur le prix 
de base pour se procurer ces produits (Ipsos Reid, 2012; Peng, West et Wang, 2006; 
West et al. , 2002; West et Larue, 2004). Cette attitude est déterminée, par exemple, 
par les croyances des consommateurs du lien qui existe entre la diète et la santé, les 
bénéfices santé liés à la consommation de ces produits (Ipsos Reid, 2005; Henson, 
Cranfield et Herath, 2010; Labrecque et al, 2006; West et Larue, 2004; West et al., 
22 Exemple: épiceries, gros détaillants, etc. (Khamphoune, 20 13). 
E À utili ser avec prudence (Khamphoune, 2013). 
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2002), les propriétés fonctionnelles de ces produits (Henson, Cranfield et Herath, 
2010) et les allégations santé inscrites sur les aliments santé et leur crédibilité (Hailu 
et al, 2009; Henson, Cranfield et Herath, 2010; Labrecque et al, 2006; West et Larue, 
2004). 
Pour ce qui est des croyances des consommateurs de la corrélation entre leurs régimes 
alimentaires et la maladie, une étude pan canadienne réalisée par Ipsos Reid, en 2012, 
montre que les Canadiens ont un niveau élevé de conscience et de connaissance des 
aliments fonctionnels et des maladies (CQVB, 2013)23 . En effet, 68 % des Canadiens 
sont en mesure de faire le lien entre un aliment et la prévention de risque de maladie 
qui lui est associée. Ceci a entraîné une grande consommation d'aliments 
fonctionnels et de PSN. Ainsi, une très large proportion des Canadiens (96%) 
achètent des aliments fonctionnels et 81% ont déclaré avoir consommé un PSN. Pour 
les aliments fonctionnels, les céréales à haute teneur en fibres ou à base de grains 
entiers, les collations santé et les yaourts avec probiotiques sont les aliments les plus 
consommés. Pour les PSN, les vitamines et les minéraux, les acides gras oméga-3 et 
les probiotiques représentent les PSN les plus recherchés. De plus , selon la même 
enquête, 94 % des Canadiens qui ont acheté des aliments fonctionnels 1' ont fait dans 
une épicerie et 61% l'ont fait chez les détaillants de masse comme Walmart et 
Costco. Les pharmacies (35%), les magasins d'aliments naturels (33 %) et les 
épiceries biologiques (23%) sont aussi pour les consommateurs d' autres lieux 
d'achats d'aliments fonctionnels. Pour ce qui est des PSN, 60% des répondants les 
achètent en pharmacie et 50% en épicerie. 
Concernant les allégations santé et leur crédibilité, les consommateurs sont septiques 
et manquent de confiance (Hobbs, 2002; Zou and Hobbs, 2006) . Selon l'étude 
d'Ipsos Reid (2012), les consommateurs sollicitent le plus souvent des sources 
23 Centre Québécois de Valorisation des Biotechnologies. 
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d'information comme les professionnels de la santé, les sites Internet, les magazines 
et les journaux , les amis et membres de la famille et les émissions télévisées (CQVB , 
2013). 
Par ailleurs, plusieurs études considèrent que les allégations santé et leur crédibilité 
constituent un déterminant très important dans l' acceptation des aliments santé par les 
consommateurs canadiens (Hailu et al , 2009; Henson, Cranfield et Herath , 2010; 
Ipsos Reid, 2012; Labrecque et al., 2006; West et Larue, 2004) et donc au succès de 
l' industrie (Malla et al , 2013). Ainsi, en plus d' un processus d' approbation 
réglementaire stricte, une communication basée sur des sources d' info rmation fiables 
et crédibles comme le gouvernement et les experts en soin de la santé s'avère 
également primordiale (Hailu et al , 2009; Malla et al. , 2013). 
En gmse de conclusion, il ressort suite à la description de la réglementation des 
aliments santé au Canada, des. caractéristiques de la demande et de l' offre au Canada, 
que les entreprises d' aliments santé opèrent dans une industrie en pleine évolution, 
dynamique et complexe. Elles opèrent également dans un marché incertain et un 
environnement (réglementaire, technologique et scientifique) très changeant. Ceci 
pose pour les entreprises des défis au niveau de 1' élaboration d ' une stratégie 
m(:lrketing efficace permettant la mise en œuvre d'actions visant un meilleur accès au 
marché des consommateurs (Cloutier et El Ourabi, 2014). Ainsi, cette thèse 
s'intéresse à la problématique de la distribution des aliments santé et aux intentions 
de comportement des consommateurs à leur égard . 
CHAPITRE II 
ARTICLE 1 
DEVELOPMENT OF A CONCEPTUAL FRAMEWORK FOR IMPROVING 
HEALTH ENHANCING FOOD DISTRIBUTION 
FOREWORD 
The purpose of the first article of this thesis is to develop a shared conceptual 
framework that identifies and prioritizes initiatives aimed at improving the 
distribution of health enhancing foods by involving various industry stakeholders 
such as ingredient-makers, food manufacturers/processors, experts and researchers in 
food technology development, in consumer sciences, in food distribution and 
marketing, and government representatives. To do so , this study uses an innovative 
structured conceptualization technique named Concept mapping (Kane and Trochim, 
2007), developed by Trochim (1987). This approach is very useful in exploratory 
studies, bec a use it can bring ri gor to exploratory research' s process. 
Concept mapping is a generic term that describes any process for structuring and 
illustrating ideas into graphical representations (Kane and Trochim, 2007) . Actually, 
other forms of concept mapping exist such as cognitive m.apping or nûnd mapping 
(Kolb and Shephred, 1997). In order to avoid confusion, it is important to highlight 
the difference between concept mapping developed by Trochim ( 1987), th at this 
study applies , and cognitive mapping or mind mapping. According to Kolb and 
Shephred (1997), the main difference lies on how the maps are constructed and 
interpreted. While, cognitive mapping or mind mapping is a technique where data is 
structured and analyzed without using statistical methods to construct maps, 
Trochim' s concept mapping is an integrated method where the data are structured, 
analyzed and quantified using both qualitative and quantitative techniques (Kolb and 
Shephred, 1997). Concept mapping combines group discussion technique and 
multivariate statistical techniques, namely multidimensional scaling (MDS) and 
agglomerative Hierarchical Cluster Analysis (HCA). According to Jackson and 
Trochim (2002), the combination of these multivariate statistical techniques is the 
main strength that concept mapping offers to validity. In fact , instead of forcing 
respondents with prior categories or semantic scales, sorting concepts allows 
generating a web of concept interrelationships about a particular issue that represents 
sorters' social reality (Trochim, 1989; Jackson and Trochim, 2002; Kane and 
Trochim, 2007; Miller, Rosas and Hall, 2011). Moreover, by using diverse sorters to 
create their own categories, this helps to ensure that the categories are exhaustive 
(Jackson and Trochim, 2002). 
Concept mapping has been applied to address substantive issues in the social 
services, mental health, health care, educational administration, and theory 
development (Trochim, 1993). However, it was little used in marketing (Bigné et al., 
2002). In marketing, concept mapping was applied to study sorne issues in few areas 
---~----
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such as travel (Bigné et al., 2002); e-commerce (Su et al., 2008) and health care 
marketing (Hall, 2008; Shewchuk and O'Connor, 2002). In Bigné et al., (2002) , 
concept mapping was used to identify the determinants of consumer loyalty in the 
travel agencies sector. According to these authors, concept mapping has benefits in 
marketing because it uses group discussion , structures results in an objective form 
and represents ideas in a perceptual map. For Su et al. (2008), concept mapping was 
applied to conceptualize consumers' perceptions of e-commerce quahty. Regarding 
Shewchuk and O'Connor (2002), concept mapping was employed as a framework to 
provide suggestions for elderly health care marketing and planning (Shewchuk and 
O'Connor, 2002). Finally, Hall (2008)24 used concept mapping for planning 
persuasive messages in non-profit health care services. 
24 In Hall 's study concept mapping was used in conjunction with Direct Magnitude Estimation. 
ABSTRACT 
Major societal, economie and technological changes have occurred in recent years in 
the global food industry (Bigliardi and Galati, 2013; Boehlje, Roucan-Kane and 
Broring, 2011) and have caused critical challenges for firms related to innovation, 
structural change and uncertainty (Boehlje, Roucan-Kane and Broring, 2011; Hobbs, 
2002). These challenges limit managers to establish managerial initiatives to best 
reach consumers' markets (Cloutier and El Ourabi , 2014) . 
Furthermore, sorne authors such as Ardley (2011) and McCole (2004) have argued 
that there is a gap between the marketing management literature and the practitioner 
community because theory fails to provide adequate insights for managers in their 
decision making process. In fact , conventional research methods in marketing such as 
surveys and focus groups are not well suited to address complexity, uncertainty and 
dynamics of the market (Gummesson , Kuusela and Narvanen, 2014). 
This exploratory prospective study contributes to knowledge by developing a 
conceptual framework that identifies and prioritizes initiatives aimed at improving the 
distribution of health enhancing foods while involving various industry stakeholders 
such as ingredient-makers, food manufacturers/processors , experts and researchers in 
food technology development, in consumer sciences, in food di stribution and in 
marketing, and government representatives. This article uses an integrated mixed-
method, namely concept-mapping (Kane and Trochim, 2007). The results of this 
study show that the improvement of health enhancing food distribution goes beyond 
product/market boundaries and include more contextual initiatives. Finally, results of 
this study can help marketing managers understanding issues related to the 
distribution of their products and assist them in identifying potential useful actions for 
strategie planning. 
KEY WORDS: Concept mapping, health enhancing foods, distribution, Issues, 
initiatives, strategie planning. 
RÉSUMÉ 
Des changements sociétaux, économiques et technologiques majeurs ont eu lieu ces 
dernières années à l'échelle mondiale dans l'industrie alimentaire (Bigliardi et Galati , 
2013; Boehlje, Roucan-Kane et Broring, 2011). Ces changements ont engendré pour 
les entreprises alimentaires des défis marketing liés à 1' innovation, au changement 
structurel et à l'incertitude (Boehlje, Roucan-Kane and Broring, 2011). Pour les 
gestionnaires, ces défis brouillent la mise en place d'initiatives marketing permettant 
un meilleur accès au marché des consommateurs (Cloutier et El Ourabi, 2014). 
Par ailleurs, selon certains auteurs (Ardley, 2011; McCole, 2004) il existe un écart 
entre la littérature en management du marketing et la communauté des praticiens 
parce que la théorie a échoué à soutenir les gestionnaires dans leur processus de prise 
de décision. En effet, les méthodes conventionnelles utilisées en recherche marketing 
telles que les questionnaires et les groupes de di scussion en eux-mêmes ne sont pas 
appropriés pour aborder la complexité, l ' incertitude et la dynamique du marché 
(Gummesson, Kuusela et Narvanen, 2014). 
Cette étude exploratoire prospective contribue à l'avancement des connaissances en 
développant un cadre conceptuel qui identifie et priOI-ise des interventions spécifiques 
à entreprendre visant l'amélioration de la distribution des aliments santé tout en 
impliquant diverses parties prenantes de l'industrie des aliments santé telles que les 
fabricants d'ingrédients, les fabricants et les transformateurs , les experts et les 
chercheurs en développement de la technologie, en sciences de la consommation, en 
distribution et en marketing alimentaire, et les représentants du gouvernement. Cet 
article utilise une méthode mixte intégrée appelée cartographie des concepts en 
groupe (Kane et Trochim, 2007). Au plan théorique, les résultats de cette étude 
montrent que l'amélioration de la distribution des aliments santé dépasse les 
frontières produit/marché et inclut plus de variables contextuelles. Au plan pratique, 
les résultats de cette recherche pourraient aider les gestionnaires de marketing à 
comprendre les défis reliés à la distribution de leurs produits et les soutenir dans 
l ' identification d'actions utiles à la planification stratégique. 
MOTS-CLÉS : Cartographie des concepts en groupe, aliments santé, distribution, 
défis, interventions, planification stratégique 
2.1 Introduction 
Several factors have fuelled the increasing popularity of health enhancing foods 25 
such as the increase in public health consciousness , the aging population, the 
escalation of health care costs, recent advances in research , technology and science-
based evidence, the changes in regulations and the growing interest among consumers 
for the link between health and wellness (Belem, 1999; Roberfroid , 2000a, 2000b ). 
Over the past two decades, diverse food, pharmaceutical and retail companies alike 
have entered this lucrative market with the aim to gain higher returns and generate a 
competitive advantage (Herath et al. , 2008; Kleef et al. , 2002; Lagorce, 2009) . 
However, major societal, economie and technological changes have occurred in the 
global food industry (Bigliardi and Galati, 2013; Boehlje, Roucan-Kane and Broring, 
2011) and have caused critical challenges for firms (Boehlje, Roucan-Kane and 
Broring, 2011) throughout the entire value chain (Bigliardi and Galati , 2013). These 
challenges revolve around uncertainty, innovation and structural change (Boehlje, 
Roucan-Kane and Broring, 2011; Hobbs, 2002). First, managers make decisions in an 
environment with increasing uncertainty. Second, it is crucial to develop and adopt 
technology and innovation to ensure long-term financial success. Third, it is essential 
to respond to changes in industry structure, the competition landscape and industry 
boundaries to maintain a market position (Boehlje, Roucan-Kane and Broring, 2011). 
These challenges blur the establishment of managerial initi<itives about how to best 
reach consumers' markets for firms seeking to commercialize health enhancing foods 
(Cloutier and El Ourabi, 2014). 
25 Health enhancing food is defined as being a food that-beyond its basic nutritional value- provides 
demonstrated health benefits that can justify the use of nutritional , functional or risk reduction 
allegation (Corcuff et al. , 20 Il). Comparatively to a conventional food product, health enhancing food 
has a native or induced composition oris developed from a particular technology aimed at improving 
its nutrient content and/or bioactive compounds and thus providing scientifically demonstrated health 
benefits (Cortuff et al. , 2011). The health enhancing food category includes functional foods , natural 
health product (NHP) , food supplement, etc.) . 
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Furthermore, the marketing management literature fails to provide adequate insights 
for managers in their decision making (Ardley, 2011; McCole, 2004). The focus in 
mainstream marketing is on measuring what has taken place in the past rather than 
dealing with complexity, uncertainty and dynamics of the present and the future 
(Gummesson, Kuusela and Narvanen, 2014). In fact, mainstream marketing has put 
little focus on managing complex networks of intenelationships where many 
stakeholders interact and create value (Gummesson, Kuusela and Narvanen, 2014). 
As a consequence, managers are stiil looking in vain for structured methods that they 
can use to deal with the complexity of their organizational systems (Trochim and 
Cabrera, 2005). Given the complexity, the uncertainty and the dynamics of the 
market, Gummesson, Kuusela and Narvanen (2014) stated that strategie decision 
making in marketing should focus on ail stakeholders and be oriented towards the 
future and not be based on static, simplistic and disconnected history-oriented 
metrics. Moreover, Logman (2011) suggested that marketing planning/strategie 
management should no longer be limited to analysis of data within product/market 
boundaries but should emphasize more on contextual information that exceeds 
product/market boundaries. Thereby, a new paradigm in marketing theory has started 
to form recently (Gummesson, Kuusela and Narvanen, 2014) . It emphasizes ail 
stakeholders, complexity and a higher leve] of theory generation and therefore 
attempts to provide a systemic, holistic view, without neglecting the detail 26 
(Gummesson, Kuusela and Narvanen, 2014). 
Within the context of this emerging paradigm, the aim of this exploratory prospective 
study is to develop a shared conceptual framework to identify and prioritize 
initiatives aimed at improving the distribution of health enhancing foods while 
26 According to Gummesson, Kuusela and Narvanen (2014), this is already an important trad ition 
within the Nordic School (Gronroos and Ravald, 20 Il; Gummesson, 20 12; Gummesson and Gronroos , 
2012). 
-------------------------------------------------------------------------------------------------
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involving various industry stakeholders. The key research questions examined are the 
following: 
1) What consensuses may, or may not, emerge amongst stakeholders regarding 
initiatives to be undertaken in establishing an effective consumer-oriented 
distribution strategy for health enhancing foods? 
2) What is the conceptual framework that stakeholders m health enhancing 
foods industry share on initiatives to be undertaken to improve the distribution 
of their products? 
3) What are key themes and priorities which emerge for these initiatives to be 
undertaken? 
To answer these questions, concept mapping (Kane and Trochim, 2007; Trochim , 
1993) is used as a research method in this exploratory prospective study to develop a 
shared bottom-up conceptual framework of the stakeholders involved that can be 
translated and interpreted bath quantitatively and qualitatively. As a structured mixed 
research method, concept mapping enables diverse stakeholders or individuals to 
develop a shared understandable representation that address complexity and therefore 
enables them to align their actions with broader organizational or systems thinking 
(Trochim and Cabrera, 2005). In fact , concept mapping as an inductive method « . .. is 
consistent with an evolving paradignt of complex adaptive systems thinking and helps 
groups address complexity» (Trochim and Cabrera, 2005, p. 12). 
In the following section, a literature revœw 1s presented. In section 2.3, the 
methodological framework is introduced. The data analysis and research results are 
presented in section 2.4. Findings are discussed in section 2.5. Finally the article 
concludes, in section 2.6, with manageria1 implications as well as limitations and 
opportunities for future research. 
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2.2 Literature review 
There is an increasing recognition in the literature of the importance of distribution 
in marketing strategies (Rosenbloom, 2012; Rushton, Croucher and Baker, 2014). 
Several authors have argued that distribution should be considered at the 
highest management level and included in the strategie planning process (Coughlan et 
al., 2006; Mentzer and Williams, 2001; Rosenbloom, 2012) . To better understand the 
strategie role of distribution, this section is organized as follows. First, the 
major challenges in distribution and supply chains are presented in sub-section 
2.2.1. Second, the challenges associated with the distribution of health enhancing 
foods are described in sub-section 2.2.2. Finally, in light of these challenges, the 
importance of distribution in the firm's overall objectives and strategies is highlighted 
in sub-section 2.2.3. 
2.2.1 Major challenges in distribution and supply chains 
Major changes have dramatically transfonned the distribution and supply chains over 
the past decade, and thus, have created a metamorphosis in distribution systems 
(Rosenbloom, 2012; Rushton, Croucher and Baker, 2014). The most important ones 
are related to the increasing expectations of consumers, globalization, both in tenus 
of global brands and global markets, and the emergence of new technologies. 
Globalization is affecting almost every firm whatever its size (Armstrong and Kotler, 
2011),. With globalization, a buge flow of products and services is possible across 
national boundaries (Rosenbloom, 2012). This impacts the distribution strategies of 
firms and their competitiveness (Rosenbloom, 2012; Rushton, Croucher and Baker, 
2014), especially as consumers are increasingly seeking to access worldwide products 
and services at affordable priees (Rosenbloom, 2012). 
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Like globalization, new technologies have also transformed distribution as well as 
consumers' expectations (Deloitte, 2014; Rosenbloom, 2012). In fact, the explosion 
of information technology, e-commerce and social media offer firms the opportunity 
to respond more quickly to market demand, interact with their consumers at a lower 
cost and therefore gain substantial competitive advantage (Rosenbloom, 2012). 
Furthermore, e-cotnmerce, mobile commerce and social media have made consumers 
more powerful (Deloitte, 2014). With these new technologies, consumers play active 
roles as value co-creators (Vargo and Lush, 2008). They interact with each others as 
well as with firms (Gummesson, Ku use la and Narvanen, 2014) and therefore expect 
better channel choices for gaining access to a variety of products and services 
(Rosenbloom, 2007; Venkatesan, Kumar and Ravishanker, 2007). 
2.2.2 Challenges in health enhancing food distribution 
During the last decade, the global food and agribusiness industries have experienced 
se veral societal, economie and technological changes (Bigliardi and Galati, 2013; 
Boehlje, Roucan-Kane and Bri:iring, 2011) which have significantly impact the entire 
food value chain, starting from agricultural production, through food processing and 
distribution of food, to end consumers (Bigliardi and Galati , 2013). These changes 
suggest three fundamental critical future issues for the sector, namely innovation, 
structural change, and uncertainty (Boehlje, Roucan-Kane and Bri:iring, 2011; Hobbs , 
2002). Each of these challenges is examined hereafter. 
a) Challenges in the food industry: Innovation 
Several previous studies have stressed the importance of innovation for food firms as 
well as for the overall profitability of the industry (Costa and Jongen, 2006; Kelly, 
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2009; Sarkar and Costa, 2008; Traill and Mueulenberg, 2002). However, the 
innovation in the food industry is mainly incrementai (Costa and Jongen, 2006). In 
fact , the majority of new products are 'me too products ' and only 1 to 2% new 
products are considered truly differentiated products or radical innovation (Costa and 
Jongen, 2006). According to Khan et al. (2013), the food industry bas been 
characterized as a market searcher rather than a market developer. This is due to 
several factors su ch as the consumer' s risk aversion, the shortening of the product 
life-cycle by the introduction of private labels, the Jack of an innovation climate and 
restrictive health and safety regulations (Broring, 2008; Ronteltalp et al. , 2007). 
Important changes bath in the nature of food demand and food supply chain 
organization, in conjunction with a more competitive environment, have provided an 
opportunity for addressing this balance (Costa and Jongen , 2006; Matthyssens , 
Vandenbempt and Berghman, 2006; Ziggers, 2005). Consumer requirements in food 
production and processing have changed considerably (Bigliardi and Galati , 2013). 
Consumers are increasingly seeking products tailored to their needs, aimed at 
preventing chronic illnesses and optimizing their health potential (Costa et al. , 2001, 
2007; Menrad, 2003; Roberfroid, 2000b). Moreover, consumers' demand for food is 
rapidly evolving into a mass customization market (Boland, 2008). Consumers are 
now telling companies what they want to eat (Aguilera, 2006). 
As the tempo of these changes accelerates, food companies are facing additional 
challenges (Khan et al., 2013). Indeed, food companies are moving from incrementai 
innovations toward radical innovations (Matthyssens, Vandenbempt and Berghman, 
2006; Ziggers, 2005). Nevertheless, moving toward radical innovation requires higher 
technologies, analytical novel knowledge and specialist skills for evidence based 
claims (Khan et al., 2013). These requirements command the need for a diverse 
network of collaborations with external partners (Khan et al., 2013) and also a better 
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institutional coherence within the network (Siedlok, Smart and Gupta, 2010) to 
enhance the innovation capability of the firm. In short, there is a need for food 
companies to manage the whole chain in an integrated and interactive manner 
(Bigliardi, Bottani and Galati, 2010; Khan et al., 2013) . 
b) Challenges in the food industry: Structural change 
The impacts of structural change (consolidation/concentration, vertical and horizontal 
integration, and changes in the boundaries of the firms) underway now in the food 
sector are profound and dramatic (Rogers, 2001; Stiegert, Wang and Rogers, 2009). 
The pervasive structural change affect almost ali participants in the food and 
distribution industries such as food manufacturers , input supply manufacturers , 
retailers, consumers, public regulators, educators and researchers (Boehlje, Roucan-
Kane and Broring, 2011). 
Health enhancing foods are at the food and medicine boundaries (Broring and 
Cloutier, 2008; Siedlok, Smart and Gupta, 2010; Vergari , Tibuzzi and Basile, 2010) , 
and therefore companies in this industry compete in vitamin and pharmaceutical 
markets for natural health products (NHP) and in conventional food market for 
functional foods . Furthermore, in Canada, the pharmaceutical and food processing 
industries alike are highly concentrated (Hobbs, 2002). In fact , the health enhancing 
food industry is dominated by large and established finns (AAFC, 2009) . This limits 
the ability of small companies to gain market share (AAFC, 2009) because in such 
situations, companies maintain their market power through barriers to entry (economy 
of scales, multiple brands, etc). Consequently, strategie alliances or partnerships can 
be formed upstream or downstream the supply chain to access financial and human 
capital resources (Hobbs, 2002; Malla et al. , 2013). To sum up, market concentration 
intensifies competition (Bigliardi and Galati, 2013) . It is a challenging issue for 
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health enhancing food companies. It affects market access and the formation of new 
relationships between firms along the supply chain (Hobbs, 2002; Malla et al. , 2013). 
Besides the intensive upstream competition, health enhancing foods manufacturers 
are also facing downstream competition from food retailers (Hobbs, 2002) , 
especially, because direct selling to retailers is the main27 distribution channel for 
these firms (Kamphoune, 2013). The Canadian grocery retail market is highly 
concentrated and vertically integrated into food distribution , with the top six28retailers 
accounting for 80% of total food sales (OSEC29 , 2011) . 
Coupled with retail market concentration, the enlargement of food supermarkets' 
sizes and the advent of nontraditional actors whose main activity is not food 
distribution such as Dollarama, drugstores, etc., have generated for food 
manufacturers an aggressive competition for shelf space (MAPAQ, 2007, 2009). 
According to Betancourt and Goutschi (1998); Matlack (2009); Messinger and 
Narasimhan (1995) and Rosenbloom (2012), the increasing size of retailers, their 
consolidation (through mergers and acquisitions), their use and application of 
advanced technology and sophisticated marketing strategies, make them more 
powerful. The power is defined in distribution and marketing channel literature, as 
the ability to control the decision variables of another member (El-Ansary and Stern, 
1972) or the ability to influence decision-making and actions of the other party 
(Wilkinson, 1973; 1996). As an example of exerting power, food retailers levy their 
suppliers slotting fees (payments) in order to occupy shelf space or when low demand 
27Retailers accounted for approximately 37% of sales (Kamphoune, 20 13). 
28Loblaws, Sobeys, Metro , Costco Canada Safeway and Walmart Canada. 
290SEC (20 ll) .The Canadian Food Retail Sector.Opportunities for Swiss companies. Available online 
at: http://www.s-ge.com/en/fi lefield-private/files/2344/field blog public files/ l272 
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is realized (Hobbs, 2002; Marasteanu, Jaenicke and Dimitri, 2011; Nocke and 
Thanassoulis, 2014; Tamilia, 1999). 
In addition, retailers are solidifying their power in the market place by means of 
private labels (Hodgins, 2011; Lawrence and Burch, 2008). In Canada, private label 
packaged food attained in 2012 a market value of 6.6 billion dollars and a market 
share of 12.7% (Euromonitor, 2013 in AAFC, 2013). From 2007 to 2012, the market 
grew at a compound average annual growth rate (CAGR) of 4.8% (Euromonitor, 
2013 in AAFC, 2013). This situation is challenging food manufacturers by shortening 
the product-life cycle (Broring, 2008; Ronteltalp et al., 2007) , especially as 
consumers no longer buy private labels only for value pricing or budget shopping 
purposes (Martfnez-Ruiz et al., 2014) and therefore no longer con si der them as a 
weak alternative to branded food products (Hale, 2010; Hardy, 2010 in Khan et al. , 
2013). 
c) Challenges in the food industry: Uncertainty 
The environment in which Canadian health enhancing food companies operate is 
uncertain (Hobbs, 2002; Siedlok, Smart and Gupta, 2010). This is mainly because 
products are based on new and evolving technology and sold into new and evolving 
markets in a restrictive and uncertain regulatory environment (Hobbs, 2002). 
Health enhancing foods are heavily based on higher advances in technologies, novel 
knowledge and SQecialist skills CI<han et al., 2013). Although evolving technologies 
offer opportunities to target new markets, they come with additional challenges 
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(Hobbs, 2002; Siedlok, Smart and Gupta, 2010). In fact , the time span30 from 
discovery to market and R&D activities are additional sources of uncertainty. In 
addition, consumers' market for health enhancing foods is characterized by a rapid 
change in consumer opinions (Childs and Poryzees, 1997), consumer skepticism and 
information asymmetry (Grunert, Bech-Larsen and Bredahl, 2000; Zou and Hobbs, 
2006) . Given consumers are seeking products aimed at preventing chronic diseases 
and optimizing their health potential (Costa et al. , 2001 , 2007 ; Menrad, 2003; 
Roberfroid, 2000b), health enhancing foods suffer from a lack of trust from 
consumers (Hobbs, 2002 ; Siedlok, Smart and Gupta, 2010). In fac t, health enhancing 
foods have credence attributes and consumers cannot adequately assess their 
properties, quality or safety bef ore or even after purchase (Verbeke, 2005 ; Zou and 
Hobbs, 2006) . In such situation, market failures arise due to information asymmetry 
between buyers and sellers (Verbeke, 2005). Sellers have more knowledge 
concerning the production process, product origin , nutritional content, or about safety 
issues than buyers do (Verbeke, 2005). 
Because of information asymmetry and credence attributes of health enhancing foods, 
labelling plays a determinant role in helping consumers make informed choices 
(Garretson and Burton, 2000; Hailu et al. , 2009 ; Kozup, Creyer and Burton, 2003 ; 
Malla, Hobbs and Perger, 2005; Roe, Levy and Derby, 1999;Wansink, 2003). 
However, two challenges have limited health enhancing food companies in using 
labels to signal the health benefits of products, namely regulatory uncertainty and the 
credibility of health daims (Hobbs, 2002). 
The regulatory environment for health enhancing foods in Canada has evolved 
considerably in recent years (Blandon, Cranfield and Henson, 2007 ; Malla, Hobbs 
30 According to Dr Howard Tennant- Council Member of the National Research Council of Canada 
and President Emeritus of the University of Lethbridge, the length of time from idea to market for 
highly innovative products such nutraceuti cals is averaging 13 years. 
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and Sogah, 2013). In January 2004, a new regulatory reg1me for natural health 
products (NHP) was implemented in Canada under the Natural Health Product 
Regulations (Health Canada, 2007). Currently, 26 structure/function claims31 are 
approved in Canada for foods and nine disease risk reduction claims32 are permitted 
both on foods and on NHP (Malla, Hobbs and Sogah, 2013). 
Despite this evolution, the Canadian regulatory environment still lags behind the rest 
of the world regarding the regulation for these products (Malla, Hobbs and Sogah, 
2013). In fact, compared to Japan, the United States and the European Union , Canada 
bas a relatively strict regulatory system in the area of functional foods and NHP 
(Crowley, 2008; L'Abbe et al., 2008; Malla, Hobbs and Sogah, 2013). Only nine 
disease risk reduction health claims are permitted in Canada, while seventeen disease 
risk reduction claims are allowed in the United States (Malla, Hobbs and Sogah, 
2013). The qualified health claims33 and the product specifie claims34 on food are 
prohibited in Canada but allowed in the United States and Japan (Malla, Hobbs and 
Sogah, 2013) . Moreover, most of structure/function claims in Canada are approved as 
disease risk reduction claim in other countries such as the United States (Malla, 
Hobbs and Sogah, 2013). Finally, NHPs are regulated in Canada differently than food 
31 Structure/function claims relate to the effects that a food has on the normal functions of the body . 
They are based on the role that the food or the food constituent plays when consumed at levels 
consistent with normal dietary patterns.(Canadian Food Inspection Agency, 20 14 ). This information is 
available online at: http://www. inspecti on. gc.ca/food/labell i mdfood-labcll in g-for-industrv/health-
claims/eng/1392834838383/ 1392834887794 'lchap= 7#s 13c7 
32 Disease risk reduction claim are .statements that link a food to a reduced ri sk of developing a diet-
related disease or condition in the context of the total diet (Canadian Food Inspection Agency , 2014). 
This information is available online at: http://www.inspection.gc.calfooclllabclline:/food-labelling-for-
industrv/health-claims/eng/ J392834838383/ l 392834887794?chap= 14 
33 Qualified health claims are claims that contain cred ible but inconclusive evidence (Malla, Hobbs and 
Sogah, 2013). 
34 Product specifie claims are used only by products that undergo a reg i st~ation process for a claim that 
specifies a relationship between the food or food constituents and a health benefit (Malla, Hobbs and 
Sogah, 2013). 
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by using a product specifie system which requires a more substantial level of 
evidence. While for example, in Japan and in the United States, NHPs are treated 
similarly to foods , they are considered distinct from food without unposmg 
significantly different regulations (Malla, Hobbs and Sogah, 2013). 
These differences in regulations, policies and health claims are challenging the health 
enhancing foods industry in Canada (Malla, Hobbs and Sogah, 2013 ; Malla et al., 
2013). The lack of an internationally agreement or standards on the appropriate 
definition of health enhancing foods and different regulatory contexts that exist 
amongst countries is problematic for firms (Hobbs, 2002; Siedlok, Smart and Gupta, 
2010). It raises costs, creates uncertainty for exporting films and acts as a brake on 
the expansion of international trade (Hobbs, 2002; Malla et al., 2013). 
Besides, the Canadian regulatory system is also considered slow moving (Crawley, 
2008; Malla et al., 2013) and unpredictable (Hobbs, 2002; Malla et al., 2013). In fact, 
the approval process is considered to be "slow" and cumbersome (Malla et al, 2013) 
and regulations do not follow the rate of innovation advances of health enhancing 
food companies (Crawley, 2008). Further, the variety of terminologies and 
definitions for health enhancing foods (Siedlok, Smart and Gupta, 2010) creates 
confusion, a high level of uncertainty (Malla et al. , 2013 ; Siedlok, Smart and Gupta, 
2010;Vergari , Tibuzzi, and Basile, 2010) and distrust among health professionals and 
consumers (Malla et al., 2013). 
Such concerns might restrict and discourage the development and marketing of new 
products with potential health benefits for consumers (Burdock, Carabin and 
Griffiths, 2006; Hobbs, 2002), increase the costs of product marketing, postpone new 
product launches, and increase innovation risks (Burdock, Carabin and Griffiths, 
2006; Coppens, Fernandes and Pettman, 2006). 
----~-~~ ~~~--~~~~~~~-------------------
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As stated by Herath et al. (2008), given the direct impact of regulations on health 
enhancing foods firms, severa} studies have highlighted the importance of 
streamlining the regulatory situation in bath the international (Gray, Armstrong and 
Farler, 2003; Heasman, 2005; Taylor, 2004; Wrick, 2005) and in the Canadian 
contexts (Doering, 2005; Fitzpatrick, 2004, 2005; Gnirss , 2004; Ramsay, 2002; 
Kondro, 2004 ). 
2.2.3 Importance of distribution in strategie planning and in marketing mix strategy 
Given the significance of the challenges, described earlier, severa} authors highlight 
the great importance of distribution for the firm ' s overall objectives and strategies as 
well as for the firm's fundamental marketing strategies (such as segmentation, 
differentiation and positioning strategies), and thus, highly recommend including 
distribution in the strategie planning process (Coughlan et al., 2006; Mentzer and 
Williams, 2001; Rosenbloom, 2012). The success of many companies is tightly 
related to the priority given to distribution strategies. In toda y' s highly competitive 
markets, companies that dismiss distribution as a key decision area when formulating 
their overall objectives and strategies limit their capabilities to compete effectively 
(Rosenbloom, 2012). 
Regarding the role of distribution in the marketing mix, it bas been argued that place 
(the fourth P of marketing mix strategy) may be equal or more important than the 
other Ps, namely, product, priee and promotion (Rosenbloom, 2012; Tamilia, 1999). 
Indeed, it has become very difficult for firms, in toda y' s aggressive competitive 
landscape, to gain a sustainable competitive advantage by focusing only on product, 
priee, and promotion (Rosenbloom, 2012). Comparing to product strategy, priee 
strate gy and promotion strate gy, distribution strate gy is difficult to copy by 
competitors because it requires long term commitment and relationship-building with 
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retailers and significant investment in infrastructure and human skills (Fites, 1996; 
Rosenbloom, 2012). 
Shortly, following the explosion of information technology and e-commerce, the 
greater difficulty in gaining a sustainable competitive advantage, the increasing 
power of mass retailers in marketing channels, and the need to reduce distribution 
costs, managers have increased their attention to distribution (Rosenbloom, 2012; 
Tamilia, 1999). As a consequence of these challenging changes , retailers are 
considered to have become "Gate-keepers" into the consumer marketplace 
(Rosenbloom and Mollenkopf, 1993; Rosenbloom, 2012). 
Furthermore, the growing importance of distribution in marketing has coincided with 
the reallocation of manufacturers' marketing budgets from advertising or marketing 
pull to marketing push (trade marketing) (Kumar, 1997; Tamilia, 1999; Tsao et al. , 
2014). In fact, manufacturers are now allowing larger proportions of their marketing 
budgets to trade promotions, fees, discounts, and merchandising activities to retailers 
and wholesalers (Rosenbloom, 2012; Tsao et al. , 2014). 
2.3 Methodological framework 
This exploratory and prospective study uses an integrated-mixed research method, 
namely, group concept mapping (Kane and Trochim, 2007; Rosas and Kane, 2012) to 
gather data and information from diverse groups of participants. Group concept 
mapping methods are appropriate to analyze complex systems (Trochim and Cabrera, 
2005). In particular, the establishment of effective distribution of health enhancing 
foods should involve many stakeholders in the value chain. 
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The participants in this study are stakeholders involved in the health enhancing foods 
sector m Quebec, Canada, such as ingredient-makers and/or food 
manufacturers/processors , industry experts/researchers m food technology 
development, consumer sciences, food distribution and marketing, and government 
representatives. The data collected was about specifie initiatives to be undertqken to 
establish effective consumer-oriented distribution strategy of health enhancing foods. 
Participants were selected according to their knowledge and· experience -judgment 
sampling- (Cooper and Schindler, 2008). The aim was to achieve a wide variety of 
ideas and viewpoints from participants involved in the health enhancing foods 
industry. Thus, sampling was heterogeneous and purposeful rather than representative 
(Kane and Trochim, 2007). 
Six basic steps were followed to generate concept maps from this group of 
participants. These steps are as follows: preparation of the concept mapping project, 
idea generation, idea structuring, concept mapping analysis, interpretation of the 
concepts maps from the bridging and anchoring indices obtained and finally, 
presentation of the concepts maps to participants of this study. Each of these steps is 
detailed below. 
At the first step, the preparation of the concept mapping project was carried out 
following the guidelines suggested by Kane and Trochim (2007). The research team 
of this study, in collaboration with experts in leading organizations that support 
health enhancing foods industry in Quebec, identified a group of potential 
participants with different perspectives. This step was important to ensure external 
representational validitl5 (Rosas and Kane, 2012) . The typical profile of targeted 
participants included senior executives (sales, marketing and R&D) in health 
35 Refers to the extent to which the conceptualized mode! represents the reality it is aimed to represent 
(Rosas and Ka ne, 20 12). 
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enhancing food companies, experts and researchers in food technology development, 
in consumer sciences, in food distribution and marketing, and government 
representatives , who have relevant experience and knowledge in the area of health 
enhancing foods. 
In step 2, ideas generation, 18 participants generated, during two group discussion 
sessions36 , a set of 120 statements that aimed to complete the following focus prompt 
« A specifie initiative to undertake to improve health enhancing food distribution 
is ... ». To evaluate whether these statements represent the conceptual domain under 
inquiry, and therefore ensure external representational validity (Rosas and Kane, 
2012), the research team members in collaboration with some experts37 in the field of 
health enhancing foods reviewed them and agreed that they captured well the reality 
of the firms. The 120 statements represented the participants ' ideas about a set of 
initiatives to be undertaken for improving the distribution of health enhancing foods . 
The qualitative statements (ideas, opinions) generated between participants during the 
two group discussions, handled in this study, were translated into a structured 
questionnaire to quantitatively measure these same statements in an integrated 
methodological framework (Geoffrion, 2010). Thereby, six researchers38 participated 
in severa} revision rounds to eliminate statements' redundancies, inconsistencies , 
simplify the terminology and pretest the measuring instrument (Kane and Trochim, 
2007). After completing rounds of revisions, the research team approved a list of 80 
consolidated statements. 
36 Nine (09) participants in each group discussion session . 
37In food technology development and in food marketing. 
38The researchers are in management, in marketing, in strategy and in food technology development. 
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In step 3 (ideas structuring), participants completed individually the rating and sorting 
tasks necessary for data gathering. These tasks were performed by an extended group 
of 21 participants, including fourteen managers (VP marketing, VP sales, VP 
Research and Development) in SME health enhancing food companies (ingredient-
makers and/or food manufacturers/processors), five experts/researchers in food 
technology development, in consumer sciences, in food distribution and marketing, 
and two representatives from government ministries. During this step, each 
participant rated the relative importance and relative feasibility of each of the 80 
statements on a five-point numerical Likert-type scale. For the completion of the 
sorting task, participants were provided with a deck of cards, business card format , of 
the 80 statements. Each statement was printed individually on a card and given an 
identifying number. Following sorne specifie instructions39 , the participants sorted 
out the set of statements into piles based on the similarity of idea or theme (Kane and 
Trochim, 2007). At the end of the sorting task, each participant recorded the 
identifying number of each statement in a sorted pile and gave it a descriptive label or 
a descriptive sentence for each one. 
In step 4, the data gathered from participants was entered into a dedicated software, 
namely: Concept System® program (Trochim, 1987) for aggregation and generation 
of a two-dimensional solution, called a concept map. The concept map was generated 
by using a Multidimensional Scaling (MDS) analysis (Borg and Groenen, 2005; 
Davidson, 1983) of the total similarity square matrix of the 80 statements followed by 
an agglomerative Hierarchical Cluster Analysis (HCA) (Anderberg, 1973; Rencher 
and Christensen, 2012). 
39 (a) A statement cannat be in two or more different piles; (b) A statement thought to be unique can be 
placed in its own separate pile; and (c) unrelated statements cannat be placed in a one pile such as a 
miscellaneous pile (Kane and Trochim, 2007). 
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The MDS first provides a point map that illustrates the distribution of ali statements 
in a bi-dimensional Euclidian space (Kane and Trochim, 2006) and allows for 
establishing interrelationships arnongst the data points (Abrahams, 2010). Statements 
that are close to each others are those which were most often sOited together by 
participants while those that are far from each others are those who were piled Jess 
frequently together by participants (Kane and Trochim, 2007). The agglomerative 
HCA provides a cluster map that depicts how statements are located relative to one 
another and grouped into clusters. 
To proceed with the interpretation of the generated concept maps (step 5), q. 
systematic procedure was followed. This procedure consisted in determining the 
number of clusters to be selected that best represent the shared conceptual framework 
of the participants. Kane and Trochim (2007) recommend handling a 
bridging/anchoring analysis and a cluster label analysis. Following Kane and 
Trochim (2007), the research team examined individually and independently, the 
fifteen clusters solution generated by the Concept System® software (Trochim, 1987) 
and proceeded to reduce successively the number of clusters until achieving both a 
coherent and meaningful empirical and theoretical interpretations of results (Iris, 
Ridings and Conrad, 2010). The research team members independently achieved a 
concept map of six clusters. 
Finally, the results of this study were presented to participants for the purpose of 
discussing resulting concepts maps (Kane and Trochim, 2007) and for assessing face 
validity (Iris, Ridings and Conrad, 2010). First, the results were presented to two 
experts in leading organizations which support the health enhancing foods sector and 
to a manager in a public institution dedicated to the health enhancing foods industry. 
Second, results were presented during a face-to face meeting to a subgroup of thirteen 
participants (executive managers in health enhancing food firms, government 
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representatives, experts and researchers in food science and food marketing) . Upon 
this meeting, participants agreed that the concepts maps well-represented issues of 
health enhancing food distribution. 
2.4 Results 
The data was analyzed and a set of concept maps was obtained. These maps helped 
facilitate the interpretation of the data, and enabled the identification and 
conceptualization of initiatives aimed at improving the distribution of health 
enhancing foods. 
Concept mapping generates two basic types of maps , namely: the cluster map and the 
cluster rating map (Abrahams, 2010). Each type of map shows a different level of 
detail revealed in the analysis (Abrahams, 201 0). The elus ter map displays titled 
clustered polygons and the cluster rating map reports layers showing ratings based on 
a given scale (e.g. importance, feasibility, bridging/anchoring indices) . 
The cluster map (Figure 2.1) of this study was generated by using the results of the 
MDS to group the 80 statements into clusters by performing an agglomerative HCA. 
The MDS analysis of the total similarity matrix converged after 9 iterations 
producing a final stress value of 0.2440 . The stress value is the normalized residual 
variance for a perfect relationship of a monotone regression of di stance upon 
dissimilarity or similarity (Kruskal , 1964 ). lt indicates the goodness of fit of the final 
40In a study of 69 concept mapping projects, Rosas and Ka ne (20 12) reported th at the average stress 
value was 0.28 (SD = 0.04, range: 0.17-0.34, 95% CI [0.27-0.29]) . Therefore, the stress value obtained 
in thi s study is comparable, and even better than the mean obtained in previous concept mapping 
studies. 
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representation of the distance matrix (x,y) coordinates with respect of the total 
similarity matrix (raw data) (Kruskal and Wish, 1978). Moreover, a squared 
correlation coefficient (r2) was calculated in this study to assess the proportion of 
shared variance of the input and output data (Rosas and Kane, 2012). This estimate 
indicates that on average 55%41 of the variation in the aggregated participant sort was 
accounted for by the conceptual framework. Thereby, the stress value and the squared 
correlation coefficient value obtained in this study reflect the judgments made by 
participants in organizing information to produce the model. In fact, there is evidence 
of internai representational validity, as thi s far exceeds established standards (Rosas 
and Kane, 2012). In addition to internai representational validity, the cluster map of 
this study is reliable. A set of reliability estimates was computed for assessing 
partcipants' rating and sorting statements. These estimates are presented in Appendix 
2.1. 
The cluster map (Figure 2.1) represents the shared conceptual framework by 
participants who completed the rating and sorting tasks. The six clusters were labeled 
as follows: (1) Communication with health professionals and regulatory options, (2) 
Information and communication with consumers, (3) Market-oriented innovation 
management, (4) Networking and institutional support, (5) Retailers' relationship 
management, and (6) Marketing strategies. The statements contained in each of these 
clusters are presented respectively in Appendices 2.2 to 2.7. 
4 1In a poo led analysis of 69 concept mapping projects, Rosas and Kane (20 12) reported that the 
average squared correlation coefficient value was 0.44 (SD = 0.09, range: 0.28-0.68, 95 % CI [0.42-
0.46]) . Therefore, the squared correlation coefficient value obtained in thi s study is comparable, and 
even better than the mean obtained in previous concept mapping studies. 
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Furthermore, the cluster map illustrates the interrelationship among statements as 
clusters on the map (Abrahams, 2010). Thereby, the smaller the cluster is, the greater 
the interrelationship between the statements, and vice versa. 
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Figure 2.1 Improving health enhancing food distribution: Final six-cluster map 
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The cluster rating map depicts the degree of importance for clusters (Figure 2.2). The 
degree of importance is represented by the number of layers in each cluster (values 
between 1 and 5). Clusters with more layers indicate a high importance rating while 
those with few layers indicate a low importance rating (Kane and Trochim, 2007). 
Based on the participants' rating task, Figure 2.2 illustrates the mean importance 
ratings for each of the six clusters obtained in this study. 
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As noted in Figure 2.2 and Table 2.1, the 'Information and communication with 
consumers' cluster had the highest mean importance rating (3.91 on a scale of 5) and 
the lowest bridging value (0.2). This means participants rated this cluster as an 
important issue and sorted the statements within this cluster together more frequently. 
Thereby, 'Information and communication with consumers' was the most important 
and distinctive concept in the overall conceptual framework of this study. The 
'Markei-oriented innovation management' cluster was rated second highest (3.85 on 
a scale of 5) with a midrange bridging value of 0.56. Although participants rated the 
statements within this cluster as important, they dispersed the statements of this 
cluster in other piles during the sorting process. The 'Retailers ' relationship 
nwnagenœnt' cluster had an importance rating of 3.69 on a scale of 5 and a low 
bridging value of 0.32. The 'Communication with health professionals based on 
regulatory options' cluster had an average importance rating of 3.59 on a scale of 5 
and a bridging value of 0.61, suggesting this cluster is quite highly related to other 
clusters on the map. The 'Networking and institutional support' cluster achieved a 
mean overall importance rating of 3.59 on a scale of 5 and had a midrange bridging 
value of 0.55, evidencing a modest degree of internai consistency. Finally the 
'Marketing strategies' cluster was rated 3.38 on a scale of 5 for importance and had a 
low bridging value of 0.28, suggesting that this cluster is clearly differentiated from 
the other clusters. 
In summary, 'Infonnation and conununication with conswners ', 'Retailers ' 
relationship management' and 'Marketing strategies ' have low bridging values and 
are the most differentiated and cohesive concepts in the shared concept mapping 
framework of this study. However, 'Market-oriented innovation management', 
'Communication with health professionals and regulatory options ' and 'Networking 
and institutional support' have high bridging values and therefore are the less well 
differentiated concepts in this study' s framework (Table, 2.1 ). 
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Figure 2.2 Improving health enhancing food distribution: Cluster rating map 
Table 2.1 Cluster rating 
Cl us ter Cluster name Bridgingl Mean 
# anchoring importance 
values 
1 Information and communication with 0.20 3.91 
consumers 
2 Market-oriented innovation 0.56 3.85 
management 
3 Retailers' relationship management 0.32 3.69 
4 Communication with health 0.61 3.59 
professionals and regulatory options 
5 Networking and institutional support 0.55 3.59 
6 Marketing strategies 0.28 3.38 
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In addition to the elus ter map (Figure 2.1) and the elus ter ra ting map (Figure 2.2), the 
results relate to pattern matching analysis that contrasts the importance ratings and 
the feasibility of each cluster obtained in this study. In fact, pattern matching analysis 
identifies, by cluster, the most important and feasible initiatives to undertake for 
improving the distribution of health enhancing foods. 
As illustrated in Table 2.2, generally, clusters with the highest importance rating are 
also perceived by participants as the most feasible. Likewise, clusters rated as less 
important are also considered less feasible by respondents of this study. However, the 
'Marketing strategies' cluster bad the lowest importance rating but was rated as 
highly feasible within 6 months (2nd in ranking and less feasible within a range of 6 
months-2 years. 
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Table 2.2 Pattern matching analysis 
Cluster Name Mean Feasibility Feasibility 
importance (0 - 6 months) (6months - 2 
years) 
order index order index Order index 
Information and 1 3.91 3 2.90 2 3.87 
communication with 
consumers 
Market -oriented 2 3.85 1 3.24 1 4.04 
innovation 
management 
Retail ers' relationship 3 3.69 4 2.89 3 3.75 
management 
Communication with 4 3.59 5 2.66 6 3.60 
health professionals 
and regulatory 
o tians 
Networking and 5 3.59 6 2.52 5 3.47 
institutional support 
Marketing strategies 6 3.38 2 2.94 4 3.71 
The cluster rating map (Figure 2.2) and the cluster statement list (Appendices 2.2 to 
2. 7) were used to partition the six clusters related to initiatives aimed at improving 
the distribution of health enhancing foods into three meaningful conceptual domains: 
Communication and regulatory options initiatives , Scientific initiatives , and 
Commercial initiatives (Figure 2.3). This partition was handled by the research team 
and supported by participants during the result interpretation held during the final 
group meeting 
Comunication and regulatory options initiatives partition 
Scientific initiatives partition 
Commercial initiatives partition 
Figure 2.3 Improving health enhancing food distribution: Partitioned cluster rating 
map 
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The upper side of the cluster rating map (Figure 2.3) includes two clusters: 
'Information and conununication with consumers ' and 'Cmnmunication with health 
professionals and regulatory options '. They represent initiatives aimed at improving 
the distribution of health enhancing foods pertaining to communication and 
regulatory options. In fact , the statements in these two clusters express the need for an 
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effective communication of health enhancing foods benefits to consumers and the 
means for performing that communication. This finding is coherent with previous 
studies which highlighted that support from health professionals is an important mean 
to communicate to consumers the benefits of health enhancing foods and therefore 
reduce their lack of credibility toward these products and their health benefits (e.g. 
Hobbs, 2002; Siedlok, Smart and Gupta, 2010). 
Furthermore, participants in this study perceived the prominence of initiatives related 
to communication in improving the distribution of health enhancing foods. As seen in 
Table 2.3, the high importance rating of this first partition (3 .75) was assigned by 
participants, to the statements contained in the two clusters forming this partition . 
Among 'Information and communication with consumers ' cluster were statements (2) 
and (12) respectively labeled 'Ensure that the health allegation of health products is 
well understood by the consumer'42 and 'Sensitize the consumer to the benefits 
associated with the consumption of health enhancing foods' 43. Regarding the 
'Communication with health professionals and regulatory options' cluster, amid the 
most important statements were statements (20) and (27) respectively entitled 'Make 
sure that the message delivered to the consumer on the health enhancing foods 
conforms with the regulations of national authorities e.g. Health Canada' 44 and 'Make 
the information about health enhancing foods available to health professionals e.g. 
doctors, prevention workers, etc. ' 45 Thereby, while statements (2) and (12) focused 
on effective communication to consumer through sensitization about health 
enhancing foods benefits and better understanding of these benefits by consumers , 
statements (20) and (27) pinpointed the means for an effective communication of 
42Importance rating 4.65 on 5. 
43Importance rating 4.45 on 5. 
44Importance rating 4.55 on 5. 
45Importance rating 4.00 on 5. 
- --·------ -- --------
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health enhancing foods benefits to consumers, namely the conformity of the message 
with the regulatory authorities (Health Canada) and the reliance on health 
professionals to help consumers with their food choices. 
Table 2.3 Rating of the conceptual partitioning of clusters 
Cluster Partition/Cluster name 
# 
Communication and regulation partition 
1 Information and communication with 
consumers 
4 Communication with hea1th professionals 
and regulatory options 
Scientific partition 
2 Market-oriented innovation management 
5 Networking and institutional support 
Commercial partition 
3 Retailers' relationship management 
6 Marketing strategies 
Average 
Cl us ter 
Ra ting 
3.91 
3.59 
3.85 
3.59 
3.69 
3.38 
Average 
Partition 
Ra ting 
3.75 
3.72 
3.53 
Based upon the analysis of the cluster rating map (Figure 2.2) and cluster statement 
list (Appendices 2.2 and 2.3) , the clusters- 'Communication with health professionals 
and regulatory options' and 'Information and conununication with consumers' could 
be considered together as a meaningful conceptual domain related to Communication 
initiatives and regulation aimed at improving the distribution of health enhancing 
foods. 
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On the left side of Figure 2.3, two clusters-'Market-oriented innovation nwnagentent' 
and 'Networking and institutional support' -invoke initiatives related to scientific 
aspects that bear upon the improvement in the distribution of health enhancing foods. 
lndeed, the statements contained in these two clusters address the need for more 
innovation and ways to achieve this innovation. Moreover, participants felt that 
scientific initiatives require substantive investments and collaboration with external 
partners to improve the distribution of health enhancing foods. This finding is 
supported in previous studies (Bigliardi, Bottani and Galati, 2010; Khan et al. , 2013; 
Siedlok, Smart and Gupta, 2010). 
The average importance rating attributed by participants about statements that make 
up the two clusters of the scientific initiatives partition was 3.72. For example, the 
most important statements, amongst others, in the 'Market-oriented innovation 
management ' cluster were statements (68) , (69) and (70) respectively named 
'Innovate on the scientific dimension of health enhancing foods' 46 ; ' Innovate on the 
product/market dimension of health enhancing foods' 47 and ' lnnovate on the selling 
dimension of the health enhancing foods '48 . Concerning the 'Networking and 
institutional support' cluster, among the most important statements we find 
statements . (13), (57) and (74) respectively labeled 'Support the R&D of health 
enhancing foods by financial incentives (grants , tax credits etc.,)' 49 ; 'Facilitate 
partnerships between companies and institutions responsible for the R&D of health 
enhancing foods ' 50 and 'Encourage open innovation to share the costs associated with 
46Importance rating 4.00 on 5. 
47Importance rating 3.95 on 5. 
48Importance rating 3.90 on 5. 
49Importance rating 4.30 on 5. 
50Importance ra ting 4.10 on 5. 
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clinical trials of health enhancing foods' 51 . As statements (68) , (69) and (70) 
emphasized on various aspects of innovation (scientific, marketing and selling), 
statements (13) , (57) and (74), dwell on the ways to accomplish that innovation 
especially through partnerships with health enhancing food companies, ingredient 
suppliers, research centers and all the stakeholders in the health enhancing foods 
value chain. 
From the analysis of the cluster rating map (Figure 2.2) and cluster statement li st 
(Appendices 2.4 and 2.5), the two clusters- 'Market-oriented innovation management' 
and 'Networking and institutional support' form together a significant conceptual 
domain that affects the distribution of health products , namely the scientific partition. 
At the right bottom side of figure 2.3 , there are two clusters- Retailers' relationship 
management' and 'Marketing strategies '- which correspond to commercial initiatives 
impacting the distribution of health enhancing foods. Indeed, statements within these 
two clusters express the need for a better marketing management process through 
more market research, well defined marketing strategies and doser relationships with 
retailers. This finding is consistent with previous studies which highlighted the need 
to align distribution and retailers' relationship management with a firm ' s overall 
objectives and strategies (Coughlan et al. , 2006; Kumar, 1997 ; Mentzer and 
Williams, 2001; Rosenbloom, 2012) . 
Additionally, participants highlighted the importance of commercial initia ti v es for 
improving the distribution of health enhancing foods. As depicted in Table 2.3, the 
average rating of commercial partition (3.59) was ascribed by participants regarding 
statements in these two clusters during rating sessions. For instance, amongst 
51Importance rating 3.80 onS. 
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important statements about actions to be undertaken in the 'Marketing strategies' 
cluster are statements (3) , (66), (65) and (77) respectively, titled 'Improve the 
marketing management process of the company' 52 ; 'Conduct market research to 
determine the consumer's perceived satisfaction about health enhancing foods' 53 ; 
'Conduct market research to determine the consumer' s understanding of the health 
aspects of health enhancing foods ' 54 and 'Continuously differentiate the company' s 
products from its competitors' 55 . 
As for the 'Retailers ' relationship nwnagement ' cluster, amongst the important 
statements are statements (61) , (36) and (67) respectively labeled 'Ensure that the 
retailer is committed to promote and valorize health enhancing foods' 56 , 'Provide 
training on health enhancing foods to retailers and brokers ' and 'Persuade the retailer 
about the advantages of the health enhancing foods comparatively to conventional 
foods'. 
In summary, ali these statements are interrelated. In fact , while statement (3) 
emphasized on a better marketing management process, statements (66) , (65) , (77) , 
(61), (36) and (67) focused both on marketing actions (e.g. market research, training 
programs to retailers and brokers of health enhancing foods , doser relationships with 
retailers) and marketing strategies (e.g. differentiation strategy) to improve the 
marketing management process of health enhancing food companies and thus the 
distribution of their products. In other words, improving the di stribution of health 
52Importance rating 3.75 on 5. 
53Importance rating 4.35 on 5. 
54Importance rating 4.15 on 5. 
55Importance rating 4.05 on 5. 
56Importance rating 4.30 on 5. 
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enhancing foods reqmres (1) evaluating consumers' knowledge, satisfaction and 
understanding of health enhancing foods' aspects through market research, (2) 
improving consumers' knowledge, satisfaction and understanding of health 
enhancing foods' benefits through retail ers' implication (doser relationships and 
training) and finally (3) differentiating continuously health enhancing foods and thus 
creating original positioning in consumers' minds. Following the analysis of the 
cluster rating map (Figure 2.2) and cluster statement list (Appendices 2.6 and 2.7), 
the two clusters: 'Retailers' relationship nwnagement' and 'Marketing strategies' can 
form a meaningful conceptual domain, namely commercial partition to improve the 
distribution of health enhancing foods. 
2.5 Discussion 
The concept mapping process used in this study provided a framework to identify and 
prioritize specifie initiatives aimed at improving the distribution of health enhancing 
foods. The discussion summarizes key findings of group concept mapping analysis. 
The findings are significant because they are consistent with the literature and 
statements within the clusters from collective representation of a diverse group of 
participants brought to the sample. There are severa] noteworthy findings: 
1) The high importance of the Information and communication with consumers 
cluster and its close proximity to the Communication with health professionals 
and regulatory options cluster; 
2) The high importance attributed to the Market-oriented innovation 
managem.ent cluster and its association with the Networking and institutional 
support cluster; 
3) The high importance rating of Retailers' relationship nwnagem.ent cluster 
and its closeness to Marketing strategies cluster. 
68 
The importance rating of the Information and communication with consumers cluster 
and its proximity to the Communication with health professionals and regulatory 
options cluster is consistent with previous studies on health enhancing foods. 
According to Ronteltap et al. , (2007), communication plays a crucial role in 
determining how novel foods are received by the consumer. The commercialization 
of these products will not be successful without relevant communication to help 
consumers making informed choices and including such products to their diets 
(Frewer, Scholderer and Lambert, 2003). Health enhancing foods have inherent 
credence attributes and therefore cannot be experienced directly by consumers either 
before or after purchase (Verbeke, 2005; Zou and Hobbs, 2006). Given this 
uncertainty, consumers have to use other product eues such as information labelling, 
health daims, educational programs, trusted source such as nutritionist, doctors, etc. 
to make informed choices (Garreston and Burton, 2000; Hailu et al., 2009; Kozup, 
Creyer and Burton, 2003; Roe, Levy and Derby, 1999; Wansink, 2003). In fact , the 
lack of trust from consumers toward the benefits of health enhancing foods could 
potentially be overcome with sufficient education and support from the health and 
government organizations (Siedlok, Smart and Gupta, 2010). The communication of 
health benefits of health enhancing foods to consumers requires: (1) information 
activities that are targeted to consumers and opinion-leaders (nutritionist, medical 
doctors, etc.) (Hobbs, 2002), and (2) regulatory structures to validate the safety and 
efficacy of these products and therefore boast consumer confidence (Ray, 2004). 
Thereby, the communication partition (Figure 2.3) provides a response to the 
challenge of uncertainty that health enhancing food companies are facing, especially 
the uncertainty that is related to market acceptance and information asymmetry. 
The importance of Market-oriented innovation nwnagem.ent cluster is heavily 
supported by previous studies. It is recognized that innovation helps firms gain profits 
(Costa and Jongen, 2006; Kelly, 2009; Sarkar and Costa, 2008; Traill and 
-~- -- ------------------------------
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Mueulenberg, 2002) and maintain a sustainable competitive advantage (Bard, 
Balachandra and Kaufman, 1988; Kirwin, Sporleder and Hooker, 2008; Mikkola 
2001). 
Regarding the association of Market-oriented innovation managem.ent cluster with 
Networking and institutional support cluster, this lends evidence to the contentions of 
previous studies. According to Siedlok, Smart and Gupta (2010) , inter-finn, inter-
industrial and, to sorne extent, inter-institutional collaborations are driven by 
advances in technology and innovation and changes in the social trends . In fact, 
Tether (2002) , argues that innovation is no longer considered as an individual 's 
action but rather, a collective action between diverse partners. Diverse collaborative 
networks and arrangements are critical to develop radical innovative products, such 
as health enhancing foods, and therefore improve the innovation capability of the firm 
(Khan et al., 2013) . Hence, the role of pharmaceutical and nutraceuticals firms , food 
ingredient firms, packaging firms, nanotech firms, research institutes are important 
(Broring and Cloutier, 2008; Chiaroni, Chiesa and Frattini , 2011; Hobbs, 2002; 
Matthyssens, Vandenbempt and Berghman, 2008; Sarkar and Costa, 2008) for 
proving clinical efficacy of health enhancing foods and developing effective 
commercialization strategies to boast consumer awareness and acceptance of these 
products (Khan et al. 2013; Sarkar and Costa, 2008; Siedlok, Smart and Gupta, 2010). 
Furthermore, collaborations with heterogeneous stakeholders have diverse 
advantages. They enable to reduce the time frame to market and thereby counteract 
consumer's resistance; attain a comparatively speedy return on investment (Khan et 
al. , 2013); and broadening the nature of innovation (Hardy, 2010 in Khan et al., 
2013). 
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In addition, government support in the form of financial resources and regulatory 
structure is also important for enhancing collaborative knowledge development and 
resource sharing activities among academies, industry and research institutes 
stakeholders (Khan et al., 2013).This is essential for SMEs, who are more likely to 
avoid the challenges of establishing strategie collaborations with external partners 
because of the lack of resources and skills to adapt themselves in a rapidly changing 
innovation environment (Khan et al. , 2013). 
The Scientific partition (Figure 2.3) provides a response to the challenge of 
innovation that health enhancing food companies are facing. As stated by Khan et al. 
(2013, p.35) «The challenges of resource expansion and tùne reduction may be ntet 
through open source development and open innovation, collaborative R &D activities 
and collaborative networks (pharmaceuticallbiotech companies, research institutes 
and ingredient suppliers)». 
The high rating of retailers ' relationship management cluster and its proximity to 
marketing strategies cluster is evidenced by findings in previous studies. Given the 
intensive competition in health enhancing foods (Bigliardi and Galati , 2013; Hobbs , 
2002) and the growing power of retailers (Burch and Lawrence, 2005; Lawrence and 
Burch, 2008 ;), the access to consumers' market is mainly through the giant retailers 
(Menrad, 2003).Thereby, it is critical for health enhancing foods firms to establish 
networks with diverse channels in order to enhance the scope and speed to market 
(Sarkar and Costa, 2008). Besides, firms are increasingly required to use 
sophisticated marketing techniques to better understand the differentiated consumer 
needs (De Jong et al., 2006). 
From these findings , it appears that issues related to the distribution of health 
enhancing foods are interrelated and intertwined. In fact , for health enhancing food 
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companies, success depends heavily on management conduct, in finding high 
technologies (Kotilainen et al., 2006; Mark-Herbert, 2004) and in communicating 
effectively (Frewer, Scholderer and Lambert, 2003) the benefits of their products to 
consumers through trusted sources such as nutritionists and doctors. 
2.6 Conclusion and future research 
The a1m of this prospective exploratory research was to develop a conceptual 
framework that identifies and priorities initiatives aimed at improving the distribution 
of health enhancing foods while involving various industry stakeholders such as 
ingredient-makers, food manufacturers/processors, experts and researchers in food 
technology development, in consumer sciences, in food distribution and marketing, 
and government representatives. Concept mapping was applied in this study. The 
results generate a number of findings about how to improve the distribution of health 
enhancing foods and therefore how to best reach consumers ' market. 
First of all, the results highlight the multidimensionality of the initiatives to be 
undertaken to improve the distribution of health enhancing foods . In fact, initiatives 
are grouped into six clusters , namely: (1) Information and communication with 
consumers; (2) Market-oriented innovation management; (3) Retailers' relationship 
management; (4) Communication with health professionals and regulatory options; 
(5) Networking and institutional support; and (6) Marketing strategies . Second, the 
results provide the importance of each cluster of initiatives and therefore offer a 
useful guidance in the process of decision making by identifying the most important 
and feasible initiatives. Finally, the results provide a better understanding of the 
interrelationships between these initiatives. 
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Regarding the implications, the shared bottom-up conceptual framework about 
stakeholders involved in the improvement of health enhancing food distribution have 
both managerial and theoretical implications. On the practical front, results obtained 
can be used for planning strategie action and public policy implementations. On the 
theoretical front, the aim of this exploratory prospective study was to follow the new 
paradigm in marketing (Gummesson, Kuusela and Narvanen, 2014) which stresses 
the importance of focusing on ali stakeholders and being oriented toward the future . 
The findings show that improvements in the health enhancing food distribution go 
beyond product/market boundaries and include more contextual initiatives and 
stakeholders. The results of this study can be used to conduct further empirical 
confirmatory research for theory development regarding these aspects . 
Although the proposed framework bas been empirically produced by the analyses 
presented, and is consistent with the cunent state of knowledge in the literature, it 
may be incomplete and therefore this exploratory study bas sorne limitations. 
Participation in this project was limited to managers, government representatives and 
experts in health enhancing foods in a specifie territory (Quebec City). Future 
research should extend the present research sample to other regions and countries to 
facilitate the generalization of these findings and to perform subgroup analyses . In 
addition, the use of concept mapping in this study was limited to the identification 
and prioritization of initiatives aimed at improving health enhancing food 
distribution. Nevertheless, concept mapping is also appropriate for scale development 
and validation (Rosas and Camphausen, 2007). Future research should use clusters 
and statements generated in this study to develop and validate a scale for improving 
health enhancing food distribution. Finally, the bottom-up conceptual framework of 
this study does not provide insights to better understand interrelationships between 
initiatives aimed at improving health enhancing food distribution. Future studies can 
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focus on understanding the interaction between these initiatives and how their 
interrelationships affect the decision making process in health enhancing foods firms 
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APPENDICES 
Appendix 2.1 Reliability in concept mapping 
The traditional theory of reliability, as applied in social science, is neither directly 
appropriate nor applicable to concept mapping (Trochim, 1993). While the traditional 
theory of reliability is based on a priori known or assumed correct answer for each 
test item, there is no assumed .conect answer or correct sort in concept mapping 
(Trochim, 1993). Moreover, in traditional theory of reliability the data is typically 
stored in a matrix with respondents as the rows and items as the columns (Trochim, 
1993). In concept mapping the structure of the data matrix is reversed, with the 
columns being respondents and the rows being items (or pairs of items) (Trochim, 
1993). Thus, in traditional theory of reliability the emphasis is on each test item , or 
the total score (Trochim, 1993), whereas in concept mapping the emphasis is on the 
consistency across participants (Trochim, 1993). Therefore, it is relevant, in concept 
mapping, to speak of the reliability of the similarity matrix or the reliability of the 
map, but not of the reliability of individual statements (Trochim, 1993). 
The assessment of the reliability in concept mapping can be conducted by using the 
sorting and rating data (Rosas and Kane, 2012). A set of reliability estimates can be 
computed for assessing participants ' sorting and rating consistency. 
a) Sorting reliability 
For sorting reliability, Trochim (1993) proposed five estimates , namely: Split-half 
total matrix reliability (rsHT); Split-half map reliability (rsHM); Individual to individual 
88 
sort reliability (r11); Individual-to-total reliability (r1T) and Individual-to-map 
reliability (riM). 
The split-half total matrix reliability (rsHT) and the split-half map reliability (rsHM) are 
calculated by dividing randomly the participants into two subgroups A and B and by 
computing separately the similarity matrices (TA and T s) and the MDS maps (XA and 
X8 ) (Trochim, 1993). As shown in figure 2.4, the correlation between the similarity 
matrices for each subgroup (TA and T s) is called the Split-Half Total matrix 
reliability (rsHT) and the correlation between the two MDS maps (XA and Xs) gives 
an estimate called the Split-Half Map reliability (rsHM).These two reliability estimates 
are traditionally corrected with the Spearman-Brown correction5\Nunnally, 1978) 
because the reliability is affected by the number of participants in a given group 
concept mapping estimates (Trochim, 1993 ). Re garding the estimation of the 
individual-to-total reliability (r1T) and the lndividual-to-map reliability (r,M), one can 
compute respectively the correlation between each participant's binary sort matrix 
(SNxN) and the total si.milarity matrix (T NxN) (Trochim, 1993) and the correlation 
between each person's binary sort matrix (SNxN) and the distances on the final map 
(DNxN) (Trochim, 1993) (Figure 2.4 ). Finally, the individual-to-Individual sort 
reliability (r11) is calculated by computing the correlations between ali pairs of 
participant's binary sort matrix (SNxN) (Trochim, 1993) (Figure 2.4). 
In this study, all these sorting reliability tests are depicted in Table 2.4. The split-half 
total matrix reliability (rsHT) and the split-half map reliability (rsHM) were respectively 
57 . kfij 
Spearman-Brown correction formula: fkk = 
· 1 + ( k - 1) r ii 
Where: 
r;i = the conelation estimated from the data 
k = N/n where N is the total sample size and n is the sample size on which r;i is based 
1 
89 
(0.89 and 0.82). For the individual-to-total reliability (r1T) and the individual-to-map 
reliability (r!M), they were respectively 0.97 and 0.94. Finally, the average Individual-
to-Individual sort reliability (r11) was 0.90. These estimates indicate that there is a 
considerable consistency in the concept mapping results. Moreover, ali these 
estimates were higher than those obtained in Rosas and Kane (2012)58 and Trochim, 
(1993 )59 (Table 2.4). 
b) Rating reliability 
Rating reliability can be assessed by computing the correlation among items using 
Cronbach' s alpha and the inter-rater reliability coefficient (AI CC) (Rosas and Kane, 
2012). 
In this study, the Cronbach 's alpha coefficients for rating 1 (importance) and rating 2 
(feasibility) were respectively 0.92 and 0.90 (Table 2.4) . Although, these estimates 
are lower than Rosas and Kane (2012) (both 0.97) (Table, 2.4) , they are still excellent 
because a Cronbach's alpha higher than 0.95 can reflect excessive redundancy in 
statements and a greater number of items (Cortina, 1993).The Cronbach's alpha 
coefficients for rating 1 (importance) and rating 2 (feasibility) , obtained in this study, 
suggest that the statements on the importance and feasibility scales are highly 
intercorrelated and internally consistent (DeY ellis, 1991). 
Regarding, the average inter-rater reliability coefficient (AICC 1) for importance 
scale and the average inter-rater reliability coefficient (AICC 2) for feasibility scale, 
they were respectively 0.82 and 0.79, suggesting that across raters, the importance 
58 A poo led analysis of 69 concept mapping studies. 
59 A poo led analysis of 38 concept mapping studies. 
90 
and feasibility ratings are stable. In a pooled analysis of 69 concept mapping projects, 
Rosas and Kane (2012) reported that the average AICC 1 value was 0.89 (SD= 0.09, 
range: 0.69-0.99, 95% CI [0.88-0.91]). However, in Trochim's (1993) pooled 
analysis of 38 concept mapping projects, the AICC 1 average value was 0.78 (SD= 
0.12, range: 0.43-0.94). Therefore, the AICC 1 value obtained in this study is lower 
than AICC 1 average value reported by Rosas and Kane (2012) but higher than AICC 
1 average value reported by Trochim (1993) (Table 2.4). In fact , the number of 
participants in this study (21) is 4 times lower than participants ' average presented in 
Rosas and Kane's (2012) pooled analysis (M=81.77 , SD= 69.83 , range: 18-485, 95 % 
CI [64.99-98.54]) (Table 2.5). Nevertheless, the number of participants in this study 
is higher than the average of participants presented in Trochim' s (1993) poo led 
analysis (M= 13.94, SD= 5.69, range: 6-33) (Table 2.5) . Regarding AICC 2, Rosas 
and Kane (2012) reported that the average AICC 2 value was 0.87 (SD= 0.10, range: 
0.42-0.97, 95% CI [0.84-0.90]). Thus , the AICC 2 value obtained in this study is 
lower than AICC 2 average value reported by Rosas and Kane (2012) (Table 2.4). As 
explained for AICC1, this is mainly due to the number of participants in this study 
comparing to Rosas and Kane (2012). In fact, there is three times less the number of 
participants in this study than the one reported by Rosas and Kane (20 12) (Table 2.5). 
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Figure 2.4 The key components in the concept mapping data and the related 
reliability estimates. Source: Trochim (1993, p. 6) 
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Appendix 2.2 Cluster statement list -Communication with health professionals and 
regulatory options-
Odre No E noncés importa nts Importa nce Faisabilité Faisabilité 
d'importance énoncé moyenne (0-6mois) (6mois-
de l'énoncé 2ans) 
De s'assurer que le contenu du message livré 
1 20 au consommateur sur ces ali ments est 4,55 x x 
confo rme à la réglementation des autorités 
nationales responsables (ex. Santé Canada) 
De rendre l' information au sujet des ces 
2 27 ali ments disponi ble auprès des 4,00 x x 
profess ionnels de la santé (ex. médecins, 
intervenants en prévention, etc.) 
D' interpréter la valeur scienti fiq ue des 
3 72 ingrédients de ces aliments pour aider les 3,85 x x 
consommateurs à faire de bons choix 
De simplifier et d' uni formiser les logos de 
4 53 certifi cations ou d' homologation de ces 3,75 
aliments 
De fa ire des relations publiq ues avec le 
5 79 réseau des professionnels de la santé 3,70 x x 
Appendix 2.3 Cluster statement list -Information and communication with 
consumers-
Odre No Enoncés importants Importance Faisabilité 
d'importance énoncé moyenne (0-6mois) 
de l'énoncé 
De s'assurer que le contenu d'une all égation 
1 2 santé de ces aliments soit compris par le 4,65 
consommateur 
De s 'assurer que le consommateur soit en 
2 44 mesure de lire est de comprendre l'étiquette 4,45 x 
de ces aliments 
De sensibili ser le consommateur aux 
3 12 bienfaits associés à la consommation de ces 4,45 x 
aliments 
D' informer les consommateurs sur les 
4 21 bienfaits de ces aliments par le meilleur 4,45 x 
canal de communication di sponible 
De s'assurer que le message au sujet des 
5 1 bienfaits de ces aliments soit transmis 4,40 
clairement tout au long de la chaîne 
jusqu 'au détaillant 
D'attirer l'attention des médias(reponages 
6 42 télé, radio, journaux, magazines) pour 4 ,15 x 
faciliter la di stribution de ces aliments 
De sensibiliser le consommateur sur les 
7 38 bienfaits de ces aliments par des articles de 
vulgari sation dans les magazines et journaux 4, 15 x 
de masse 
De vulgari ser les termes trop <<Sc ientifiques» 
8 4 ou <<techniques>> typiquement utili sés pour 4 ,10 x 
que les consommateurs comprennent les 
bienfaits de ces aliments 
9 6 De bien positionner ces aliments par rappon 4,10 x 
à leurs principaux bienfa its sur la santé 
JO De sensibiliser le consommateur aux 
3 1 bienfaits de ces aliments par des 4,05 
informati ons spécifiques à leur suj et sur les 
étiquettes 
De faciliter la reconnaissance par les 
Il 45 consommateurs de ces aliments par des 3,95 
programmes de promotion ou labels (ex. 
semblable à celui de << Aliments du Québec>>) 
De mettre en ligne des portail s 
12 80 d' informations que le consommateur peut 3,95 x 
consulter pour s' informer au sujet des 
ingrédients de ces aliments 
De communiquer de manière di stincte, mais 
13 73 cohérente, les bienfaits de ces aliments selon 3,90 x 
les différents types de détaillants (ex. : un 
pharmacien, un gérant de supermarché ou de 
boutique spécialisée, un chef cuisinier dans 
un restaurant, etc.) 
95 
Faisabilité 
(6mois-
2ans) 
x 
x 
x 
x 
x 
x 
x 
x 
x 
96 
Appendix 2.4 Cluster statement list -Market-oriented innovation management-
Odre No E noncés importants Importance Faisabilité Faisabilité 
d'importance énoncé moyenne (0-6mois) (6mois-
de l'énoncé 2ans) 
De s'assurer de comprendre son propre 
1 46 modèle d' affaires lors de la recherche et du 4 ,20 x x 
développement de ces ali ments 
De s'assurer de comprendre son propre 
2 47 modèle d'affaires lors de la mise en marché 4 ,15 x x 
de ces aliments 
De prendre en compte parall èlement les 
3 7 1 dimensions scientifiques, réglementaires et 4,00 
marché/produit de ces ali ments 
D' intégrer la cu lture d' innovation dans la 
4 15 mission de l' entrepri se 4 ,00 x x 
D' innover sur la dimension scientifique de 
5 68 ces aliments 4,00 x 
D' innover sur la di mension marché/produit 
6 69 de ces ali ments 3,95 
D' innover sur la dimension vente de ces 
7 70 ali ments 3,90 
Appendix 2.5 Cluster statement list -Networking and insti tutional support-
Odre No E noncés importa nts Importance Faisabilité Faisabilité 
d ' importance énoncé moyenne (0-6mois) (6mois-
de l'énoncé 2ans) 
D'appuyer la recherche et le développement 
1 13 de ces aliments par des incitatifs fi nanciers 4,30 x x (ex. subventions, crédits d' impôt aux 
entrepri ses) 
De favori ser les partenariats entre les 
2 57 entreprises et les institutions (ex . centres de 4, 10 x x 
recherche) responsables de la recherche et 
développement de ces aliments 
D'améliorer le lien de confiance et de 
3 56 compréhension entre l'ensemble des 
intervenants pour les al iments santé 
3,85 x x 
D 'encourager l ' innovation ouverte pour 
4 74 partager les coûts des essai s cl iniques des 3,80 x x 
ingrédients de ces a liments 
De mettre à la di sposition des fab ri cants un 
5 10 programme de fi nancement d' études 3,70 x 
cliniques de ces aliments 
De mettre en place des procédures de 
6 52 réduction du délai d'obtention d' un NPN 3,65 
(Numéro de Produit Natu rel)-homologué par 
Santé Canada) pour les PSN (Produits de 
Santé Naturels) 
De favoriser les partenariats entre les 
7 58 entrepri ses liées à la fab ri cation de ces 3,60 x x 
aliments 
97 
Appendix 2.6 Cluster statement list -Retailers' relationship management-
Odre No Enoncés importants Importance Faisabilité Faisabilité 
d'importance énoncé moyenne (0-6mois) (6mois-
de l'énoncé 2ans) 
De connaître la perception du consommateur 
1 22 face aux bienfaits de ces aliments 4 ,35 x x 
De s'assurer que le détaillant est détenniné à 
2 6 1 promouvoir et à mettre en valeur ces 4,30 x x 
aliments 
De s' assurer que le prix de ces aliments 
3 78 refl ète une légère prime qui soit acceptable 4 ,20 x x 
pour le consommateur 
De savoir si le consommateur di stingue les 
4 64 aspects santé, fonctionnels et nutritifs de ces 
aliments 
4 ,05 x x 
De prendre des initiatives peu coûteuses 
5 60 mais efficaces à mettre en place pour 
promouvoir ces aliments 
3,90 x x 
De di spenser des formati ons au suj et de ces 
6 39 aliments aux détaillants et aux comt iers 3,85 x 
De favoriser les partenariat s entre les 
7 36 entreprises liées à la fabrication de ces 
aliments 
3,70 x 
De convaincre le détaillant de l' avantage de 
8 67 ces aliments comparati vement aux a liments 
conventionnels 
3,70 x 
Appendix 2.7 Cluster statement list -Marketing strategies-
Odre Nu Enoncés importants Importance Faisabilité Faisabilité 
d'importance énoncé moyenne (0-6mois) (6mois-
de l'énoncé 2ans) 
De mener des études pour connaître la 
1 66 sati sfaction perçue de ces aliment s suite à leur 
consommation 
4 ,35 x x 
De mener des études de comportement du 
2 65 consommateur pour connaître sa 
compréhension de l'aspect santé de ces 
4 ,15 x x 
aliments 
De différencier constamment l' offre de 
3 77 l' entreprise de celle de ses concurrents 4,05 x x 
De connaître la sensibilité du consommateur 
4 33 face aux prix de ces aliments 3,90 x x 
D'améliorer le processus de gesti on marketing 
5 3 de J' entreprise pour ces produits 3,75 x x 
CHAPITRE III 
ARTICLE 2 
IMPROVING THE DISTRIBUTION OF HEALTH ENHANCING FOODS : A 
QUALITATIVE SYSTEM DYNAMICS APPROACH 
r 
1 
FOREWORD 
This paper builds on results of Article 1 of this thesis. Following, the study conducted 
in Article 1, a conceptual framework was generated to help individual stakeholders in 
the health enhancing foods industry to identify and prioritize initiatives aimed at 
improving distribution of the ir products . The se initiatives were grouped by 
participants into six clusters, namely: (1) Information and communication with 
consumers; (2) Market-oriented innovation management; (3) Retailers' rel ationship 
management; (4) Communication with health professionals and regulatory options; 
(5) Networking and institutional support; and (6) Marketing strategies . Thereby, it 
has been shown after handling concept mapping in Article 1 that the improvement of 
health enhancing food distribution goes beyond product/market boundaries and 
includes more contextual initiatives. Although, results of Article 1 can help marketing 
managers understand issues related to the distribution of their products, assist them in 
îdentifying potential useful actions for strategie planning and improve their deci sion 
making process , it does not provide a deeper understanding about the complexity of 
feedback loops between initiatives as they relate to the improvement of health 
enhancing food distribution. To do so, a qualitative System Dynamics (SD) approach 
was used in Article 2. According to Gharajedaghi (2006) , Homer (1996) , Luna-Reyes 
and Anderson (2003), Senge (1990) and Sterman (2000, 2001) SD heJp understand 
the underlying structure of complex systems. 
SD was developed in 1958 by Jay W. Forrester to study complex systems in which 
severa] variables are interrelated (Sterman, 2001). The core premise in SD modeling 
is viewing all variables in a system as having both dependent and independent 
relationships (Luna-Reyes and Andersen, 2003; Sterman, 2000). Th us, the purpose of 
SD is to understand the system behavior and its evolution over time. It is based on 
systemic thinking rather than linear thinking that ignores side effects (Senge, 1990; 
Sterman, 2000). According to Cloutier (2001) , SD has several advantages, it helps: 
- Increase understanding of the impact of decisions over time; 
- Identify strengths and weaknesses of available options; 
- Provide a "safe" environment for discussing strategies; 
- ldentify strategies that meet business objectives; 
- Provide analysis that represents multiple points of view; 
- Disseminate information more quickly in the organization. 
This paper focuses on interrelationships between initiatives aimed at improving the 
distribution of health enhancing foods . By using qualitative SD approach, this study 
takes into account the complexity, the structure to depict the uncertainty of the health 
enhancing foods industry and provides a systemic perspective. 
-------------------- - --- - - - - · -
ABSTRACT 
This article develops an influence diagram (ID) to analyze interactions between a set 
of initiatives to be undertaken by a group of stakeholders working toward the 
improvement of health enhancing food distribution. The analysis is based on a 
conceptual framework designed for improving the distribution of health enhancing 
foods (El Ourabi, Cloutier and Filiatrault, 2015) and applies a qualitative System 
Dynamics (SD) approach. The ID emphasizes dynamic forces, namely 
communication and regulatory options dynamics, commercial and scientific 
dynamics. These dynamic forces are represented by the interrelationships amongst: 
(1) Information and communication with consumers, (2) Communication with health 
professionals and regulatory options, (3) Market-oriented innovation management, 
(4) Networking and institutional support, (5) Retailers' relationship management, and 
(6) Marketing strategies . 
Data collected from unstructured individual interviews with experts in health 
enhancing foods and from two group discussion sessions with a heterogeneous group 
of 18 participants (ingredient-makers, food manufacturers/processors, experts and 
researchers in food technology development, in consumer sciences, in food 
distribution and in marketing, and government representatives) was used to represent 
these interactions. 
The data was analyzed by applying inductive system diagram methods (Burchill and 
Fine, 1993, 1997) that combines aspects of grounded the01·y methods (Glaser, 1978; 
Glaser and Strauss, 1967; Strauss, 1987) and System Dynamics (Goodman, 1974; 
Randers, 1980). 
The results show that the systemic improvement of the health enhancing food 
distribution depends simultaneously on the interaction amongst various initi atives 
related to communication and regulatory dynamics, commercial dynamics and 
scientific dynamics. The results bring some understanding of the interplay and 
complexity of feedback loops between regulatory, commercial and scientific-related 
variables and parameters as they relate to health enhancing food distribution. 
KEY WORDS : System dynamics (SD), initiatives, inductive system diagram, 
distribution, health enhancing foods, qualitative analysis, influence diagram (ID). 
------------ --------------- -----
1 
RÉSUMÉ 
Un diagramme d'influences (DI) a été élaboré dans cet article afin d'analyser les 
interactions entre les interventions spécifiques à entreprendre par les parties prenantes 
de l'industrie des aliments santé pour améliorer la distribution de ces produits . 
L'analyse se base sur un cadre conceptuel conçu pour l'amélioration de la distribution 
des aliments santé (El Ourabi, Cloutier et Filiatrault, 2015) et utilise une approche 
qualitative de la dynamique· des systèmes (DS) . Le DI met l'accent sur les forces 
dynamiques à savoir la communication et les possibilités réglementaires, la 
dynamique commerciale et la dynamique scientifique. Ces forces dynamiques sont 
représentées par les interrelations parmi : (1) Information et communication avec les 
consommateurs , (2) Communication avec les professionnels de la santé et possibilités 
réglementaires, (3) Gestion de l ' innovation contextualisée avec le marché, (4) 
Réseautage et support institutionnel, (5) Gestion de la relation avec les détaillants, et 
(6) Stratégie marketing. 
Des données recueillies à partir d'entrevues individuelles non structurées avec des 
experts en aliments santé et également à partir d' un groupe de discussion avec 18 
participants (fabricants d'ingrédient, fabricants/transformateurs , experts et chercheurs 
en développement de la technologie, en sciences de la consommation, en distribution 
et en marketing alimentaire et des représentants du gouvernement) ont servi à la 
représentation de ces interrelations. L ' analyse des données a été réalisée par 
l'utilisation de la méthode inductive du diagramme d'influence de la dynamique des 
systèmes (inductive system diagram method) (Burchill et Fine, 1993, 1997) qui 
combine des aspects de la théorie enracinée (Glaser, 1978; Glaser et Strauss, 1967; 
Strauss, 1987) et la dynamique des systèmes (Goodman, 1974; Randers, 1980). Les 
résultats montrent que l'amélioration de la distribution des aliments santé dépend 
simultanément de l'interaction entre différentes interventions liées à la dynamique de 
communication et réglementation, la dynamique commerciale et la dynamique 
scientifique. Les résultats approfondissent la compréhension de l ' interaction entre les 
enjeux réglementaires, commerciaux et scientifiques dans l'amélioration de la 
distribution des aliments santé. 
MOTS-CLÉS : Dynamique des systèmes (DS), interventions, méthode inductive du 
diagramme d'influence de la dynamique des systèmes (inductive system diagram 
method), distribution, aliments santé, analyse qualitative, diagramme d'influence 
(DI). 
3.1 Introduction 
Severa! factors affect the growth of an industry such as the competitive dynamics, 
customer power, technology and innovation, regulation and policy structures, system 
complexity, etc. (Fine, 1999). The health enhancing foods 60 industry is evolving and 
dynamic (Hobbs, 2002; Malla et al., 2013) . It is characterized by changing consumer 
market and technology environments (Hobbs, 2002; Siedlok, Smart and Gupta, 
2010), transformed supply chains (Hobbs, 2002) and changing regulations (Hobbs, 
2002; Malla, Hobbs and Sogah, 2013; Siedlok, Smart and Gupta, 2010). 
These characteristics pose both great opportunities and maJor challenges for 
companies and their marketing strategies. Indeed, food, pharmaceuticaJ and retail 
companies alike enter the health enhancing foods market and are Jooking for ways to 
earn profits and gain a competitive advantage (Herath et al., 2008 ; Kleef et al. , 2002; 
Lagorce, 2009). However, the characteristics of the food industry in general are 
challenging the static equilibriurn assumptions of traditional economie the01·y 
(Boehlje, Roucan-Kane and Broring, 2011 ). Indeed, managers are making decisions 
in a cornplex environment characterized by nonlinear processes, open systems, 
incomplete information, errors and biases in decisions (Boehlje, Roucan-Kane and 
Broring,20 11). 
First, managers make decisions in a changing technology environment, a changing 
consumer market, an uncertain regulatory and highly competitive environment both 
60 Health enhancing food is a food that-beyond its basic nutritional value- provides demonstrated health benefits 
which can justify the use of nutritional, functi onal or ri sk reducti on allegation (Corcuff et al. , 20 Il ). 
Comparatively to a conventional food product, health enhancing food has a native or induced compositi on or is 
developed from a particular technology aimed at improving its nutrient content and/o r bioactive compounds and 
thus providing scientificall y demonstrated health benefi ts (Cortuff et al. , 20 11 ). The health enhancing food 
category includes functi onal foods , natural health product (NHP), fo od supplement, etc.). 
- ·-- - - ---------------.., 
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downstream and upstream the value chain (Bigliardi and Galati, 2013; Boehlje, 
Roucan-Kane and Broring, 2011; Hobbs, 2002; Siedlok, Smart and Gupta, 2010) 
Second, supply chains are very complex (Broring, 2008; Hobbs, 2002; Sakaran, 
2005; Sakaran and Mouly, 2007) fragmented and not well coordinated (Broring, 
2008). Third, the health enhancing food industry is evolving and dynamic (Hobbs, 
2002; Malla et al. , 2013). Food value chains are now being demand driven (Elfers, 
2005; Evans and Lozinski 2004; Hodgins, 2011 ; Sakaran, 2005) with empowered and 
nutritionally aware consumers (Sakaran, 2005) and more consolidated and powerful 
retailers (Burch and Lawrence, 2005; Elfers, 2005; Hodgins , 2011). These challenges 
influence marketing managers ' decision making process about how to improve the 
commercialization and distribution of health enhancing foods. 
Furthermore, previous research in food and agribusiness has mostly used static 
analytical frameworks (Boehlje, Roucan-Kane and Bré:iring, 2011) , while in 
marketing, decisions have indirect, delayed, nonlinear and multiple feedback effects, 
and multiple inputs and outputs (Sisodia and Hm·Jey, 2002; Richardson and Otto, 
2008). In fact , the decision process requires broader and more powerful analytical 
frameworks that must be dynamic both in time and uncertainty dimensions 
(Beinhocker, 2006; Boehlje, Roucan-Kane and Broring, 2011). According to Boehlje, 
Roucan-Kane and Broring (2011), firms in food and agribusiness industries must 
utilize qualitative and/or quantitative methods to determine the scope of possible 
outcomes and adjust their strategies accordingly. 
Moreover, it has been argued recently, that mainstream research methods in 
marketing and in social science in general, focus on simple and unidirectional causal 
relationships between a few variables and therefore shun complexity, uncertainty and 
dynamics of the marke.t (Gummesson, Kuusela and Narvanen, 2014). As a 
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consequence, strategie decision making in marketing is without systemic or holistic 
views and understanding of the market (Gummesson, Kuusela and Narvanen, 2014). 
Therefore, a new paradigm in marketing theory has recently emerged (Gummesson, 
Kuusela and Narvanen, 2014). lt is based on integration, interdependency, network 
and systems thinking (Gummesson, Kuusela and Narvanen, 2014) . This paradigm's 
emphasis is on ali stakeholders, and thus, on complexity and higher level the01·y 
generation (Gummesson, Kuusela and Narvanen, 2014). 
In response to this new paradigm and to the research needs identified by Boehlje, 
Roucan-Kane and Broring (2011), the aim of this research is to identify and provide a 
better understanding of the dynamics between a set of initiatives to be undertaken by 
individual stakeholders working toward the improvement of health enhancing food 
distribution. The main research questions this paper answers are the following: 
1) What is the structure of the initiatives aimed at improving the distribution of 
health enhancing foods? 
2) How do the initiatives aimed at improving the distribution of health 
enhancing foods interact together? 
A qualitative System Dynamics (SD) approach was used as a research method in this 
exploratory study to map interactions between a set of initiatives to be undertaken by 
individual stakeholders aimed at improving the distribution of health enhancing 
foods . The use of qualitative SD modeling in this research is appropriate because it 
supports managers understanding the interactions and the underlying structure of 
complex systems in which all variables have both dependent and independent 
relationships and therefore improve their decision making process (Gharajedaghi, 
2006; Homer, 1996; Luna-Reyes and Anderson 2003; Sengè, 1990; Sterman, 2000, 
2001). Moreover, SD is appropriate because managers are limited in their thinking by 
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bounded rationality and often adopt linear thinking that ignores feedback processes 
that impedes them to better know the complexity of their systems. Consequently, this 
may affect negatively their decision making process (Desthieux, Joerin and Lebreton, 
2010; Eden, 1994; GroBler, Millinga and Winch, 2004; Sterman, 2000). Finally, as 
suggested by Behara (1995), system thinking has maximum impact when applied to : 
- Issues that span multiple disciplines and involve high degree of complexity 
and dynamic behavior that require a significant amount of management time. 
- Situations involving chronic problems with multiple interconnected 
operational issues. 
- Problem situations that have resisted traditional solutions. 
The remainder of this article is organized as follows. In the next section , a literature 
review is presented. The paper theo presents, in section 3.3, the research methods. 
The results are described in section 3.4. Findings are discussed in section 3.5. The 
paper concludes, in section 3.6, with a summary of managerial implications, 
limitations and avenues for future research. · 
3.2 Literature review 
This section describes the context of the health enhancing foods .industry and 
summarizes results of the literature. The challenging characteristics of the health 
enhancing foods industry are presented in subsection 3.2.1. Then, section 3.2.2, 
presents a conceptual framework for improving health enhancing food distribution 
(El Ourabi, Cloutier and Filiatrault, 2015) that this article builds on to map the 
interactions between a set of initiatives aimed at improving the distribution of these 
products. 
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3.2.1 The challenging characteristics of the health enhancing foods industry 
The health enhancing foods industry exhibits a number of challenging characteristics. 
First, supply chains are complex (Broring, 2008; Hobbs , 2002; Sakaran, 2005; 
Sakaran and Mouly, 2007), fragmented and not well coordinated (Broring, 2008). 
Second, the supply chains are evolving and dynamic (Hobbs , 2002). They have 
evolved into being buyer driven (Elfers , 2005; Evans and Lozinski , 2004; Hodgins, 
2011; Sakaran, 2005). Finally, the environment is highly volatile and un certain 
(Boehlje, Roucan-Kane and Broring, 2011; Hobbs, 2002; Siedlok, Smart and Gupta, 
2010). Each of these challenging characteristic is described below. 
a) Challenging characteristics: Complex supply chains 
Several studies both on agri-food products (Boehlje, Roucan-Kane and Broring, 
2011; Pritchard and Burch, 2003; Yakovleva and Flynn, 2004) and health enhancing 
foods (Broring, 2008; Hobbs, 2002; Sakaran, 2005; Sakaran and Mouly, 2007) stated 
supply chains are complex, fragmented and not well coordinated. 
The complexity of supply chains of health enhancing foods is mainly due to the 
nature of functions61, participants involved and their relationships (Hobbs, 2002; 
Sankaran 2005; Sakaran and Mouly, 2007). In fact , the functions within the health 
enhancing foods chains are numerous; they follow the commercialization pathway 
from idea!basic R&D, technology development, technology transfer, 
production/processing, product approval , and elaboration of marketing strategies 
(Herath et al., 2008; Hobbs , 2002). This process is complex and costly (Kleef et al., 
2002, 2005). It requires resources from academie, commercial and regulatory 
interests (Jones and Jew, 2007). 
61 That are needed to turn an innovation into a marketable product (Herath et al. , 2008). 
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First, significant research efforts are needed. This includes identifying bioactive 
compounds in foods and assessing their physiological effects, developing appropriate 
food matrix, taking into account bio-availability and possible changes during 
processing and food preparation and clinical trials on product efficacy to obtain 
health claims for marketing (Kotilainen et al., 2006). Second, strict legislative aspects 
must be taken into account when developing and commercializing health enhancing 
foods (Jones and Jew, 2007; Malla, Hobbs and Sogah, 2013). Finally, the marketing 
of health enhancing foods requires developing new markets, developing packaging 
and design, building strong marketing and branding programs, elaborating consumer 
education programs, etc. (Jones and Jew, 2007; Mark-Herbert, 2003 ; Siedlok, Smart 
and Gupta, 2010). Important financial resources over a long period of time are also 
required for basic research, technology development and commercialization, product 
approval, and elaboration of marketing strategies (Hobbs, 2002; Siedlok, Smart and 
Gupta, 2010). 
Given the complexity of the health enhancing foods market (Hobbs, 2002; Sankaran 
2005; Sakaran and Mouly, 2007; Siedlok, Smart and Gupta, 2010), multiple actors 
participate along the value chain and form complex relationships to better coordinate 
fonctions to be undertaken (Siedlok, Smart and Gupta, 2010) . Hence, collaborative 
arrangements such as alliances, partnerships and joint ventures are formed between 
diverse partners along the supply chains (Chiaroni , Chiesa and Frederico, 2011; Khan 
et al. , 2013; Hobbs, 2002; Sakaran, 2005 ; Siedlok, Smart and Gupta, 2010). 
Moreover, research procedures and collaboration partners change several times 
during this process (Sakaran, 2005). As illustrated in Figure 3.1, a complex web of 
nontraditional actors are participating in the Canadian health enhancing foods 
industry such as pharmaceutical companies, food processors, research institutions, 
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universities, policy making agencies, farm inputs companies, retailers , consumers, 
health care givers, financial corppanies, etc. (Basu, Thomas and Acharya, 2007). 
These actors form an interconnecting network for technological development and 
intellectual property, for clinical testing to prove health daims, and for brand 
development and market entry (Mark-Herbert, 2002; Sakaran, 2005). Furthermore, 
when firms go beyond a collectively shared knowledge framework to seek the 
expertise they lack through collaboration, they engage in 'knowledge networking' 
(Lang1ais, Janasik and Bruun, 2004). Collaboration between diverse actors is critical 
to deliver new products to the market (Broring and Cloutier, 2008; Chiaroni, Chiesa 
and Frederico, 2011; Hobbs, 2002; Khan et al. , 2013; Matthyssens,Vandenbempt and 
Berghman, 2008; Sarkar and Costa, 2008; Siedlok, Smart and Gupta, 2010) . 
Figure 3.1 Principal stakeholders in the Canadian health enhancing foods industry. 
Source: Basu, Thomas and Acharya (2007, p. 2) 
----------------------
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b) Challenging characteristics: Evolving and dynamic supply chains 
The health enhancing foods is an evolving and a dynamic industry (Hobbs, 2002; 
Malla et al. , 2013). In Canada, food supply chains are controlled by nontraditional 
actors at the consumption end rather than at the production end of the spectrum 
(Hodgins, 2011). Indeed, food value chains have evolved over time into being 
demand driven (Elfers, 2005; Evans and Lozinski , 2004; Hodgins, 2011; Sakaran, 
2005) and controlled by powerful retailers (Burch and Lawrence, 2005 ; Elfers, 2005; 
Hodgins, 2011 ). Following major drivers in the health enhancing foods such as, 
consolidation (concentration), technology development, globalization and health shift 
from therapeutic to preventive (Hodgins, 2011 ), consumers are increasingly 
empowered and nutritionally aware (Sakaran, 2005) and retailers are more 
consolidated and operate in highly concentrated markets. 
Regarding consumers, they are increasingly seeking products tailored to their needs, 
aimed to prevent chronic diseases such as osteoporosis, cardiovascular disease and 
Alzheimer' s disease and optimize their health , for example by boosting the immune 
system and by increasing energy (Regmi and Gehlhar 2005 ; Sadler, 2005). Moreover, 
consumers are now telling the companies what they want as foods (Aguilera, 2006) 
and these requests have evolved into mass customization (Boland, 2008). 
Consequently, consumers are pulling products through diverse channel members 
rather than products being pushed through the system by manufacturers/suppliers. 
Furthermore, the digital revolution such as e-commerce and social media has 
empowered customers (Deloite, 2014 ; Leeflang et al. , 2014). By using these 
technologies, consumers play an active role as value co-creators (Vargo and Lush, 
2008). However, this is challenging companies. For instance the social media content 
is affecting consumers more than advertising (Leeflang et al. , 2014). lndeed, it has 
--------------------------------------------------- -- -
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been argued that more than 90% of consumers read online reviews before they buy 
products and 67% of all purchases are based on user-generated content (Codes and 
Silva, 2012). Consequently, this content plays an important role in consumer's 
decision making (Codes and Silva, 2012). Essentially, consumers read at least four 
reviews before making a purchase. 
Concerning the grocery retail market, it is highly . concentrated and vertically 
integrated into food distribution (OSEC62, 2011).The six largest63 food retailers in 
Canada account for 80% of total food sales. This retail market concentration makes 
the retailers very powerful (Burch and Lawrence 2005). As defined in the distribution 
and marketing channelliterature, power is the ability to control the decision variables 
of another member (El-Ansary and Stern, 1972) or the ability to influence decision-
making and actions of other parties (Wilkinson, 1973; 1996). 
Retailers are solidifying their power in the marketplace by means of private labels 
(Elfers 2005; Hodgins, 2011; Lawrence and Burch, 2008). In Canada, private label 
packaged food reached a market value estirnated at 6.6 billion dollars in 2012 and a 
market share of 12.7% (Euromonitor, 2013 in AAFC64, 2013). 
c) Challenging characteristics: Uncertain environment 
The agribusiness industry in general is highly volatile and uncertain (Boeh1je, 
Roucan-Kane and Broring, 2011). The technological , regulatory, market, social and 
620SEC (20 Il ).The Canadian Food Retail Sec tor. Opportunities for Swiss companies A vailable online 
at: http://www.s-ge.com/en/filefield-private/fï les/2344/ fie ld blog public fil es/ 1272 
63Loblaws , Sobeys, Metro, Costco Canada, Safeway and Walmart Canada. 
64Agriculture and Agri -Food Canada. 
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competition environments are uncertain (Hobbs, 2002; Siedlok, Smart and Gupta, 
2010). Following major societal , economie and technological changes (Bigliardi and 
Galati, 2013; Boehlje, Roucan-Kane and Broring, 2011 ), the types and sources of 
uncertainties faced by the agribusiness decision makers have recentl y multiplied 
(Boehlje, Roucan-Kane and Broring, 2011 ). 
Table 3.1 summarizes key strategie uncertainties that agribusiness firms are facing 
and describes sorne exposures to each. Comparing to traditional ri sks, uncertainties 
are more complex and difficult to analyze and manage because they are not 
predictable in frequency and consequence (Boehlje, Roucan-Kane and Broring, 
2011) . Although uncertainty cannat be quantified, firms cannot ignore it (Boehlje, 
Roucan-Kane and Broring, 2011 ). In fact, uncertainty would have an effect on firm 's 
objectives (Hillson, 2003). Accordingly, managers must be proactive in managing 
uncertainty to create long-term added value (Pascale, Millemann and Gioja, 2000). 
Table 3.1 Strategie uncertainties in Agribusiness 
Types of strategie uncertainty 
Business/ Operational 
- Operations and business practices 
- Human resources 
- Strategie positioning 
Financial 
- Finaneing and finaneial structure 
- Financial markets 
Market conditions 
- Market priees and terms of trade 
- Competitors 
- Customer relationships 
- Reputation and image 
Technology 
-Technologieal change 
Business relationships 
- Business partners and partnerships 
- Distribution systems and ehannels 
Policy and regulation 
- Politieal clirnate 
- Regulatory and legislative climate 
Examples of exposures 
-Business interruption 
- Los s of key employees 
- Increasing interest rates 
- Loss of lender 
- Highly leveraged 
- Pricing pressure/discounting by 
eompetitors 
- Loss of market share 
- Consolidation 
- Hyper competition 
- Lirnited acceptance of biotechnology 
- Slow to eornmercialize new products 
- Competitor has preferred 
standards/platforrns 
- Dependence on distributors 
- Not a preferred supplier to processor 
- Not a key account to suppliers 
- Changes in intelleetual property 
- Changes in industry subsidies or tax 
poli ci es 
- Loeallimits on technology adoption 
Source: Adapted from Boehlje, Roucan-Kane and Broring (2011) 
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The uncertainty of the health enhancing food industry is mainly due to the evolving 
nature of the technology environment, consumers' acceptance of these products, 
increased competition, and the uncertainty of the regulatory environment (Hobbs, 
2002; Siedlok, Smart and Gupta, 2010). Each of these uncertainties is described 
hereafter. 
Technological uncertainty 
Following advances in technology and in social trends, the food industry shifted from 
a traditionally low-technology industry into a high-technology industry (Khan et al., 
2013; Siedlok, Smart and Gupta, 2010). The development and commercialization of 
health enhancing foods require novel knowledge, specialist skills and high 
technologies such as biotechnology, nanotechnology and genomics (Khan et al., 
2013). As a consequence, the health enhancing foods industry is a high technology 
research-intensive industry (Siedlok, Smart and Gupta, 2010) and is considered under 
the umbrella of the bioeconomy (Gault, 2007). 
Although critical to target new markets and develop radical innovative products, 
these high technologies bring additional challenge for firms (Siedlok, Smart and 
Gupta, 2010). They result in a much longer timeframe to market (Sakaran, 2005) 
because of the need for evidence based clairns (Hobbs, 2002), perturb or transform 
the whole industry (Saives, 2009), transform or displace some or all of established 
supply networks (Siedlok, Smart and Gupta, 2010) and thus reinforce high levels of 
market and environrnental uncertainties (Hobbs, 2002; Siedlok, Smart and Gupta, 
2010). Following technological changes, firrns have to manage, in an orchestrated 
way, discontinuities such as convergence, indeterrninate industry boundaries, 
disintermediation and eco-sensitivity ( consurners concerns and ac cep tance) (Siedlok, 
Srnart and Gupta, 2010). 
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Competitive environment uncertainty 
The health enhancing foods market is characterized by intensive upstream and 
downstream competition (Bigliardi and Galati, 2013; Hobbs, 2002; Lawrence and 
Burch, 2008). Regarding the upstream competition, health enhancing foods firms are 
competing with each other and with other conventional foods and pharmaceutical 
companies for bath market share, shelf space (Hobbs, 2002) and also in attracting 
investments (Hodgins, 2011). Moreover, the pharmaceutical and food processing 
industries alike are concentrated in Canada (Hobbs, 2002). 
According to AAFC (2009), the health enhancing food industry is dominated by large 
and already established firms that restrict market share gains by small companies. In 
fact, market concentration intensifies competition (Bigliardi and Galati, 2013). In 
such competitive situation, established companies maintain their market power 
through barriers to entry (economy of scales, multiple brands, etc.) and therefore limit 
the entry of small scale innovators. Consequently, small firms form strategie alliances 
or partnerships in upstream or downstream the supply chain to access financial and 
human capital resources (Hobbs, 2002; Malla et al., 2013). 
Furthermore, as mentioned above, health enhancing foods manufacturers are also 
facing downstream competition from consolidated and highly concentrated food 
retailers. Besides, food retailing concentration, the enlargement of food supermarkets' 
sizes and the advent of nontraditional actors whose main activity is not food 
distribution such as Walmart, Dollarama, drugstores, etc., are challenging food 
manufacturers who create a fier ce competition for shelf space (MAPAQ, 2007, 2009). 
In fact, it has been argued in the marketing literature that given their increasing size, 
their use of advanced technologies and sophisticated marketing strategies, retailers 
are gaining even more power (Betancourt and Goutschi, 1998; Matlack, 2009; 
~------------------------- --~-- ----- -
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Messinger and Nasasimhan, 1995; Rosenbloom, 2012). This power is continuously 
reinforced by the me ans of private labels (Elfers 2005; Hodgins , 2011; Lawrence and 
Burch, 2008). This challenges food manufacturers by shortening their product-life 
cycle (Broring, 2008; Ronteltalp et al., 2007) , especially that consumers no longer 
buy private labels only for value pricing (Martînez-Ruiz et al. , 2014) and consider 
them as lower quality substitutes (Hardy, 2010 in Khan et al., 2013; Tamilia, 1999). 
Market acceptance 
Despite the growing number of consumers who have sorne knowledge about the 
relationship between diet and diseases and their interest toward health enhancing 
foods to prevent chronic diseases or optimize their health (Sadler, 2005; Regmi and 
Gehlhar, 2005), consumers' acceptance of these products persists and translates into 
an uncertain future demand (Moorsel , Cranfield and Sparling, 2007; Siedlok, Smart 
and Gupta, 2010). In fact, health enhancing foods have credence attributes and 
consumers cannat adequately assess their properties , quality or safety before or even 
after purchase (Verbeke, 2005; Zou and Hobbs, 2006). Due to information 
asymmetry between buyers and sellers, market failures arise (Verbeke, 2005). In such 
situation, sellers have more knowledge concerning the production process, product 
origin, nutritional content, or about safety issues than buyers do (Verbeke, 2005). As 
a result, consumers are skeptical and lack trust regarding benefits of health enhancing 
foods (Hobbs, 2002; Siedlok, Smart and Gupta, 2010). 
Given information asymmetry and credence attributes of health enhancing foods, it 
was argued that labelling plays a determinant role in helping consumers make 
informed choices (Garretson and Burton, 2000; Hailu et al., 2009; Kozup, Creyer and 
Burton, 2003 ; Roe, Levy and Derby, 1999; Wansink, 2003). 
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Regulatory environment uncertainty 
In recent years, the Canadian regulatory environment for health enhancing foods has 
changed and evolved considerably. The major changes in the regulation relate to 
controls on health claims and approval of natural health products (NHP)65 (Blandon, 
Cranfield and Henson, 2007; Malla, Hobbs and Sogah, 2013). In January 2004, a new 
regulatory regime for NHP was implemented (Health Canada, 201 2). Following thi s 
new reg1me, nutraceuticals came under the broader category of NHP66 (Cinnamon, 
2007). 
Regarding health claims, 26 structure/function claims67 are currentl y approved in 
Canada for foods and nine disease risk reduction claims68 are permitted both on foods 
and on NHP (Malla, Hobbs and Sogah, 2013). These disease ri sk reduction claims are 
the following (Malla, Hobbs and Sogah, 2013): 
1. Low sodium and high potassium linked to the reduced risk of hypertension; 
2. Adequate vitamin D and calcium intake, linked to reduced risk of 
osteoporosis; 
3. A diet low in saturated fat and trans fat, and the reduced ri sk of heart disease; 
65 Such as herbai remedies, homeopathie medicines, vitamins, minerais, traditi onal medicines, 
probiotics , amino acids and essential fatty acids. 
66 Following sorne qualitati ve testing with the industry, NHP was the most commonl y used and 
accepted (Cinnamon, 2007). 
67 Structure/functi on claims relate to the effects that a food has on the normal functions of the body. 
They are based on the role that the food or the food constituent plays when consumed at levels 
consistent with normal dietary patterns.(Canadian Food Inspection Agency, 2014). Avail able online 
at:htt.p:/ /www. inspection. gc.ca!food/labell ingjfood-labe lli n g- for- i nd ustry/heal th-
claims/eng/ 1392834838383/ 1392834887794 ?chap=7#s 13c7 
68 Disease ri sk reduction claim are stateme nts that link a food to a reduced ri sk of developing a diet-
related di sease or condition in the contex t of the total di e t (Canadian Food Inspection Agency, 2014 ). 
A v ai labie onlineat: http :1 Jwww . inspection. gc.ca!food/labeii in g/food-labell in g-for-ind ustry/heal th-
claims/eng/ 1392834838383/ 1392834887794 ?chap= 14 
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4. A diet rich in vegetables and fruits, and the reduced risk of sorne types of 
cancer; 
5. Maxima fermentable carbohydrates in gum, hard candy or breath-freshening 
products, and the reduced risk of dental caries. 
6. Plant sterols and the lowing of blood cholesterol 
7. Oat products and the lowing of blood cholesterol 
8. Barley products and blood cholesterollowering 
9. Unsaturated fat and blood cholesterollowering 
Despite the positive impact of these changes on the health enhancing foods industry, 
considerable frustrations remain, especially for small and medium-sized enterprises 
(SMEs) concerning, for example the rate and the delay of approval and the ability to 
make product-specific daims (Blandon, Cranfield and Henson, 2007; Ma11a et al., 
2013). According to Saives (2009) these changes leaded to a strategie dilemma for 
firms that do not have advanced technological capabilities and thus have to consider 
opening their product portfolio to others to register their products. 
First, sorne studies stated that the Canadian regulatory system for health enhancing 
foods is still restrictive in comparison with that of other countries such as Japan, the 
United States and the European Union (Crawley, 2008; L'Abbé et al. , 2008; Ma11a, 
Hobbs and Sogah, 2013). For instance, while seventeen disease risk reduction daims 
are permitted in the United States, only nine disease risk reduction daims are 
permitted in Canada (Ma11a, Hobbs and Sogah, 2013). Further, whereas the United 
States and Japan a11ow qualified health daims69 and product specifie daims70 on 
69 Qualified health claims are claims that contain credible but inconclusive evidence (Malla, Hobbs and 
Sogah, 2013). 
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food, Canada prohibits them (Malla, Hobbs and Sogah, 2013). Moreover, most of 
structure/function daims in Canada are approved as disease risk reduction claiin in 
the United States (Malla, Hobbs and Sogah, 2013). Ultimately, Canada regulates the 
NHPs differently than food by using a product specifie system with a more 
substantial level of evidence. While, for example, in Japan NHPs are treated in a 
similar manner than food, and in the United States, they are considered distinct from 
food without imposing significant different regulations (Malla, Hobbs and Sogah, 
2013). 
Second, the regulatory regime is considered cumbersome and slow moving (Crawley, 
2008; Malla et al., 2013). Indeed, the approval process did not follow the changes in 
the foods' industry and the underlying science (Crawley, 2008; Malla et al. , 2013) 
and regulations do not follow the rate of innovation advances of health enhancing 
food companies (Crawley, 2008). 
Finally, the Canadian regulatory environment is also considered to be uncertain 
(Hobbs, 2002; Malla et al., 2013). This is mainly due to the differences in 
international regulatory systems and differences in terminologies (Hobbs, 2002; 
Malla et al., 2013). 
To sum up, it was argued that all these regulatory concerns act as barriers to the 
development and commercialization of new products , increase costs of bringing 
praduct to market, delay praduct launch, increase the risks of innovation (Burdock, 
Carabin and Griffiths, 2006; Coppens, Da Silva and Pettman, 2006) and cause 
distrust among health professionals and consumers (Malla et al. , 2013). 
70 Product specifie claims are used only by products that undergo a registration process for a claim that 
specifies a relationship between the food or food constituents and a health benefit (Malla, Hobbs and 
Sogah, 2013). 
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3.2.2 A conceptual framework for improving health enhancing food distribution 
This article builds on a conceptual framework for improving health enhancing food 
distribution (El Ourabi , Cloutier and Filiatrault, 2015). While taking into account the 
challenges that health enhancing foods industry is facing, the conceptual framework 
identifies initiatives to be undertaken by individual stakeholders working toward the 
improvement of the distribution of their products by using an integrated mixed-
method, namely concept mapping (Kane and Trochim, 2007). 
The initiatives were generated and grouped by participants (ingredient-makers, food 
manufacturers/processors, experts and researchers in food technology development, 
consumer sciences, food distribution and marketing, and government representatives) 
into six (6) clusters namely: (1) Information and communication with consumers; (2) 
Market-oriented innovation management; (3) Retailers ' relationship management; (4) 
Communication with health professionals and regulatory options; (5) Networking and 
institutional support and ( 6) Marketing Strategies. Figure 3.2 illustrates the 
conceptual framework for improving the distribution of health enhancing foods. 
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Figure 3.2 A conceptual framework for improving health enhancing food distribution 
Source: El Ourabi, Cloutier and Filiatrault (20 15) 
Although, this framework offers a shared bottom-up conceptual framework of 
stakeholders involved in the improvement of the distribution of health enhancing 
foods, it does not provide an explanation of the structure of interaction that takes 
place between the initiatives that can be undertaken to improve the distribution of 
these products over time. To do so, the SD methodology was used in this study. 
3.3 Research methods 
This exploratory study applies qualitative SD (Forrester, 1969; Mayo, Callaghan and 
Dalton, 2001; Sterman, 2000; Sterman, Repenning and Kofman, 1997) to examine 
relationships between diverse initiatives aimed at improving the distribution of health 
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enhancing foods. Previous studies that have used qualitative SD have demonstrated 
its usefulness and capability in supporting decisions (Meadows et al., 1972; 
Morecroft and van der Heijden, 1992). SD can help understand patterns of 
interactions and the underlying structure of complex systems (Homer, 1996; Senge, 
1990; Sterman, 2001). In fact, SD, as one of the system thinking approaches, is 
appropriate when applied to complex issues, dynamic behavior, and situations with 
numerous interconnected elements that span multiple disciplines (Behara, 1995). 
Especially, the environment of health enhancing foods firms is highly volatile, 
uncertain, complex, evolving and dynamic (Broring, 2008; Hobbs, 2002; Malla et al., 
2013; Sakaran, 2005; Sakaran and Mouly, 2007; Siedlok, Smart and Gupta, 2010) 
and consequently the decision process is characterized by nonlinearity , open systems, 
incomplete information, errors and biases in decisions (Boehlje, Roucan-Kane and 
Broring, 2011). In this complex environment, both the system and agents within the 
system (stakeholders) influence the industry dynamics (Lane, 1995). Thereby, the use 
of qualitative SD in this research is appropriate. 
In accordance with previous studies describing modeling processes (Sterman, 2000; 
Randers, 1980; Richardson and Pugh, 1981; Roberts et al. , 1983; Wolstenholme, 
1990), three · stages were followed in this study, namely conceptualization, 
formulation and testing. Each of these stages is briefly described below. 
a) Conceptualization stage 
The conceptualization stage involves problem articulation and a dynamic hypothesis7 1 
formulation (Sterman, 2000) following the qualitative principles of SD (Coyle, 2000; 
71 According to Sterman (2000) , a dynamic hypothesis provides an explanation of the dynamics 
characterizing the problem using feedback loops to show the the causal relationships amongst variables 
with arrows from a cause to an effect. 
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Wolstenholme, 1990), and the specifie steps suggested by Luna-Reyes and Andersen 
(2003) (Table 3.2). 
Table 3.2 System Dynamics modeling process and potential qualitative methods 
Steps in the modeling process 
Conceptualization 
Formulation 
Testing 
Problem 
articulation 
System 
conceptualization 
Mode] 
formulation 
Analysis of mode] 
behavior 
Qualitative methods 
potentially useful 
Techniques that can be 
used for problem 
identification and 
elaboration of a dynamic 
hypothesis: 
-Interviews (ranging 
from informai 
conversation to 
standardized, closed, 
fi xed-field response 
interviews) 
-Oral history 
-Focus groups 
-Henneneutics 
-Discourse analysis 
-Content analysis 
Techniques to guide 
mode] formul ation: 
-Grounded theory 
-Ethnographie decision 
models 
Techniques to obtain 
expert judgment about 
mode! structure and 
behavior: 
Mode] evaluation -Interviews 
-Focus groups 
-Delphi groups 
-Experimental 
a roaches 
Adapted from Luna-Reyes and Andersen (2003) 
Qualitative methods 
used in this study 
-Unstructured interviews 
with two ex pe1ts in health 
enhancing food sector 
-Two group discussion 
sess ions with ingredient-
makers, food 
manufacturers/processors, 
expe1ts and researchers in 
food technology 
development, consumer 
sciences, food distributi on 
and marketing, and 
go vern ment 
representatives 
-Grounded theory. 
-Interviews with 3 experts 
in health enhancing foods 
industry 
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Problem articulation 
To scope the problem of this research, identify concepts/variables and the behavior 
that should be considered in this study, unstructured interviews with two experts in 
health enhancing foods was held in December 2011. According to these experts, the 
distribution of health enhancing foods is complex. It is affected by scientific, 
regulatory and commercial issues. In other words, the decision making process 
regarding the distribution of health enhancing foods depends on the simultaneous 
consideration of (1) scientific advancements m health enhancing foods' 
transformation and processing, (2) regulatory aspects concerning approval and 
labelling of such products, and (3) consumers' needs, expectations and commercial 
aspects. This is described in the following excerpt from experts ' discourse: 
« ... Given complexity, the re are many interventions to align. The re are the 
science aspect, the regulatory aspect and the commercial aspect ... ft is a 
multitude of things that need to be connected ... The re is a collection of 
strategie infonnation in the health enhancing foods' world that must be 
cons ide red other than selling taste, se !ling pleasure. lt's even more complex ... 
. d dfl' 72 a nee sa goo re ectwn». 
During the unstructured interviews, the experts highlighted the need of convergence 
between what they called <dhe Science Sphere», the «Regulatory Sphere», and «the 
Commercial Sphere». Besides, previous studies also demonstrated the importance of 
scientific, regulatory and commercial aspects m the development and 
commercialization of health enhancing foods (El Ourabi, Cloutier and Filiatrault, 
2015; Jones and Jew, 2007; Mark-Herbert, 2003; Siedlok, Smart and Gupta, 2010). 
For example, in a recent study, El Ourabi, Cloutier and Filiatrault (2015) found that 
the improvement of the distribution of health enhancing foods depends 
72 To refer to the original excerpt in French, see excerpt #1 in Appendix 3.1. 
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simultaneously on initiatives related to scientific, communication and regulatory and 
commercial dynamics . 
Based on unstructured interviews with experts and the literature, it can be inferred 
that these issues are critical and intertwined. Figure 3.3 , illustrates the 
interrelationships between scientific, commercial and regulatory issues. 
Figure 3.3 Problem articulation related to the distribution of health enhancing foods 
Dynamic hyopothesis formulation 
The dynamic hypothesis provides an explanation of the dynamics characterizing a 
problem in terms of feedback loops that show causal links amongst variables with 
arrows from a cause to an effect (Sterman, 2000). The determination of the dynamics 
of a system involves the identification and representation of the structure of feedback 
loops (Sterman, 2001). There are two types of feedback loops: reinforcing feedback 
loops (denoted 'R') and balancing feedback loops (denoted 'B ' ). A reinforcing 
~ ~~ ~ - -------------------------------------
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feedback loop (R) 73 tends to strengthen and amplify the behavior of a system. A 
balancing feedback loop (B) 74 is an equilibrating loop which is goal or balance-
seeking. The interaction of these feedback loops generates the dynamic behavior of a 
system structure (Sterman, 2001). 
To proceed with the formulation of the dynamic hypothesis , three steps were 
followed, namely: (1) identification of themes, (2) interrelationships between themes, 
and (3) feedback loop analysis of theme structure. These steps are described in detail 
in section 3.4. 
b) Formulation stage 
The formulation stage is based on a discussion of emerging feedback loops (Luna-
Reyes and Andersen, 2003). To discuss the causalloops designed in this study, Luna-
Reyes and Andersen (2003) propose grounded theory as a qualitative data analysis 
technique. This technique has a critical role in rigourous system dynamics efforts 
(Sterman, 2000). According to Burchill and Kim (1993; 1997), the combination of 
grouded theory and SD is called inductive system diagramming. While grounded 
theory can be used to identify variables that have explanatory power and are 
intimately tied to the data, the SD shows the cause and effect relationships amongst 
these variables (Burchill and Kim, 1993). The combination of grounded theory and 
causal-loop diagramming allows researchers to generate and communicate 
empirically-based theoretical propositions (Burchill and Kim, 1993). Following 
73 In this loop, the tendency is to reinforce the initial action that is, the variables have ail the same signs 
(+)or(-) . 
74 In this loop, the tendency is to oppose the initial action , th at is the variables have opposite signs ( + 
and-) 
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Burchill and Kim (1993, 1997), inductive system diagram was used in this study to 
discuss emerging feedback loops. 
c) Testing stage 
In the testing stage, the model constructed should mirror the 'real world' (system) and 
therefore must not contradict known and existing knowledge about its structure 
(Luna-Reyes and Andersen, 2003). To do so , Forrester and Senge (1980) propose to: 
(1) review the model assumptions by persons highly knowledgeable about the real 
system, (2) compare the model assumptions with a description of decision making 
and organizational relationships found in relevant litterature. 
The ID testing of this study was realized, based on the guidelines of Forrester and 
Senge (1980). Thereby, the empirical evidence supporting each loop of the ID was 
analyzed through data gathering techniques such as interviews with highly 
knowledgeable field experts75 and supplemented by a comparison of the relationships 
with theoretical background of innovation, open innovation and networking. 
Moreover, to ensure the trustworthiness of this qualitative study, triangulation was 
used. Triangulation increases credibility (internai validity) (Logman, 2011). In this 
study, we used both data triangulation and methodological triangulation. Data 
triangulation consists in combining diverse sources 76 wh en gathering data while 
methodological triangulation or analytical triangulation (Langley, 1999) requires 
using more than one method in interpreting data (Logman, 2011). 
751nterviews were conducted with three experts in the field of health enhancing foods industry. 
76Participants of this study have diverse perspectives: ingredient-makers, food 
manufacturers/processors, experts and researchers in food technology development, in consumer 
sciences, in food distribution and marketing, and government representatives. 
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3.4 Formulation of the dynamic hypothesis 
The formulation of the dynamic hypothesis is not the ultimate goal but rather a mean 
to better understand the problem studied and reach a consensus on its representation 
(Vennix, 1996). As mentioned earlier, the formulation of the dynamic hypothesis 
takes the form of an ID that follows the three steps namely (1) identification of 
themes, (2) interrelationships between themes , and (3) feedback loop analysis of 
theme structure. 
It should be noted here, that the elaboration of the dynamic hypothesis in this study 
was based on unstructured interviews conducted with experts in the health enhancing 
foods industry, results from El Ourabi , Cloutier and Filiatrault (2015)77 and existing 
literature (e.g. Jones and Jew, 2007; Mark-Herbert, 2003; Siedlok, Smart and Gupta, 
2010). 
3 .4.1 Identification of themes: Communication and regulatory options dynamics, 
commercial dynamics ~nd scientific dynamics 
The identification of themes was based on a previous study (El Ourabi, Cloutier and 
Filiatrault, 2015) that developed a conceptual framework for improving the 
distribution of health enhancing foods. According to this study, six clusters of 
initiatives aimed at improving the distribution of health enhancing foods can be 
grouped into three major themes78 . As depicted in Figure 3.4, theme I 
(Communication and regulatory options dynamics) is composed of clusters 1 and 2 
respectively Communication with health professionals and regulatory options and 
77The first article of this thesis. 
78This partition was approved by partiCipants during the data interpretation step of the concept 
mapping project used in that study. 
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Information and communication with consumers. Theme II (Commercial dynamics) 
consists of clusters 3 and 4, namely: Marketing strategies of health enhancing foods' 
firm (cluster 3) and Retailers' relationship management with health enhancing foods 
manufacturers (cluster 4). Finally, theme III (Scientific dynamics) is made up of 
clusters 5 and 6, respectively: Networking and institutional support and Market-
oriented innovation nwnagement. 
Communication with health 
Theme 1: K professionals and regulatory options Communication and regulatory options dynamics Information and communication with 
consumers 
Marketing strategies K Theme II: Commercial dynamics Retailers' relationship 
management 
Networking and institutional 
K Theme III: support Scientiflc dynamics Market-oriented 
innovation management 
Figure 3.4 Themes related to the improvement of the distribution of health enhancing 
foods. Source: Adapted from El Ourabi, Cloutier and Filiatrault (2015) 
3.4.2 Interrelationships between themes: Communication and regulatory options 
dynamics, commercial dynamics and scientific dynamics 
As an iterative process (Sterman, 2000), SD modeling begins with a summary view 
of the interrelationships between themes. Figure 3.5 depicts the interaction between 
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communication and regulatory options dynamics (theme 1), commercial dynamics 
(theme II) and scientific dynamics (theme III). 
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Figure 3.5 Interrelationships between themes 
Communication and regulatory options dynamics (theme 1) interact with commercial 
dynamics (theme Il). This interrelationship is represented by the balancing feedback 
loop B6. In fact , initiatives related to Information and communication with consumers 
affect negatively those associated with Retailers' relationship managenœnt. These 
last initiatives support initiatives related to Information and communication with 
consumers. Furthermore, the commercial dynamics (theme Il) influences the 
scientific dynamics (theme III) and vice versa. This interaction is represented by the 
reinforcing feedback loop (R7). Thereby, initiatives related to Marketing strategies 
affect positively those related to Market-oriented innovation m.anagement and vice 
versa (R7). Finally, scientific dynamics (theme Ill) has an impact on communication 
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and regulatory options dynamics (theme 1). lndeed, initiatives related to Networking 
and institutional support influence positively Communication with health 
professionals and regulatory options. 
The description of interactions between the themes associated with the improvement 
of health enhancing food distribution (Figure 3.5) provides only insights about the 
macro behavior of the themes ' dynamics. The microstructure responsible for the 
macro behavior depicted in figure 3.5 is described hereafter by a dynamic hypothesis. 
For each of the three themes multiple feedback loops represented m the ID are 
formulated and documented. 
3.4.3 Feedback loop analysis of identified theme structure 
a) Theme 1: Communication and regulatory options dynamics 
Theme 1 describes the communication and regulatory options dynamics related to the 
improvement of the distribution of health enhancing foods. As illustrated earlier in 
Figure 3.4, the communication and regulatory options dynamics theme is made up of 
two clusters, namely: Conununication with health prof essionals and regulatory 
options and Infonnation and conununication with conswners. 
Figure 3.6 illustrates the feedba~k loops related to these clusters and the interaction 
between them. lndeed, the balancing feedback loops B 1 and B2, labeled bath 
Conununication with health professionals and regulatory options, depict the 
dynamics of initiatives related to Communication with health professionals and 
regulatory options that aim at improving the distribution of health enhancing foods. 
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The balandng feedback loop B3, named Information and communication with 
conswners, captures the dynamics of initiatives related to Jnfonnation and 
conununication with consumers and therefore aimed at improving the distribution of 
health enhancing foods. Finally, the balancing feedback loop B4 shows the 
interrelationships between Communication with health professionals and regulatory 
options (Bl and B2) and Information and communication with consumers (B3). A 
description of the feedback loops B 1, B2 and B3 followed by an analysis of their 
interaction, as delineated by (B4) is presented hereafter. 
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At the top of Figure 3.6, an illustration of the balancing feedback loops B 1 and B2 
(Conununication with health professionals and regulatory options) is provided. In 
fact, the more health enhancing food companies make the information available about 
the health benefits of their products to health professionals (for example through 
awareness approaches, information activities, and public relations) , the more they 
favor collaboration with them. Furthermore, the collaboration between health 
enhancing foods firms and health professionals facilitates the interpretation of the 
scientific value of health enhancing foods ingredients to consumers. For instance, 
when a nutritionist in a store or supermarket, provides information to consumers 
about the benefits of these products and their ingredients, the service to consumers 
would then be improved. This interpretation and dissemination of the scientific value 
of health enhancing foods ingredients to consumers leads to an alignment of the 
scientific evidence of health enhancing foods ingredients with the message sent to 
consumers. Thus, it helps consumers with health enhancing foods choices. Finally, 
when consumers are assisted with health enhancing foods choices through (1) the 
alignment of the transmitted message with the scientific evidence of health food 
ingredients, (2) the simplification and standardization of health enhancing foods 
certification logos, and (3) the conception of a general public health message related 
to health benefits, the health enhancing food companies will be less inclined to 
develop awareness approaches toward health professionals. At the same time, health 
enhancing food companies will undertake fewer initiatives aimed to consumer 
sensitization and advertising. This, however, will negatively affect the conception of 
a general public health message and therefore engenders less consumer support. 
At the bottom of Figure 3.6, the balancing loop B3 Infonnation and communication 
with consumers is illustrated. The more health enhancing food companies inform 
consumers about benefits of their products by means of diverse initiatives (for 
example, information dissemination by health professionals in media, online portais, 
134 
the presence of a nutritionist in a health food store and vulgarization of the technical 
and scientific terms), the easier they get them interested in their offers . Moreover, the 
more consumers are interested in health enhancing foods , the easier health enhancing 
food companies can sensitize them about benefits of such products and consequently 
the easier they can clearly position their products relatively to their main benefits. 
However, when health enhancing foods are clearly positioned in consumers' minds 
relatively to their perceived benefits, health enhancing food companies will be 
brought to put less effort to inform their consumers about benefits of their products. 
The Balancing feedback loop B4 depicts the interaction between Communication with 
health professionals and regulatory options (B 1 and B2) and lnfonnation and 
communication with consumers (B3). The more health enhancing food companies 
collaborate with health professionals, the more consumers are well-informed about 
the benefits of these products. However, the more consumers are informed, the less 
health enhancing food companies feel the necessity to put much emphasis on 
collaboration with health professionals. 
b) The me II: Commercial dynamics 
As mentioned earlier, theme II delineates the commercial dynamics associated with 
the improvement of the distribution of health enhancing foods. As depicted earlier in 
Figure 3.4, the commercial dynamics theme is composed of initiatives related to 
Marketing strategies (cluster 3) and Retailers' relationship managentent (cluster 4). 
Figure 3.7 illustrates the feedback loops related to Marketing strategies (cluster 3), 
Retailers' relationship management (cluster 4) and their interrelationships. Thereby, 
the reinforcing feedback loop Rl labeled Marketing strategies, shows the 
interrelationships between initiatives related to marketing strategies aimed at 
improving the distribution of health enhancing foods . The balancing feedback loop 
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BS, labeled Retailers' relationship management, captures the interaction between 
initiatives related to retailers ' relationship management. Finally, the reinforcing 
feedback loop R2 shows the interrelationship between the feedback loops Marketing 
strategies (Rl) and Retailers' relationship management (BS). A description of each 
feedback loop (Rl) and (B5) followed by an analysis of the feedback loop (R2) is 
presented below. 
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A representation of the reinforcing feedback loop R1 Marketing strategies is provided 
in Figure 3.7. Renee, the more health enhancing foods firms conduct market surveys 
(for example on consumers' satisfaction, consumers understanding of health aspects 
of foods or on consumers' priee sensitivity, etc.), the more they improve their 
marketing management process. In fact by conducting surveys on consumers, health 
enhancing food companies learn more about and understand consumers needs and 
wants toward health enhancing foods and can therefore target specifie market 
segments and differentiate constantly their products from competition. By doing so, 
companies can then create more value to their consumers and consequently stimulate 
customers' loyalty. The more companies stimulate consumers ' loyalty, the more they 
build long-term customer equity (Armstrong and Kotler, 2011). Similarly, thè more 
companies capture value (revenues, loyalty, customer equity) from their customers 
the more they have resources to conduct market surveys. 
Figure 3.7 also shows the balancing feedback loop BS, Retailers ' Relationship 
management. An increase of retailers ' and brokers' training about health enhancing 
foods make them more convinced about the priee premium of these products 
comparatively to conventional foods. Similarly, the more retailers are convinced, the 
more they will valorize and promote health enhancing foods. Thereby, the more 
retailers promote and valorize health enhancing foods, the more manufacturers can 
list advantageously their products on retailers' shelf space. The more health 
enhancing food products are advantageously listed on retailers ' store shelves, the 
more the demand for the product is stimulated. However, an increase in demand for 
health enhancing foods can engender a decrease in training typically provided by 
health enhancing food manufacturers to retailers and brokers since consumers are 
becoming increasingly aware about benefits of health enhancing foods. 
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The reinforcing feedback loop R2 depicts the interaction between Marketing 
strategies (Rl) and Retailers' relationship management (BS). The more companies 
capture value from their customers, the more they can afford training sessions to 
retailers about health enhancing foods and consequently the more they improve their 
marketing management process. 
c) Theme III: Scientific dynamics 
Theme III describes the scientific dynamics related to the improvement of the 
distribution of health enhancing foods. As mentioned earlier in figure 3.4, the 
scientific dynamics theme is made up of two clusters, namely: Market-oriented 
innovation managen1ent (cluster 5) and Networking and institutional support (cluster 
6). 
Figure 3.8 illustrates the feedback loops related to Market-oriented innovation 
management (cluster 5), Networking and institutional support (cluster 6) and their 
interrelationships. In fact, the reinforcing feedback loop R3 named Market-oriented 
innovation nwnagement, captures the dynamics of initiatives aimed at improving the 
distribution of health enhancing foods related to Market-oriented innovation 
management. The reinforcing feedback loops (R4 and RS) are labeled conjointly 
Networking and institutional support (cluster 6). They bath illustrate the dynamics of 
initiatives aimed at improving the distribution of health enhancing foods related to 
Networking and institutional support. Finally, the reinforcing feedback loop R6 
depicts the interrelationships between the feedback loops Market-oriented innovation 
management (R4) and Networking and institutional support (RS and R6). A 
description of the reinforcing feedback loops R3, R4 and RS followed by a 
description of R6 is provided hereafter. 
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An illustration of the reinforcing feedback loop R3 Market-oriented innovation 
m.anagement is provided in Figure 3.8. Here, an increase in innovation on the 
scientific dimension of health enhancing foods leads to an increase of innovation on 
the product/market dimension of health enhancing food products . Similarly, more 
innovation on the product/market dimension, leads to more innovation on the sale 
dimension of health enhancing foods and consequently engenders more original and 
novel health enhancing food with a more added value to consumers. An increase of 
consumers' added value leads to an increase in the innovation culture of health 
enhancing foods firms. Finally, the more a health enhancing foods finn integrates the 
innovation culture into its mission, the more it brings in opportunities for innovation 
on the scientific dimension through open innovation. To illustrate this, an example of 
the commercialization of a new food supplement is provided in what follows. The 
commercialization of a hydrolyzed whey protein targeting blood pressure required the 
development of a technology to identify a new protein sequence that regulates blood 
pressure and the elaboration of successfully marketing strategies to launch the 
product on the nutraceuticals' market (Brëiring and Cloutier, 2008). Following 
Brëiring and Cloutier's example, the more a company innovates on the scientific 
dimension (e.g. new technology development) , the more it cornes with an innovation 
on the product/market dimension (new product targeting a new market of food 
supplement) and the more it can therefore innovate on the sale dimension (e.g. the 
presence of a nutritionist in a health food store). 
The reinforcing feedback loops R4 and RS on Networking and institutional support is 
provided in Figure 3.8. The more health enhancing food companies stimulate open 
innovation, the more they promote partnerships with other stakeholders such as R&D 
institutions , government, etc., at one band, and with other health enhancing foods 
manufacturers, at the other band. These partnerships improve trust between all 
industry stakeholders, yielding to an increase of financial support to health enhancing 
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food companies through funding programs to conduct clinical studies and trials. The 
more R&D activities of health enhancing food companies are supported, the more 
R&D and clinical trials costs are shared between all stakeholders. Similarly, the more 
R&D and clinical trials costs are shared through collaboration and partnerships , the 
more health enhancing food companies are able to counter multinational companies' 
competition. Finally, the more they counter competition, the more open innovation 
will be ·stimulated. 
The reinforcing feedback loop R6 depicts the interrelationship between Market-
oriented innovation m.anagement (R3) and Networking and institutional support (R4 
and RS). The more health enhancing foods companies innovate on the scientific 
dimension, the more they foster open innovation. In the same way, the more they 
encourage open innovation, the more they will innovate on the scientific dimension 
of their health enhancing foods. Indeed, as shawn in the example of Broring and 
Cloutier (2008) . The development of new technology (innovation on the scientific 
dimension) prior to product conception leads health enhancing food companies to 
look for open innovation through collaborations at different levels : inter-firm, inter-
industrial and inter-institutionallevel (Broring and Cloutier, 2008; Siedlok, Smart and 
Gupta, 2010). 
3.5 Discussion 
Following the analysis of the dynamic hypothesis developed in the context of the 
improvement of the distribution of health enhancing foods , conducted using the 
principles of System Dynamics (SD), the themes , namely: communication and 
regulatory options dynamics, commercial dynamics and scientific dynamics, can be 
used to answer the research questions of this article: ( 1) Wh at is the structure of 
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initiatives aimed at improving the distribution of health enhancing foods interact 
together? (2) How do the initiatives aimed at improving the distribution of health 
enhancing foods interact together? 
To answer the research questions of this study, the results were discussed, first 
accordingly to communication and regulatory options dynamics , commercial 
dynamics and scientific dynamics then relatively to the interaction between all these 
factors and outcomes. 
Communication and regulatory options dynamics 
The study revealed that there is an interaction between initiatives related to 
Con11nunication with health professionals and regulatory options (elus ter 1) and 
those associated with Information and communication with conswners (cluster 2). 
This is supported by the literature as well as by the qualitative data from group 
discussion sessions held during this study. 
Given consumers ' risk aversion toward health enhancing foods and their con cern 
about technologies used to develop such products, severa} previous studies 
demonstrated the importance of information activities targeted to consumers and 
health professionals (Garreston and Burton, 2000; Hailu et al. , 2009; Kozup , Creyer 
and Burton, 2003; Malla, Hobbs and Perger, 2005; Roe, Levy and Derby, 1999; 
Siedlok, Smart and Gupta, 2010; Wansink, 2003) and the need of regulatory 
structures to validate the safety and efficacy of health enhancing foods to boost 
consumers' confidence (Ray, 2004; Siedlok, Smart and Gupta, 2010). 
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Furthermore, this study is consistent with these findings. In fact, participants to this 
study clearly stated the following: 
« ... If we want to highlight the nutritional daim, functional daim, or risk 
reduction daim, the re are, from a regulatory point of view, three ( 3) different 
ways. These are three levels of interpretation at the consumer leveZ that are 
completely different ... ali stakeholders must understand that this is not the 
same leveZ of intervention because ultimately it is not the same understanding 
of the health benefit that we'd like to promote». 79 
This study extends the existing literature and provides a better understanding of the 
interaction between initiatives related to communication with health professionals, 
consumers , and regulation aspects alike to overcome with market uncertainty that 
characterizes the health enhancing foods industry. 
Commercial dynamics 
Given intensive upstream and downstream competition in health enhancing foods 
(Bigliardi and Galati, 2013; Hobbs , 2002; Lawrence and Burch, 2008), firms are 
increasingly required to use sophisticated techniques to better understand consumers 
needs and wants (De Jong et al., 2006; Mark-Herbert, 2003) and to develop 
collaborations and partnerships with diverse channels (Sarkar and Costa, 2008) to 
improve the scope and speed to market. According to these studies, marketing 
strategies and relationships with retailers are critical. 
These studies did not provide an explanation about the interaction between marketing 
actions and strategies and relationships with channel intermediaries. However, the 
present study brings sorne clarifications on the interaction between initiatives related 
to marketing strategies and retailers ' relationship management that play a role in 
79 To refer to the original excerpt in French, see excerpt #2 in Appendix 3.1. 
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improving the distribution of health enhancing foods. It highlights how affording 
training to retailers coupled with manufacturers' marketing strategies improves health 
enhancing food distribution and therefore create value to consumers. In fact, given 
the credence nature of these products (Verbeke, 2005; Zou and Hobbs, 2006) and 
consequently consumers' skepticism (Moorsel, Cranfield and Sparling, 2007; 
Siedlok, Sm art and Gupta, 201 0), retail ers play a cri ti cal role in transmitting and 
getting from consumers valuable information about health benefits. 
During group discussion sessiOns of this study, participants highlighted both 
marketing actions and strategies and relationships with retailers. This is depicted in 
the following excerpts from participants' discourse: 
« The important thing ta understand is, ultimately, what the consumer 
understands about the se products? Where is he ta receive the health aspect? 
... the firm must consider how it would like ta position itself? .. . With good 
consumer behavior studies, we can understand what the consumer is capable 
ta receive as information? What ta do with this? What we 'd like ta accomplish 
with the se products? Once we understand this we will look at the distribution 
channel and will also analyze what the distribution channel has as business 
madel? Because, as we know, in distribution channels there are mass markets 
versus niche markets (specialized channels). Sa once again, if a company does 
not engage in a process for understanding this, it will be difficult ta define the 
right positioning and ta be effective». 80 
« .. . How ta sel! our product ta a retailer who is seeking transactions, volume 
and sales ... and we want ta come up with products improved nutritionally, it 's 
attractive and we 'd like ta sel! them .. . hence, we must convince the 
retailer». 81 
«Our intervention is ta provide training ta retailers ta raise their awareness ta 
our product. We provide training sessions direct/y ta vendors on the floor or 
sometùnes through the distribution network. What we noticed is that providing 
this type of training ta vendors (who are in direct contact with the conswner) 
80 To refer to the original excerpt in French, see excerpt #3 in Appendix 3.1. 
81 To refer to the original excerpt in French, see excerpt #4 in Appendix 3.1. 
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we have a lot offeedbackfrmn these people (what the consumer likes, what he 
does not like, etc.). What we found interesting is that having an indirect 
contact with the consumer via the distributor, we gain very interesting 
. ,f: . 82 
mJormatwn». 
Scientific dynamics 
Considering the advances in technology and innovation and the changes in social 
trends, inter-firm, inter-industrial and inter-institutional collaborations are critical for 
the development and commercialization of health enhancing foods (Broring and 
Cloutier, 2008; Khan et al, 2013; Matthyssens et al. , 2008; Siedlok, Smart and Gupta, 
201 0). Furthermore, it was stated, during group discussion sessions, th at innovation 
and networking are both critical for the development and commercialization of health 
enhanced foods. The following excerpts from participants emphasize these factors: 
«ft is important to work together for innovation as well as for conswner 
awareness ... The re are four ( 4) companies working on products without 
nitrates including competitors ».83 
«At MAPAQ84, we are currently conducting with the federal governm.ent a 
program to support innovation and see if we can fund clinical studies for 
firms. This is important for firms to pur sue the ir innovation». 85 
Compared to prevwus studies, this study highlights the interaction between 
networking and innovation and how these scientific antecedents and consequences 
can improve the distribution of health enhancing foods. 
82 To refer to the original excerpt in French, see excerpt #5 in Appendix 3.1. 
83 To refer to the original excerpt in French, see excerpt #6 in Appendix 3.1. 
84 Ministère de l' Agriculture, des Pêcheries et de l'Alimentation Québec. 
85 To re fer to the original excerpt in French, see excerpt #7 in Appendix 3 .1 . 
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Interactions between scientific, commercial and communication and regulatory 
options dynamics 
Results of this research show that the improvement of the distribution of health 
enhancing foods is a complex task. In arder to enhance the distribution of their 
products, health enhancing foods firms should undertake a set of interdependent 
initiatives related to scientific dynamics, commercial and communication and 
regulatory dynamics alike. Given the complexity of supply chains (Broring, 2008; 
Hobbs, 2002; Sakaran, 2005; Sakaran and Muly, 2007), the uncertainty and volatility 
of the technological, regulatory, market, social and competition environments 
(Hobbs , 2002; Siedlok, Smart and Gupta, 2010) and the dynamic and evolving nature 
of supply chains (Hobbs, 2002), firms are not only required to undertake a set of 
initiatives but also understand the interaction between their initiatives, the dynamics 
that took place between commercial, scientific and regulatory issues and how these 
dynamics affect their decision making. This was also highlighted during group 
discussion sessions by the following quotation: 
« ... Sa what we're trying to dois ta undertake interventions on the 'science' 
aspect, that is, what is in the 'science' that has sante credible value for the 
consumer? What is at the regulatory level feasible ? We must align three 
planets: 'science' planet, regulatory planet and consumer planet and find an 
inteiface between the three.. . it is not easy ta find, there is no magic 
. 86 
rectpe». 
As seen in the existing literature (Jones and Jew, 2007; Mark-Herbert, 2003; Siedlok, 
Smart and Gupta, 2010), this study has stressed that consumer, regulatory and 
scientific and technological aspects are critical for the development and 
commercialization of health enhancing foods. However, this study brings additional 
86 To refer to the original excerpt in French, see excerpt #8 in Appendix 3 .1. 
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information of the systemic interactions between scientific, commercial and 
regulatory dynamics, as depicted in figure 3.5. A discussion of these interactions is 
provided below. 
- Interaction between scientific dynamics and commercial dynamics 
This interaction was evidenced by Baden-Fuller and Haefliger (2013). Accordingly 
changes in the business model87 influence technological innovation and vice versa. 
The interaction between scientific dynamics and commercial dynamics was 
highlighted by the reinforcing loop R7 as illustrated in Figures 3.5 and 3.9. In fact 
when health enhancing foods firms innovate by introducing new technology, they 
offer new products that create value for consumers. This value creation reinforces the 
innovation culture of companies and stimulates their openness and collaboration with 
diverse stakeholders. As stated by Baden-Fuller and Haefliger (2013, p.424) : 
«Different stakeholders perceive different domains as nwre central or 
dominant. Technology developers understand the agenda and possibilities for 
a technology to be used but nwy miss the implications for nwnetization or 
market demand. On the other hand, nwrketing experts nwy hold deep insights 
into customer behavior but may not understand what a given technology could 
be expected to deliver». 
Furthermore, during group discussion sessions, it was stated that: 
« ... Innovation in this sec tor is complex. Why ? Because, it is a world of 
cleverness. We must communicate different/y, we m.ust find the exception. So 
imagine, innovation is not just in the science aspect and in the product 
aspect that we want to sel! but also in the sale aspects to finally align the 
planets». 88 
87 According to Baden-Fuller and Haefliger (2013) , business model is a framework by which firms 
create value and capture value from consumers. 
88 To refer to the original excerpt in French, see excerpt #9 in Appendix 3.1. 
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- I n t e r a c t i o n  b e t w e e n  c o m m e r c i a l  d y n a m i c s  a n d  c o m m u n i c a t i o n  a n d  r e g u l a t o r y  
o p t i o n s  d y n a m i c s  
S o r n e  p r e v i o u s  s t u d i e s  m e n t i o n e d  t h e  i m p o r t a n c e  o f  r e g u l a t o r y  a s p e c t s  a n d  
c o m m e r c i a l  a s p e c t s  f o r  t h e  d e v e l o p m e n t  a n d  m a r k e t i n g  f o r  h e a l t h  e n h a n c i n g  f o o d s  
( M a r k - H e r b e r t ,  2 0 0 3 ,  2 0 0 4 ) .  T h e  i n t e r a c t i o n s  b e t w e e n  c o m m e r c i a l  d y n a m i c s  a n d  
c o m m u n i c a t i o n ,  a n d  t h e  r e g u l a t o r y  o p t i o n  d y n a m i c s  i s  e x e m p l i f i e d  i n  F i g u r e s  3 . 5  a n d  
3 . 9  b y  t h e  b a l a n c i n g  f e e d b a c k  l o o p  B 6 .  I n d e e d ,  t h e  c o l l a b o r a t i o n  b e t w e e n  h e a l t h  
e n h a n c i n g  f o o d s  f i r m s  a n d  r e t a i l e r s  r e i n f o r c e s  c o n s u m e r s '  i n t e r e s t  t o w a r d  t h e s e  
p r o d u c t s .  H o w e v e r ,  t h e  m o r e  c o n s u m e r s  a r e  i n f o r m e d  a b o u t  h e a l t h  e n h a n c i n g  f o o d s '  
b e n e f i t s ,  t h e  l e s s  h e a l t h  e n h a n c i n g  f o o d s '  m a n u f a c t u r e r s  w i l l  s e e k  t o  c o l l a b o r a t e  w i t h  
r e t a i l  e r s .  
I n  a d d i t i o n ,  t h i s  w a s  a l s o  a r g u e d  d u r i n g  g r o u p  d i s c u s s i o n  s e s s i o n s .  T h e  f o l l o w i n g  
e x c e r p t  e m p h a s i z e s  t h e  n e e d  f o r  b o t h  m a r k e t i n g  a n d  r e g u l a t o r y  c o n s i d e r a t i o n s :  
«  W e  a r e  v e r y  c o n c e r n e d  . . .  I n  m a r k e t i n g  i t  i s  a l s o  w h a t  i s  a l l o w e d  t o  s a y  t a  
c o n s u m e r s .  Y o u  c a n  h a v e  a  g o o d  m a r k e t i n g  s t u d y  b u t  w h a t  H e a l t h  C a n a d a  
w i l l  a l l o w  y o u  t o  s a y  t o  c o n s u m e r s ?  T h i s  i s  o u r  1 n a i n  p r o b l e m . . .  T h e  r e  a r e  
m a n y  i n g r e d i e n t s ,  i n t e r e s t i n g  t h i n g s ,  t h a t  c a n  b e  a d d e d  t o  a  f o o d  p r o d u c t  b u t  
h o w  f a s t  w i l l  i t  b e  ap~roved ? W h a t  a r e  w e  g o i n g  t o  s a y ?  W h a t  w i l l  t h e  
c o n s w n e r  u n d e r s t a n d ?  
9
.  
- I n t e r a c t i o n  b e t w e e n  s c i e n t i f i c  d y n a m i c s  a n d  c o m m u n i c a t i o n  a n d  r e g u l a t o r y  
o p t i o n s  d y n a m i c s  
A c c o r d i n g  t o  S i e d l o k ,  S m a r t  a n d  G u p t a  ( 2 0 1 0 ) ,  t h e  c o m b i n a t i o n  o f  s c i e n t i f i c  a s p e c t s  
f o r  h e a l t h  e n h a n c i n g  f o o d s  w i t h  p u b l i c  p o l i c y  s u p p o r t  f r o m  g o v e r n m e n t s  a n d  m a s s  
e d u c a t i o n  a r e  c r i t i c a l  t o  h e l p  a l l e v i a t e  c o n s u m e r s '  c o n c e r n s .  A l t h o u g h  t h e s e  a u t h o r s  
h a v e  s h o w n  t h e  i m p o r t a n c e  o f  s c i e n c e  a n d  r e g u l a t i o n  t o  r e d u c e  c o n s u m e r s '  s k e p t i c i s m  
8 9  
T o  r e f e r  t o  t h e  o r i g i n a l  e x c e r p t  i n  F r e n c h ,  s e e  e x c e r p t  #  1 0  i n  A p p e n d i x  3 . 1 .  
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toward health enhancing foods, they did not bring in further explanation about their 
relationships. In this study, the link between scientific dynamics and communication 
and regulatory options dynamics was evidenced in Figures 3.5 and 3.9. Indeed, in 
innovating and in seeking partnerships with diverse stakeholders, health enhancing 
food companies can put their efforts together to sensitize and educate consumers and 
develop awareness approaches toward health professionals. This was also stated by 
participants during group discussion sessions of this study in the following excerpts: 
«For the products we make, we conducted a pan Canadian study on the 
consum.ers' perception about these products ... There are conswners to whom. 
it gives some scare. They think it is a bit too scientific, a bit too m.edicinal for 
a food. So it's a balance between what the ingredient that you make can do, 
what you can say on the product package that is allowed by regulation and 
that does not scare the consumer ... be cause ultimately we do not want to be in 
the NHP section. We want to stay in the mass market ... This is the biggest 
challenge».90 
«In addition to well-established scientific evidence required by Health 
Canada, it is also important to send a clear message to the consumer. We can 
transmit the statements of science to the conswner but we must ensure that he 
understands them. .. Training and the impact of health professionals is 
important in this case. They are important in conswner's understanding, 
adoption and use of the product .. . Health professionals are a good vehicle. 
We participated in seminars of 'Ordre Professionnel Des Diététistes Du 
Québec '. We distributed free samples of our product, we explained our 
product to them ... they are good am.bassadors ». 91 
3.6 Conclusion and future research 
The main objective of this research was to identify and provide a better understanding 
of the dynamics between a set of initiatives to be undertaken by individual 
stakeholders working toward the improvement of the distribution of health enhancing 
foods. To achieve this objective, a dynamic hypothesis that describes the 
90 To refer to the original excerpt in French, see excerpt #Il in Appendix 3.1. 
91 To refer to the original excerpt in French, see excerpt #12 in Appendix 3.1. 
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microstructure responsible for the macro behavior of the dynamics that took place 
between these initiatives has been elaborated. A qualitative System Dynamics (SD) 
approach was applied to structure the dynamic hypothesis using data collected from 
unstructured interviews with experts in health enhancing foods and two group 
discussion sessions held with a heterogeneous group of 18 participants, representing a 
vast range of stakeholders (ingredient-makers, food manufacturers/processors , experts 
and researchers in food technology development, in consumer sciences, in food 
distribution and marketing, and government representatives) in the health enhancing 
foods industry. 
The article presents an influence diagram (ID) that envisions scientific dynamics, 
commercial dynamics and communication~ and regulatory options dynamics , each 
playing a role in the improvement of the distribution of health enhancing foods. 
The present study contributes to the advancement of the existing literature. In fact, 
following the new paradigm in marketing (Gummesson, Kuusela and Narvanen, 
2014) concerning complexity, uncertainty and dynamics of markets , this study 
focuses on interdependencies between a set of initiatives aimed at improving the 
distribution of health enhancing foods and uses system thinking by elaborating a 
dynamic hypothesis. This study also takes into account the complexity, the dynamics 
and the uncertainty of the health enhancing foods industry and provides therefore 
systemic and holistic views. 
From a managerial standpoint, the description of the systemic behavior obtained in 
this study could support managers of health enhancing food companies in their 
decision making process. It provides a better understanding of complex interactions 
between initiatives that can be undertaken to improve the distribution of their 
151 
products and enable them to better assess the scope and consequences of their 
initiatives. 
Finally, the results of this study were based on qualitative modeling and thus have not 
been tested by a simulation using a formai quantitative model. Although static, the ID 
developed in this paper can only provide a better static understanding of the 
complexity among initiatives aimed at improving the distribution of health enhancing 
foods. Future studies should conduct a quantitative simulation model (level-rate 
model) to better understand the systemic behavior of initiatives aimed at improving 
the distribution of health enhancing foods. Moreover, improving health enhancing 
food distribution may differ in other Canadian provinces and of course in other 
countries. Further studies should compare the dynamics forces between various 
regions and countries. 
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APPENDICES 
Appendix 3.1 Translation (French to English) of excerpts from participants' discourse 
# Excerpts in French English translation 
1 « .... Il y a une collection « ... Given complexity, there are many 
d'interventions à aligner compte interventions to align. There is the 
tenu de la complexité; il y a science aspect, the regulatory aspect and 
l'aspect science, l'aspect the consumer aspect ... ft is a m.ultitude of 
réglementaire et l'aspect things that need to be connected ... The re 
commercial. .. c'est une multitude is a collection of strategie information in 
de choses qu'i!faut connecter .... il the health enhancing foods' world that 
ya une collection d'information must be considered other than selling 
stratégique dans le monde des taste, selling pleasure. lt's even nwre 
alùnents santé qu'on doit prendre complex ... it needs a good rejlection» 
en considération autre que vendre 
du goût, que vendre du plaisir, 
c 'est encore plus complexe, ... il 
faut faire une bonne réflexion» 
2 « ... Si on veut mettre en valeur « ... If we want to highlight the nutritional l'aspect nutritif, fonctionnel ou claùn, functional claùn, or risk reduction 
l'aspect réduction de risque face à claim, the re are, front a regulatory point 
la santé, c'est trois ( 3) chemins of view, three ( 3) different ways. The se 
différents d'un point de vue are three levels of interpretation at the 
réglementaire. C'est trois ( 3) consum.er leveZ that are cmnpletely 
niveaux d'interprétation au niveau different ... ali stakeholders m.ust 
du consmnmateur qui sont understand that this is not the same leve! 
complètement différents ... il faut of intervention because ultimately it is 
comprendre ça ... Tous les not the sante understanding of the health 
intervenants doivent comprendre benefit that we 'd like to promote» 
que ce n'est pas les mêmes niveaux 
d'intervention parce que ce n'est 
pas la même compréhension en 
bout de ligne de l'effet santé qu'on 
veut promouvoir» 
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Appendix 3.1 Translation (French to English) of excerpts from participants' discourse 
(continued .. . ) 
# Excerpts in French English translation 
3 «L'important c'est de comprendre ce «The important thing to understand is, 
que le consommateur comprend en ultimately, what the consumer 
bout de piste. Il en est où pour understands about the se products ? 
recevoir finalement l'aspect santé? Il Where is he to receive the health 
faut à un moment donné réfléchir aspect? ... The finn ntust consider how 
comment on veut se positionner? .. . it would like to position itself? ... With 
Avec de bonnes analyses de good consumer behavior studies, we 
comportement de cons01nmation on can understand what the consumer is 
peut comprendre qu'est ce que le capable to receive as information ? 
consommateur est capable de What to do with this? What we 'd like to 
recevoir et pis c'est quoi qu'on peut accomplish with these products ? 
faire avec ça? C'est quoi qu 'on veut Once we understand this we will look 
accomplir avec ces produits? Une at the distribution channel and will also 
fois qu'on comprend ça on va analyze what the distribution channel 
regarder le réseau de distribution et has as business madel ? Be cause, as we 
on va aussi analyser ce que le réseau know, in distribution channels there are 
de distribution a aussi comme mass market versus niche market 
modèle d 'affaire parce qu 'on sait (specialized channels). So once again, 
qu'au niveau des réseaux de if a company does not engage in a 
distribution il y en des spécialisés, il process for understanding this, it will 
y en a des plus nichés et il y en a des be difficult to be positioned and to be 
moins nichés. C'est donc la effective» 
problématique de marché de masse 
versus marché de niche. Si encore 
une fois l 'entreprise ne fait pas cette 
démarche de compréhension là, et 
bien ça va être difficile de se 
positionner et d'être efficace» 
4 «Comment vendre notre produit à un « .. . How to self our product to a distributeur qui veut faire la retailer who is seeking transactions, 
transaction et le volume et pis un volume and sales ... and we want to 
chiffre d'affaire précis ... et pis on come up with nutritionally improved 
veut arriver avec des produits à products, it's attractive and we'd like 
valeur nutritive améliorés, c'est sexy to self them ... hence, we must convince 
et on veut passer ça, beh .. là il faut the retailer» 
convaincre le distributeur de ça» 
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Appendix 3.1 Translation (French to English) of excerpts from participants ' discourse 
(continued ... ) 
# Excerpts in French English translation 
5 «La manière dont on intervient c'est « Our intervention is to provide 
qu 'on va donner une formation à training to retailers to raise their 
ceux qui vont distribuer notre produit awareness to our product. We provide 
pour les conscientiser par rapport à training sessions directly to vendors on 
notre produit. Pis on va donner des the floor or smnetilnes through the 
formations aux vendeurs sur le distribution network. What we noticed 
plancher par le biais du réseau de is that providing this type of training ta 
distribution qu 'on a ou parfois en vendors (who are in direct contact with 
direct. Ce que nous avons réalisé, the consumer) we have a lot of 
c'est d'aller donner ce type de feedbackfrmn these people (what the 
formation aux vendeurs, aux consumer likes, what he does not like, 
personnes qui sont en contact direct etc.). What wefound interesting is that 
avec le consonunateur (qu'est ce que having an indirect contact with the 
le consom.mateur aime, qu'est ce qui consumer via the distributor, we gain 
l'intéresse, qu'est ce qui ne very interesting information» 
l 'intéresse pas) on a énormément de 
feedback de ces gens là. là où on a 
trouvé un intérêt c'est d'avoir un lien 
indirect avec le consommateur via le 
distributeur on se retrouve avec des 
informations très intéressantes» 
6 «C'est important de travailler «ft is important to work together for 
ensemble au niveau de l'innovation innovation as well as for consum.er 
et également au niveau de la awareness ... The re are four ( 4) 
conscientisation du consomm.ateur. Il 
companies working on products 
y a quatre ( 4) entreprises qui 
travaillent sur des produits sans without nitrates including competitors» 
nitrates dont des compétiteurs» 
7 «Au niveau du MAPAQ, on est en <<At MAPAQ, we are currently 
train de mener un programme de conducting with the federal 
soutien à l'innovation avec le fédéral government a pro gram to support 
pour voir si on peut financer des innovation and see if we can fund 
études cliniques. Ceci est important clinicat studies for firms. This is 
pour les entreprises pour toujours important for firms to pur sue the ir 
innover» innovation» 
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Appendix 3.1 Translation (French to English) of excerpts from participants' discourse 
( continued ... ) 
# Excerpts in French English translation 
8 « ... Alors ce qu 'on essaye defaire « ... So what we're trying to dois to 
c'est d 'avoir des interventions sur undertake interventions on the 
l'aspect science c'est à dire qu 'est ce 'science' aspect, that is, what is in the 
qu'il y a dans la science qui a une 'science' that has some credible value 
certaine valeur crédible pour le for the conswner? What is at the 
consommateur, qu'est ce qui est au regulatory leveZ feasible ? We nmst 
niveau réglementaire est faisable . Il align three planets: 'science' planet, 
faut aligner trois planètes la planète regulatory planet and consumer 
science, la planète réglementaire et la planet and find an interface between 
planète consommateur et trouver une the three ... it is not easy to find, the re 
interface entre les trois ... pis ce n 'est is no a magic recipe» 
pas facile à trouver, il n'y a pas de 
recette magique» 
9 «L 'innovation dans ce secteur là est «Innovation in this sector is complex. 
complexe. Pourquoi? Parce que c'est Wh y? Because, it is a world of 
un monde d 'astuces. Il faut cleverness. We n1ust communicate 
communiquer différemment, il faut dif.ferently, we mustfind the exception. 
trouver l 'exception .... Alors imaginez- So imagine, innovation is not just in 
vous, l 'innovation n'est pas juste dans the science aspect and in the product 
l 'aspect science pis dans l 'aspect aspect that we want to sell but also in 
produit qu 'on veut vendre mais sur the sale aspects to finally align the 
l'aspect vente pur et simple pour planets» 
aligner les planètes» 
10 «On est très concernés .. . au niveau « We are very concerned .. . In 
marketing c'est aussi ce qui est marketing it is also what is allowed to 
permis. On peut avoir une bonne étude say to consumers. Y ou can have a 
marketing mais qu'est ce que Santé good marketing study but what Health 
Canada va permettre de dire. Ceci est Canada will allow you to say to 
notre principale problématique ... . Il y consumers? This is our main 
a un paquet de d'ingrédients problem ... There are many 
intéressants, de choses intéressantes ingredients, interesting things, that 
qu'on peut mettre dans un aliment can be added to a food product but 
mais à quelle vitesse ça va être how fast will it be approved? What 
approuvé? pis qu'est ce qu'on va are we going to say? What will the 
pouvoir dire ? et pis qu'est ce que le consumer understand?» 
consommateur va comprendre?» 
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Appendix 3.1 Translation (French to English) of excerpts from participants' discourse 
(continued . . . ) 
# Excerpts in French English translation 
11 «Au niveau des produits qu'on «For the products we nwke, we 
fabrique, nous avons m.ené une étude conducted a pan Canadian study on 
pan canadienne sur la perception des the consumers' perception about 
consommateurs à l'égard de ces the se products ... The re are 
produits ... Il y a des consommateurs consumers to whom it gives some 
que ça leur fait un peu peur. Ils scare. They think it is a bit too 
trouvent que c'est un peu trop scientific, a bit too m.edicinal for a 
scientifique, un peu trop médicinal food. So it's a balance between what 
pour un aliment. Donc c'est un the ingredient that you make can do, 
équilibre entre ce que l'ingrédient what you can say on the product 
que vous faites peut donner pis ce que package that is allowed by regulation 
qu'on peut dire d'un point de vue and that does not scare the 
réglem.entaire sur l' em.ballage qui ne conswner ... because ultùnately we do 
fait pas peur au consommateur car en · not want to be in the NHP section. 
bout de ligne on ne veut pas se We want to stay in the mass m.arket .. . 
retrouver dans la section des PSN This is the biggest challenge» 
(produits de santé naturels). On veut 
rester dans la m.asse ... Fait que le plus 
gros défi c'est ça» 
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Appendix 3.1 Translation (French to English) of excerpts from participants' discourse 
(continued ... ) 
# Excerpts in French English translation 
12 «En plus d'une preuve scientifique «In addition to well-established 
bien établie, exigée par Santé scientific evidence required by Health 
Canada, il faut aussi un discours Canada, it is also important to send a 
clair au consommateur. On peut clear 1nessage to the conswner. We 
transiter les énoncés de la science au can transnût the statements of science 
consommateur mais il faut s'assurer to the consumer but we must ensure 
que ce dernier comprenne ... la that he understands them ... Training 
formation et l 'impact des and the impact of health professionals 
professionnels de la santé est is important in this case. They are 
important dans ce cas. Ce sont des important in consumer's 
éléments importants dans la understanding, adoption and use of 
compréhension, l 'adoption et the product ... Health professionals 
l 'utilisation du produit par le are a good vehicle. We participated in 
consommateur ... Les professionnels seminars of 'Ordre Professionnel Des 
de la santé sont un bon véhicule. On Diététistes Du Québec'. We 
a participé à maintes reprises à des distributed free samples of our 
colloques de l'Ordre Professionnel product, we explained our product to 
Des Diététistes Du Québec', on leur them .. . they are good am.bassadors » 
a donné des échantillons de notre 
produit, on leur a expliqué c'est quoi 
notre produit ... Ce sont de bons 
ambassadeurs» 
CHAPITRE IV 
ARTICLE 3 
EFFECTS OF TRACEABILITY, HEALTH CLAIMS AND VERIFICATION OF 
HEALTH CLAIMS ON CONSUMERS ' BEHA VI ORAL INTENTIONS TOW ARD 
FOODS ENRICHED WITH OMEGA-3 FATTY ACIDS 
FOREWORD 
The purpose of this foreword is to highlight the relationship of Article 3 with the 
previous Articles (1 and 2) of this thesis. While, the focus of both Articles 1 and 2 is 
on the representation of the whole health enhancing food (functional foods , natural 
health products (NHP), etc.) distribution system, the emphasis of Article 3 is on 
consumers' behavioral intentions toward functional foods, and more specifically, 
foods enriched with omega-3 fatty acids. In Article 1 a set of initiatives aimed at 
improving health food distribution were identified and prioritized by a group of 
diverse stakeholders (ingredient-makers, food manufacturers/processors, experts and 
researchers in food technology development, in consumer sciences, in food 
distribution and marketing, and government representatives). In Article 2, an 
influence diagram was developed to describe the dynamics that took place between 
these initiatives by using a qualitative System Dynamics (SD) approach. Unlike the 
first two papers, Article 3 focuses only on specifie initiatives related to the 
improvement of health enhancing food distribution . In fact it has been shawn in 
Article 1that 'Information and communication with consumers' cluster contains very 
important92 initiatives to be undertaken for improving the distribution of health 
enhancing foods. These initiatives are related to health d aims, product labelling, and 
certification logos. Thus, a part of the findings of Article 1 were used to conduct the 
study in Article 3. Specifically, the aim of Article 3 is to investigate the effects of 
information traceability, health daims and verification of health clairns on 
consumers' behavioral intentions toward foods enriched with omega-3 fatty acids. 
92This cluster hadthe highest mean importance rating (3.9 1 on a scale of 5). 
ABSTRACT 
This research a1ms at investigating the effects of information traceability, health 
daims and verification of health daims on consumers' behavioral intentions 
(intention to purchase, intention to recommend and intention to serve) toward foods 
enriched with omega-3 fatty acids. The experimental design is a mixed between-
within-subjects analysis of variance. The between-subjects factors examined are 
traceability with two treatments ( completely traceable- not traceable) and health 
daims with three treatments (functional daim, disease risk reduction daim and 
disease prevention claim). The first within-subjects factor is verification of health 
daims with two levels (Health Canada, a federal government agency and Heart and 
Stroke Foundation, a third party organization). The second within-subjects factor is 
about food product categories (meat products, eggs, cereal products, dairy products 
and processed fruits or vegetables products). Thereby, six versions of a questionnaire 
were administered to six groups of participants (n = 463), one version per group 
(varying between 72 and 83 respondents) in Montreal and Ottawa. Results show 
support for the effect of traceability and verification of health claims on consumers' 
behavioral intentions. Moreover, a significant two-way interaction between health 
claims and verification of health daims was obtained for intention to recommend the 
omega-3 fatty acids enriched foods to others. A significant three-way interaction 
between traceability, health claims and verification of health claims was also obtained 
for intention to recommend to others foods enriched with omega-3 fatty acids. 
Results of this study contribute to a deeper understanding of the simultaneous effects 
of traceability, health claims and verification of health daims on consumers' 
behavioral intentions of health enhancing foods, a phenomenon still largely 
unexplored. Results also have implications in bath marketing strategy and public 
policy. For marketers, findings show how information eues such as traceability, 
health daims and verification of health claims influence consumers ' behavioral 
intentions of omega-3 fatty acids enriched foods and hence help them elaborating 
effective communication strategies. For policy makers, findings of this study might 
be of particular interest for elaborating effective regulatory framework for functional 
foods industry. 
KEY WORDS : Traceability, health daims, verification of health claims, intention to 
purchase, intention to recommend, intention to serve, omega-3 fatty acids, a mixed 
between-within subjects analysis of variance. 
RÉSUMÉ 
L'objectif de cette recherche consiste à examiner les effets de la traçabilité, des 
allégations santé et de la vérification des allégations santé sur les intentions de 
comportement des consommateurs (intention d'achat, intention de recommandation et 
intention de servir aux autres) à l'égard des aliments enrichis d'acides gras oméga-3. 
Le design expérimental consiste en une analyse de variance mixte de type inter et 
intra-sujets . Les facteurs inter-sujets sont la traçabilité avec deux traitements 
(complètement traçable-pas traçable) et les allégations santé avec trois traitements 
(allégation fonctionnelle, allégation de réduction de risque de maladie et allégation de 
prévention de maladie). Le premier facteur intra-sujets concerne la vérification des 
allégations santé avec deux niveaux (Santé Canada, une agence gouvernementale 
fédérale et la Fondation des maladies du cœur, une organisation à but non lucratif) . 
Le deuxième facteur intra-sujet porte sur les catégories de produits enrichis d'acides 
gras oméga-3 avec cinq traitements (viandes, œufs, produits céréaliers, produits 
laitiers et fruits ou légumes transformés). Ainsi, six versions d'un questionnaire ont 
été administrées à six groupes de participants (n = 463) , une version par groupe 
(variant entre 72 et 83 répondants) à Montréal et à Ottawa. Les résultats montrent que 
la traçabilité et la vérification des allégations santé ont des effets significatifs sur les 
intentions de comportement du consommateur. De plus , des effets d' interaction 
significatifs double et triple ont été également trouvés entre les allégations santé et la 
vérification des allégations santé, d'une part et entre la traçabilité, les allégations 
santé et la vérification des allégations santé, d'autre part. Les résultats de cette étude 
contribuent à approfondir la compréhension des effets simultanés de la traçabilité, des 
allégations santé et de la vérification des allégations santé sur les intentions de 
comportement des consommateurs à l'égard des aliments santé, un phénomène encore 
largement inexploré. De plus, les résultats de cette étude présentent des implications 
au niveau managérial et au niveau des politiques publiques. Pour les gestionnaires en 
marketing, les résultats de cette étude peuvent les aider à mieux comprendre comment 
les indices d'informations tels que la traçabilité, les allégations santé et la vérification 
des allégations santé influencent les intentions de comportement des consommateurs 
à 1' égard des aliments enrichis d'acides gras oméga-3 et ainsi les aider à élaborer des 
stratégies de communication efficaces. Pour les responsables de la réglementation, les 
résultats de cette étude pourraient être d'un intérêt particulier dans l'élaboration de 
cadres réglementaires efficaces pour l'industrie des aliments fonctionnels 
MOTS-CLÉS : Traçabilité, allégation santé, vérification des allégations santé, 
intention d 'acheter, intention de recommander, intention de servir, acides gras oméga-
3, analyse de variance mixte de type inter et intra-sujets. 
4.1 Introduction 
Despite the healthy image and the scientific evidence of functional foods benefits, 
consumers are uncertain about the functionality, health impact and safety of these 
products (Hobbs , 2002; Moorsel, Cranfield and Sparling, 2007; Siedlok, Smart and 
Gupta, 2010; Verbeke, 2005a). In fact, foods in general have intangible 
characteristics called credence attributes (such safety, nutritional and health benefits, 
etc.) that cannot be adequately assessed before or even after purchase (Lobb and 
Mazzocchi, 2007; Moser, Raffaelli and Thilmany-McFadden, 2011; Verbeke, 2005b; 
Zou and Hobbs, 2006). As a result, before making purchase decisions , uncertainty 
emerges in consumers' mind (Hobbs, 2004; Singh and Sirdeshmukh, 2000; Zou 
2011), increases risk perception and may negatively affect purchase intentions. In 
such situation, consumers will try to gather additional information to decrease 
perceived uncertainty (Kim and Benbasat, 2003) and restore their confidence (Golan 
et al., 2004; Hobbs, 2004, van Rij swijk and Frewer, 2012) by using extrinsic quality 
eues such as brand names or information on labels93 (Bredahl , 2004; Verbeke, 2005; 
Zeithaml, 1988). According to Verbeke (2005b), considering how many food items 
are low involvemenë4 products, it is likely consumers use labelling information such 
93Refers to ali information on food packaging including health claims, nutritional information , 
ingredient lists, etc. (EdComs, 2007). 
94 According to Zaichkowsky (1985 , p. 342), involvement is «a person's perceived relevance of the 
abject based on inherent needs, values, and interests». A person can be involved with advertisements 
(Krugman, 1977), with products (Howard and Sheth 1969; Hupfer and Gardner 1971 ), or with 
purchase decisions (Clarke and Belk 1978). As stated by Howard and Sheth ( 1969), involvement with 
products leads to greater perception of attribute differences , perception of greater product importance, 
and greater commitment to brand choice. In consumer behavior, involvement is viewed by theorists in 
terms of a two-fold dichotomy : low involvement and high involvement (Engel and Blackwell , 1982). 
For low involvement-product, the purchase decision is less significant than high involvement-product 
(Ahmed et al. , 2004). 
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as nutritional value or contents, traceability95 , production methods, origin and health 
daims as heuristics to help judge of a product' s quality and safety. 
Several studies have argued that information on labels help consumers make 
informed choices (Garretson and Burton, 2000; Hailu et al. , 2009; Hoefkens and 
Verbeke, 2013; Kozup, Creyer and Burton, 2003; Roe, Levy and Derby, 1999; 
Wansink, 2003). Information on food labels has a direct potential impact on 
consumers' decision making (V er beke and Ward, 2006). It transforms credence 
attributes of food products into search attributes96 (Bernués, Olaizola and Corcoran, 
2003; Cas weil and Mojduszka, 1996; Caswell and Padberg, 1992; Drichoutis, 
Lazaridis and Nayga, 2006) and therefore influences consumers' perception, attitude, 
beliefs and behavior (Behrens, Villanueva and Da Silva, 2007; Grunert, 2005; 
Steenkamp and van Trijp, 1996; Stranieri et al., 2010). 
However, irrelevant and/or information overload on product labels can engender 
misunderstanding, ignorance, boredom and impatience for consumers (Salaün and 
Flores , 2001; Verbeke, 2005b). In a situation of a large amount of information, 
consumers can decide to remain rationally ignorant since the time and effort allocated 
for information processing exceeds the expected marginal benefit (McCluskey and 
Swinnen, 2004) and therefore use only a limited part of the available information on 
product labels (Verbeke and Ward, 2006). Given the limited space on labels, the 
limited human cognitive capacity and the potential for information overload, it is 
95 
«Traceability is the ability to follow an item or group of items - animais, food products or 
ingredients -from one point in the supply chain to another. Tags, tattoos, and logbooks are all 
elements of traceability that have be en used for years by both industry and government. Traceability 
systems are based on three basic elements: animal!product identification; premises identification; and 
animal/produc! movement» (Health Canada, 20 13). This information is available on li ne at: 
http://www5 .agr.gc.ca/englindustry-markets-and-trade/traceability/?id= 138297 1713721 ) 
96 Contrary to credence attributes, search attributes are attributes that can be evaluated before purchase 
(Caswell , and Mojduszka, 1996). 
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important for marketers and regulatory agencies to help consumers in their decision-
making. In fact, adequate labelling of functional foods is necessary for market 
definition and growth (Basu, Thomas and Acharya, 2007). 
Regarding labelling information affecting consumers' valuation of food , past studies 
focused on traceability (Chen and Huang, 2013; Chen, Zhao, and Liu, 2014; Choe et 
al., 2009; Hobbs et al. 2005; Loureiro and Umberger, 2007; Stranieri, Baldi and 
Banterle, 2010; Ubilava and Poster, 2009), health daims (Hoefkens and Verbeke, 
2013; Saba et al., 2010; Sabbe et al., 2009; Van Trijp and Van der Lans, 2007; Van 
Kleef, van Trijp and Luning, 2005; Verbeke, Scholderer and Lahteenmaki, 2009) , and 
verification of health daims (Cox, Evans and Evans, 2008; 2011; Hailu et al., 2009; 
Zou, 2011). 
Traceability «[ ... ] refers to the information trail thatfollows the physical trail of food 
from farm to table, and can affect every mem.ber of the supply chain - including the 
end consumer» (Newman et al., 2014, p.6). Food safety crises, major outbreaks of 
food borne illnesses and product recalls have affected, in recent years, consumers' 
confidence about food quality and safety (Hobbs, 2004; Johnson, 2011; Verbeke, 
2005b). Introduced by governments and food inanufacturers, traceability systems 
become a major instrument for ensuring food safety and delivering quality assurances 
(Hobbs et al., 2005) and therefore enables consumers a better product choice 
(Verbeke and Ward, 2006). 
Health daims are defined as information statements printed on food labels, placed in-
front-of the product to describe their expected health outcomes, specifie health related 
functions or role in a healthy lifestyle (Uihteenmaki, 2013). In functional foods 
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studies, nutrition claim97 , functional98 and disease risk reduction99 health claims were 
mostly incorporated to investigate their effects on consumers' purchase behavior (e.g. 
Hoefkens and Verbeke, 2013; Saba et al. , 2010; Sabbe et al., 2009; Van Trijp and 
Van der Lans, 2007; van Kleef, van Trijp and Luning, 2005 ; Verbeke, Scholderer and 
Uihteenmaki , 2009).The disease prevention 100 health claim, considered the most 
difficult health claim to substantiate (Malla, Hobbs and Sogah, 2013) , has received 
little attention in the literature. Except for Zou (20 11), the disease prevention health 
claim has never been considered in past studies. All these health claims are different 
in terms of regulatory mechanisms and standards of evidence. In Canada, functional 
and disease risk reduction health claims are exempted by Food and Drug Regulation 
and cao be used on food products. However, disease prevention health claims are not 
exempted from drug claim and cannot be used on food labels (AAFC, 2012). 
Concerning the standard of evidence, disease risk reduction and disease prevention 
health claims require the highest standard of evidence, while for functional health 
claim, a lower standard of evidence is sufficient. Despite these regulatory differences, 
consumers do not categorize health claims in the same way as regulators do. In fact, 
97Nutrition or nutrient claim describes the amount of a nutrient in a food . Example: A good source of 
iron, source offiber, high in vitamin A, Sodiumfree or transfatfree (Health Canada, 201 0) . 
98Relate to the effects that a food has on the normal functions of the body. It is based on the role that 
the food or the food constituent pla ys when consumed at level s consistent with normal dietary patterns. 
For example, "[Naming the food or food constituent] promotes regularity or laxation" (Canadian Food 
Inspection Agency, 2014). This information is avail able on line at: 
http :/ /www. inspection. gc.ca/food/labell i n g/foocl-label l ing- for- i nclustry/hea lth -
claims/eng/ 1392834838383/1392834887794 'lchap= 7#s 13c7 
99 Is a statement that links a food to a reduced ri sk of developing a diet-related di sease or condition in 
the context of the total diet. For example, "[Naming the food or food constituent] may reduce the ri sk 
of cardiovascular disease". (Canadian Food Inspection Agency , 2014 ).Thi s information is av ai labie 
online at: http://www.inspection .gc.ca/foocl/labelling/food-labelling-for- industrv/health -
claims/eng/ 1392834838383/1392834887794 ?chap= 14 
100Refers to the treatment or mitigation of a di sease or health-related condition , or about restoring , 
correcting or modifying body functions. For example, "[Naming the food or food constituent] lowers 
blood cholesterol". (Canadian Food Inspection Agency , 2014 ). This information is available on li ne at: 
http:/ /www. inspection. gc.ca/food/labell in g/food-label 1 in g-for -i ndustry/health-
claims/eng/ 1392834838383/ 1392834887794?chap= 14#s47cl4 
178 
consumers often do not know about these differences and do not even always 
understand differences between health daims categories (Edcoms, 2007) . 
Unlike health daims, the verification of health daims has received little attention, 
especially in Canada (Hailu et al. , 2009; Zou, 2011). However, the role of verification 
of health daims in consumers' acceptance of food has been acknowledged in some 
studies (Hailu et al., 2009; Innes and Hobbs, 2011). Verification of health daims, as 
quality signal, is important to establish the credibility of health claims (Hailu et al., 
2009; Ronteltap et al., 2007). In fact, although consumers perceive health daims as 
potentially useful, they are at the same time often unable to understand sorne of them 
(EdComs, 2007). Moreover, consumers are skeptical and confused about the real 
benefits referred to specifie health daims (Pothoulaki and Chryssochoidis, 2009) . 
Thus, a potential market failure arises due to information asymmetry between buyers 
and sellers. To reduce information asymmetry and avoid market failure, credible 
quality signais are necessary (Caswell and Mojduszka, 1996). 
lt is important to note that health daims are regulated by government while the 
verification of health daims accuracy can be canied out both by private certifiers 
(retailers, manufacturers), third-party certifiers (Fulponi 2006; Hatanaka, Bain and 
Busch, 2005; Henson and Reardon 2005) or public certifiers. Nevertheless, effects of 
endorsement by regulatory agencies are limited in empirical studies (EdComs, 2007; 
Zou, 2011). 
Even if previous studies have examined traceability, health claims and verification of 
health daims, the nexus of these types of labelling information has remained 
unexplored. Given the importance of these information eues , their simultaneous 
effects should bring in additional evidence about consumers' valuations of functional 
foods . Indeed, according to Verbeke and Ward (2006) consumers can weigh up 
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information on food labels and/or specifie information eues on labels against other 
characteristics or attributes during the stage of product evaluation in their decision 
making process. 
The mm of this article is to in vestigate the effects of traceabili ty (complete! y 
traceable, not traceable) , health daims (functional health daim: «Good for your 
heart», disease risk reduction health daim «Reduces the risks of heart disease and 
cancer» and disease prevention health daim «Helps to prevent coronary heart 
disease and cancer») and verification of health daims accuracy (carried by Health 
Canada, a federal government agency and Heart and Stroke Foundation, a non-profit 
organization) on consumers' behavioral intentions toward omega-3 fatty acids 
enriched foods. In particular, this study addresses the following research questions: 
1) What is the influence of traceability (complete! y traceable, not traceable) on 
consumers' behavioral intentions toward foods enriched with omega-3 fatty 
acids? 
2) Do health daims (functional health daim, disease risk reduction health daim 
or disease prevention health daim) differ in affecting consumers' behavioral 
intentions toward foods enriched with omega-3 fatty acids? 
3) What is the impact of verification of health daim accuracy carried by a 
government agency (Health Canada) versus a non-profit third party 
organization (Heart and Stroke Foundation) on consumers ' behavioral 
intentions toward foods enriched with omega-3 fatty acids? 
4) Does traceability interacts with verification of health daims? How 
differences in product tracea:bility (completely traceable, not traceable) coupled 
with the party that verified the accuracy of health daim type (a government 
agency, Health Canada- or a third party organization, Heart and Stroke 
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Foundation) influence consumers' behavioral intentions toward foods enriched 
with omega-3 fatty acids? 
5) Do health daims vary with the verification of health daims? How 
differences in health daims (functional; disease risk reduction and di sease 
prevention) , in conjunction with the party that verified the accuracy of health 
daim type (a government agency, Health Canada or a third party organization, 
Heart and Stroke Foundation) influence consumers' behavioral intentions 
toward foods enriched with omega-3 fatty acids? 
6) Does traceability interacts simultaneously with health daims and verification 
of health daims? How differences in product traceability (complete} y traceable-
not traceable) in conjunction with health daims (functional-disease risk 
reduction and disease prevention) and the party that verified the accuracy of 
health claim type (a government agency, Health Canada or a third party 
organization, Heart and Stroke Foundation) affect consumers' behavioral 
intentions toward foods enriched with omega-3 fatty acids? 
A mixed between-within subjects analysis 101 of variance is used as a research method 
in this study to investigate the effects of traceability, health daims and verification of 
health daims on consumers' behavioral intentions toward foods enriched with 
omega-3 fatty acids. 
This study has additional contributions. First, while traceability has been widely 
examined for conventional foods (e.g. Chen and Huang, 2013; Chen, Zhao, and Liu, 
2014; Choe et al , 2009; Hobbs et al. 2005; Loureiro and Umberger, 2007; Stranieri, 
101 Also known as sp lit-plot ANOV A, this method is a combination of two differe nt types of one-way 
ANOV A into one study: a between-subjects ANOV A and a within-subjects ANOV A (Stevens, 2009). 
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Baldi and Banterle, 2010; Ubilava and Foster, 2009) it has never been examined in 
the context of functional foods. Second, previous studies most commonly have 
focused on a specifie behavioral intention such as intention to purchase or willingness 
to buy (Uihteenmaki, 2013). Other behavioral intentions such as intentions to 
recommend and intentions to serve are important variables in the context of food 
consumption. Thus, this research incorporates intentions to purchase, intentions to 
recommend and intentions to serve foods enriched with omega-3 fatty acids as 
dependent variables. Finally, previous studies have mainly focused on specifie food 
as carriers for functional ingredient such as fruit juice, yoghurt, spread, bread, 
marganne, soup, etc. (Hoefkens and Verbeke, 2013; Van Kleef, van Trijp and 
Luning, 2005; Verbeke Scolderer and Liihteenmiiki, 2013). None has considered food 
products categories in general. Following «Eating Weil with Canada 's Food Guide» 
(Health Canada, 2011), this study considers five food products categories enriched 
with omega-3 fatty acids, namely: meat products, eggs, cereal products, dairy 
products and processed fruits or vegetables. 
The remainder of this article is structured as follows. Section 4.2 provides the 
theoretical underpinnings that justify the developed hypotheses of this research. 
Section 4.3 describes the research methods employed, with detail s about research 
design, sample, procedure and dependent variables' measures. Empirical findings are 
presented in section 4.4. The results are discussed in section 4.5. Finally, the paper 
concludes in section 4.6 with theoretical contributions, both managerial and public 
policy implications, limitations and avenues for future research. 
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4.2 Hypotheses development 
In this section are presented hypotheses related to the effects of independent factors 
(traceability, health daims and verification of health daims) on consumers' 
behavioral intentions (intention to purchase, intention to recommend and intention to 
serve) toward omega-3 fatty acids enriched foods. First, hypotheses related to main 
effect of traceability (hypothesis 1), the role of health daims (hypothesis 2) and the 
impact of verification of health daims (hypothesis 3) on consumers' behavioral 
intentions are proposed. Second, hypotheses related to interaction effects of health 
daims and verification of health daims (hypothesis 4) , traceability and verification of 
health daims (hypothesis 5) and traceability, health daims and verification of health 
daims (hypothesis 6) are respectively presented. 
4.2.1 Main effects of independent variables 
a) Traceability 
Following food safety crises about food quality and safety (Hobbs , 2004; Verbeke, 
2005b ), it bas been argued that traceability systems help resto re consumers' 
confidence (Gellynck and Verbeke, 2001; Hobbs , 2004; Liao, Chang and Chang, 
2011; van Rijswijk et al., 2008) . In fact, food traceability systems represent a means 
to disseminate information provision to consumers (Bosona and Gebresenbet, 2013; 
Menozzi et al., 2013; Hobbs, 2004; Van Rijswij and Frewer, 2011) , and bence, 
constitute a major instrument for addressing food safety issues (Van Rij swijk et al., 
2008; Verbeke, 2005b). 
The aim of information traceability is to reduce information asymmetry arising from 
food safety and food quality attributes (van Rijswijk and Frewer, 2008; Hobbs, 2004). 
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It can reduce possible consumers' anxiety about food safety as it provides sorne sort 
of quality assurance (Golan et al., 2004; Hobbs et al., 2005; McCarthy and Henson, 
2005; Van Rijswijk et al. , 2008; Van Wezemael et al., 2010) and therefore, enables a 
better product choice for consumers (Verbeke and Ward, 2006). It has been shown 
that traceability strengthens consumers' purchase intentions (Chen and Huang, 2013; 
Chen, Zhao, and Liu, 2014;Choe et al, 2009; Hobbs et al. 2005; Loureiro and 
Umberger, 2007;Stranieri, Baldi and Banterle, 2010; Ubilava and Poster, 2009). 
These findings lead to formulate, the following hypothesis: 
. Hl: Traceability has a positive impact on consumers' behavioral intentions: 
- Hla: Consumers are more likely to purchase completely traceable than non 
traceable omega-3 fatty acids enriched foods. 
- Hlb: Consumers are more likely to recommend to others completely 
traceable than non traceable omega-3 fatty acids enriched foods. 
- Hlc: Consumers are more likely to serve to others to whom they care for 
completely traceable than non traceable omega-3 fatty acids enriched foods . 
b) Health claims 
Given the growing interest of consumers and public in general for health related 
issues (Cardillo et al., 2011; Fernqvist and Ekelund, 2014), health daims have been 
widely studied (Fernqvist and Ekelund, 2014). Given health benefits of food products 
are credence attributes, health daims have become a typical mean to convey these 
attributes to consumers (Hoefkens and Verbeke, 2013; Sabbe et al, 2009). In fact , in 
the absence of health daims, health benefits remain unknown to potential consumers 
(Van Trijp and van der Lans , 2007; Williams, 2005; Lord, Eastlack and Stanton, 
1987). Consequently, health daims help consumers make better-informed and 
possibly healthier food choices (Baglione, 2012; Drichoutis et al., 2008; Williams and 
Ghosh, 2008). Previous studies used nutrition daim, functional and disease risk 
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reduction health claims to investigate whether consumers' behavioral intentions differ 
significantly (Grunert et al, 2009; Hoefkens and Verbeke, 2013; Saba et al., 2010; 
Sabbe et al., 2009; Van Trijp and Van der Lans, 2007; Van Kleef, van Trijp and 
Luning, 2005; Verbeke, Scholderer and Uihteenmaki, 2009). For instance, Hoefkens 
and Verbeke (2013); Verbeke, Scholderer and Lahteenmaki (2009) focused on 
nutrition, functional and disease risk reduction health claims. Grunert et al (2009); 
Saba et al. (2010), Van Kleef, van Trijp and Luning (2005) were interested in 
functional and disease risk reduction health claims. Sabbe et al. (2009) emphasized 
nutrition claim. Van Trijp and Van der Lans (2007) studied nutrition and disease risk 
reduction health claims. 
However, these previous studies have found mixed results. While Hoefkens and 
Verbeke (2013), Sabba et al. (2010) 102 , Verbeke, Scholderer and Lahteenmaki (2009) 
argued, on the one hand, consumers are more likely to btiy functional food with a 
nutrition claim or a functional health claim than with a disease risk reduction claim, 
Van Kleef, van Trijp and Luning (2005), Sabba et al. (2010) 103 , and Grunert et al. 
(2009) have demonstrated, on the other hand, consumers were more likely to buy 
functional foods labeled with a risk reduction than those labeled with a functional 
health claim. Moreover, Grunert et al. (2009), van Kleef, van Trijp and Luning (2005) 
found that positive claims (i.e., functional health claims) did not have any major 
impact on consumer response. Considering these inconsistencies in research results, 
hypothesis 2 (H2) is proposed without specifying any expected particular difference 
between health claims types (functional, disease risk reduction and disease 
prevention) in affecting consumers' behavioral intentions: 
102 This was found only for consumers in the United Kingdom. 
103 This finding was obtained for consumers in Finland and Germany. 
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H2: Health daims (functional, disease risk reduction and disease prevention) differ 
significantly in affecting consumers' behavioral intentions toward foods enriched 
with omega-3 fa tt y ac ids 
c) Verification of health claims 
Verification of health claims plays an important role in consumers' acceptance of 
both functional foods (Hailu et al., 2009) and agri-foods (Innes and Hobbs , 2011) . It 
supports effective development of marketing strategies , especially when the 
functional ingredient is novel and associated health effects are unknown (Hailu et al. , 
2009). In fact , given health benefits from functional foods are credence attributes that 
cannot be experienced by consumers, verification of health claims by credible 
organizations can help reduce consumers ' uncertainty and reinforce the credibility of 
health claims (Ronteltap et al., 2007). 
Despite their importance for consumer acceptance, trustworthiness of functional 
foods, verification of health daims accuracy by different organizations have been less 
investigated (Niva and Makela, 2007). According to Hailu et al. (2009), fewer studies 
have examined the link between verification of health daims by different 
organizations and consumer acceptance of functional foods (Cox, Evans and Lease, 
2008, 2011; Hailu et al., 2009). These studies have found that consumers' acceptance 
of functional foods is higher when these products mention on their labels that the 
verification of functional health daim and disease risk reduction health daim was 
carried by government (Cox, Evans and Lease, 2008, 2011; Hailu et al., 2009). 
Moreover, similar findings were also obtained in studies about public acceptance of 
new food technologies (Cardello, Schutzb and Lesherc, 2007; Mohr et al., 2007). All, 
these research results lead to the following hypothesis: 
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H3: Verification of health daims (functional, disease risk reduction and disease 
prevention) accuracy by Health Canada (a government agency) has greater effect on 
consumers ' behavioral intentions than verification of these health daims types 
accuracy by Heart and Stroke Foundation (a third party organization). 
- H3a: Consumers are more likely to pm·chase foods enriched with omega-3 
fatty acids indicating on their labels that 'Health Canada' verified the health 
daim type (functional, disease risk reduction or disease prevention) as being 
accurate than to buy those indicating that 'Heart and Stroke Foundation' 
verified the accuracy for such health daims. 
- H3b: Consumers are more likely to recommend to others foods enriched 
with omega-3 fatty acids indicating on their labels 'Health Canada' verified the 
health daim (functional, disease risk reduction or disease prevention) than to 
recommend those indicating that 'Hemt and Stroke Foundation' verified the 
accuracy for such health daims. 
- H3c: Consumers are more likely to serve to others foods enriched with 
omega-3 fatty acids indicating on their labels 'Health Canada' verified the 
health claim (functional, disease risk reduction or disease prevention) than to 
serve to others those indicating that 'Hemt and Stroke Foundation ' verified the 
accuracy for such health daims. 
4.2.2 Interaction effects between independent variables 
a) Interaction between health daims (functional , disease risk reduction and disease 
prevention) and verification of such health daim types by a government and a third 
party organization 
According to Ford, Smith and Swasy (1988) , even after using a product, health daims 
cannot be verified by consumers due to Jack of technical expertise or practical 
possibilities. Uitbeennmaki (2013) asserted that nutrition and health claims are just 
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one piece of information that consumers may use to evaluate a product's potential 
benefit. Moreover, Verbeke and Ward (2006) assumed that during the stage of 
product evaluation, consumers can weigh up labelling information and/or specifie 
information eues on labels against other characteristics or attributes. 
Furthermore, it has been argued that verification of health daims, in general, plays an 
important role in consumers' acceptance of functional foods (Hailu et al., 2009) and 
also agri-foods (Innes and Hobbs, 2011). According to Hailu et al. (2009) and 
Ronteltap et al. (2007), the verification of health daims, as a quality signal, is 
important to establish the credibility of health daims. Therefore, a potential 
interaction between a health daim and verification of a health daim can be expected. 
However, despite previous studies (Cox, Evans and Lease, 2008, 2011; Hailu et al. , 
2009) have found that consumers' acceptance of functional foods is higher when it is 
mentioned on food products' labels that the health claim has being verified accurately 
by a government agency. Mixed results were found regarding health daim 
differences in affecting consumers' behavioral intentions (Hoefkens and Verbeke, 
2013; Sabba et al., 2010; Verbeke, Scholderer and Uihteenmaki, 2009 and Van Kleef, 
van Trijp and Luning, 2005) 
Following these arguments and considering these research results inconsistencies, 
hypothesis 4 (H4) is proposed without specifying any expected particular difference 
between health daims types (functional , disease risk reduction and disease 
prevention) and the verification of health claim accuracy in affecting consumers.' 
behavioral intentions: 
H4: The differences between health daim types (functional, disease risk reduction or 
disease prevention) vary in conjunction with the verification of health daim accuracy 
carried by a government agency (Health Canada) vs. by a third party organization 
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(Heart and Stroke Foundation) in affecting consumers' behavioral intentions toward 
foods enriched with omega-3 fatty acids. 
- H4a: The differences between health daim types (functional, disease risk 
reduction or disease prevention) vary in conjonction with a verification of 
health daim accuracy carried by a government agency (Health Canada) vs. by a 
third party organization (Heart and Stroke Foundation) in affecting consumers' 
purchase intentions of omega-3fatty acids enriched foods. 
- H4b: The differences between health daim types (functional, disease ri sk 
reduction or disease prevention) vary in conjunction with a verification of 
health daim accuracy carried by a government agency (Health Canada) vs. by a 
third party organization (Heart and Stroke Foundation) in affecting consumers' 
intentions to recommend omega-3 fatty acids enriched foods. 
- H4c: The differences between health daims types (functional , disease risk 
reduction or disease prevention) vary in conjonction with verification of a 
health daim accuracy carried by a government agency (Health Canada) vs . by a 
third party organization (Hemt and Stroke Foundation) in affecting consumers' 
intentions to serve omega-3 fatty acids enriched foods. 
b) Interaction between: (1) traceability and verification of health daims (by a 
government vs. by a third party organization) and (2) traceability, health daims 
(functional, disease risk reduction and disease prevention) and verification of health 
daims (by a government vs. by a third party organization) 
Verbeke and Ward (2006) and Hobbs et al. (2005) have demonstrated that consumers 
are not interested in traceability information per se. Renee, consumer interest for and 
understanding of traceability cannot be taken for granted (Hobbs, 2005; Verbeke et 
al., 2006). Traceability is more difficult for consumers to understand than other 
information eues, su ch as country of origin or quality certifications (Grunert, 2005; 
Van Rijswijk et al. , 2008; Verbeke and Ward, 2006). Consequently, traceability as 
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such has little marketing potential and thus is of limited value to consumers unless 
accompanied by trustworthy quality verification (Hobbs et al., 2005; Verbeke, 2005b; 
Verbeke and Ward, 2006). Moreover, Van Rijswijk and Frewer (2008) argued that 
traceability may be a powerful tool to help establishing the authenticity of food and to 
check the veracity of food daims made by producers. In general, it has been stated 
that credence attributes necessitate traceability systems to check the integrity of 
information daims on labels (Galan et al., 2004; Tronstad et al. , 2005). 
Furthermore, Drichoutis, Lazaridis and Nayga (2006) and Stranieri , Baldi and 
Banterle (20 10) have stated that traceability and sources of information, amongst 
others, are important determinants of the consumers use of nutrition information. 
Moreover, Dickinson and Bailey (2002) have argued that food safety, traceability, 
and health information are valuable information for consumers. First, it has been 
shown that traceability strengthens consumers' purchase intentions (Chen and Huang, 
2013; Chen, Zhao and Liu, 2014; Choe et al, 2009; Hobbs et al. 2005; Loureiro and 
Uinberger, 2007; Stranieri, Baldi and Banterle, 2010; Ubilava and Foster, 2009). 
Second, Cox, Evans and Lease (2008 , 2011). Second, Hailu et al. (2009) have found 
that the verification of a health daim accuracy by a government entity increases 
consumers' acceptance of functional foods. Finally, mixed results have been found 
regarding health daim types in affecting behavioral intentions toward functional 
foods (Hoefkens and Verbeke, 2013; Sabba et al. , 2010; Verbeke, Scholderer and 
Lahteenmaki, 2009 and Van Kleef, van Trijp and Luning, 2005) . 
These research outputs lead to suggest that interactions between: (l) traceability and 
verification of health daims and (2) traceability, health daims and verification of 
health daims are worth y of being examined, as formulated in hypotheses H5 and H6. 
190 
H5: The impact of traceability on consumers' behavioral intentions toward omega-3 
fatty acids enriched foods varies in conjonction with verification of health daims. 
- H5a: Consumers are more likely to purchase completely traceable than non 
traceable omega-3 fatty acids enriched foods which health daim accuracy is 
verified by a government agency (Health Canada) than by a third party 
organization (Heart and Stroke Foundation). 
- H5b: Consumers are more likely to recommend to others completely 
traceable than non traceable omega-3 fatty acids enriched foods omega-3 fatty 
which health daim accuracy is verified by a government agency (Health 
Canada) than by a third party organization (Heart and Stroke Foundation). 
- H5c: Consumers are more likely to serve to others completely traceable than 
non traceable omega-3 fatty acids enriched foods which health claim accuracy 
is verified by a government agency (Health Canada) than by a third party 
organization (Heart and Stroke Foundation). 
For hypothesis 6 (H6), given research inconsistencies regarding health daim, this 
hypothesis is proposed without specifying any expected particular difference between 
traceability, health daims types (functional, disease ri sk reduction and disease 
prevention) and verification of health daim accuracy in affecting consumers' 
behavioral intentions: 
H6: The impact of traceability on consumers' behavioral intentions toward foods 
enriched with omega-3 fatty acids varies with health daims (functional, disease risk 
reduction or disease prevention) and verification of health daims. 
- H6a: The impact of traceability on consumers' intentions to purchase foods 
enriched with omega-3 fatty acids varies with health daims (functional, disease 
risk reduction or disease prevention) and verification of health daim type 
accuracy carried by a government agency (Health Canada) vs. by a third party 
organization (Heart and Stroke Foundation). 
- - - -· --·--- ---------------------------------------~ 
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- H6b: The impact of traceability on consumers' intentions to recommend to 
others foods enriched with omega-3 fatty acids varies with health claims 
(functional, disease risk reduction or disease prevention) and verification of 
health claim type accuracy carried by a government agency (Health Canada) vs. 
by a third party organization (Heart and Stroke Foundation). 
- H6c: The impact of traceability on consumers ' intentions to serve to others 
foods enriched with omega-3 fatty acids varies with health clairns (functional, 
disease risk reduction or disease prevention) and verification of health claim 
type accuracy carried by a governrnent agency (Health Canada) vs . by a third 
party organization (Heart and Stroke Foundation). 
4.3 Research method 
4.3.1 Research design 
The hypotheses were tested by means of a mixed between-within subjects analysis of 
variance design. This method was employed to assess the impact of traceability 
(traceable, not traceable), health claims (a functional health claim, a disease risk 
reduction health clairn and a disease prevention health claim), verification of health 
claim accuracy (a government or a third party organization) and food product 
categories (meat products, eggs, cereal products, dairy products and processed fruits 
or vegetables products) on consurners' behavioral intentions toward foods enriched 
with omega-3 fatty acids. Traceability and health claims are two between-subjects 
factors, while verification of health claim accuracy and food product categories are 
two within-subjects factors . Thereby a two-between two-within subjects analysis of 
variance was conducted. 
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As detailed in Table 4.1, the experiment was repeated for five product categories 
enriched with omega-3 fatty acids, namely: meat products , eggs, cereal products, 
dairy products and processed fruits or vegetables products. This, required six variants 
of the questionnaires to incorporate the between subjects health claims and 
traceability manipulations for each of the five selected product categories. Thus, each 
respondent completed a questionnaire assessing one health claim type (functional or 
disease risk reduction or disease prevention) , one level of traceability (completely 
traceable or not traceable) for each of the five categories of food products (meat, 
eggs, cereal products, dairy products and processed fruits or vegetables products) and 
two treatments of verification of health daims accuracy (Health Canada - a federal 
government agency - or Heart and Stroke Foundation- a third party non-profit 
organization). 
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4.3.2 Sample and procedure 
A pretest of the questionnaire was conducted during the Spring 2013 with a sample of 
30 students in Montreal, Canada who were similar in terms of demographie profile to 
the final sample. The pretest was useful to assess the understanding of questions and 
consistencies between questionnaires. 
After the pre test, a total of 810 questionnaires were distributed to undergraduate 
students in Montreal and Ottawa (Canada) during the Summer and Fall 2013. In total 
500 questionnaires were returned. Only 463 questionnaires were usable for statistical 
analysis. In this sample, 47% of respondents are male, 99% are less than 25 years old, 
98% are single and 30% have an annual income of $25 000 or less. 
Each of the 463 respondents randomly received one of the s1x variants of 
questionnaires (Clto C6, see Appendix 4.la and 4.lb). The number of respondents in 
each of the six between-subject conditions of the experiment was varying between 72 
and 83 (Table 4.1). 
The six questionnaire variants were structured in the same manner, consisting of three 
sections. The first section provided definitions of terms for omega-3 fatty acids and 
its uses, health daims and traceability. The second section included a set of 
instructions about how to answer the questionnaire and the ten product profiles. 
Finally, the third section consisted of sociodemographic questions (Appendix 4 .1). 
It is important to note that the level of measurement and sample size requirements 
were satisfied (Appendix 4.2- descriptive statistics). In fact according to Tabachnick 
and Fidell (2013) , the minimum sample size for the total number of subjects is 10 + 
1 
1 
----- ---------------------------------------------------------------------------------~ 
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number of levels in the within-subjects factor and the minimum number in each cell 
is 5. All these requirements are satisfied. The total numbers of subjects were 452, 457 
and 434 respectively for intentions to purchase, intentions to recommend and 
intentions to serve (these are greater than 10 + the number of levels in the repeated 
factors (5 for food product categories and 2 for verification of health daims 
accuracy)) . In addition, the smallest cells in the analysis had 68, 71 and 66 cases, 
respectively, for intentions to purchase, intentions to recommend and intentions to 
serve. Therefore the requirement of five or more subjects per cell is satisfied. 
4.3.3 Measures 
a) Dependent variables 
The dependent variables used in this study were behavioral intentions, namely: 
intentions to purchase, intentions to recommend and intentions to serve. Each 
behavion\1 intention was measured with one item on a seven-point semantic 
differentiai scale. The measure of the intentions to purchase was achieved by 
obtaining one's intention to buy by evaluating the following statement on a seven-
point scale: «1 mn unlikelyllikely to purchase this product». Intentions to recommend 
was measured by evaluating the following statement: «ft is unlikelyllikely that 1 
would recommend this product to others». Finally, the measure of intentions to serve 
was obtained by evaluating the following statement on the same type of scale: «ft is 
unlikelyllikely that I would serve this product to people Icare for». 
b) Independent variables 
Traceability. Two levels of traceability were incorporated in the experimental design 
of this study, namely: completely traceable and not traceable foods enriched with 
196 
omega-3 fatty acids. Therefore, if omega-3 fatty acids enriched food is completely 
traceable, a government agency or an individual could trace its production at every 
step and identify all parties involved in its processing and distribution, from the farm 
to the kitchen table. On the other band, if omega-3 fa tt y ac ids enriched food is not 
traceable, a government agency or an individual could not trace it from the farm to 
the kitchen table. 
Health daims. Three types of health daims related to foods enriched with omega-3 
fatty acids were investigated in this study: (1) a functional daim: «Good for your 
heart», (2) a disease risk reduction health daim: «Reduces the risks of heart disease 
and cancer» and (3) a disease prevention health daim: «Helps to prevent coronary 
heart disease and cancer». 
Verification of health daims. Two parties for the verification of bealth daims' 
accuracy were induded in the design of this study. The first one is Health Canada (a 
federal government agency) and the second one is Heart and Stroke Foundation (a 
non-profit organization or third-party organization). 
Food product categories. The food product categories used in this study were selected 
accordingly to «Eating Well with Canada' s Food Guide»87 and two previous studies 
on functional foods (Kotilainen et al., 2006; Menrad, 2003). Health Canada 
distinguishes between four food product groups, namely: (1) meat and alternatives, 
(2) milk and alternatives, (3) grain products and (4) vegetables and fruits . Kotilainen 
et al. (2006) and Menrad (2003) argued that functional foods have been developed in 
87Health Canada (20 li) . Available on li ne at: http://www. hc-sc.gc.ca/fn-an/food-gui de-a liment/i ndex-
eng. php 
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all food categories (dairy, confectionery, bakery, soft drinks, etc.). The categories of 
foods enriched with omega-3 fatty acids chosen in this study were (1) meat products 
(e.g. beef, chicken, park, etc), (2) eggs, (3) cereal products (e.g. sliced bread, pita, 
tortilla, bagel , breakfast cereals, pasta, couscous), (3) dairy products (milk, kefir, 
yogurt, cheese, etc.) and (5) processed fruits or vegetables (fruit juice, vegetable 
juice, etc.). 
4.4 Results 
4.4.1 Main effects 
This section presents results related to how independent variables , namely: 
traceability, health daims and verification of health daims affect consumers' 
behavioral intentions (intentions to purchase, intentions to recommend and intentions 
to serve) toward foods enriched with omega-3 fatty acids. 
It should be noted that the effect of food product categories (meat product, eggs, 
ce real products, dairy products and processed fruits or vegetables products) on 
consumers' behavioral intentions toward foods enriched with omega-3 fatty acids was 
not developed as a hypothesis; as it is a demonstration for the experimental design of 
this study rather than a theoretical proposition. This effect, presented at the end of this 
section, is aimed at extending findings' discussion of this article. 
a) Traceability 
The results show that traceability has three significant main effects on consumers' 
behavioral intentions toward foods enriched with omega-3 fatty acids . First, as 
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depicted in Tables 4.2 and 4.3, traceability has a significant effect on consumers' 
purchase intentions of foods enriched with omega-3 fatty acids. Subjects were more 
likely to purchase completely traceable than non traceable food products enriched 
with omega-3 fatty acids (M: completely traceable = 4.965, not traceable = 4.609, 
Type III Sum of Squares= 142.764, F(l, 446) = 9.882, p = 0.002 < 0.01). Thus, H1a 
is supported. Second, the effect of traceability on consumers' intentions to 
recommend to others, foods enriched with omega-3 fatty acids, is also significant 
(Tables 4.2 and 4.3). Consumers are more likely to recommend these products to 
others when they are completely traceable than when they are not (M: completely 
traceable = 4.908, not traceable = 4.536, Type III Sum of Squares = 157.196, F (1 , 
451) = 9.918, p = 0.002 < 0.01). Thus, H1b is supported. Finally, traceability has a 
significant main effect on consumers ' intentions to serve to individuals they care for, 
foods enriched with omega-3 fatty acids. As illustrated in Tables 4.2 and 4.3, 
consumers are more likely to serve completely traceable than non traceable foods 
enriched with omega-3 fatty acids (M: completely traceable = 5.070, not traceable = 
4.576, Type III Sum of Squares= 263.944, F(l , 428) = 17.384, p = 0.000 < 0.01). 
Thus, H3c is supported. 
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Table 4.2 Effects of traceability and health claims on behavioral intentions: Between-
Subjects ANOV A 
DV: Intentions to purchase 
df Type III Sum F p 
of Squares 
Source of variation: 
Traceability 1 142.764 9.882 0.002 
Health Claim 2 23.104 0.800 0.450 
Err or 446 6443.126 
DV: Intentions to recommend 
Source of variation: 
Traceability 1 157.196 9.918 0.002 
Health Claim 2 50.908 1.606 0.202 
Err or 451 7148.391 
DV: Intentions to serve 
Source of variation: 
Traceability 1 263.944 17.384 0.000 
Health Claim 2 17.704 0.583 0.559 
Err or 428 6498.218 
Abbreviation: DV =Dependent variable, df =degrees of freedom, F = Fisher's test 
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Table 4.3 Effects on dependent variables: Marginal Means and Standard Deviations 
DV: Intentions to purchase 
Traceability 
-Completely traceable 
-Not traceable 
Health daims 
-Functional: «Goodfor your Heart» 
-Disease risk reduction: «Reduces the risks of heart 
dise ases» 
-Disease prevention: «Helps to prevent coronary heart 
disease and cancer» 
Verification of health daims 
-A government agency: Health Canada 
- A third-party organization: Heart and Stroke Foundation 
Food product categories 
-Meat(beef, chicken, pork, etc.) 
-Eggs 
-Cereal products (sliced bread, pita tortilla, bagel, 
breakfast cereals, pasta, couscous, etc.) 
-Dairy products (milk, kefir, yogurt, cheese, etc.) 
-Processed fruits or vegetables (fruit juice, vegetable juice, 
etc.) 
DV: Intentions to recommend 
Traceability 
-Completely traceable 
-Not traceable 
Health daims 
-Functional: «Goodfor your Heart» 
-Disease risk reduction: «Reduces the risks of heart 
dise ases» 
-Disease prevention: «Helps to prevent coronary heart 
disease and cancer» 
Verification of health daims 
- A government agency: Health Canada 
-A third-party organization: Heart and Stroke Foundation 
M 
4.965 
4.609 
4.742 
4.730 
4.888 
4.930 
4.644 
4.763 
4.890 
4.870 
4.870 
4.563 
M 
4.908 
4.536 
4.633 
4.663 
4.870 
4.837 
4.607 
SD 
0.082 
0.078 
0.097 
0.100 
0.098 
0.059 
0.064 
0.070 
0.070 
0.070 
0.075 
0.083 
SD 
0.083 
0.084 
0.101 
0.104 
0.102 
0.060 
0.069 
Abbreviations: DV = Dependent variable, M = Mean, SD = Standard deviation 
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Table 4.3 Effects on dependent variables: Marginal Means and Standard Deviations 
( ... Continued) 
DV: Intentions to recommend 
Food product categories 
. -Meat 
-Eggs 
-Cereal products (sliced bread, pita tortilla, bagel, breakfast 
cereals, pasta, couscous, etc.) 
-Dairy products (milk, kefir, yogurt, cheese, etc.) 
-Processed fruits or vegetables (fruit juice, vegetable juice, 
etc.) 
DV: Intention to serve 
Traceability 
- Completely traceable 
-Not traceable 
Health Claims 
-Functional: «Goodfor your Heart» 
-Disease risk reduction: «Reduces the risks of heart 
diseases» 
-Disease prevention: «Helps to prevertt coronary heart 
disease and cancer» 
Verification of health daims 
-A government agency: Health Canada 
-A third-party organization: Heart and Stroke Foundation 
Food product categories 
-Meat (beef, chicken, pork, etc.) 
-Eggs 
-Cereal products (sliced bread, pita tortilla, bagel, breakfast 
cereals , pasta, couscous, etc.) 
-Dairy products (milk, kefir, yogurt, cheese, etc.) 
-Processed fruits or vegetables (fruit juice, vegetable juice, 
etc.) 
M 
4.693 
4 .795 
4.750 
4.816 
4.556 
M 
5.070 
4.576 
4.778 
4.778 
4.913 
5.009 
4.637 
4.417 
4.900 
4.884 
4.894 
4.620 
SD 
0.088 
0.070 
0.072 
0.072 
0.080 
SD 
0.083 
0.085 
0.102 
0.104 
0.102 
0.061 
0.068 
0.070 
0.071 
0.071 
0.073 
0.083 
Abbreviations: DV =Dependent variable, M = Mean, SD = Standard deviation 
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b) Health daims 
Hypothesis H2 suggest that there are significant differences between health daims 
(functional health daim, disease risk reduction health daim and disease prevention 
health daim) in affecting consumers' behavioral intentions toward foods enriched 
with omega-3 fatty acids. As shown in Table 4.2, there are no significant differences 
between health daims. The reported p-values for all the dependent variables 
(intentions to purchase, intentions to recommend and intentions to serve) are superior 
to 0.05 and thus hypothesis H2 is not supported. For consumers, whether foods 
enriched with omega-3 fatty acids are labeled with a functional health daim ('Good 
for your heart') , a disease risk reduction health daim ('Reduces the risk of heart 
disease and cancer') or a disease prevention health daim ('Helps to prevent coronary 
heart disease and cancer') , their behavioral intentions toward these products 
(intentions to purchase, intentions to recommend and intentions to serve others) do 
not vary significantly. 
c) Verification of health daims 
Results indicate that verification of health daims' (VHC) accuracy have significant 
main effects on consumers' intentions to purchase as weil as intentions to recommend 
and intentions to serve to others foods enriched with omega-3 fatty acids. First of all, 
consumers are more likely to purchase foods enriched with omega-3 fatty acids that 
state on their labels that 'Health Canada' (a government agency) verified the accuracy 
of health daim type than those indicating on their labels that 'Heart and Stroke 
Foundation' (a third party organization) verified the health daim type as being 
accurate (M: Health Canada VHC = 4.930, Heart and Stroke Foundation VHC = 
4.644, Type III Sum of Squares = 91.772, F(l , 446) = 37.847, p = 0.00 < 0.01) 
(Tables 4.3 and 4.4). Thus, H3a is supported. Moreover, consumers are more likely to 
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recommend to others foods enriched with omega-3 fatty ac ids th at mention on the ir 
labels that 'Health Canada' (a government agency) verified the accuracy of health 
claim type than those specifying on their labels that 'Heart and Stroke Foundation ' (a 
third party organization) verified the accuracy of health claim(M: Health Canada 
VHC = 4.837, Heart and Stroke Foundation VHC = 4.607, Type III Sum of Squares = 
60.284, F(1 , 451) = 20.045, p = 0.00 < 0.01) (Tables 4.3 and 4.4). Thereby, H3b is 
supported. Finally, consumers are more likely to serve to others foods enriched with 
omega-3 fatty acids which indicate on their labels that the accuracy of health claim 
type bas been verified by 'Health Canada' (a government agency) than those 
indicating on their labels that 'Heart and Stroke Foundation ' (a third party 
organization) verified the health claim type as being accurate (M: Health Canada 
VHC = 5.009, Heart and Stroke Foundation VHC = 4.637, Type III Sum of Squares= 
149.515, F(l, 428) = 56.640, p = 0.00 < 0.01). This finding supports H3c. 
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Table 4.4 Within-Subjects ANOV A 
Source of DV: Intentions to purchase 
variation 
df Type III Sum of F p 
Squares 
VHC 1 91.772 37.846 0.000 
Food product 4 64.468 6.422 0.000 
categories 
HCxVHC 2 7.088 1.462 0.233 
TxVHC 1 0.365 0.150 0.698 
TxHCxVHC 2 5.709 1.177 0.309 
Error df 446 
Source of DV: Intentions to Recommend 
variation 
VHC 1 60.284 20.045 0.000 
Food product 4 39.468 3.638 0.009 
categories 
HCx VHC 2 15.497 2.577 0.077 
TxVHC 1 0.012 0.004 0.950 
TxHCxVHC 2 14.9 19 2.480 0.085 
Error df 451 
Source of DV: Intentions to serve 
variation . 
VHC 1 149.515 56.640 0.000 
Food product 4 48.525 5.717 0.000 
categories 
HCx VHC 2 2.082 0.394 0.674 
TxVHC 2 2.871 1.087 0.298 
TxHCx VHC 2 3.302 0.625 0.535 
Error df 428 
Abbreviations: VHC= verification of health daims; HC = health daims; T= 
traceability; df = degrees of freedom; F = Fisher's test 
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d) Main effect of food product categories 
As shown in Table 4.4, food product categories enriched with omega-3 fatty acids 
have significant main effects on consumers' behavioral intentions. All the p-values 
for intentions to purchase (p= 0.000), intentions to recomniend (p= 0.009) and 
intentions to serve (p= 0.000) are inferior to 0.01. 
As depicted in Figure 4.1 and Appendix 5.4a, consumers are more likely to buy eggs 
(M= 4.890) , followed by cereal products (sliced bread, pita tortilla, bagel , breakfast 
cereals, pasta, couscous, etc.) (M= 4.870) and dairy products (milk, kefir, yogurt, 
cheese, etc) (M= 4.847) enriched with omega-3 fatty acids . Enriched meat products 
with omega-3 fatty acids (beef, chicken, pork, etc) come in the fourth position (M= 
4.763). Finally, the lowest score of consumers' intentions to buy is for processed 
fruits or vegetables (fruit juice, vegetable juice, etc.) enriched with omega-3 fatty 
acids (M= 4.565). 
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Figure 4.1 Effect of food product categories enriched with omega-3 fatty acids on 
consumers' purchase intentions 
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Besides, consumers are more likely to recommend to others enriched dairy products 
(milk, kefir, yogurt, cheese, etc) (M= 4.816) , followed very closely by enriched eggs 
(M= 4.795), and successively by enriched cereal products (sliced bread, pita tortilla, 
bagel, breakfast cereals, pasta, couscous, etc.) (M= 4.750) and enriched meat 
products (beef, chicken, pork, etc.) (M= 4.693) with omega-3 fatty acids (Figure 4.2 
and Appendix 4.4b). However, consumers are less likely to recommend to others 
processed fruits or vegetables (fruit juice, vegetable juice, etc.) enriched with omega-
3 fatty acids (M= 4.556). 
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3 = Cereal products 
4 = Dairy products 
5 = Processed fruits 
or vegetables 
Figure 4.2 Effect of food product categories enriched with omega-3 fatty acids on 
consumers' intentions to recommend 
Finally, for consumers' intentions to serve to other people they care for, foods 
enriched with omega-3 fatty acids (Figure 4.3 and Appendix 4.4c), the highest score 
is for eggs (M= 4.900). In the second, third and fourth positions are respectively dairy 
products (milk, kefir, yogurt, cheese, etc) (M= 4.894), cereal products (sliced bread, 
pita tortilla, bagel, breakfast cereals, pasta, couscous, etc.) (M= 4.884) and meat 
products (beef, chicken, pork, etc.) (M= 4.817). The lowest score of consumers' 
intentions to serve is again for processed fruits or vegetables (fruit juice, vegetable 
juice, etc.) enriched with omega-3 fatty acids (M= 4.620). 
------------ -----
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Figure 4.3 Effect of food product categories enriched with omega-3 fatty acids on 
consumers' intentions to serve 
The Bonferroni comparison test (Appendices 5.4a, 5.4b and 5.4c) reveals that for all 
behavioral intentions (intentions to purchase, intentions, to recommend and intentions 
to serve), there are only significant differences between the following foods enriched 
with omega-3 fatty acids: 
- Eggs and processed fruits or vegetables (p < 0.05) , 
- Cereal products and processed fruits or vegetables (p < 0.05) , 
- Dairy products and processed fruits or vegetables (p < 0.05). 
In summary, consumers seem to accept the enrichment of eggs, cereal products , dairy 
products and to a lesser extent meat products with omega-3 fatty acids. However, 
they seem reluctant to buy, recommend or serve to others processed fruits or 
vegetables (fruitjuice, vegetable juice, etc) enriched with omega-3 fatty acids . 
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4.4.2 Interaction effects 
a) Health daims by verification of health daims 
The hypothesis 4 (H4) proposed that the differences between health daims 
(functional health claim, disease risk reduction health claim or disease prevention 
health claim) vary in conjunction with the party that verified the accuracy of health 
claim type (a government agency-Health Canada- or a third party organization- Heart 
and Stroke Foundation-) in affecting consumers' behavioral intentions toward foods 
enriched with omega-3 fatty acids. For purchase intentions of omega-3 fatty acids-
enriched foods , this interaction is statistically not significant, Type III Sum of 
Squares= 7.088, F (2,446) =1.462, p = 0.233 > 0.05) (Table 4.4). Renee H4a is not 
supported. Concerning intentions to recommend to others omega-3 fatty acids-
enriched foods, the interaction between health claims and verification of health 
claims is significant, Type III Sum of Squares= 15.497, F (2,451) = 2.577, p = 0.077 
< 0.1) (Table 4.4). Thus, this interaction supports H4b. 
A Bonferroni three-group comparison test (Appendix 4.4b) confinns that the source 
of interaction is found in differences between the verification of health claims 
treatments (Health Canada and Heart and Stroke Foundation) for both functional 
health claim ('Good for your heart ') and disease risk reduction health claim 
('Reduces the risk of heart disease and cancer') (left-hand-side of figure 4.4, p < 
0.05), but not for the disease prevention health claims ('Helps to prevent coronary 
heart disease and cancer') (right-hand-side of figure 4.4, p > 0.05). In other words, 
when foods enriched with omega-3 fatty acids are labeled with a functional health 
claim ('Good for your heart') or a disease risk reduction health claim ('Reduces the 
risks of heart disease and cancer') and at the same time state on labels that this health 
claim type has been verified as being accurate by Health Canada (a federal 
~--
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government agency), consumers are more likely to recommend to others these food 
products than those specifying on their labels that Heart and Stroke Foundation has 
verified the accuracy of this health daim type. However, there is no significant 
difference on consumers' intentions to recommend these food products to others (p > 
0.05) whether foods enriched with omega-3 fatty acids are labeled with a disease 
prevention health daim ('Helps to prevent coronary heart disease and cancer') and 
mentioning that this health daim type has been verified accurate by Health Canada (a 
federal government agency) or by Heart and Stroke Foundation (a third party 
organization) . (See Appendix 4.4b, for pairwise comparisons, Bonferroni test). 
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intentions to recommend to others enriched foods with omega-3 fa tt y ac ids 
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Finally, consumers' intentions to serve to others foods enriched with omega-3 fatty 
acids, do not differ between health daims treatments (types) and verification of health 
daims treatments (Health Canada and Heart and Stroke Foundation) (Type III Sum of 
Squares = 2.082, F (2,428) = 0.394, p= 0.674 > 0.05) (Table 4.4). H4c is not 
supported. 
b) Traceability by verification of health daims 
As illustrated in Table 4.4, the interaction between traceability and verification of 
health daims on consumers' behavioral intentions toward foods enriched with 
omega-3 fa tt y ac ids is not significant. Consumers ' behavioral intentions of omega-3 
fatty acids-enriched foods do not differ across both traceability treatments 
(completely traceable- not traceable) and organization that verified the health daim 
type as being accurate (a government agency-Health Canada- or a third party 
organization -Heart and Stroke Foundation) . First, for intentions to purchase, H5a is 
not supported (Type III Sum of Squares = 0.365, F (2, 446) = 0.150, p = 0.698 > 
0.05). Second, for intentions to recommend, H5b is also not supported (Type III Sum 
of Squares= 0.012, F (2, 451) = 0.004, p = 0.950 > 0.05). Finally, for intentions to 
serve (Type III Sum of Squares = 2.871 , F (2, 428) = 1.087, p = 0.298 > 0.05), 
hypothesis Sc (H5c) is not supported. 
In summary, differences in product traceability (completely traceable -not traceable) 
coupled with the party that verified the accuracy of health daim type (a government 
agency-Health Canada- or a third party organization-Heart and Stroke Foundation) do 
not significantly differ in affecting consumers' behavioral intentions of foods 
enriched with omega-3 fatty acids. 
212 
c) Traceability by health daims by verification of health daims 
Hypothesis 6 (H6) proposed that there is a triple interaction between traceability, 
health daims and verification of health daims on consumers' behavioral intentions. 
The results in Table 4.4 show that the three-way interaction of traceability, health 
daims and verification of health daims is only significant for intentions to 
recommend (Type III Sum of Squares= 14.919, F(2, 451) = 2.480, p = 0.085 < 0.1). 
Renee, hypothesis 6b (H6b) is supported. Nevertheless, for intentions to purchase 
(Type III Sum of Squares= 5.709, F(2, 451) =1.177, p = 0.309 > 0.05) and for 
intentions to serve to others foods enriched with omega-3 fatty acids (Type III Sum of 
Squares = 3.302, F(2, 428) = 0.625 , p = 0.535 > 0.05). H6a and H6c are not 
supported. 
As illustrated in Figure 4.5 and according to Bonferroni comparison test (See 
Appendix 4.4b- pairwise comparison, Bonferroni test) , the difference between 
verification of health daim accuracy by Health Canada (VHC 1) and verification of 
health daim by Heart and Stroke Foundation (VHC 2) is significant between 
traceability treatments (completely traceable -not traceable) only for the functional 
health daim ('Good for your heart') (p = 0.072 < 0.10) and not for the disease risk 
reduction health daim ('Reduces the risk of heart disease and cancer') (p = 0.388 > 
0.05) nor for the disease prevention health daim ('Helps to prevent coronary heart 
disease and cancer ') (p =0.374 > 0.05). In other words, when foods enriched with 
omega-3 fatty acids are completely traceable, labeled with a functional health daim 
('Good for your heart') and at the same time stating on labels that this health daim 
has been verified as being accurate by Health Canada (a federal government agency), 
consumers are more likely to recommend to others these foods than those which are 
not traceable, labeled with a functional health daim ('Good for your heart ') and 
213 
indicating on labels that this health claim has been verified accurate by Heart and 
Stroke Foundation (a third party organization). 
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consumers' intentions to recommend to others foods enriched with omega-3 fatty acids 
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4.5 Discussion 
This study reports on the effects of traceability, health daims and verification of 
health daims on consumers' intentions to purchase, intentions to recommend and 
intentions to serve omega-3 fatty acids-enriched foods. The discussion summarizes 
key findings of the mixed between-within analysis of variance used to test the main 
effects as well as the interaction effects. of traceability, health daims and verification 
of health daims. Findings related to main effects are firstly discussed, followed by 
those related to interaction effects . 
4.5.1 Discussion of main effects 
First, the results demonstrate th at traceability has mam effects on consumers' 
behavioral intentions toward foods enriched with omega-3 fatty acids. Consumers are 
more likely to pm·chase, to recommend and to serve to others completely traceable 
than non traceable omega-3 fatty acids enriched foods . This finding is consistent with 
previous studies which found that traceability strengthens consumers ' purchase 
intentions of conventional food such as fast food (Chen and Huang, 2013) , agri-food 
products (Chen, Zhao, and Liu, 2014; Choe et al, 2009) meat products (beef, pork) 
(Hobbs et al. 2005; Loureiro and Umberger, 2007; Ubilava and Foster, 2009). In fact, 
traceability seems to be a good mean of information (Bosona and Gebresenbet, 2013; 
Hobbs, 2004; Menozzi et al., 2013; Van Rijswij and Frewer, 2011) . It serves as a 
form of quality assurance (Golan et al., 2004; Hobbs et al., 2005; McCarthy and 
Henson, 2005; Van Rijswijk et al., 2008; Van Wezemael et al., 2010) and enables a 
better product choice for consumer (Verbeke and Ward, 2006) . 
Second, this study reports no significant differences between health daims in 
affecting consumers' behavioral intentions toward foods enriched with omega-3 fatty 
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acids. Whether foods enriched with omega-3 fatty acids are labeled with a functional 
health claim ('Good for your heart'), a disease risk reduction health claim ('Reduces 
the risk of heart disease and cancer') or even with a disease prevention health daim 
('Helps ta prevent coronary heart disease and cancer') , consumers' intentions to 
purchase, intentions to recommend and intentions to serve these food products to 
others do not vary significantly. A possible explanation may be that consumers may 
purchase from habit, experience and past behavior, do not seek to read labels and/or 
that they do not understand the information that they read on labels (Pothoulaki and 
Chryssochoidis, 2009). According to sorne authors, this is because of the complexity 
of health daims (Verbeke et al., 2009) and the presence of too much information on 
food packaging (EdComs, 2007). · 
Furthermore, this finding is contradictory with sorne previous studies which argued 
that functional and disease risk reduction health claims differ in affecting consumers' 
purchase intentions of functional foods (Hoefkens and Verbeke, 2013; Saba et al., 
2010; Sabbe et al., 2009; Van Trijp and Van der Lans, 2007; van Kleef, van Trijp and 
Luning, 2005; Verbeke, Scholderer and Ui.hteenmaki, 2009) 104. However, this finding 
is in accordance with what Lahteenmaki (2013) noticed that there are relatively few 
consistent findings about consumers' responses to functional foods' health daims. 
Third, verification of health daim accuracy has a significant effect on consumers' 
behavioral intentions toward foods enriched with omega-3 fatty acids. Consumers are 
more likely to purchase, to recommend and to serve to others these foods when it is 
mentioned on their labels that 'Health Canada' (a government agency) verified the 
health daim type than to purchase, recommend or serve those indicating on their 
labels that 'Heart and Stroke Foundation' (a third party organization) verified the 
104 lt is important to note that these studies focused on health daims without reference to the source of 
health claim verification. 
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health daim type accuracy. This finding is in line with previous studies that found 
that consumers' acceptance of functional foods is higher when these products 
mention on their labels that the verification of health daims cornes from a reliable 
source outside the food industry such as government (Cox, Evans and Lease, 2008, 
2011; Hailu et al., 2009). Using conjoint analysis to investigate consumers ' 
preferences over functional foods attributes 105 , these previous studies incorporated 
functional and disease risk reduction health daims. According to Malla et al. (2013) , 
given the growing number of functional food products and health daims, consumers 
are confused. Verification of health daims, as quality signal , is important to establish 
the trustworthiness of health daims (Hailu et al., 2009; Ronteltap et al. , 2007) . 
It is important to note that, Heart and Stroke Foundation (HSF) has recently 
announced the abolition of its Health Check program from food products labels and 
restaurants' menus (HSF, 2014) 106 . According to sorne dietitians, the program was 
outdated. The criteria used were mostly related to heart health and Jess to fiber, salt 
and sugar (Allard, 2014). Moreover, consumers were not very interested by this logo 
(HSF, 2014). Again, the finding of this study seems to provide a practical rationale 
for the decision by Heart and Stroke Foundation to withdraw its logo. 
Finally, results of this paper indicate that consumers do not have the same behavioral 
intentions (intentions to purchase, intentions to recomrnend and intentions to serve) 
toward different food product categories enriched with omega-3 fatty acids. 
Consumers have more favorable intentions to buy, to recommend and to serve to 
others eggs, cereal products (sliced bread, pita tortilla, bagel, breakfast cereals, pasta, 
couscous, etc.), dairy products (milk, kefir, yogurt, cheese, etc.) and at a less extent 
105Base product, health daims, verification of health daims and priee. 
106Heart and Stroke Foundation (2014) . This information is available online at: 
http://www. he al thcheck.org/story/heallh-chec k -exit 
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meat products (beef, chicken, pork, etc.) enriched with omega-3 fatty acids. This 
finding is consistent with sorne previous studies. For instance Zou (2011) found that 
consumers have positive responses toward omega-3 enriched milk and Verbeke, 
Scolderer and Uihteenmaki (2009) found that consumers have quite positive 
valuations of omega-3 fatty acids enriched spread. According to Verbeke, Scolderer 
and Lahteenmaki (2009) and Verbeke et al. (2005) these favorable intentions may 
result from the association with omega-3 that has built a quite strong reputation. 
However, for processed fruits or vegetables (fruit juice, vegetable juice, etc.) enriched 
with omega-3 fatty acids, consumers have the lowest intentions to buy, to recommend 
and to serve to others. In other words, consumers seem to consider artificial the 
enrichment of processed fruits or vegetables with omega-3 fatty acids. For instance, 
consumers consider that fruits juices have already a healthy image (Bech-Larsen and 
Grunert, 2003). Consequently, the combination of a healthy image product (fruit 
juice) and a less natural type of enrichment (omega-3 fatty acids opposed to fiber) is 
perceived less natural and apparently results in lower consumers ' behavioral 
intentions (Verbeke, Scolderer and Lahteenmaki, 2009). 
4.5.2 Discussion of interaction effects 
Regarding the interaction effects, this research reports a significant interaction 
between health daims and verification of health daims only for consumers' 
intentions to recommend to others foods enriched with omega-3 fatty acids . In 
addition, significant three-way interaction effects of traceability, health daims and 
verification of health daims was also found on consumers' intentions to recommend 
to others foods enriched with omega-3 fatty acids . These interactions are discussed 
hereafter. 
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This research finds that the impact of a given health daim (a functional health daim, 
a disease risk reduction health claim or a disease prevention health daim) on 
consumers' intentions to recommend foods enriched with omega-3 fatty acids varies 
in conjunction with the organization that verified the accuracy of health daim type (a 
government agency, Health Canada or a third party organization, Heart and Stroke 
Foundation). Indeed, wh en foods enriched with omega-3 fatty acids are labeled with a 
functional health daim ('Good for your heart') or a disease risk reduction health 
daim ('Reduces the risks of heart disease and cancer') and at the same time specified 
on labels that this health daim type has been verified accurate by Health Canada (a 
federal government agency), consumers are more likely to recommend to others these 
food products than to recommend those labeled with a functional health daim or a 
disease risk reduction health daim which has been verified accurate by Heart and 
Stroke Foundation (a third party organization). 
Besicles, results demonstrate there is a significant triple interaction of traceability, 
health daims and verification of health daims on consumers' intentions to 
recommend to others omega-3 fatty acids enriched foods. Confirmed by a Bonfenoni 
test, the difference between verification of health daim accuracy by Health Canada 
(VHC 1) and verification of health daim by Heart and Stroke Foundation (VHC 2) is 
significant between traceability treatments (completely traceable -not traceable) only 
for the functional health daim ('Good for your heart') and not for the disease risk 
reduction health daim ('Reduces the risk of heart disease and cancer') nor for the 
disease prevention health daim ('Helps to prevent coronary heart disease and 
cancer'). Consumers have significantly higher intentions to recommend to others 
completely traceable omega-3 fatty acids enriched foods labeled with a given 
functional health daim ('Goodfor your heart') and at the same time mentioning that 
the accuracy of this health daim has been verified by Health Canada (a government 
agency). 
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An explanation of both the two-way 107 and there-way 108interactions can be provided 
by the elaboration likelihood mode! of Petty and Cacioppo (1986) and Chaiken, 
Liberman and Eagly (1989). Since foods are low involvement products, consumers 
will not follow a systematic decision making processing (Verbeke, 2005b). They will 
rather use heuristics without much further cognitive elaboration or deep thought 
(Leathwood et al. , 2007; Verbeke, 2005). Moreover, memory is organized as an 
associative network of information (Solomon, 1996). Thereby, pieces of information 
that are perceived to be related can be linked to each other and grouped together 
under general categories (Leathwood et al., 2007). In this study, source that can be 
trusted (Health Canada), and traceability are examples of heuristics that are used by 
consumers in conjunction with health daims to elicit their intentions to recommend 
omega-3 fatty acids fatty acids enriched foods to others. Given that, health benefits 
are credence attributes that cannot be instantly experienced, consumers will use 
during their purchase decision process verification of health daims, as a quality 
signal, and traceability as a quality and safety product assurance. In fact , verification 
of health daims has been considered critical in establishing the trustworthiness of 
functional foods' health daims (Hailu et al. , 2009). 
4.6 Conclusion and future research 
The main objective of this research was to investigate the effects of traceability, 
health daims and verification of health daims on consumer' s behavioral intentions 
toward foods enriched with omega-3 fatty acids. A mixed between-within subjects 
analysis of variance was used to achieve this objective. A questionnaire with 6 
variants was administrated to 463 subjects. 
107 Interaction between health daims and verification of health daims. 
108Interaction between traceability, health claims and verification of health cl ai ms. 
~----------------------------------------------------------------------------- --- ----
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This research is the first study to examine simultaneously the effects of traceabüity, 
health daims and verification of health daims on consumers' behavioral intentions 
toward functional foods. Previous studies highlighted the importance of these labels 
information eues in consumers' food choice without investigating the interaction 
effects between them. One of the contributions of this study is addressing this gap in 
the literature. In addition, this research focused on several behavioral intentions 
(intention to purchase, intention to recommend and intention to serve) as dependent 
variables whereas previous studies most commonly used intention to purchase as 
dependent behavioral variable (Uihteenmaki, 2013). Moreover, previous studies 
usually emphasized on specifie functional food products such as calcium enriched 
fruit juice (Hoefkens and Verbeke, 2013; Verbeke, Scholderer and Uitheenmaki, 
2013), omega-3 enriched spread and fiber enriched cereal (Verbeke, Scholderer and 
Latheenmaki, 2013) and bread, bar of chocolate, chewing gum, margarine, ice-cream, 
soup, tea, etc. (Van Kleef et al., 2005). In contrast, this study is interested in 
consumers' behavioral intentions toward five omega-3 fatty acids enriched foods 
categories, namely: meat products, eggs, cereal products, dairy products and 
processed fruits or vegetables. Another contribution of this study is to investigate the 
effects of different types of health daims at the same time. Specifically, this study 
examines a functional health daim, a disease risk reduction health daim and a 
disease prevention health claim. Finally, this study enriches the knowledge about the 
verification of health daims for functional foods. In fact , there is limited research in 
this area, especially in Canada (Hailu et al. , 2009; Zou, 2011). Thereby, this study 
examined the health daims verification accuracy carried by different organizations: 
Health Canada (a government organization) and Heart and Stroke Foundation (a third 
party or non-profit organization). 
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In this section a summary of the major research findings is first presented. Second, 
implications for functional food industry and public policy are highlighted. Finally, 
this section condudes with limitations and future research. 
a) Summary of major research findings 
The results indicate that consumers are more likely to purchase, to recommend and to 
rather serve completely traceable than non traceable enriched foods with omega-3 
fatty acids. Given the credence nature of functional foods , traceability, as a labelling 
information eue, seems to help consumers during their decision making process. 
Whereas previous studies demonstrated the influence of traceability on consumers' 
purchase intentions of conventional foods (Chen and Huang, 2013 ; Chen, Zhao, and 
Liu, 2014; Choe et al, 2009; Hobbs et al. 2005; Loureiro and Umberger, 2007; 
Ubilava and Foster, 2009), this study is the first to demonstrate this same effect in the 
context of functional foods. 
Regarding health daims, this study reports that there is no difference between the 
three types of health daims (functional , disease risk reduction or disease prevention) 
in affecting consumers' behavioral intentions. Whether the health daim on foods 
enriched with omega-3 fatty acids is a functional health daim ( Good for your he art) , 
a disease risk reduction health daim (Reduces the risks of heart disease and cancer' ) 
or a disease prevention health daim (Helps to prevent coronary heart disease and 
cancer') , consumers' behavioral intentions (intentions to purchase, intentions to 
recommend, and intentions serve to others these foods) do not vary significantly. 
For verification of health daims, results show that consumers are more likely to 
purchase, to recommend and to serve to others foods enriched with omega-3 fatty 
acids stating on their labels that 'Health Canada' (a government agency) verified the 
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accuracy of health claim type than those indicating on their labels that 'Heart and 
Stroke Foundation' (a third party organization) verified the health claim type as being 
accurate. 
With regard to food products categories enriched with omega-3 fatty acids , 
consumers are more likely to purchase, to recommend and to serve to others eggs, 
cereal products, dairy products and, at a less extent, meat products . However, for 
processed fruits or vegetables (fruit juice, vegetable juice, etc.) enriched with omega-
3 fatty acids, consumers seem reticent to buy, recommend or serve them to others. 
Finally, findings report on significant interactions effects of (1) health daims 
(functional , disease risk reduction and disease prevention) and verification of health 
daim type accuracy (carried by a government agency vs. a third party organization) 
and (2) traceability, health daims (functional, disease risk reduction and disease 
prevention) and verification of health daim type accuracy (carried by a government 
agency vs . a third party organization) for consumers' intentions to recommend to 
others foods enriched with omega-3 fatty acids. 
b) Implications for functional foods industry and po licy makers 
Findings of this study might be of particular interest to functional food industry as 
well asto policy makers. 
For functional foods firms, findings of this research provide a better understanding of 
the main and interaction effects of traceability, health cl ai ms and verification of 
health daims on consumers ' behavioral intentions toward omega-3 fatty acids-
enriched foods. For traceability, results show that consumers are more likely to 
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purchase, to recommend and to serve to others completely traceable than non 
traceable foods enriched with omega-3 fatty acids . Consequently, with this type of 
information, both functional foods manufacturers and retailers could benefit from a 
potential increase in sales. Therefore, functional foods' producers should collaborate 
with government to provide consumers with truthful information about their 
products' safety and quality through an effective traceability system. Regarding 
health daims, results demonstrate that whether foods enriched with omega-3 fatty 
acids are labeled with a functional health daim ('Goodfor your heart'), a disease risk 
reduction health daim ('Reduces the risk of heart disease and cancer') or a disease 
prevention health daim ('Helps to prevent coronary heart disease and cancer'), 
consumers' behavioral intentions (intentions to purchase, intentions to recommend 
and intentions to serve to others) do not vary significantly. However, results show 
that the differences between health daim types vary in conjunction with verification 
of health daims in affecting consumers' intentions to recommend to others foods 
enriched with omega-3 fatty acids. Especially, functional and disease risk reduction 
health daims when combined with verification carried by a credible government 
agency (Health Canada), consumers are more likely to recommend to others omega-3 
fatty acids enriched foods. Functional foods' manufacturers should collaborate with 
policy makers in order to authorize functional and disease risk reduction health 
daims. 
For policy makers, results of this study suggest that traceability and verification of 
health daims accuracy by a government agency (Health Canada) have effects on 
consumers' intentions to purchase, to recommend and to serve omega-3 fatty acids 
enriched foods. Therefore, government regulatory agencies should establish both 
effective traceability system and verification of health daims accuracy programs for 
functional foods. In fact, since traceability is a quality and a safety assurance 
(Grunert, 2005), it is critical for public policy makers to provide a mean to check the· 
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authenticity of the information and thus build trust between sellers and consurners 
(Choe et al., 2009). Concerning, the verification of health clairns, it is important for 
the governrnent regulatory agency to set prograrns that allow functional food industry 
stating on the ir products' labels th at the health clairn type has been verified ace urate 
by a governrnent agency as long as functional foods rnanufacturers cornply to health 
clairns regulations. 
c) Limitations and future research 
Sorne limitations of this study must be acknowledged. First, this study focused only 
on sorne specifie labels eues such as traceability, health clairns and verification of 
health clairns to investigate their impact on consurners' behavioral intentions toward 
foods enriched with ornega-3 fatty acids. However, during their decision-rnaking 
process, consurners may use other attributes or extrinsic eues such as priee and brand 
narnes which can affect their food decision rnaking (Bredahl, 2004) . Moreover, 
Fernqvist and Ekelund (2014) argued that in a real situation, many products present 
more than one type of credence together with many other extrinsic and intrinsic 
quality eues. Future research can include other label eues such as nutritional 
information or production rnethod technology (e.g. nanotechnology, genetic 
engineering). Second, the sarnple of this study is lirnited to students. Future studies 
are recornrnended to investigate respondents with diverse socio demographie profiles. 
For instance, gender and age affect consumer reactions to functional foods and health 
clairns (Ares and Garnbaro, 2007; Verbeke, 2005b). Third, like most consumer 
research, this study, used self-reported data. According to Fisher (1993) studies using 
self reported data may suffer from social desirability bias. Therefore, future studies 
should use more experimentation and observation with real product settings and 
shopping environrnents. Finally, this study did not incorporate in the experimental 
design covariates such as personality traits which are of great interest because they 
225 
are at the heatt of consumer attitude formation and behavioral intentions (Dabholkar 
and Bagozzi, 2002). Future research should use, for example, health consciousness as 
a personality trait. In fact, previous studies found that health consciousness predicts 
consumers' attitude, intention and purchase of functional foods (Landstrom et al., 
2007; Naylor, Droms and Haws, 2009). 
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APPENDICES 
Appendix 5.1.a First version of the questionnaire (Condition 1: Cl) 
Dear Participant, 
We are researchers at Université du Québec à Montréal (UQAM) and HEC-Montréal 
who are conducting a study on the perceptions of foods which are enriched with 
omega-3 Fatty Acids. The findings of this study will be published and will provide 
the scientific community, public policy organizations, as well as the food industry 
with a better understanding of how consumers perceive and feel about such foods. 
In the following pages, you will find a questionnaire which you are kindly invited to 
complete. There are no right or wrong answers . Your task is to simply provide 
responses that best reflect your impressions of various foods. The completion of this 
questionnaire should take approximately thirty minutes of your time. In order to 
respond easily and accurately, we ask that you follow precisely the procedures and 
instructions provided for each section of this questionnaire. 
Please note that all the collected information will remain strictly confidential and 
completely anonymous. The collected responses will in fact only be used for 
statistical purposes and there is rio way for the researchers; or anyone else for that 
matter, to associate a respondent to the questionnaire he or she has completed. 
Y our participation is voluntary. Y ou are completely free to participate or not in this 
research and you may stop your participation at any time. Please note that providing 
responses to this questionnaire will be considered as consent on your part to 
participate in this study. Also note that given the strict confidentiality measures which 
are taken, your participation in this study should not cause you any prejudice 
whatsoever nor should it benefit you directly in any way. 
This study has been approved by the Comité d'éthique de la recherche/Research 
Ethics Committee of Université de Québec à Montréal (UQAM). It therefore 
complies with ethical standards in research involving human subjects. For any 
questions pertaining to ethical issues with respect to this research project, please feel 
free to contact a member of the UQAM Research Ethics Committee by telephone at 
(514) 987-3000 (Ext. 7753). 
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If you have any questions about this questionnaire or our study, please feel free to 
contact one of the researchers whose name and contact information appear below. 
Finally, we would thank you very much for your participation and hope you will 
enjoy completing this questionnaire and contributing to the advancement of 
knowledge in this area of research. 
PARTI 
Instructions: 
In the following pages, you will be asked to evaluate various descriptions or profiles 
of food products. Before you begin, it is important that you read and understand the 
following notions because they will help you to assess each food product profile. 
A. · Description of 'omega-3' Fatty Acids and their Uses 
Omega-3 Fatty Acids are considered to be 'good' fats' (polyunsaturated fats) and are 
commonly found in marine (i.e., fish and seafood) and plant (e.g.flax and canola) 
sources. Scientific evidence indicates that Olnega-3 Fatty Acids have a positive 
impact on health. Despite these robust research findings , there is still an apparent lack 
in the intake of omega-3 Fatty Acids by Canadian consumers. 
Omega-3 Fatty Acids can be added to various fooqs. For instance, they can be 
incorporated into eggs by feeding chickens with flax , a grain rich in omega-3 Fatty 
Acids. Alternatively, it can be given to livestock in the form of feed grains enriched 
in omega-3 Fatty Acids. In turn, the resulting meat will be rich in omega-3 Fatty 
Acids and thus provide benefits to the consumer. 
Another way to increase this intake could involve adding plant or fish oils to various 
processed food products without altering their original taste. In fact, with current 
technologies such as nûcroencapsulation, the enrichment of processed foods with 
omega-3 oils has NO impact on the taste of the food whatsoever. Examples of such 
foods include yogourts, breads, milk, cheeses, tofu, soy beverages, cereals , pasta, fruit 
juices and many other readily available processed foods. 
B. Definition of 'Health Claim' 
A health claim is any representation in labelling or advertising that states, suggests, or 
implies that a relationship exists between good health and the consomption of a food, 
or an ingr~dient in the food. Food companies can make certain health claims by 
linking food consomption to the prevention of certain illnesses. For instance, 
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cornrnonly found ·daims in the rnarketplace suggest that "sodium intake is related to 
high blood pressure"; that "calcium may reduce the risk of osteoporosis"; that 
"saturated fat intake is related to heart disease"; and that "fruits and vegetables may 
help reduce the risk of cancer." Governrnent agencies and various foundations can 
verify and regulate health daims. 
C. Definition of 'Traceability' 
Traceability is the ability to track an item or group of items - animais , plants, 
processed food products or ingredients - from one point in the supply chain to 
another. An effective traceability system would be based for instance on the ability to 
trace a food product from its initial production location (ex: a farrn in Canada or 
elsewhere) to the consurner's kitchen table in Canada. It would therefore allow one to 
trace the food through all stages of the food production process and the identification 
of all interrnediaries involved in the distribution of the food to consumers. 
Therefore, if a food product is cornpletely traceable, a governrnent agency or an 
individual could trace its production at every step and identify all parties involved in 
its processing and distribution, from the farrn to the kitchen table. On the other band, 
if a food is not traceable, a government agency or an individual could not trace it 
from the farrn to the kitchen table. 
Traceability is very important in crisis situations involving tainted foods because it 
may greatly enhance the ability to contain and stop the flow of 'high risk' products in 
the distribution chain to consurners. Here are sorne exarnples where food traceability 
would be highly desirable: 
Exl: Identification of a farm from which originated an animal which was infected 
with a particular disease which can be transmitted to consumers. 
Ex2: Identification of the producer of a vegetable grown in soil contaminated by 
pollutants. 
Ex3: Identification of the packing plant where tainted meat was processed. 
Ex4: Identification of the producer of a cereal which was farmed by using prohibited 
and harmful pesticides or herbicides. 
~------------------------------------------------------------------------- --
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PART II 
Instructions: In the following pages, you will be asked to evaluate ten (10) 
descriptions or profiles of food products. As you know, there are many food groups. 
For the purposes of this study, we essentially arrived at ten (10) categories of foods 
which seem to make sense to most consumers and which can involve enrichment with 
omega-3 Fatty Acids. When thinking about these food categories, think only of foods 
enriched with omega-3 Fatty Acids. 
Please .read carefully all the characteristics that are presented in the description of 
each profile and then answer the statements following this description by circling the 
numbers that best describe your impressions. There are no right or wrong answers . It 
is your impressions that matters. 
Also note that you are asked to evaluate each of the following product profiles 
independently of the other profiles you have read. Just focus on the information 
provided in a particular profile and provide responses for that profile. Then, go 
on to the next one, and so forth ... 
Product profile 1: 
• A meat product enriched with omega-3 fatty acids (ex: beef, chicken, pork, 
etc.). 
• The following health daim appears on the packaging: «Good for your 
heart». 
• The health daim has been verified as being accurate by: Health Canada, a 
federal government agency. 
• This product is completely traceable, from the farm to the kitchen table. 
Please use the following scales to evaluate this product by circling one answer on 
each row 
1 am unlikely to purchase this 
product 
lt is unlikely that 1 would 
recommend this product to 
others 
lt is unlikely that 1 would serve 
this product to people 1 care 
for 
1 2 3 4 5 6 7 I am likely to purchase thi s 
product 
1 2 3 4 5 6 7 It is likely that I would 
recommend this product to others 
1 2 3 4 5 6 7 It is likely that 1 would serve this 
product to people I care for 
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Product profile 2: 
• ~ enriched with omega-3 fatty acids. 
• The following health daim appears on the packaging: «Good for your 
heart». 
• The health daim has been verified as being accurate by: Health Canada, a 
federal government agency. 
• This product is completely traceable, from the farm to the kitchen table. 
Please use the following scales to evaluate this product by circling one answer on 
each row 
I am unlikely to purchase this 
product 
It is unlikely that I would 
recommend this product to 
others 
It is unlikely that I would serve 
this product to people I care 
for 
Product profile 3: 
1 2 3 4 5 6 7 I am likely to puz·chase thi s 
product 
1 2 3 4 5 6 7 It is likely that I would 
recommend this product to others 
1 2 3 4 5 6 7 It is likely that I would serve this 
product to people I care for 
• A cereal product enriched with omega-3 fatty acids (sliced bread, pita, 
tortilla, bagel, breakfast cereals, pasta, couscous, etc.). 
• The following health daim appears on the packaging: «Good for your 
heart». 
• The health daim has been verified as being accurate by: Health Canada, a 
federal government agency. 
• This product is completely traceable, from the farm to the kitchen table. 
Please use the following scales to evaluate this product by circling one answer on 
each row 
I am unlikely to purchase this 
product 
It is unlikely that I would 
recommend this product to 
others 
It is unlikely that I would serve 
this product to people I care 
for 
1 2 3 4 5 6 7 I am likely to purchase this 
product 
1 2 3 4 5 6 7 It is likely that I would 
recommend this product to others 
1 2 3 4 5 6 7 It is likely that I would serve this 
product to people I care for 
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Product profile 4: 
• A dairy product enriched with omega-3 fatty acids (ex: milk, kefir, yogurt, 
cheese, etc.). 
• The following health claim appears on the packaging: «Good for your 
heart». 
• The health claim bas been verified as being accurate by: HeaJth Canada, a 
federal government agency. 
• This product is completely traceable, from the farm to the kitchen table. 
Please use the following scales to evaluate this product by circling one answer on 
each row 
I am unlikely to purchase this 
product 
It is unlikely that I would 
recommend this product to 
others 
It is unlikely that I would serve 
this product to people I care 
for 
Product profile 5: 
1 2 3 4 5 6 7 I am likely to purchase this 
product 
1 2 3 4 5 6 7 It is likdy that I would 
recommend this product to others 
1 2 3 4 5 6 7 It is likely that I would serve this 
product to people I care for 
• A processed fruit or vegetable product enriched with omega-3 fatty acids 
(ex: fruitjuice, vegetablejuice, etc.). 
• The following health daim appears on the packaging: «Good for your 
heart». 
• The health daim bas been verified as being accurate by: Health Canada, a 
federal government agency. 
• This product is completely traceable, from the farm to the kitchen table. 
Please use the following sc ales to evaluate this product by circling one answer on 
each row 
I am unlikely to purchase this 
product 
It is unlikely that I would 
recommend this product to 
others 
It is unlikely that I would serve 
this product to people I care 
for 
1 2 3 4 5 6 7 I am likely to purchase this 
product 
2 3 4 5 6 7 It is likely that I would 
recommend this product to others 
1 2 3 4 5 6 7 It is likely that I would serve this 
product to people I care for 
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Product profile 6: 
• A meat product enriched with omega-3 fatty acids (ex: beef, chicken, pork, 
etc). 
• The following health daim appears on the packaging: «Good for your 
heart». 
• The health daim has been verified as being accurate by: a Heart and 
Stroke Foundation, a non-governmental organization. 
• This product is completely traceable, from the farm to the kitchen table. 
Please use the following scales to evaluate this product by circling one answer on 
each row 
I am unlikely to purchase this 
product 
It is unlikely that I would 
recommend this product to 
others 
It is unlikely that I would serve 
this product to people I care 
for 
Product profile 7: 
1 2 3 4 5 6 7 I am likely to purchase this 
product 
1 2 3 4 5 6 7 It is likely that I would 
recommend this product to others 
1 2 3 4 5 6 7 It is likely that I would serve this 
product to people I care for 
• ~enriched with omega-3 fatty acids. 
• The following health daim appears on the packaging: «Good for your 
heart». 
• The health daim has been verified as being accurate by: a Heart and 
Stroke Foundation, a non-governmental organization. 
• This product is completely traceable, from the farm to the kitchen table. 
Please use the following scales to evaluate this product by circling one answer on 
each row 
I am unlikely to purchase this 
product 
It is unlikely that I would 
recommend this product to 
others 
It is unlikely that I would serve 
this product to people I care 
for 
1 2 3 4 5 6 7 I am likely to pUI·chase this 
product 
1 2 3 4 5 6 7 It is likely that I would 
recommend this product to others 
1 2 3 4 5 6 7 It is likely that I would serve this 
product to people I care for 
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Product profile 8: 
• A cereal product enriched with omega-3 fatty acids (sliced bread, pita, 
tortilla, bagel, breakfast cereals, pasta, couscous, etc.). 
• The following health daim appears on the packaging: «Good for your 
heart». 
• The health daim bas been verified as being accurate by: a Heart and 
Stroke Foundation, a non-governmental organization. 
• This product is completely traceable, from the farm to the kitchen table. 
Please use the following scales to evaluate this product by circling one answer on 
each row 
I am unlikely to purchase this 
product 
It is unlikely that I would 
recommend this product to 
others 
It is unlikely that I would serve 
this product to people I care 
for 
Product profile 9: 
1 2 3 4 5 6 7 I am likely to pm·chase this 
product 
1 2 3 4 5 6 7 It is likely that I would 
recommend this product to others 
1 2 3 4 5 6 7 It is likely that I would serve this 
product to people I care for 
• A dairy product enriched with omega-3 fatty acids (ex: milk, kefir, yogurt, 
cheese, etc.) 
• The following health daim appears on the packaging: «Good for your 
heart». 
• The health daim bas been verified as being accurate by: a Heart and 
Stroke Foundation, a non-governmental organization. 
• This product is completely traceable, from the farm to the kitchen table. 
Please use the following sc ales to evaluate this product by circling one answer on 
each row 
I am unlikely to purchase this 
product 
It is unlikely that I would 
recommend this product to 
others 
It is unlikely that I would serve 
this product to people I care 
for 
1 2 3 4 5 6 7 I am likely to pur·chase this 
product 
1 2 3 4 5 6 7 It is likely that I would 
recommend this product to others 
1 2 3 4 5 6 7 It is likely that I would serve this 
product to people I care for 
1 
1 
1 
· 1 
1 
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Product profile 10: 
• A processed fruit or vegetable product enriched with omega-3 fatty acids 
(ex: fruit juice, vegeta ble juice, etc.). 
• The following health daim appears on the packaging: «Good for your 
heart». 
• The health daim bas been verified as being accurate by: aHeart and 
Stroke Foundation, a non-governmental organization. 
• This product is completely traceable, from the farm to the kitchen table. 
Please use the following scales to evaluate this product by circling one answer on 
each row 
I am unlikel y to pure hase this 
product 
It is unlikely that I would 
recommend this product to 
others 
It is unlikely that I would serve 
this product to people I care 
for 
1 2 3 4 5 6 7 I am likely to purchase this 
product 
1 2 3 4 5 6 7 It is likely that I would 
recommend this product to others 
1 2 3 4 5 6 7 It is likel y th at I would serve this 
product to people I care for 
'------------------------- - - - -
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PART III 
SOCIODEMOGRAPHIC VARIABLES 
1. Are you the main food grocery shopper in your household? 
Yes D 
No D 
2. How frequently do you personally do the grocery shopping for your household? 
Weekly (once or severa! times a week) D 
A few times a month D 
o~a~~ D 
Less than once a month D 
N~cr D 
3. How much do you approximately spend monthly on food? 
Less than 200$ D 
2oo-2so$ D 
251-3oo$ D 
301-350$ D 
351-4oo$ D 
More than 400$ D 
4. Do you think that your food choice is in preventing chronic 
diseases? 
Very important D 
Somewhat important D 
Not very important D 
Not at all important D 
5. Before purchasing a new food product, do you _____ read the label? 
Always D 
Often D 
Sometimes D 
Never D 
6. Do you consider that you are ________ informed about foods 
enriched with omega-3 fatty acid? 
Very informed 
Somewhat informed 
Not very informed 
Not at all informed 
D 
D 
D 
D 
7. Are you ________ worried about having chronic diseases? 
Not at all 
Somewhat 
Very 
8. What is your gender? 
Male 
Fe male 
9. What is your marital status? 
Single, never married 
Separated 
0 Married 
0 Divorced 
D 
D 
D 
D 
D 
0 Common-law partner 
0 Widowed 
0 
0 
10. How many children do you have?---------------
11. How many children currently live with you? __________ _ 
12. What was the total annual incarne, before taxes, of your household in 2012? 
$25 000 or less 
Between $50 001 to $75 000 
$ 100 000 and over 
0 Between 25 001 to $50 000 
0 $75 001 to $100 000 
0 
13. How many years of schooling have you completed? 
D 
0 
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Primary schoo1 0 High school D College or D 
Cégep 
University- D University- D 
undergraduate gradua te 
-----------------------------------------------------~ 
14. To which age group do you belong? 
Less than 25 years 
old 
45 to 54 years old 
D 25 to 34 years old D 35 to 44 years old 
0 55 to 64 years old D 65 years old and 
more 
15. With which ethnie group do you 
identify? ____________________________________ _ 
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D 
D 
16. Wh at is y our nationality? __________________________________ __ 
THANK YOU FOR YOUR COLLABORATION! 
' 1 
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Appendix 4.2b Modified parts of the five other versions of the questionnaire (C2, C3, 
C4, CS and C6) 
Second version of the questionnaire (Condition 2: C2) 
Product profile 1: 
• A meat product enriched with omega-3 fatty acids (ex: beef, chicken, pork, 
etc.). 
• The following health claim appears on the packaging: «Reduces the risks 
of heart disease and cancer». 
• The health claim bas been verified as being accurate by: Health Canada, a 
federal government agency. 
• This product is completely traceable, from the farm to the kitchen table. 
Please use the following scales to evaluate this product by circling one answer on 
each row 
I am unlikely to purchase this 
product 
It is unlikely that I would 
recomrnend this product to 
others 
It is unlikely that I would serve 
this product to people 1 care 
for 
1 2 3 4 5 6 7 I am likely to purchase this 
product 
1 2 3 4 5 6 7 It is likely that I would 
recornmend this product to others 
1 2 3 4 5 6 7 It is likely that I would serve this 
product to people 1 care for 
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Product profile 2: 
• ~ enriched with omega-3 fatty acids. 
• The following health daim appears on the packaging: «Reduces the risks 
of heart disease and cancer». 
• The health daim bas been verified as being accurate by: Health Canada, a 
federal government agency. 
• This product is completely traceable, from the farm to the kitchen table. 
Please use the following scales to evaluate this product by circling one answer on 
each row 
I am unlikely to purchase this 
product 
It is unlikely that I would 
recommend this product to others 
It is unlikely that I would serve 
this product to people I care for 
Product profile 3: 
1 2 3 4 5 6 7 I am likely to purchase this 
product 
1 2 3 4 5 6 7 It is likely that I would 
recommend this product to others 
1 2 3 4 5 6 7 It is likely that I would serve this 
product to people I care for 
• A cereal product enriched with omega-3 fatty acids (sliced bread, pita, 
tortilla, bagel, breakfast cereals, pasta, couscous, etc.). 
• The following health daim appears on the packaging: «Reduces the risks 
of heart disease and cancer». 
• The health daim bas been verified as being accurate by: Health Canada, a 
federal government agency. 
• This product is completely traceable, from the farm to the kitchen table. 
Please use the following scales to evaluate this product by circ ling one answer on 
each row 
I am unlikel y to purchase this 
product 
It is unlikely that I would 
recommend this product to 
others 
It is unlikely that I would serve 
this product to people I care 
for 
1 2 3 4 5 6 7 I am likely to purchase this 
product 
1 2 3 4 5 6 7 It is likely that I would 
recommend this product to others 
1 2 3 4 5 6 7 It is likely that I would serve this 
product to people I care for 
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Product profile 4: 
• A dairy product enriched with omega-3 fatty acids (ex: milk, kefir, yogurt, 
cheese, etc.). 
• The following health claim appears on the packaging: «Reduces the risks 
of heart disease and cancer». 
• The health claim bas been verified as being accurate by: Health Canada, a 
federal government agency. 
• This product is completely traceable, from the farm to the kitchen table. 
Please use the following scales to evaluate this product by circling one answer on 
each row 
1 am unlikel y to purchase this 
product 
lt is unlikely that 1 would 
recommend this product to 
others 
lt is unlikely that 1 would serve 
this product to people l care 
for 
Product profile 5: 
1 2 3 4 5 6 7 
1 2 3 4 5 6 7 
1 am likely to purchase this 
product 
lt is likely that 1 would 
recommend this product to others 
1 2 3 4 5 6 7 lt is likely that 1 would serve this 
product to people 1 care for 
• A processed fruit or vegetable product enriched with omega-3 fatty acids 
(ex: fruit juice, vegetable juice, etc.). 
• The following health claim appears on the packaging: «Reduces the risks 
of heart disease and cancer». 
• The health claim bas been verified as being accurate by: Health Canada, a 
federal government agency. 
• This product is completely traceable, from the farm to the kitchen table. 
Please use the following scales to evaluate this product by circling one answer on 
each row 
1 am unlikel y to purchase this 
product 
lt is unlikely that 1 would 
recommend this product to 
others 
lt is unlikely that 1 would serve 
this product to people 1 care 
for 
1 2 3 4 5 6 7 
1 2 3 4 5 6 7 
1 am likely to purchase this 
product 
lt is likely that 1 would 
recommend this product to others 
1 2 3 4 5 6 7 lt is likely that 1 would serve this 
product to people 1 care for 
- --··-------------------------------
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Product profile 6: 
• A meat product enriched with omega-3 fatty acids (ex: beef, chicken, pork, 
etc). 
• The following health daim appears on the packaging: «Reduces the risks 
of heart disease and cancer». 
• The health daim has been verified as being accurate by: a Heart and 
Stroke Foundation, a non-governmental organization. 
• This product is completely traceable, from the farm to the kitchen table. 
Please use the following scales to evaluate this product by circling one answer on 
each row 
I am unlikel y to purchase this 
product 
It is unlikely that I would 
recommend this product to 
others 
It is unlikely that I would serve 
this product to people I care 
for 
Product profile 7: 
1 2 3 4 5 6 7 I am likely to purchase this 
product 
1 2 3 4 5 6 7 It is likely that I would 
recommend this product to others 
1 2 3 4 5 6 7 It is likely that I would serve this 
product to people I care for 
• ~enriched with omega-3 fatty acids. 
• The following health daim appears on the packaging~ <~Reduces the risks 
of heart disease and cancer». 
• The health claim has been verified as being accurate by: a Heart and 
Stroke Foundation, a non-governmental organization. 
• This product is completely traceable, from the farm to the kitchen table. 
Please use the following scales to evaluate this product by circling one answer on 
each row 
I am unlikely to purchase this 
product 
It is unlikely that I would 
recommend this product to 
others 
It is unlikely that I would serve 
this product to people I care 
for 
1 2 3 4 5 6 7 
1 2 3 4 5 6 7 
I am likely to purchase this 
product 
It is likely that I would 
recommend this product to others 
1 2 3 4 5 6 7 It is likely that I would serve this 
product to people I care for 
------------------------------------- ---
--··--------------------------------------
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Product profile 8: 
• A cereal product enriched with omega-3 fatty acids (sliced bread, pita, 
tortilla, bagel, breakfast cereals, pasta, couscous, etc.). 
• The following health daim appears on the packaging: «Reduces the risks 
of heart disease and cancer». 
• The health daim bas been verified as being accurate by: a Heart and 
Stroke Foundation, a non-governmental organization. 
• This product is completely traceable, from the farm to the kitchen table. 
Please use the following scales to evaluate this product by circling one answer on 
each row 
I am unlikely to purchase this 
product 
It is unlikely that I would 
recommend this product to 
others 
It is unlikely that I would serve 
this product to people I care 
for 
Product profile 9: 
1 2 3 4 5 6 7 I am likely to pUI·chase this 
product 
1 2 3 4 5 6 7 It is likely that I would 
recommend this product to others 
1 2 3 4 5 6 7 It is likely that I would serve this 
product to people I care for 
• A dairy product enriched with omega-3 fatty acids (ex: milk, kefir, yogurt, 
cheese, etc.) 
• The following health daim appears on the packaging: «Reduces the risks 
of heart disease and cancer». 
• The health daim bas been verified as being accurate by: a Heart and 
Stroke Foundation, a non-governmental organization. 
• This product is completely traceable, from the farm to the kitchen table. 
Please use the following sc ales to evaluate this product by circling one answer on 
each row 
I am unlikely to purchase this 
product 
It is unlikely that I would 
recommend this product to 
others 
It is unlikely that I would serve 
this product to people I care 
for 
1 2 3 4 5 6 7 I am likely to pUI-chase this 
product 
1 2 3 4 5 6 7 It is likely that I would 
recommend this product to others 
1 2 3 4 5 6 7 It is likel y th at I would serve this 
product to people I care for 
1 
1 ' 
1 
1 
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Product profile 10: 
• A processed fruit or vegetable product enriched with omega-3 fatty acids 
(ex: fruit juice, vegeta ble juice, etc.). 
• The following health daim appears on the packaging: «Reduces the risks 
of heart disease and cancer». 
• The health claim bas been verified as being accurate by: aHeart and 
Stroke Foundation, a non-governmental organization. 
• This product is completely traceable, from the farm to the kitchen table. 
Please use the following scales to evaluate this product by circling one answer on 
each row 
I am unlikely to purchase this 
product 
It is unlikely that 1 would 
recommend this product to 
others 
It is unlikely that 1 would serve 
this product to people 1 care 
for 
1 2 3 4 5 6 7 I am likely to purchase this 
product 
1 2 3 4 5 6 7 It is likely that 1 would 
recommend this product to others 
1 2 3 4 5 6 7 lt is likely that 1 would serve this 
product to people 1 care for 
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Third version of the questionnaire (Condition 3: C3) 
Product profile 1: 
• A meat product enriched with omega-3 fatty acids (ex: beef, chicken, pork, 
etc.). 
• The following health daim appears on the packaging: «Helps to prevent 
coronary heart disease and cancer». 
• The health daim has been verified as being accurate by: Health Canada, a 
federal government agency. 
• This product is completely traceable, from the farm to the kitchen table. 
Please use the Jollowing scales to evaluate this product by circling one answer on 
each row 
1 am unlikely to purchase this 
product 
lt is unlikely that 1 would 
recommend this product to 
others 
lt is unlikely that 1 would serve 
this product to people 1 care 
for 
1 2 3 4 5 6 7 1 am likely to purchase this 
product 
1 2 3 4 5 6 7 lt is likely that 1 would 
recommend this product to others 
1 2 3 4 5 6 7 lt is likely that I would serve this 
product to people 1 care for 
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Product profile 2: 
• ~ enriched with omega-3 fatty acids. 
• The following health daim appears on the packaging: «Helps to prevent 
coronary heart disease and cancer». 
• The health daim has been verified as being accurate by: Health Canada, a 
federal government agency. 
• This product is completely traceable, from the farm to the kitchen table. 
Please use the following scales to evaluate this product by circling one answer on 
each row 
I am unlikel y to pure hase this 
product 
It is unlikely that I would 
recommend this product to 
others 
It is unlikely that I would serve 
this product to people I care 
for 
Product profile 3: 
1 2 3 4 5 6 7 I am likely to purchase this 
product 
1 2 3 4 5 6 7 It is likely that I would 
recommend this product to others 
1 2 3 4 5 6 7 It is likely that I would serve this 
product to people I care for 
• A cereal product enriched with omega-3 fatty acids (sliced bread, pita, 
tortilla, bagel, breakfast cereals, pasta, couscous, etc.). 
• The following health daim appears on the packaging: «Helps to prevent 
coronary heart disease and cancer». 
• The health daim bas been verified as being accurate by: Health Canada, a 
federal government agency. 
• This product is completely traceable, from the farm to the kitchen table. 
Please use the following scales to evaluate this product by circling one answer on 
each row 
I am unlikely to purchase this 
product 
It is unlikely that I would 
recommend this product to 
others 
It is unlikely that I would serve 
this product to people I care 
for 
1 2 3 4 5 6 7 I am likely to purchase this 
product 
1 2 3 4 5 6 7 It is likely that I would 
recommend this product to others 
1 2 3 4 5 6 7 It is likely that I would serve this 
product to people I care for 
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Product profile 4: 
• A dairy product enriched with omega-3 fatty acids (ex: milk, kefir, yogurt, 
cheese, etc.). 
• The following health daim appears on the packaging: «Helps to prevent 
coronary heart disease and cancer». 
• The health daim bas been verified as being accurate by: Health Canada, a 
federal government agency. 
• This product is completely traceable, from the farm to the kitchen table. 
Please use the following scales to evaluate this product by circling one answer on 
each row 
I am unlikely to purchase this 
product 
It is unlikely that I would 
recommend this product to 
others 
It is unlikely that I would serve 
this product to people I care 
for 
Product profile 5: 
1 2 3 4 5 6 7 I am likely to purchase this 
product 
1 2 3 4 5 6 7 It is likely that I would 
recommend this product to others 
1 2 3 4 5 6 7 It is likely that I would serve this 
product to people I care for 
• A processed fruit or vegetable product enriched with omega-3 fatty acids 
(ex: fruit juice, vegeta ble juice, etc.). 
• The following health daim appears on the packaging: «Helps to prevent 
coronary heart disease and cancer». 
• The health daim bas been verified as being accurate by: Health Canada, a 
federal government agency. 
• This product is completely traceable, from the farm to the kitchen table. 
Please use the following scales to evaluate this product by circling one answer on 
each row 
I am unlikely to purchase this 
product 
It is unlikely that I would 
recommend this product to 
others 
It is unlikely that I would serve 
this product to people I care 
for 
1 2 3 4 5 6 7 I am likely to purchase this 
product 
1 2 3 4 5 6 7 It is likely that I would 
recommend this product to others 
1 2 3 4 5 6 7 It is likely that I would serve this 
product to people I care for 
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Product profile 6: 
• A meat product enriched with omega-3 fatty acids (ex: beef, chicken, pork, 
etc). 
• The following health daim appears on the packaging: «Helps to prevent 
coronary heart disease and cancer». 
• The health daim bas been verified as being accurate by: a Heart and 
Stroke Foundation, a non-governmental organization. 
• This product is completely traceable, from the farm to the kitchen table. 
Please use the following scales to evaluate this product by circling one answer on 
each row 
1 am unlikely to purchase this 
product 
lt is unlikely that 1 would 
recommend this product to 
others 
lt is unlikely that 1 would serve 
this product to people 1 care 
for 
Product profile 7: 
1 2 3 4 5 6 7 1 am likely to purchase this 
product 
1 2 3 4 5 6 7 lt is likely that 1 would 
recommend this product to others 
1 2 3 4 5 6 7 lt is likely that 1 would serve this 
product to people 1 care for 
• ~enriched with omega-3 fatty acids. 
• The following health daim appears on the packaging: «Helps to prevent 
coronary heart disease and cancer». 
• The health daim bas been verified as being accurate by: a Heart and 
Stroke Foundation, a non-governmental organization. 
• This product is completely traceable, from the farm to the kitchen table. 
Please use the following scales to evaluate this product by circ ling one answer on 
each row 
1 am unlikely to purchase this 
product 
lt is unlikely that 1 would 
recommend this product to 
others 
lt is unlikely that 1 would serve 
this product to people 1 care 
for 
1 2 3 4 5 6 7 1 am likely to purchase this 
product 
1 2 3 4 5 6 7 lt is likely that 1 would 
recommend this product to others 
1 2 3 4 5 6 7 lt is likely that 1 would serve this 
product to people 1 care for 
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Product profile 8: 
• A cereal product enriched with omega-3 fatty acids (sliced bread, pita, 
tortilla, bagel, breakfast cereals, pasta, couscous, etc.). 
• The following health daim appears on the packaging: «Helps to prevent 
coronary heart disease and cancer». 
• The health daim bas been verified as being accurate by: a Heart and 
Stroke Foundation, a non-governmental organization. 
• This product is completely traceable, from the farm to the kitchen table. 
Please use the following scales to evaluate this product by circling one answer on 
each row 
1 am unlikel y to pure hase this 
product 
lt is unlikely that 1 would 
recommend this product to 
others 
lt is unlikely that 1 would serve 
this product to people 1 care 
for 
Product profile 9: 
1 2 3 4 5 6 7 1 am likely to purchase this 
product 
1 2 3 4 5 6 7 lt is likely that 1 would 
recommend this product to others 
1 2 3 4 5 6 7 lt is likely that 1 would serve this 
product to people 1 care for 
• A dairv product enriched with omega-3 fatty acids (ex: milk, kefir, yogurt, 
cheese, etc.) 
• The following health daim appears on the packaging: «Helps to prevent 
coronary heart disease and cancer». 
• The health daim bas been verified as being accurate by: a Heart and 
Stroke Foundation, a non-governmental organization. 
• This product is completely traceable, from the farm to the kitchen table. 
Please use the following scales to evaluate this product by circling one answer on 
each row 
1 am unlikel y to pure hase this 
product 
lt is unlikely that 1 would 
recommend this product to 
others 
lt is unlikely that 1 would serve 
this product to people 1 care 
for 
1 2 3 4 5 6 7 1 am likely to purchase this 
product 
1 2 3 4 5 6 7 lt is likely that 1 would 
recommend this product to others 
1 2 3 4 5 6 7 lt is likely that 1 would serve this 
product to people 1 care for 
- - - - --------------------------------, 
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Product profile 10: 
• A processed fruit or vegetable product enriched with omega-3 fatty acids 
(ex: fruit juice, vegetable juice, etc.). 
• The following health daim appears on the packaging: «Helps to prevent 
coronary heart disease and cancer». 
• The health daim bas been verified as being accurate by: aHeart and 
Stroke Foundation, a non-governmental organization. 
• This product is completely traceable, from the farm to the kitchen table. 
Please use the following scales to evaluate this product by circling one answer on 
each row 
I am unlikely to purchase this 
product 
It is unlikely that I would 
recommend this product to 
others 
It is unlikely that I would serve 
this product to people I care 
for 
1 2 3 4 5 6 7 
1 2 3 4 5 6 7 
I am likely to purchase this 
product 
It is likely that I would 
recommend this product to others 
1 2 3 4 5 6 7 It is likely that I would serve this 
product to people I care for 
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Fourth version of the questionnaire (Condition 4: C4) 
Product profile 1: 
• A meat product enriched with omega-3 fatty acids (ex: beef, chicken, pork, 
etc.). 
• The following health daim appears on the packaging: «Good for your 
heart». 
• The health daim bas been verified as being accurate by: Health Canada, a 
federal government agency. 
• This product is not traceable. 
Please use the following sc ales to evaluate this product by circling one answer on 
each row 
I am unlikely to purchase this 
product 
It is unlikely that I would 
recommend this product to 
others 
It is unl.ikely that I would serve 
this product to people I care 
for 
1 2 3 4 5 6 7 I am likely to pm·chase this 
product 
1 2 3 4 5 6 7 It is likely that I would 
recommend this product to others 
1 2 3 4 5 6 7 It is likely that I would serve this 
product to people I care for 
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Product profile 2: 
• ~ enriched with omega-3 fatty acids. 
• The following health daim appears on the packaging: «Good for your 
heart». 
• The health daim bas been verified as being accurate by: Health Canada, a 
federal government agency. 
• This product is not traceable. 
Please use the following scales to evaluate this product by circling one answer on 
each row 
1 am unlikely to purchase this 
product 
lt is unlikely that I would 
recommend this product to 
others 
lt is unlikely that I would serve 
this product to people I care 
for 
Product profile 3: 
1 2 3 4 5 6 7 
1 2 3 4 5 6 7 
I am likely to purchase this 
product 
It is likely that I would 
recommend this product to others 
1 2 3 4 5 6 7 It is likely that 1 would serve this 
product to people 1 care for 
• A cereal product enriched with omega-3 fatty acids (sliced bread, pita, 
tortiiJa, bagel, breakfast cereals, pasta, couscous, etc.). 
• The following health daim appears on the packaging: «Good for your 
heart». 
• The health daim has been verified as being accurate by: Health Canada, a 
federal government agency. 
• This product is not traceable. 
Please use the following scales to evaluate this product by circling one answer on 
each row 
1 am unlikely to purchase this 
product 
lt is unlikely that 1 would 
recommend this product to 
others 
lt is unlikely that I would serve 
this product to people 1 care 
for 
1 2 3 4 5 6 7 
1 2 3 4 5 6 7 
I am likely to purchase this 
product 
It is likely that I would 
recommend this product to others 
1 2 3 4 5 6 7 It is likely that 1 would serve this 
product to people I care for 
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Product profile 4: 
• A dairy product enriched with omega-3 fatty acids (ex: milk, kefir, yogurt, 
cheese, etc.). 
• The following health daim appears on the packaging: «Good for your 
heart». 
• The health daim has been verified as being accurate by: Health Canada, a 
federal government agency. 
• This product is not traceable. 
Please use the following sc ales to evaluate this product by circling one answer on 
each row 
1 am unlikely to purchase this 
product 
lt is unlikely that 1 would 
recommend this product to 
others 
lt is unlikely that 1 would serve 
this product to people 1 care 
for 
Product profile 5: 
1. 23 4567 I am likely to pm-chase this 
product 
1 2 3 4 5 6 7 lt is likely that 1 would 
recommend thi s product to others 
1 2 3 4 5 6 7 lt is likely that 1 would serve this 
product to people 1 care for 
• A processed fruit or vegetable product enriched with omega-3 fatty acids 
(ex: fruitjuice, v~getablejuice, etc.). 
• The following health claim appears on the packaging: «Good for your 
heart». 
• The health daim has been verified as being accurate by: Health Canada, a 
federal government agency. 
• This product is not traceable. 
Please use the following sc ales to evaluate this product by circling one answer on 
each row 
1 am unlikely to purchase this 
product 
lt is unlikely that 1 would 
recommend this product to 
others 
lt is unlikely that 1 would serve 
this product to people 1 care 
for 
1 2 3 4 5 6 7 1 am likely to purchase this 
product 
1 2 3 4 5 6 7 lt is likely that 1 would 
recommend this product to others 
1 2 3 4 5 6 7 It is likely that 1 would serve this 
product to people 1 care for 
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Product profile 6: 
• A meat product enriched with omega-3 fatty acids (ex: beef, chicken, pork, 
etc). 
• The following health daim appears on the packaging: «Good for your 
heart». 
• The health daim bas been verified as being accurate by: a Heart and 
Stroke Foundation, a non-governmental organization. 
• This product is not traceable. 
Please use the following scales to evaluate this product by circ ling one answer on 
each row 
I am unlikely to purchase this 
product 
It is unlikely that I would 
recommend this product to 
others 
It is unlikely that I would serve 
this product to people I care 
for 
Product profile 7: 
1 2 3 4 5 6 7 1 am likely to purchase this 
product 
1 2 3 4 5 6 7 It is likely that I would 
recommend this product to others 
1 2 3 4 5 6 7 It is likely that I would serve this 
product to people I care for 
• ~enriched with omega-3 fatty acids. 
• The following health claim appears on the packaging: «Good for your 
heart». 
• The health claim bas been verified as being accurate by: a Heart and 
Stroke Foundation, a non-governmental organization. 
• This product is not traceable. 
Please use the following scales to evaluate this product by circling one answer on 
· 1 am unlikely to purchase this 
product 
It is unlikely that I would 
recommend this product to 
others 
It is unlikely that I would serve 
this product to people I care 
for 
each row 
1 2 3 4 5 6 7 I am likely to purchase thi s 
product 
1 2 3 4 5 6 7 It is likely that I would 
recommend this product to others 
1 2 3 4 5 6 7 It is likely that I would serve this 
product to people I care for 
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Product profile 8: 
• A cereal product enriched with omega-3 fatty acids (sliced bread, pita, 
tortilla, bagel, breakfast cereals, pasta, couscous, etc.). 
• The following he.alth daim appears on the packaging: «Good for your 
heart». 
è The health daim bas been verified as being accurate by: a Heart and 
Stroke Foundation, a non-governmental organization. 
• This product is not traceable. 
Please use the jollowing sc ales to evaluate this product by circling one answer on 
each row 
I am unlikel y to purchase this 
product 
It is unlikely that I would 
recommend this product to 
others 
It is unlikely that I would serve 
this product to people I care 
for 
Product profile 9: 
1 2 3 4 5 6 7 I am likely to purchase this 
product 
1 2 3 4 5 6 7 It is likely that I would 
recommend this product to others 
1 2 3 4 5 6 7 It is likely that I would serve this 
product to people I care for 
• A dairy product enriched with omega-3 fatty acids (ex: milk, kefir, yogurt, 
cheese, etc.) 
• The following health daim appears on the packaging: «Good for your 
heart». 
• The health daim bas been verified as being accurate by: a Heart and 
Stroke Foundation, a non-governmental organization. 
• This product is not traceable. 
Please use the following scales to evaluate this product by circling one answer on 
each row 
I am unlikely to purchase this 
product 
It is unlikely that I would 
recommend this product to 
others 
It is unlikely that I would serve 
this product to people I care 
for 
1 2 3 4 5 6 7 I am likely to purchase this 
product 
1 2 3 4 5 6 7 It is likely that I would 
recommend this product to others 
1 2 3 4 5 6 7 It is likely that I would serve this 
product to people I care for 
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Product profile 10: 
• A processed fruit or vegetable product enriched with omega-3 fatty acids 
(ex: fruit juice, vegeta ble juice, etc.). 
• The following health daim appears on the packaging: «Good for your 
heart». 
• The health daim bas been verified as being accurate by: a Heart and 
Stroke Foundation, a non-governmental organization. 
• This product is not traceable. 
Please use the following sc ales to evaluate this product by circling one answer on 
each row 
1 am unlikely to purchase this 
product 
lt is unlikely that 1 would 
recommend this product to 
others 
lt is unlikely that 1 would serve 
this product to people 1 care 
for 
1 2 3 4 5 6 7 1 am likely to purchase this 
product 
1 2 3 4 5 6 7 lt is likely that 1 would 
recommend this product to others 
1 2 3 4 5 6 7 lt is likely that 1 would serve this 
product to people 1 care for 
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Fifth version of the questionnaire (Condition 5: CS) 
Product profile 1: 
• A meat product enriched with omega-3 fatty acids (ex: beef, chicken, pork, 
etc.). 
• The following health daim appears on the packaging: «Reduces the risks 
of heart disease and cancer». 
• The health daim bas been verified as being accurate by: Health Canada, a 
federal government agency. 
• This product is not traceable. 
Please use the following scales to evaluate this product by circling one answer on 
each row 
I am unlikely to purchase this 
product 
It is unlikely that I would 
recommend this product to 
others 
It is unlikely that I would serve 
this product to people I care 
for 
1 2 3 4 5 6 7 
1 2 3 4 5 6 7 
I am likely to purchase this 
product 
It is likely that I would 
recommend this product to others 
1 2 3 4 5 6 7 It is likely that I would serve this 
product to people I care for 
,-- - - - - ------------------------------------------
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Product profile 2: 
• ~ enriched with omega-3 fatty acids. 
• The following health daim appears on the packaging: «Reduces the risks 
of heart disease and cancer». 
• The health daim bas been verified as being accurate by: Health Canada, a 
federal government agency. 
• This product is not traceable. 
Please use the following scales to evaluate this product by circling one answer on 
each row 
I am unlikely to purchase this 
product 
It is unlikely that I would 
recommend this product to 
others 
It is unlikely that I would serve 
this product to people I care 
for 
Product profile 3: 
1 2 3 4 5 6 7 I am likely to purchase this 
product 
1 2 3 4 5 6 7 It is likely that I would 
recommend this product to others 
1 2 3 4 5 6 7 lt is likely that I would serve thi s 
product to people I care for 
• A cereal product enriched with omega-3 fatty acids (sliced bread, pita, 
tortilla, bagel, breakfast cereals, pasta, couscous, etc.). 
• The following health daim appears on the packaging: «Reduces the risks 
of heart disease and cancer». 
• The health daim bas been verified as being accurate by: Health Canada, a 
federal government agency. 
• This product is not traceable. 
Please use the following scales to evaluate this product by circling one answer on 
each row 
I am unlikel y to pure hase this 
product 
It is unlikely that I would 
recommend this product to 
others 
It is unlikely that I would serve 
this product to people I care 
for 
1 2 3 4 5 6 7 I am likely to purchase this 
product 
1 2 3 4 5 6 7 lt is likely that I would 
recommend this product to others 
1 2 3 4 5 6 7 It is likely that I would serve this 
product to people I care for 
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Product profile 4: 
• A dairy product enriched with omega-3 fatty acids (ex: milk, kefir, yogurt, 
cheese, etc.). 
• The following health daim appears on the packaging: «Reduces the risks 
of heart disease and cancer». 
• The health daim bas been verified as being accurate by: Health Canada, a 
federal government agency. 
• This product is not traceable. 
Please use the following scales to evaluate this product by circling one answer on 
each row 
I am unlikely to purchase this 
product 
It is unlikely that I would 
recommend this product to 
others 
It is· unlikely that I would serve 
this product to people I care 
for 
Product profile 5: 
1 2 3 4 5 6 7 
1 2 3 4 5 6 7 
I am likely to purchase this 
product 
It is likely that I would 
recommend this product to others 
1 2 3 4 5 6 7 It is likely that I would serve this 
product to people I care for 
• A processed fruit or vegetable product enriched with omega-3 fatty acids 
(ex: fruit juice, vegetable juice, etc.). 
• The following health ·daim appears on the packaging: «Reduces the risks 
of heart disease and cancer». 
• The health daim bas been verified as being accurate by: Health Canada, a 
federal government agency. 
• This product is not traceable. 
Please use the following scales to evaluate this product by circling one answer on 
each row 
I am unlikely to purchase this 
product 
It is unlikely that I ~ould 
recommend this product to 
others 
It is unlikely that I would serve 
this product to people I care 
for 
1 2 3 4 5 6 7 I am likely to purchase this 
product 
1 2 3 4 5 6 7 It is likely that I would 
recommend this product to others 
1 2 3 4 5 6 7 It is likely that I would serve this 
product to people I care for 
------------------------------------------------------------------------------------------------------------------------ ---- - ---
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Product profile 6: 
• A meat product enriched with omega-3 fatty acids (ex: beef, chicken, pork, 
etc). 
• The following health daim appears on the packaging: «Reduces the risks 
of heart disease and cancer». 
• The health daim bas been verified as being accurate by: a Heart and 
Stroke Foundation, a non-governmental organization. 
• This product is not traceable. 
Please use the following scales to evaluate this product by circling one answer on 
each row 
I am unlikely to purchase this 
product 
It is unlikely that I would 
recommend this product to 
others 
It is unlikely that I would serve 
this product to people Icare 
for 
Product profile 7: 
1 2 3 4 5 6 7 
1 2 3 4 5 6 7 
I am likely to purchase this 
product 
It is likely that I would 
recommend this product to others 
1 2 3 4 5 6 7 It is likely that I would serve this 
product to people I care for 
• ~enriched with omega-3 fatty acids. 
• The following health daim appears on the packaging: «Reduces the risks 
of heart disease and cancer». 
• The health daim bas been verified as being accurate by: a Heart and 
Stroke Foundation, a non-governmental on!anization. 
• This product is not traceable. 
Please use the following scales to evaluate this product by circling one answer on 
each row 
I am unlikely to purchase this 
product 
It is unlikely that I would 
recommend this product to 
others 
It is unlikely that I would serve 
this product to people 1 care 
for 
1 2 3 4 5 6 7 I am likely to purchase this 
product 
1 2 3 4 5 6 7 It is likely that 1 would 
recommend this product to others 
1 2 3 4 5 6 7 It is likely that I would serve this 
product to people 1 care for 
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Product profile 8: 
• A cereal product enriched with omega-3 fatty acids (sliced bread, pita, 
tortilla, bagel, breakfast cereals, pasta, couscous, etc.). 
• The following health daim appears on the packaging: «Reduces the risks 
of heart disease and cancer». 
• The health daim bas been verified as being accurate by: a Heart and 
Stroke Foundation, a non-governmental organization. 
• This product is not traceable. 
Please use the following sc ales to evaluate this product by circling one answer on 
each row 
1 am unlikely to purchase this 
product 
lt is unlikely that 1 would 
recommend this product to 
others 
1t is unlikely that 1 would serve 
this product to people 1 care 
for 
Product profile 9: 
1 2 3 4 5 6 7 1 am likely to purchase this 
product 
1 2 3 4 5 6 7 lt is likely that 1 would 
recommend this product to others 
1 2 3 4 5 6 7 lt is likely that 1 would serve this 
product to people 1 care for 
• A dairy product enriched with omega-3 fatty acids (ex: milk, kefir, yogurt, 
cheese, etc.) 
• The following health daim appears on the packaging: «Reduces the risks 
of heart disease and cancer». 
• The health daim bas been verified as being accurate by: a Heart and 
Stroke Foundation, a non-governmental organization. 
• This product is not traceable. 
Please use the following sc ales to evaluate this product by circling one answer on 
each row 
1 am unlikely to purchase this 
product 
lt is unlikely that 1 would 
recommend this product to 
others 
lt is unlikely that 1 would serve 
this product to people 1 care 
for 
1 2 3 4 5 6 7 1 am likely to purchase this 
product 
1 2 3 4 5 6 7 lt is likely that 1 would 
recommend this product to others 
1 2 3 4 5 6 7 lt is Iikely that 1 would serve this 
product to people 1 care for 
r-------------------------------------------------------------------------------------------
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Product profile 10: 
• A processed fruit or vegetable product enriched with omega-3 fatty acids 
(ex: fruit juice, vegeta ble juice, etc.). 
• The following health daim appears on the packaging: «Reduces the risks 
of heart disease and cancer». 
• The health daim bas been verified as being accurate by: a Heart and 
Stroke Foundation, a non-governmental organization. 
• This product is not traceable. 
Please use the following scales to evaluate this product by circling one answer on 
each row 
I am unlikel y to pure hase this 
product 
It is unlikely that I would 
recommend this product to 
others 
It is unlikely that I would serve 
this product to people I care 
for 
1 2 3 4 5 6 7 I am likely to purchase this 
product 
1 2 3 4 5 6 7 It is likely that I would 
recommend this product to others 
1 2 3 4 5 6 7 It is likely that I would serve this 
product to people I care for 
.1 
..._____ ___ _ j 
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Sixth version of the questionnaire (Condition 6: C6) 
Product profile 1: 
• A meat product enriched with omega-3 fatty acids (ex: beef, chicken, pork, 
etc.). 
• The following health daim appears on the packaging: «Helps to prevent 
coronary heart disease and cancer». 
• The health daim bas been verified as being accurate by: Health Canada, a 
federal government agency. 
• This product is not traceable. 
Please use the following scales to evaluate this product by circ ling one answer on 
each row 
I am unlikely to purchase this 
product 
It is unlikely that I would 
recommend this product to 
others 
lt is unlikely that I would serve 
this product to people I care 
for 
1 2 3 4 5 6 7 I am likely to purchase this 
product 
1 2 3 4 5 6 7 It is likely that I would 
recommend this product to others 
1 2 3 4 5 6 7 It is likely that 1 would serve this 
product to people I care for 
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Product profile 2: 
• ~ enriched with omega-3 fatty acids. 
• The following health daim appears on the packaging: «Helps to prevent 
coronary heart disease and cancer». 
• The health claim bas been verified as being accurate by: Health Canada, a 
federal government agency. 
• This product is not traceable. 
Please use the following scales to evaluate this product by circ ling one answer on 
each row 
I am unlikel y to purchase this 
product 
It is unlikely that I would 
recommend this product to 
others 
It is unlikely that I would serve 
this product to people I care 
for 
Product profile 3: 
1 2 3 4 5 6 7 I am likel y to pure hase this 
product 
1 2 3 4 5 6 7 It is likely that I would 
recommend this product to others 
1 2 3 4 5 6 7 It is likely that I would serve this 
product to people I care for 
• A cereal product enriched with omega-3 fatty acids (sliced bread, pita, 
tortilla, bagel, breakfast cereals, pasta, couscous, etc.). 
• The following health daim appears on the packaging: «Helps to prevent 
coronary heart disease and cancer». 
• The health claim bas been verified as being accurate by: Health Canada, a 
federal government agency. 
• This product is not traceable. 
Please use the following scales to evaluate this product by circling one answer on 
each row 
I am unlikely to purchase this 
product 
It is unlikely that I would 
recommend this product to 
others 
It is unlikely that I would serve 
this product to people I care 
for 
1 2 3 4 5 6 7 I am likely to purchase this 
product 
1 2 3 4 5 6 7 It is likely that I would 
recommend this product to others 
1 2 3 4 5 6 7 It is likely that I would serve this 
product to people I care for 
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Product profile 4: 
• A dairy product enriched with omega-3 fatty acids (ex: milk, kefir, yogurt, 
cheese, etc.). 
• The following health daim appears on the packaging: «Helps to prevent 
coronary heart disease and cancer». 
• The health daim bas been verified as being accurate by: Health Canada, a 
federal government agency. 
• This product is not traceable. 
Please use the following scales to evaluate this product by circling one answer on 
each row 
I am unlikely to purchase this 
product 
lt is unlikely that 1 would 
recommend this product to 
others 
lt is unlikely that 1 would serve 
this product to people 1 care 
for 
Product profile 5: 
1 2 3 4 5 6 7 
1 2 3 4 5 6 7 
1 am likely to purchase this 
product 
lt is Iikely that 1 would 
recommend this product to others 
1 2 3 4 5 6 7 lt is likely that 1 would serve this 
product to people 1 care for 
• A processed fruit or vegetable product enriched with omega-3 fatty acids 
(ex: fruitjuice, vegetablejuice, etc.). 
• The following health daim appears on the packaging: «Helps to prevent 
coronary heart disease and cancer». 
• The health daim bas been verified as being accurate by: Health Canada, a 
federal government agency. 
• This product is not traceable. 
Please use the following scales to evaluate this product by circling one answer on 
each row 
I am unlikely to purchase this 
product 
lt is unlikely that 1 would 
recommend this product to 
others 
It is unlikely that I would serve 
this product to people I care 
for 
1 2 3 4 5 6 7 1 am likely to purchase this 
product 
1 2 3 4 5 6 7 lt is likely that 1 would 
recommend this product to others 
1 2 3 4 5 6 7 It is likely that 1 would serve this 
product to people 1 care for 
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Product profile 6: 
• A meat product enriched with omega-3 fatty acids (ex: beef, chicken, pork, 
etc). 
• The following health daim appears on the packaging: «Helps to prevent 
coronary heart disease and cancer». 
• The health daim has been ve~ified as being accurate by: a Heart and 
Stroke Foundation, a non-governmental organization. 
• This product is not traceable. 
Please use the following scales to evaluate this product by circling one answer on 
each row 
I am unlikely to purchase this 
product 
It is unlikely that I would 
recommend this product to 
others 
It is unlikely that I would serve 
this product to people I care 
for 
Product profile 7: 
1 2 3 4 5 6 7 I am likely to purchase this 
product 
1 2 3 4 5 6 7 It is likely that I would 
recommend this product to others 
1 2 3 4 5 6 7 It is likely that I would serve this 
product to people I care for 
• ~enriched with omega-3 fatty acids. 
• The following health daim appears on the packaging: «Helps to prevent 
coronary heart disease and cancer». 
• The health daim bas been verified as being accurate by: a Heart and 
Stroke Foundation, a non-governmental organization. 
• This product is not traceable. 
Please use the following scales to evaluate this product by circling one answer on 
each row 
I am unlikely to purchase this 
product 
It is unlikely that I would 
recommend this product to 
others 
It is unlikely that I would serve 
this product to people I care 
for 
1 2 3 4 5 6 7 I am likely to purchase this 
product 
1 2 3 4 5 6 7 It is likely that I would 
recommend this product to others 
1 2 3 4 5 6 7 It is likely that I would serve this 
product to people I care for 
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Product profile 8: 
• A cereal product enriched with omega-3 fatty acids (sliced bread, pita, 
tortilla, bagel, breakfast cereals, pasta, couscous, etc.). 
• The following health daim appears on the packaging: «Helps to prevent 
coronary heart disease and cancer». 
• The health daim has been verified as being accurate by: a Heart and 
Stroke· Foundation, a non-governmental organization. 
• This product is not traceable. 
Please use the following scales to evaluate this product by circ ling one answer on 
each row 
I am unlikel y to pure hase this 
product 
It is unlikely that I would 
recommend this product to 
others 
It is unlikely that I would serve 
this product to people I care 
for 
Product profile 9: 
1 2 3 4 5 6 7 I am likely to purchase this 
product 
1 2 3 4 5 6 7 It is likely that I would 
recommend this product to others 
1 2 3 4 5 6 7 lt is likely that 1 would serve this 
product to people 1 care for 
• A dairy product enriched with omega-3 fatty acids (ex: milk, kefir, yogurt, 
cheese, etc.) 
• The following health daim appears on the packaging: «Helps to prevent 
coronary heart disease and cancer». 
• The health daim has been verified as being accurate by: a Heart and 
Stroke Foundation, a non-governmental organization. 
• This product is not traceable. 
Please use the following sc ales to evaluate this ·product by circling one answer on 
each row 
1 am unlikely to purchase this 
product 
lt is unlikely that I would 
recommend this product to 
others 
lt is unlikely that 1 would serve 
this product to people I care 
for 
1 2 3 4 5 6 7 1 am likely to pm·chase this 
product 
1 2 3 4 5 6 7 lt is likely that I would 
recommend this product to others 
1 2 3 4 5 6 7 lt is likely that 1 would serve this 
product to people I care for 
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Product profile 10: 
• A processed fruit or vegetable product enriched with omega-3 fatty acids 
(ex: fruit juice, vegeta ble juice, etc.). 
• The foiJowing health daim appears· on the packaging: «Helps to prevent 
coronary heart disease and cancer». 
• The health daim bas been verified as being accurate by: a Heart and 
Stroke Foundation, a non-governmental organization. 
• This product is not traceable. 
Please use the following scales to evaluate this product by circling one answer on 
each row 
I am unlikely to purchase this 
product 
It is unlikely that I would 
recommend this product to 
others 
It is unlikely that I would serve 
this product to people I care 
for 
1 2 3 4 5 6 7 
1 2 3 4 5 6 7 
I am likely to purchase this 
product 
It is likely that I would 
recommend this product to others 
1 2 3 4 5 6 7 It is likely that I would serve this 
product to people I care for 
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Appendix 4.3Descriptive statistics 
Traceability Health daim Mean SD N 
Pl Not traceable F 4,2800 1,65676 75 
DRR 4,6623 1,55268 77 
DP 4,7042 1,51558 71 
Total 4,5471 1,58150 223 
Completely F 4,8902 1,67041 82 
traceable DRR 4,7971 1,75382 69 
DP 4,9036 1,52711 83 
Total 4,8675 1,64028 234 
Total F 4,5987 1,68652 157 
DRR 4,7260 1,64640 146 
DP 4,8117 1,52010 154 
Total 4,7112 1,61807 457 
P2 Not traceable F 4,4400 1,64596 75 
DRR 4,7532 1,87894 77 
DP 5,1127 1,51704 71 
Total 4,7623 1,70638 223 
Completely F 5,1829 1,67868 82 
traceable DRR 5,0000 1,69775 69 
DP 5,0964 1,64994 83 
Total 5,0983 1,66862 234 
Total F 4,8280 1,69909 157 
DRR 4,8699 1,79372 146 
DP 5,1039 1,58493 154 
Total 4,9344 1,69366 457 
P3 Not traceable F 4,3733 1,78411 75 
DRR 4,9091 1,67160 77 
DP 4,5775 1,80208 71 
Total 4,6233 1,75832 223 
Completely F 5,3537 1,38218 82 
traceable DRR 4,9420 1,93941 69 
DP 5,1084 1,79438 83 
Total 5,1453 1,70968 234 
Total F 4,8854 1,65626 157 
DRR 4,9247 1,79688 146 
DP 4,8636 1,81161 154 
Total 4,8906 1,75127 457 
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Appendix 4.2 Descriptive statistics ( ... Continued) 
Tracêability Health daim Mean SD N 
P4 Not traceable F 4,6000 2,00000 75 
DRR 4,7532 1,82926 77 
DP 4,7746 1,64922 71 
Total 4,7085 1,82827 223 
Completely F 5,2683 1,47446 82 
traceable DRR 5,1594 1,82808 69 
DP 5,3012 1,65820 83 
Total 5,2479 1,64385 234 
Total F 4,9490 1,77156 157 
DRR 4,9452 1,83371 146 
DP 5,0584 1,66955 154 
Total 4,9847 1,75525 457 
PS Not traceable F 4,4000 1,83067 75 
DRR 4,6623 1,98422 77 
DP 4,7887 1,85869 71 
Total 4,6143 1,89218 223 
Completely F 4,8902 1,95635 82 
traceable DRR 4,7391 2,06264 69 
DP 4,6867 1,85399 83 
Total 4,7735 1,94671 234 
Total F 4,6561 1,90718 157 
DRR 4,6986 2,01501 146 
DP 4,7338 1,85078 154 
Total 4,6958 1,91984 457 
P6 Not traceable F 4,3733 1,63388 75 
DRR 4,2727 1,82552 77 
DP 4,6620 1,58514 71 
Total 4,4305 1,688 16 223 
Completely F 4,3902 1,76912 82 
traceable DRR 4,7101 1,95615 69 
DP 5,6747 5,8 1862 83 
Total 4,9402 3,79923 234 
Total F - 4,3822 1,70043 157 
DRR 4,4795 1,89453 146 
DP 5,2078 4,42169 154 
Total 4,69 15 2,97117 457 
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Appendix 4.2 Descriptive statistics ( ... Continued) 
Traceability Health daim Mean SD N 
P7 Not traceable F 4,4667 1,71112 75 
DRR 4,2987 1,78491 77 
DP 4,8028 1,54568 71 
Total 4,5157 1,69219 223 
Completely F 4,8293 1,63907 82 
traceable DRR 4,5652 1,81884 69 
DP 4,9880 1,67837 83 
Total 4,8077 1,70878 234 
Total F 4,6561 1,67834 157 
DRR 4,4247 1,79975 146 
DP 4,9026 1,61597 154 
Total 4,6652 1,70511 457 
P8 Not traceable F 4,3733 1,76124 75 
DRR 4,4935 1,73678 77 
DP 4,2958 1,65956 71 
Total 4,3901 1,71514 223 
Completely F 4,7927 1,49681 82 
traceable DRR 4,7536 1,88185 69 
DP 5,0241 1,67460 83 
Total 4,8632 1,67745 234 
Total F 4,5924 1,63674 157 
DRR 4,6164 1,80520 146 
DP 4,6883 1,70167 154 
Total 4,6324 1,71055 457 
P9 Not traceable F 4,2267 1,72872 75 
DRR 4,3636 1,77637 77 
DP 4,7746 1,5 1372 71 
Total 4,4484 1,68880 223 
Completely F 4,8171 1,44126 82 
traceable DRR 4,8986 1,72478 69 
DP 4,8554 1,75397 83 
Total 4,8547 1,63526 234 
Total F 4,5350 1,60739 157 
DRR 4,6164 1,76659 146 
DP 4,8182 1,64279 154 
Total 4,6565 1,67218 457 
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Appendix 4.2 Descriptive statistics ( ... Continued) 
Traceability Health daim Mean SD N 
PlO Not traceable F 4,0933 1,91843 75 
DRR 4,1299 1,89425 77 
DP 4,6620 1,91194 71 
Total 4,2870 1,91677 223 
Completely F 4,6220 1,76831 82 
traceable DRR 4,3913 1,94949 69 
DP 4,6024 1,77338 83 
Total 4,5470 1,82023 234 
Total F 4,3694 1,85461 157 
DRR 4,2534 1,91837 146 
DP 4,6299 1,83271 154 
Total 4,4201 1,87044 457 
Appendix 4.3 Between-Subjects ANOV A 
DV: Intention to purchase 
Measure: PUR CHASE 
Transformed Va riable: Ave rage 
Type Ill Sum 
Source of Squares 
lntercept 103024,348 
healclaim 23 ,104 
tracab 142,764 
healclaim * tracab 29,078 
Error 6443 ,1 26 
Computed using alpha = ,05 
df 
1 
2 
1 
2 
446 
DV: Intention to recommend 
Measure: RECOMMEND 
Transformed Va riable: Average 
Type Ill Sum 
Source of Squares 
lntercept 101422,917 
healcla im 50 ,908 
tracab 157,196 
hea lclaim • tracab 16,821 
Errer 7148,391 
Computed using alpha = ,05 
DV: Intention to serve 
Measure: SERVE 
Transform ed Variable: Average 
Type Ill Sum 
Source of Squares 
lntercept 100529,472 
healclaim 17,704 
tracab 263,944 
healclaim • tracab 34,008 
Errer 6498,218 
Computed using alpha = ,05 
df 
1 
2 
1 
2 
451 
df 
1 
2 
1 
2 
428 
Tests of Between-Subjects Effects 
Mean Square F Sig . 
103024,348 7131,454 ,000 
11 ,552 ,800 ,450 
142,764 9,882 ,002 
14,539 1,006 ,366 
14,446 
Tests of Between-Subjects Effects 
Mean Square F Sig . 
101422,917 6398,885 ,000 
25 ,454 1,606 ,202 
157 ,196 9,918 ,002 
8,410 ,531 ,589 
15,850 
Tests of Between-Subjects Effects 
Mean Square F Sig. 
100529,472 6621,294 ,000 
8,852 ,583 ,559 
263,944 17 ,384 ,000 
17,004 1,120 ,327 
15,183 
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Partial Eta Non cent. Observed 
Squared Parameter Powera 
,94 1 7131,454 1,000 
,004 1,599 ,187 
,022 9,882 ,880 
,004 2,0 13 ,225 
Partial Eta Non cent. Observed 
Squared Parameter Powera 
,934 6398,885 1,000 
,007 3,212 ,340 
,022 9,918 ,882 
,002 1,061 ,138 
Partial Eta Nonce nt. Observed 
Squared Parameter Powera 
,939 6621,294 1,000 
,003 1,166 ,147 
,039 17,384 ,986 
,005 2,240 ,247 
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Appendix 4.4alntention to purchase marginal means and standard deviation 
1. Grand Mean 
Measure: PURCHASE 
95% Confidence lnterval 
Mean Std. Error LowerBound 1 UpperBound 
4 787 057 4,675 1 4 898 
Estima tes 
Measure: PURCHASE 
95% Confidence lnterval 
traceabilitv Mean Std. Error Lower Sound UpperBound 
not traceable 4,609 ,082 4,448 4,769 
com pletely traceable 4,965 ,078 4,811 5,119 
Estima tes 
· Measure: PURCHASE 
95% Confidence lnterval 
Health Claim Mean Std. Error LowerBound UpperBound 
Functionai-Good for your 4,742 ,097 4,552 4,932 
he art 
Risk reduction-Reduces 4,730 ,1 00 4,535 4,926 
the risks ofheartdisease 
and cancer 
Disease prevention- 4 ,888 ,098 4,695 5,081 
Helps to prevent coronary 
heart disease and cancer 
Estimates 
Measure: PURCHASE 
95% Confidence lnterval 
VHC Mean Std . Error Lower Bou nd UpperBound 
1 4,930 ,059 4,814 5,045 
2 4 ,644 ,064 4,519 4,769 
Appendix 4.4alntention to purchase marginal means, standard deviation and 
Bonferroni comparison test ( .. . Continued) 
Estimates 
Measme: PURCHAS E 
95% Confi dence lnterva l 
PR ODUCTS Mean StcJ. Erro r Lower Bounci Upper Bou ncl 
1 4,763 ,070 4,626 4,900 
2 4,890 ,070 4,752 5,028 
3 4,870 ,070 4,733 5,008 
4 4,8 47 ,075 4,700 4,994 
5 4,563 ,083 4,400 4,72 7 
Paîrwîse Comparîs ons 
Measure: PURCHJI.SE 
284 
95% Confidence lnte1va l for 
Mea n 
Differe nce {1-
rn PRODU CTS fJ) PRODUCTS J) 
1 2 - ,127 
3 -.107 
4 - .084 
5 ,200 
2 1 ,'1 2 f 
3 ,019 
4 ,0 43 
. 
5 ,326 
3 1 ,1 07 
2 - ,019 
4 ,023 
. 
5 ,307 
4 1 ,084 
2 - ,043 
3 - ,023 
. 
5 ,284 
5 1 - ,200 
' 2 -,326 
. 
3 -,307 
. 
4 -,284 
Based on est1m ated rn argmal rneans 
•. Th e mean differe nce is sig nifi ca nt at th e ,05 levet. 
b. Adj ustment îor m ultip le cornpa ri so ns: Bonferroni. 
Diffe rence b 
Std. Errer Sigb Lovver Bound UpperBound 
,061 ,383 - ,299 ,045 
,077 1,000 -,325 ,110 
,068 1,000 -,276 ,1 08 
,08 6 ,206 - ,043 ,44 2 
,061 ,383 - ,045 ,299 
,074 1 ,OIJO - ,190 ,228 
,071 1,000 -,158 ,244 
,085 ,001 ,088 ,565 
,077 1,000 -,110 ,325 
,074 1,000 -,228 .190 
,070 1,000 -,174 ,220 
,073 ,000 ,1 02 .512 
,068 1,000 -,108 ,276 
,071 1,000 -,244 ,158 
,070 1,000 -,220 ,174 
,079 ,004 ,060 .50ï 
,086 ,206 - ,442 ,043 
,085 ,001 - ~ 565 - ,088 
,073 ,000 -,512 -,102 
,079 ,004 -,507 - ,060 
285 
Appendix 4.4alntention to purchase marginal means , standard deviation and 
Bonferroni comparison test( ... Continued) 
Estimates 
Measure: PURCHASE 
Hea ltl1 Clairn VHC Mean Std. Error 
Functi onai-Good for vo ur 1 4,902 ,"1 00 
he art 2 4,581 ,1 09 
Risk reducti on-Reduces 1 4,911 ,1 03 
the ri sks of t1 ea rt disease 
and ca ncer 2 4,550 '11 2 
Di sease preventi on- 1 4,976 ,1 02 
Helps to prevent coron<lllf 
2 he art disease and ca ncer 4,800 ,"1 1 0 
Pairwise Cornparisons 
Measure: PURCHASE 
Mean 
Difference (1· 
Health Claim mVHC IJl VHC J) Std. Error 
Functionai·Good foryour 1 2 ,321 ,079 
1eart 2 1 ·,321 ,079 
Risk reduction-Reduces 1 2 ,361 ,082 
Ille ri sks of he art disease 
ancl cancer 2 1 ·,361 ,082 
Disease prevention- 1 2 ,175 ,081 
Helps to prevent coronary 
he art disease and cancer 2 1 ·,175 ,081 
Based on estimated marginal me ans 
* The mean difference is signifie ani at the ,051evel. 
b. Adjustment for multiple comparisons: Bonferroni. 
95% Confidence lnterval 
Lower Bou nd Upper Bound 
4,705 5, 099 
4,368 4,795 
4,708 5, 11 3 
4,330 4,770 
4.776 5,176 
4,583 5,017 
95% Confidence lnterval for 
Difference b 
Sigb LowerBound UpperBound 
,000 ·,165 ,477 
,000 ·,477 ·,165 
,000 ,201 ,521 
,000 ·,521 ·,201 
,030 ,01ï ,334 
,030 ·,334 ·,01ï 
Appendix 4.4blntention to recommend marginal means, standard deviation and 
Bonferroni comparison test 
1. Grand Mean 
Measure : RECOMMEND 
95% Confidence lnterval 
Mean Std. Error Lower Bou nd 1 Upper Bound 
4,722 059 4 606 1 4 838 
Estimates 
Measure: RECOMMEND 
95% Confidence lnterval 
traceabilitv Mean Std . Error LowerBound UpperBound 
not traceable 4,536 ,084 4,370 4,702 
com pletely traceable 4,908 ,083 4,745 5,070 
Pairwise Comparisons 
Measure RECOMMEND 
286 
95% Co nfidence lnterval for 
Mean 
Difference (1-
m traceabi litv (J\ traceabi litv J) 
not trace ab le co mplete/y trac eable -,372 
completely trace abl e not trac eable ,3ï2 
Base ~;! on estimated marginal means 
•. The mean difference is signifi cant at tl1e ,ü5 leve!. 
b. Adjustment for multiple comparisons: Bonferroni. 
Difference b 
Std . En·or Sigb Lower Sound Upper Bound 
,118 ,002 -,604 -.140 
,118 ,002 ,140 ,604 
Appendix4.4b Intention to recommend marginal means, standard deviation and 
Bonferroni comparison test( ... Continued) 
Estimates 
Measure: RECOMMEND 
95% Confidence lnterval 
Health Claim Mean Std . Error Lower Bou nd UpperBound 
Functionai-Good for your 4 ,633 '1 01 4,436 4,831 
he art 
Risk redu ction-Reduces 4,663 '104 4,458 4,868 
the risks of heart disease 
and cancer 
Disease prevention- 4 ,870 ,102 4,670 5,070 
Helps to prevent coronary 
he art disease and cancer 
Pairwise Comparisons 
rvleasure: RECOMMEND 
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95% Confidence lnterval for 
rvlean Difference a 
Difference (1-
(1) Health Claim (J) Health Claim J) Std . Error a Lower Sound Upper Sound 
Functionai-Good for )oi)Uf Risk reduction-Reduces 
-,030 ,145 1,000 -,378 ,319 
he art the risks of heart disease 
and cancer 
Disease prevention-
-,237 ,143 ,297 -,580 ,107 
Helps to prevent coronary 
he art disease and cancer 
Risk reduction-Reduces Functionai-Good for )oi)Ur ,030 ,145 1,000 -,319 ,378 
the risks of heart disease he art 
and cancer Disease prevention- -,207 ,1 46 ,469 -,557 ,143 
Helps to prevent coronary 
heart disease and cancer 
Disease prevention- Functionai-Good for )oi)Ur ,237 ,143 ,297 -,107 ,580 
Helps to prevent coronary he art 
heart disease and cancer Risk reduction-Reduces ,207 ,1 46 ,469 -,143 ,557 
the risks of heart disease 
and cancer 
Sased on esümated marginal means 
Mjustrnent for multiple comparisons: Sonferroni. 
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Appendix4.4b Intention to recommend marginal means, standard deviation and 
Bonferroni comparison test( . .. Continued) 
Estimates 
Measure: RECOMMEND 
95% Confide nce lnterva l 
VHC Mean Std. Error Lower Bou nd Upper Bound 
1 4,837 ,060 4,720 4,955 
2 4,607 ,069 4,472 4,742 
Pairwise Comparisons 
Me asure : RECO MMEt'>J D 
Mean 
Difference (1-
(I)VHC (J ) VHC J) Std. Error 
1 2 ,230 ,051 
2 1 -,230 ,051 
Base d on estimated marginal means 
*. The mean cJifference is signifi cant at tl1e ,05 leve l. 
b. Adjustment for multiple comparisons: Bonferroni. 
Sigb 
,000 
,000 
95 % Confi dence lnterva l for 
Difference b 
Lower Bound Upp erB ound 
'129 ,331 
-,331 -,129 
Appendix4.4b Intention to recommend marginal means, standard deviation and 
Bonferroni comparison test ( . . . Continued) 
Measure: RECOMMEND 
PR ODUCTS 
2 
3 
4 
5 
Mean 
4,693 
4,795 
4,750 
4,816 
4,556 
Measure: RE COMMENO 
Estimates 
95% Confilience lnterva l 
Std. EITOI' Lower Bound Upper BüWld 
.088 4,520 4,866 
,070 4,657 4,932 
,072 4,609 4,89'1 
0"'') 
' 1 ~ 4,675 4,957 
,080 4,398 4,7 13 
Pairwise Comparisons 
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95% Confid ence lnter,•al fo r 
Mean 
Difference (1-
l'l) PR ODUCT S (J)_ PR ODUCTS J) 
1 2 -. 1 o·1 
3 - ,056 
4 - ,123 
5 ,138 
2 1 ,1 01 
3 ,045 
4 - ,021 
. 
5 ,239 
3 1 ,056 
2 - ,0 45 
4 -,066 
5 ,1 94 
4 1 ,123 
2 ,021 
3 ,066 
' 5 ,260 
5 '1 - ,1 38 
' 2 - ,239 
3 - ,-194 
·' 4 - ,260 
Basee! o n est1mated marg111 al m eans 
* Tlle mean cliffere nce is s ignifi ca nt at U1e ,05 leve !. 
b. Adjustment for multiple co m pa ri so ns: Bonferroni. 
Differe nceb 
Std. Erro r Sigb Lower Bound UpperBound 
,Oï9 1 ,000 - ,323 ,1 21 
,088 1 ,000 - ,303 ,190 
,087 1 ,000 - ,367 ,122 
,095 1 ,000 - ,1 29 ,404 
,079 1 ,000 - .121 ,323 
,070 1,000 -,153 ,243 
,068 1 ,000 -,2"13 ,170 
,078 ,022 ,020 ,458 
,088 1 ,000 - ,190 ,303 
,070 1 ,000 - ,243 ,153 
,064 1 ,000 - ,246 ,113 
,070 ,060 - ,004 ,392 
,087 1,000 - ,122 ,367 
,068 1 ,000 - ,170 ,213 
,064 1 ,000 - ,11 3 ,2 46 
,069 ,002 ,066 ,455 
,095 1 ,000 -,404 ,1 29 
,078 ,022 -,4 58 - ,020 
,070 ,060 - ,392 ,00 4 
,069 ,002 - ,455 - ,066 
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Appendix4.4b Intention to recommend marginal means , standard deviation and 
Bonferroni comparison test( . .. Continued) 
Measure: RECOMMEND 
Hea lth Claim 
Functi onai-G ooci for ')IO LH 
he a tt 
Risk reducti on-Redu ces 
tlle risks of hea t1 disease 
VHC 
"1 
2 
and cancer 2 
Di sease prevention-
Helps to preve nt coronary 
l1 ea rt ctisease and cancer 2 
Measure: RECO MMEND 
Health Claim (llVHC (cllVHC 
Functionai-Good for your 1 1 
Ile art 2 1 
Risk reduction-RecJuces 1 2 
the ri sks of he art disease 
and cancer 2 "1 
Disease prevention- 1 2 
Helps to prevent coronary 
he art disease and cancer 2 "1 
Based on estim ated marginal rneans 
Estimates 
Mean Std . Error 
4,768 '1 02 
4,498 ,117 
4,838 ,1 06 
4,488 '1 21 
4,905 ,1 03 
4,834 '11 8 
Pairwise Comparisons 
Mean 
Difference (1-
J) Std. Error 
,269 ,088 
-,269 ,088 
,350 ,091 
-,350 ,091 
,071 ,089 
-,071 ,089 
*.The mean difference is sign ifica nt at the ,05 leve!. 
b. Mjustment for multiple comparisons: Bonferroni. 
95% Confidence lnterval 
Lower Boun ct Upper Bound 
4,568 4,968 
4,269 4,728 
4,630 5,046 
4,249 4,726 
4,703 5,108 
4, 602 5,067 
95% Confidence lnle!Val for 
Difference b 
Sigb Lower Sound Upper Bound 
,002 ,097 ,442 
,002 -,442 -,097 
,000 ,171 ,529 
,000 -,529 -,171 
,422 -,103 ,245 
,422 -,245 ,1 03 
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Appendix4.4b Intention to recornrnend marginal rneans, standard deviation and 
Bonferroni cornparison test ( . .. Continued) 
NOTE: for the triple interaction Traceability x Health d aim x Verified health d aims 
a Bonferroni comparison test was handled to check if interaction between health 
d aim and verification of health d aim differ across traceability treatments. 
Estimates 
Depende nt Vari ab le: dift\ttl c 
95% Confidence lnterval 
trace ab i 1 itv Healtll Claim Mea n Std. Erro r Lower Bou nd UpperB oun d 
not tra ce ab le Functi onai-G ood for yo ur '112 ,126 -,136 ,360 
l1ea rt 
Risk reduction-Reduces ,442 ,12 4 ,199 ,685 
the ri sks of Ile art disease 
and can ce r 
Disease prevention- ,144 ,129 -,109 ,397 
Helps to prevent coronary 
Il e art di sease and cancer 
comp letely traceab le Functionai- Goo•j for yo ur ,427 '1 21 ,1 90 ,66 4 
Il e art 
Risk red ucti on-Reduces ,288 ,129 ,0 34 ,5 41 
the ri sks of l1 ea rt disease 
and cancer 
Disease preventi on- -,013 ,119 -,2 47 ,222 
Helps to prevent co ronary 
he art disease and cance r 
Comparaisons appariées 
Variatde dépendante diffvhc 
Intervalle de confian ce à 95% 
pour la différence' 
Différence Borne Borne 
Health Llaim (1) traceabil ity (J) tra ceahility moyenne (I·J) Erreur std. Signitication' inférieure supérieure 
Functionai·Good foryour not traceable completely trace able 
·.315 ,1 i5 ,072 ·,658 ,028 
he art completely traceable not traceable ,315 ,175 ,072 ·,028 ,658 
Risk reduction-Reduces not traceable completely traceable 
,154 
the risks of hèart disease 
,179 ,388 ·,1 97 ,505 
and cancer complately traceable nottraceable ·,154 ,t 79 ,388 ·,505 ,1 97 
Disease prevention· not traceable completely trace able ,156 ,175 ,374 ·,189 ,501 
Helps to preve nt coronary 
heart disease and cancer completely trace able not trace able -,156 ,175 ,37 4 ·,501 ,t 89 
Basées sur les moyennes marginales estimées 
a. ftjustement pour les comparaisons multiples. Bonferroni. 
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Appendix 4.4clntention to servemarginal means, standard deviation and Bonferroni 
comparison test 
1. Grand Mean 
Measure: SERVE 
95% Confidence lnterval 
Mean Std. Error Lower Bound 1 Upper Bound 
4 823 ,059 4 706 1 4 939 
Estima tes 
Measure: SERVE 
95%C onfidence lnterval 
traceabilitv Mean Std. Error Lower Bo und Upper Bound 
not traceable 4,576 ,085 4, 409 4,742 
com pletely traceable 5,070 ,083 4, 907 5,233 
Pairwise Comparisons 
Measure SERVE 
(1) lrac eabilitv [J) traceabil itv 
not tracea td e completely tracealJie 
completely trace able not tracea ble 
Based on estimated marginal me ans 
Mean 
Difference (1-
J) 
·,494 
,494 
* Tlle mean difference is significant at t11 e ,05 1evel. 
b. Adjustrnent for multiple compari sons Bonferroni. 
95% Co nfidence lnterval for 
Difference b 
Std. Erro r 
-+--~~---------+~~----~ 
Sigb Lower Bound UpperBound 
,11 g 
-+----~---------+--------~ 
,000 -,727 -,261 
,11 9 
~----~------~------~ 
,000 ,261 ,727 
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Appendix 4.4c Intention to serve marginal means, standard deviation and Bonferroni 
comparison test ( . .. Continued) 
Estimates 
Measure: SERVE 
95% Confidence lnterval 
Health Cla im Mean Std. Error LowerBound UpperBound 
Functionai -Good for your 4 ,778 ,102 4,577 4,979 
he art 
Risk reduction-Reduces 4,778 ,104 4,573 4,983 
the risks ofheartdisease 
and cancer 
Disease prevention- 4,91 3 '102 4,71 3 5,112 
Helps to prevent coronary 
heart disease and cancer 
Pairwise Comparisons 
lvleasure: SERVE 
95% Confidence lnterval for 
lvlean Difference" 
Difference (1-
(1) Health Claim (J) Health Claim J) Std . Error a Lower Bou nd Upper Bou nd 
Functionai-Good for ~u r Risk reduction-Reduces ,000 ,146 1,000 -,351 ,351 
he art the risks of heartdisease 
and cancer 
Disease prevention- -,135 ,144 1,000 -,481 ,211 
Helps to prevent coronary 
heart disease and cancer 
Risk reduction-Reduces Functionai-Good for your ,000 ,146 1,000 -,351 ,351 
the risks of heart disease he art 
and cancer Disease prevention- -,135 ,146 1,000 -,485 ,215 
Helps to prevent coronary 
heart disease and cancer 
Disease prevention- Functionai-Good for your ,135 ,144 1,000 -,211 .481 
Helps to prevent coronary he art 
heart disease and cancer Risk reduction-Reduces ,135 ,146 1,000 -,215 .485 
the risks of heart disease 
and cancer 
Based on es tim ated marginal means 
Mjustm ent for multiple comparisons: Bonferron i. 
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Appendix 4.4c Intention to servemarginal means, standard deviation and Bonferroni 
comparison test( . .. Continued) 
Estimates 
Measure : SERVE 
95% Confidence lnterval 
VHC Mean Std. Error Lower Bound Upper Bound 
1 5,009 ,061 4,890 5,128 
2 4,637 ,068 4 ,504 4,770 
Pairwise Comparisons 
Measure: SERVE 
Mean 
Difference (1-
Jll VHC tJ) VHC .J) Std . Error Sigb 
1 2 ,372 ,049 ,000 
2 1 -,372" ,049 ,000 
Based on estimatecl marginal means 
*. The mean difference is significant at th e ,05 level. 
b. Adjustmentfor multiple co mpa ri sons: Bonferroni. 
95% Confi dence lnterval for 
Difference b 
Lower Sound UpperBound 
,275 ,469 
-,469 -,275 
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Appendix4.4c Intention to servemarginal means, standard deviation and Bonferroni 
comparison test( . .. Continued) 
Estimates 
Measure: SERVE 
95% Confi dence lnterval 
PRODUCTS Mean Std. Erro r LowerBound Upper Bound 
1 4,817 ,070 4,679 4,955 
2 4,900 ,071 4 ,760 5,040 
3 4,884 ,071 4 ,744 5,023 
4 4,894 ,073 4,750 5,038 
5 4,620 ,083 4,456 4,783 
Pairwise Comparisons 
Measure: SERVE 
Mean 
Difference (1-
(1) PRODUCTS (J l PRODUCTS J ) 
1 2 - ,083 
3 - ,067 
4 - ,077 
5 ,197 
2 1 ,083 
3 ,016 
4 ,006 
' 5 .281 
3 1 ,067 
2 - ,016 
4 -,010 
5 ,26 4 
4 1 ,077 
2 -,006 
3 ,010 
' 5 ,275 
5 1 -,"197 
' 2 -,281 
. 
3 -,264 
4 -,275 
Based on estim ated m argrnalmeans 
*. Th e m ea n difference is s ignifi ca nt at th e ,05 leve l. 
b. Adjustment for multiple cornp arisons: Bonfe rroni. 
Std. Error Sigb 
,057 1,000 
,067 1,000 
,068 1,000 
,079 ,125 
,057 1,000 
,069 1,000 
,068 ., ,000 
,081 ,005 
,067 1,000 
,069 1,000 
,067 1,000 
,071 ,002 
,068 1,000 
,068 1,000 
,067 1,000 
,072 ,002 
,Or9 ,125 
,081 ,005 
,071 ,002 
,072 ,002 
95% Confi dence lr1te rva l for 
Difference b 
Lower Bound UpperB ound 
-,243 ,076 
-,257 .123 
-,268 ,11 4 
-,025 ,419 
- ,076 ,243 
-,177 ,210 
-,186 ,198 
,053 ,508 
-,123 ,257 
-,21 0 ,177 
-,199 ,179 
,064 ,464 
-,1 14 ,268 
-,198 ,186 
- ,179 ,199 
,070 ,479 
-, 41 9 ,025 
- ,508 - ,053 
-,464 - ,064 
- ,479 - ,070 
----·------------------------------------------------------------------------------------------------
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Appendix 4.4c Intention to servemarginal means, standard deviation and Bonferroni 
comparison test ( . .. Continued) 
Estimates 
Measure SERVE 
Hea \Ul C\aim VHC Mean Std. Error 
Functi ona i-Good for·yo ur 1 4,960 ,1 04 
hear1 2 4,596 ,117 
Risk reduction-Reduces 1 4,993 ,107 
the risks ofh ear1 disease 
and cance r 2 4,563 '11 9 
Di sease pr·evention- 1 5,07 4 ,1 04 
He\ps to prevent coronary 
t1ear1 clisease and cancer 2 4,752 ,11 6 
Pairwise Comparisons 
Me a sure SERVE 
Mean 
Difference (1-
Health C\aim (J)VHC tJlVHC J) Std. Error 
Functionai-Good for your 1 2 ,364 ,085 
he art 2 1 -,364' ,085 
Risk reduction-Reduces j 2 ,429 . ,087 
tl1e risks of t1 eart disease 
and cancer 2 1 -,429 ,087 
Disease prevention- 1 2 ,322 ,085 
He\ps to preve nt co ronary 
he art disease and cancer 2 1 -,322 ,085 
Bas ed on estimated marg ina l means 
*. The mean difference is significant atthe ,05 leve \. 
b. Adjustment for multiple comparisons: Bonferroni. 
95% Co nfi de nce lnterva \ 
Lowe rB ound Upper Bou nd 
4,755 5,165 
4,366 4,825 
4,783 5,202 
4,329 4,797 
4,870 5,2t8 
4,52 4 4,980 
95% Co nfidence lnterval for 
Differenceb 
Sigb Lower Bound UpperBound 
,000 ,197 ,532 
,000 -,5 32 -,197 
,000 ,259 ,600 
,000 -,13 00 -,259 
,000 ,156 ,489 
,000 -,489 -,156 
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Appendix 405aWithin-Subjects ANOVA-DV: Intention to purchase-
Tes ts of W ith in-Subjects Etfects 
tv1easure· PURCHASE 
Type Il l Sum Partial Eta Noncent. Observed 
Source of Squares df flœan Square F Sig. Squared Parame ter Powera 
VHC Sphericity flssumed 91 ,772 1 91 ,772 37,846 0000 ,078 37 0846 1,000 
Greenhouse-Geiss er 91 ,772 10000 91,772 37,846 ,000 ,078 37 ,846 1,000 
Huynh-Feldl 91,772 1,000 91 .772 37,846 ,000 ,078 37.846 1,000 
Lower-bound 91 ,772 1,000 91 ,772 37,846 ,000 ,078 37,846 1.000 
\.IHC • healclaim Sphericity Assumed 7,088 2 3,544 1,462 ,233 .007 2,923 .3 12 
Greenhouse-Geis s er 7,088 2,000 3,544 1,462 ,233 ,007 2.923 .312 
Huynh-Feldt 7,088 2.000 3,544 1,462 ,233 ,007 2,923 .312 
Lower-bound 7,088 2,000 3,544 1,462 ,233 ,007 2.923 .3 12 
VI-tC • tracab SphericityAss umed ,365 1 ,365 ,150 ,698 ,000 ,1 50 ,067 
Greenhouse-Geisser ,365 1,000 ,365 ,150 ,698 ,000 ,1 50 .067 
Huynh-Feld t ,365 1,000 .365 ,1 50 .698 ,000 ,150 .067 
Lower-bound ,365 1,000 .365 ,1 50 .698 ,000 ,150 .067 
VI-tC • healcla im • tracab SphericityAss umed 5,709 2 2,854 1,1 77 .309 ,005 2,354 .258 
Greenhouse-Geisser 5,709 2,000 2,854 1,1 77 ,309 .005 2.354 .258 
Hu}flh-Feldt 5,709 2.000 2.854 1,1 77 ,309 ,005 2.354 .258 
Lower-bound 5,709 2,000 2.854 1,177 ,309 ,005 2.354 .258 
Error(VI-tC) SphericityAss umed 1081,493 446 2,425 
Greenhouse-Geis s er 1081,493 446,000 2,425 
Huynh-Feldt 1081,493 446,000 2,425 
lower-bound 108 1,493 446.000 2.425 
PRODUCTS SphericityAss umed 64,468 4 16,1 17 6 ,422 ,000 ,014 25 ,686 ,991 
Greenhouse· Geisser 64,468 3,549 18 .1 66 6,422 ,000 ,0 14 22,789 .984 
Huynh·Feldt 64,468 3,62 1 17 .804 6.422 ,000 ,014 23 ,252 .986 
Lower·bound 64,468 1.000 64,468 6,422 ,012 ,014 6.422 .7 15 
PRODUCTS * healc/aim SphericityAssumed 10,810 8 1.351 ,538 ,828 ,002 4.307 .254 
Greenhouse·Geisser 10,810 7,098 1,523 ,538 .808 ,002 3,821 .239 
Huynh·Feldt 10,810 7,242 1.493 ,538 ,812 ,002 3.899 .24 1 
Lower· bound 10,810 2,000 5.405 ,538 ,584 ,002 1,077 ,139 
PRODUCTS * tracab Sphericity.Assumed 12,861 4 3.215 1.28 1 ,275 ,003 5.1 24 .405 
Greenhouse.Geisser 12,861 3,549 3,624 1,281 .277 ,003 4,546 ,3 78 
Huynh·Feldt 12,861 3,62 1 3.552 1,281 ,277 .003 4.639 .382 
Lower·bound 12,861 1,000 12,861 1,281 ,258 ,003 1,281 .204 
PRODUCTS • hea lclaim Sphericity.Assumed 27,474 8 3.4 34 1,368 ,206 ,006 10.946 .633 
• tracab Greenhouse-Geisser 27.474 7.098 3,87 1 1,368 ,214 ,006 9,712 ,594 
Huynh-Feldt 27,474 7,242 3.794 1,368 ,21 2 ,006 9,909 .600 
Lower-bound 27,474 2,000 13.737 1,368 .256 ,006 2,737 ,295 
Error(PRODUCTS) SphericityAssumed 4477,603 1784 2,510 
Greenhouse-Geisser 4477 ,603 1582,819 2,829 
Huynh-Feldt 4477,603 1614,963 2,773 
Lower-bound 4477,603 446,000 10,039 
VHC • PRODUCTS SphericityN.s umed 1,305 4 .326 ,356 ,840 ,001 1,424 ,1 32 
Greenhouse-Geisser 1,305 3,819 ,342 .356 ,831 ,001 1,360 .130 
Huynh-Feldt 1,305 3.899 ,335 ,356 .835 ,00 1 1,388 .131 
Lower-bound 1,305 1,000 1,305 ,356 ,551 ,00 1 .356 .092 
'.11C o PRODUCTS 0 SphericityAssumed 2,727 8 ,34 1 .372 .936 ,002 2.975 ,180 
healcla im Greenhouse-Geisser 2,727 7.637 .357 .372 ,930 ,002 2,840 .176 
Huynh-Feldt 2,727 7,798 ,350 ,372 ,933 ,002 2,900 .178 
Lower-bound 2,727 2,000 1,363 ,372 ,690 ,002 ,744 ,110 
VHC o PRODUCTS o SphericityAssumed 4 ,881 4 1,220 1,331 ,256 ,003 5,325 .420 
Ira cab Greenhouse-Geisser 4,881 3.819 1,278 1.331 ,257 ,003 5,084 .409 
Huynh-Feldt 4,881 3,899 1,252 1,331 ,257 ,003 5,191 .413 
Lower-bound 4,881 1,000 4.881 1,331 ,249 ,003 1,331 ,210 
VHC o PRODUCTS o SphericityAssumed 11 ,355 8 1,41 9 1,549 ,136 ,007 12 ,389 .699 
healcla im • tracab Greenhouse-Geisser 11 ,355 7.637 1.487 1,549 ,139 ,007 11 ,828 .684 
Huynh-Feldt 11 ,355 7,798 1,456 1,549 ,138 ,007 12,076 .691 
Lower-bound 11 ,355 2,000 5,678 1,549 .214 ,007 3,097 ,329 
Error{Vl-{C*PRODUCTS) Sphericity Assumed 1635,106 1784 .917 
Greenhouse-Geisser 1635,106 1703,090 ,960 
Huynh-Feldt 1635,106 1738.890 ,940 
Lower-bound 1635,106 446,000 3,666 
Computed us mg alpha= ,05 
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Appendix 405bWithin-Subjects ANOVA-DV: Intention to recommend-
Tests of Within-Subjects Effects 
tv1eas ure· RECOtvfvlEND 
Type Ill Sum Partial Eta Noncent. Observed 
Source of Squares df fvle an Square F Sig . Squared Parameter Powera 
VHC Sphericity Assumed 600284 1 600284 200045 0000 ,043 20 0045 ,994 
Greenhouse~Geisser 600284 1,000 60,284 20,045 ,000 ,043 20.045 ,994 
Huynh-Fe ldt 60,284 1.000 60,284 20 ,045 ,000 ,043 20.045 ,994 
Lower-bound 60,284 1,000 60,284 20,045 ,000 ,043 20,045 ,994 
VHC ' healclaim Sphericity Ass umed 15,497 2 7,749 2,577 ,077 ,011 5,153 ,514 
Greenhouse-Geisser 15,497 2,000 7,7 49 2,577 ,077 ,011 5,153 ,514 
Huynh-Feldt 15,497 2.000 7,749 2.577 ,077 ,011 5,153 ,514 
Lower-bound 15,497 2,000 7,749 2,577 ,077 ,0 11 5.153 ,514 
VHC • tracab SphericityAs sumed ,012 1 .012 ,004 ,950 ,000 ,004 ,050 
Greenhouse-Geisser ,012 1,000 ,012 ,004 ,950 ,000 ,004 ,050 
Hu yn h-Feldt ,0 12 1,000 ,0 12 ,004 ,950 ,000 .004 ,050 
Lower-bound ,012 1,000 ,0 12 .004 ,950 ,000 ,004 ,050 
VH C • hea lcl a im * traca b SphericityAss umed 14,919 2 7,460 2,480 ,085 ,0 11 4 ,961 ,498 
Greenhouse-Geisser 14 ,919 2,000 7,460 2,480 ,085 ,011 4 .96 1 ,498 
Hu yn h-Feld t 14,919 2,000 7,460 2,480 ,085 ,011 4,961 ,498 
Lower-bound 14,919 2.000 7,460 2,480 ,085 ,011 4 ,961 ,498 
Error(VHC) SphericîtyAss umed 1356,318 45 1 3,007 
Greenhouse-Geisser 1356,318 45 1,000 3,007 
H uyn h-Feldt 1356,318 451,000 3,007 
Lower-bound 1356,318 451.000 3,007 
PRODUCTS SphericityAss umed 39,468 4 9,867 3 ,638 ,006 ,008 14 ,551 .880 
Greenhouse-Geisser 39,468 3,457 11,415 3,638 ,009 ,008 12,578 ,841 
Huyn h-Fe ldt 39,468 3,526 11 ,193 3,638 ,008 ,008 12,827 ,846 
Lower-bound 39,468 1.000 39.468 3,638 ,057 ,008 3,638 ,477 
PRODUCTS • healclaim SphericityAss umed 25,477 8 3,185 1,174 ,311 ,005 9.393 ,553 
Greenhouse-Geisser 25,477 6,915 3,684 1,174 ,315 ,005 8 ,119 ,509 
Hu yn h-Feld t 25,477 7,052 3,613 1,174 ,31 4 ,005 8,280 ,515 
Lower-bound 25,477 2,000 12 ,738 1,174 ,310 ,005 2.348 ,257 
PRODUCTS • tracab SphericityAssumed 13,603 4 3,401 1,254 ,286 ,003 5.015 ,396 
Greenhouse-Geisser 13,603 3,457 3,934 1,254 ,288 ,003 4,335 ,365 
Huynh-Feldt 13,603 3,526 3,858 1,254 ,288 ,003 4,421 ,369 
Lower-bound 13,603 1,000 13 ,603 1,254 ,263 ,003 1,254 .201 
PRODUCTS ' healclaim Spheric.ityAssum ed 27,873 8 3,484 1,285 ,247 ,006 10.276 .600 
• tracab Greenhouse-Geisser 27 .873 6,915 4 ,031 1,285 .255 ,006 8.882 ,553 
Huynh-Fe ld t 27,873 7,052 3,952 1,285 ,254 ,006 9,059 ,559 
Lower-bound 27 ,873 2,000 13,936 1,285 ,278 ,006 2 ,569 ,279 
Error(PRODUCTS) Sphericityf!.ssu med 4893,060 1804 2,712 
Greenhouse-Geisser 4893,060 1559,322 3,138 
Hu yn h-Feldt 4893,060 1590,258 3,077 
Lower-bound 4893,060 451,000 10,849 
VHC • PRODUCTS SphericityAss umed 12,409 4 3 ,102 2 ,015 ,090 ,004 8,060 ,607 
Greenhouse-Geisser 12,409 2,709 4,581 2 ,015 ,117 ,004 5,458 ,492 
Huynh-Fel dt 12,409 2,757 4,501 2,015 ,115 ,004 5 ,555 ,497 
Lower-bound 12,409 1,000 12,409 2,015 ,156 ,004 2 ,015 ,294 
VHC o PRODUCTS o SphericityAssu med 11,496 8 1,437 ,933 ,488 ,004 7,467 ,443 
healclaim Greenhouse-Geisser 11,496 5.417 2,122 .933 ,463 ,004 5,056 ,353 
Huynh-Fe ldt 11,496 5,514 2,085 ,933 ,465 ,004 5,146 ,357 
Lowe r-bound 11,496 2,000 5,748 ,933 ,394 ,004 1,867 ,212 
VHC o PRODUCTS o SphericityAssume d 3,422 4 ,855 ,556 ,695 ,001 2,223 ,187 
tracab Greenhouse-Geisser 3,422 2.709 1.263 ,556 ,627 ,001 1,505 ,159 
Hu yn h-Fe ldt 3,422 2,757 1,241 ,556 ,630 ,001 1,532 ,160 
Lowe r-bound 3,422 1,000 3,422 ,556 ,456 ,001 ,556 ,115 
VHC o PRODUCTS • SphericityAss umed 19,280 8 2,4 10 1,565 ,130 ,007 12,523 ,705 
healclaim • tracab Greenhouse-Geisser 19.280 5.417 3.559 1,565 ,161 ,007 8,480 ,576 
Hu yn h-Feldt 19,280 5,51 4 3,497 1,565 ,160 ,007 8,631 .582 
Lower-bound 19,280 2,000 9 ,640 1,565 ,210 ,007 3,131 ,332 
Error(VHCOPRODUCTS) SphericityAss umed 2777,400 1804 1,540 
Greenhouse-Geisser 2777 ,400 1221,579 2,274 
Hu~h-Feld t 2777,400 1243,297 2,234 
Lower-b ound 2777,400 451,000 6 ,158 
Com puted us mg alpha - ,05 
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Appendix 4.5cWithin-Subjects ANOVA-DV: Intention to serve-
Tests of Within·Subjects Effects 
fv1e asure· SERVE 
Type JJI Sum Partial Eta Noncenl Observed 
Source of Squares dl Mean Square F Sig. Squared Parameter Powera 
VHC Sphericity Ass umed 149 ,515 1 149 ,51 5 56,640 ,000 ,117 56,640 1,000 
Greenhouse-Geisser 149,51 5 1,000 149,515 56,640 ,000 ,117 56,640 1,000 
H uyr~ h·Fe ld t 149,515 1,000 149,5 15 56,640 ,000 ,117 56.640 1,000 
Lower-bound 149,515 1,000 149,51 5 56,640 ,000 ,117 56,640 1,000 
Vl-IC • hea!claim SphericityAssumed 2,082 2 1,041 ,394 ,674 ,002 ,789 ,114 
Greenhouse-Geisser 2,082 2,000 1,041 ,394 ,674 ,002 ,789 ,114 
Huynh·Feldt 2,082 2,000 1,04 1 ,394 ,674 ,002 .789 ,114 
Lower-bound 2,082 2,000 1,04 1 ,394 ,67 4 ,002 ,789 ,114 
VI-tC • tracab Sphericity Ass umed 2,871 1 2,871 1,087 ,298 ,003 1,087 ,180 
Greenhouse-Geisser 2,871 1,000 2,87 1 1,087 ,298 ,003 1,087 ,180 
Huynh-Feldt 2,871 1,000 2,871 1,087 .298 .003 1.087 ,180 
Lower-bound 2,871 1,000 2,87 1 1,087 ,298 ,003 1.087 ,180 
VHC k healcla im k tracab SphericityAss um ed 3,302 2 1,651 ,625 ,535 ,003 1,251 ,155 
Greenhouse-Geisser 3,302 2,000 1.651 ,625 ,535 ,003 1,251 ,155 
Huynh-Feldt 3,302 2.000 1.651 ,625 ,535 ,003 1.251 ,155 
Lower-bou nd 3,302 2.000 1,651 ,625 ,535 ,003 1,251 ,155 
Error(VI-t C) Sphericity Assumed 1129,806 428 2,640 
Greenhouse-Geisser 1129,806 428,000 2,640 
Huynh-Feldt 1129,806 428,000 2 ,640 
Lower-bound 1129,806 428,000 2,640 
PRODUCTS Sphericîty Pss um ed 48 ,525 4 12,13 1 5,717 ,000 ,013 22 ,868 ,982 
Greenhouse-Geisser 48,525 3.626 13 ,384 5,7 17 ,000 ,013 20,728 ,973 
Hu~h-Feldt 48,525 3.703 13,104 5 ,717 ,000 ,013 21 ,171 ,975 
Lower-bound 48,525 1.000 48 ,525 5,717 ,017 ,013 5,717 ,665 
PRODUCTS • healcl aim Sphericity Pss umed 18,108 8 2.264 1,067 ,384 ,005 8.534 ,505 
Greenhouse-Geisser 18 ,108 7,251 2,497 1,067 ,383 ,005 7,735 ,477 
Hu~h -Fel d t 18,108 7,406 2 ,445 1,067 ,383 ,005 7,900 ,483 
Lower-bound 18,108 2,000 9,054 1,067 ,345 ,005 2 ,133 ,237 
PRODUCTS * tracab Sphericity Assumed 22,050 4 5,512 2,598 ,Q35 ,006 10,391 .733 
Greenhouse-Geisser 22,050 3,626 6,082 2,598 ,040 ,006 9.4 19 ,70 1 
Hu~h-Fe ldt 22,050 3,703 5,954 2,598 ,039 ,006 9,620 ,708 
Lower-bound 22 ,050 1,000 22,050 2.598 ,108 ,006 2,598 ,363 
PRODUCTS • healclaim Sphericity Assu med 25,766 8 3,221 1,518 ,146 ,007 12.143 .689 
* tracab Greenhouse-Geisser 25,766 7,251 3,553 1,518 ,154 ,007 11,006 ,655 
Hu~h-Feldt 25,766 7,406 3.479 1,518 ,152 ,007 11,241 ,663 
Lower-bound 25 ,766 2.000 12,883 1,518 ,220 ,007 3,036 ,323 
Error(PRODUCTS) SphericityAss umed 3632,794 1712 2.122 
Greenhouse-Geisser 3632,794 1551,751 2 ,341 
Hu~h-Fe ldt 3632 ,794 1584,930 2,292 
Lower-bound 3632 ,794 428,000 8.488 
\IHC • PRODUCTS Sphericity Assumed 3 ,0 10 4 ,753 ,907 .459 ,002 3 ,628 .291 
Greenhouse-Geisser 3,010 3,624 ,831 .907 .451 ,002 3,288 .276 
Hu~h-Fe ld t 3,01 0 3.702 ,813 ,907 ,453 ,002 3.358 ,279 
Lower-bound 3,0 10 1,000 3,0 10 ,907 ,341 ,002 ,907 ,158 
VHC • PRODUCTS • Sphericily Ass umed 6,350 8 ,794 ,957 ,468 ,004 7 ,654 ,454 
healclaim Greenhouse-Geisser 6,350 7.249 ,876 ,957 ,463 ,004 6.935 .429 
Hu~h-Feldt 6,350 7.404 ,858 ,957 ,464 ,004 7,083 ,434 
Lower-bound 6,350 2,000 3,175 ,957 ,385 ,004 1,913 ,216 
VHC • PRODUCTS • Sphericity Ass umed 5,794 4 1,448 1,746 ,137 ,004 6,983 ,538 
tracab Greenhouse-Geisser 5,794 3,624 1,599 1.746 ,1 44 ,004 6,328 ,509 
Hu~h-Fel dt 5,794 3,702 1,565 1,746 ,143 ,00 4 6,463 ,515 
Lower-bound 5,794 1,000 5,794 1.746 ,187 ,004 1,746 ,26 1 
VHC • PRODUCTS • SphericilyAss umed 8,369 8 1,046 1,261 ,260 ,006 10,087 ,590 
healclaim • tracab Gre enhouse-Geisser 8,369 7,249 1,155 1,261 ,265 ,006 9,140 ,558 
Hu~h-Fe ldt 8,369 7,404 1,130 1.261 ,264 ,006 9,335 .565 
Lower-bound 8,369 2,000 4 ,184 1,261 .284 ,006 2,522 ,274 
Error(\IHC• PROD U CTS) SphericityfJ.ss umed 1420,361 1712 ,830 
Greenhouse-Geisser 1420,361 155 1,204 ,916 
Huynh-Feldt 1420,361 1584.366 ,896 
Lower-bound 1420,361 428,000 3,3 19 
Computed us mg alpha:: ,05 
CONCLUSION 
Cette thèse a été principalement motivée par la volonté de contribuer à la littérature 
en marketing qui manifestement présente une limite théorique et méthodologique 
(Gummesson, Kuusela et Narvanen, 2014; Logman, 2007, 2008, 2011) , d' une part, et 
par les besoins exprimés par les experts dans l' industrie des aliments santé quant aux 
décisions à prendre dans une industrie en évolution, dynamique, caractérisée par la 
complexité et l'incertitude, d'autre part. 
Pour ce faire, le nouveau paradigme de la théorie marketing qui met l'accent sur la 
complexité, l'incertitude, la dynamique et les parties prenantes et par conséquent, qui 
fournit une vision plus systémique et holistique (Gummesson, Kuusela et Narvanen, 
2014) a été adopté dans cette thèse par articles. 
Dans le premier article une étude exploratoire prospective a permis de développer un 
cadre conceptuel partagé qui permet d'identifier et de prioriser des interventions à 
entreprendre visant 1' amélioration de la distribution des aliments santé. En utilisant la 
méthode de cartographie des concepts en groupe (Kane et Trochim, 2007), qui permet 
d'étudier la complexité (Trochim et Cabrera, 2005) , cette étude a été menée auprès de 
21 participants représentant diverses parties prenantes de l 'industrie des aliments 
santé au Québec (Canada) (fabricants d' ingrédients , fabricants et transformateurs , 
experts et chercheurs en développement de la technologie, en sciences de la 
consommation, en distribution et marketing alimentaire et représentants du 
gouvernement) . Les résultats de cette étude intègrent des interventions contextuelles 
et non seulement des interventions liées au couple produit/marché. En effet, les 
interventions à entreprendre visant 1' amélioration de la distribution des aliments santé 
touchent divers aspects à savoir: 1) Information et communication avec les 
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consommateurs; (2) Innovation contextualisée avec le marché; (3) Gestion des 
relations avec les détaillants; ( 4) Communication avec les professionnels de la santé 
et possibilités réglementaires; (5) Réseautage et support institutionnel et (6) Stratégies 
marketing. En plus de l'identification d'initiatives ayant pour but d'améliorer la 
distribution des aliments santé, ce cadre conceptuel a aussi permis de prioriser ces 
interventions selon leurs importance et leurs faisabilité. 
Toutefois, malgré que ce cadre conceptuel émergeant illustre la représentation des 
participants, il présente quelques limites. Tout d'abord, l'élaboration de ce cadre a été 
limitée à la ville de Québec et à sa région. Ensuite, l'utilisation de la cartographie des 
concepts en groupe dans cette étude s'est limitée à générer un cadre conceptuel 
émergent permettant d'identifier et de prioriser des interventions visant 1' amélioration 
de la distribution des aliments santé. Selon Rosas et Camphausen (2007) , la 
cartographie des concepts en groupe peut également être utilisée pour développer et 
valider des échelles de mesures. ll serait donc intéressant d' utiliser les groupements et 
les énoncés qui ont été générés dans le cadre de cette étude pour élaborer et tester les 
qualités psychométriques d'une échelle d' amélioration de la distribution des aliments 
santé. Finalement, le cadre conceptuel émergeant dans cette étude ne permet pas de 
comprendre les relations causales entre elles dans le cadre des analyses présentées. 
Partant de cette dernière limite, une étude qualitative a été menée dans le deuxième 
article de cette thèse dans le but de fournir une compréhension de la dynamique entre 
ces interventions qui visent l'amélioration de la distribution des aliments santé. 
Ainsi, dans l'article 2 de cette thèse, l'approche qualitative de la dynamique des 
systèmes (DS) a été utilisée. Suite à des entrevues individuelles non structurées avec 
des experts en aliments santé et à partir d'un groupe de discussion menée avec 18 
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participants 109, un diagramme d ' influence (DI) a été construit pour analyser les 
relations causales entre les interventions à entreprendre visant 1' amélioration de la 
distribution des aliments santé. L'analyse a été réalisée en employant la méthode 
inductive du diagramme des systèmes (inductive system diagram method) de Burchill 
et Fine (1993, 1997) qui jumelle les aspects de la théorie enracinée de Glasser et 
Strauss (1967) , Glaser (1978) et Strauss (1987) et de la DS (Goodman, 1974; 
Randers, 1980). Les résultats montrent que l'amélioration de la distribution des 
aliments santé dépend de l'interaction entre des interventions liées à la 
communication, à la réglementation , au consommateur et à la science. Encore une 
fois , les résultats confirment et approfondissent la compréhension de 1' interaction des 
enjeux réglementaires, commerciaux et scientifiques dans 1' amélioration de la 
distribution des aliments santé tel que énoncé durant les entrevues individuelles non 
structurées avec des experts en aliments santé et lors des séances de groupe de 
discussion auprès des participants représentant diverses parties prenantes de 
l'industrie des aliments santé au Québec (Canada). Toutefois, il est important de noter 
que le DI de cette étude permet seulement une compréhension statique de la 
complexité des interrelations entre les interventions visant l ' amélioration de la 
distribution des aliments santé. En effet, il serait pertinent de mener une étude 
utilisant l 'approche quantitative de la DS pour élaborer des modèles de simulation 
(modèle niveau-taux). 
Finalement, l 'article 3 de la présente thèse, porte sur les intentions de comportement 
des consommateurs à l'égard d' une catégorie des aliments santé à savoir les aliments 
enrichis d'acides gars oméga-3. Se basant sur certaines interventions visant 
1' amélioration des aliments santé, identifiées dans 1' article 1, cet article s' intéresse aux 
effets de la traçabilité, des allégations santé et de la vérification des allégations santé 
sur les intentions des consommateurs d'acheter, de recommander et de servir des 
109 Fabricants d'ingrédients, fabricants et transformateurs, experts et chercheurs en développement de la 
technologie, sciences de la consommation, di stributi on et marketing alimentaire et représentants du gouvernement. 
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aliments enrichis d'acides gras oméga-3. Pour cela, un design expérimental a été 
élaboré pour tester les effets principaux et d'interaction de la traçabilité, des 
allégations santé et la vérification des allégations santé sur les intentions de 
comportement des consommateurs. Ce design consiste en une analyse de variance 
mixte de type inter et intra-sujets. La traçabilité (complètement traçable-pas traçable) 
et les allégations santé (allégation fonctionnelle, allégation de réduction de risque de 
maladie et allégation de prévention de maladie) constituent les deux facteurs inter-
sujets (between-sujects factors). Quant aux facteurs intra-sujets (within-subjects 
factors), ils concernent la vérification des allégations santé (Santé Canada, une agence 
gouvernementale fédérale et la Fondation des maladies du cœur, une organisation non 
gouvernementale) et les catégories de produits enrichis d'acides gras oméga-3 
(viandes, œufs, produit céréalier, produit laitier et fruits ou légumes transformés). 
Ainsi, un questionnaire comportant six versions a été administré à six groupes de 
répondants (n = 463) à Montréal et à Ottawa. Les résultats montrent que les 
consommateurs ont des intentions de comportement plus élevées à l'égard des 
aliments enrichis d'acides gras oméga-3 qui sont traçables . De plus, les 
consommateurs ont des intentions de comportement plus élevées à 1' égard des 
aliments enrichis d'acides gras oméga-3 dont les allégations santé sont vérifiées par le 
gouvernement (Santé Canada). Par ailleurs, les consommateurs éprouvent de faibles 
intentions de comportement à l'égard des fruits et légumes transformés et des viandes 
enrichis d'acides gras oméga-3. li ressort également que les consommateurs sont plus 
enclins à recommander aux autres des aliments enrichis d'acides gras oméga-3 
lorsqu'ils comportent des allégations santé fonctionnelles et de réduction de risque 
vérifiées par le gouvernement. Finalement, les consommateurs sont plus susceptibles 
recommander les aliments enrichis d'acides gras oméga-3 lorsque ces derniers sont 
étiquetés avec une allégation santé fonctionnelle vérifiée par le gouvernement et 
qu'ils sont complètement traçables. 
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Par ailleurs, 1' étude menée dans l'article 3 de cette thèse présente certaines limites. 
Premièrement, seulement la traçabilité, les allégations santé et la vérification des 
allégations santé ont été incorporés dans l'étude alors que d'autres attributs comme le 
prix et la marque peuvent également affecter le processus de prise de décision des 
consommateurs (Bredahl, 2004). Deuxièmement, cette étude s'est limitée à un 
échantillon d'étudiants. En effet, il serait intéressant de mener une autre étude avec un 
échantillon hétérogène incluant des répondants ayant divers profils 
sociodémographiques. Troisièmement, cette étude utilise les données auto-rapportées. 
Ainsi, des études futures devraient utiliser l'expérimentation dans des contextes 
d'achat réels. Finalement, le design expérimental de cette étude ne comporte pas de 
variables modératrices comme les traits de personnalité. Étant donné, leur importance 
dans la formation des attitudes et les intentions de comportement (Dabholkar et 
Bagozzi, 2002), il serait pertinent de refaire cette étude en incorporant par exemple 
des traits de personnalité comme le 'Health consciousness ' . En effet, il a été démontré 
que ce trait de personnalité prédit l'attitude et les intentions d' achat des 
consommateurs à l'égard des aliments fonctionnels (Landstrom et al., 2007; Naylor, 
Droms et Haws, 2009). 
Les contributions de cette thèse se situent aux niveaux théorique, méthodologique et 
pratique. Au niveau théorique, cette thèse permet d'enrichir la littérature marketing 
qui selon Gummesson, Kuusela et Narvanen (2014) ne tient pas compte de la 
complexité, de l'incert~tude et de la dynamique du marché et par conséquent, est 
souvent dépourvue de vision systémique et balistique. De manière générale, cette 
thèse a contribué d'une façon significative à l'avancement des connaissances sur la 
distribution et le comportement du consommateur et a produit des nouvelles 
connaissances. 
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Au niveau méthodologique, la contribution de cette thèse réside dans l'utilisation de 
méthodes peu utilisées en marketing comme la cartographie des concepts en groupe 
(Bigné et al. , 2002) dans l'article 1 et laDS (Richardson et Otto, 2008) dans l'article 
2. Toutefois, l'application de ces méthodes dans cette thèse a prouvé qu'elles sont 
pertinentes car elles permettent de saisir et de tenir compte de la complexité et de 
l'incertitude de l'industrie des aliments santé ; donc, pouvant plus largement être 
associées à des objets d'études en marketing. 
Au mveau managérial, cette thèse permet d' aider les gestionnaires dans leur 
processus de prise de décisions relativement à la distribution des aliments santé et 
également au niveau du comportement du consommateur à l 'égard de ces produits . 
De plus, les résultats de cette thèse permettent aux gestionnaires d' aligner leurs 
actions avec une vision organisationnelle plus large et holistique incluant des 
variables contextuelles pertinentes et essentielles à leurs prises de décisions , et ce, 
tout en tenant compte de la complexité et du dynamisme de leur industrie et de 
l'incertitude de 1' environnement de leurs entreprises. 
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